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Abstract 
Estrogens estrone (E1), 17β-Estradiol (E2), and estriol (E3) are steroidal 
hormones produced naturally, and the synthetic estrogen 17α-Ethinylestradiol 
(EE2) is contained in the contraceptive pill. In 2012, the European Commission 
proposed international environmental limits in freshwater bodies on EE2 and E2, 
with Environmental Quality Standard (EQS) values of 0.035 and 0.4 ng/L, 
respectively. Despite their low concentrations (ng/L) in the environment, several 
studies demonstrated their harmful effect to aquatic organisms. Some bacteria 
have been identified to biodegrade estrogen with varied efficiency. Biodegradation 
is a low cost and sustainable method that could help in the removal of estrogens. 
This study aims to provide the framework with which to elucidate, identify and 
characterise those genes involved in estrogen degradation by a genomic 
evaluation of steroid degrading bacteria. Firstly, a putative estrogen 
biodegradation pathway was postulated, and a database of the major genes 
potentially involved in it was compiled, by combining existing information on the 
degradation of estrogen, and its better characterised analogue – testosterone, for 
which there is a complete degradation pathway.  
The genome of Rhodococcus equi ATCC13557, a known estrogen degrading 
bacterium, was sequenced, assembled and mapped. Genome analysis revealed a 
gene cluster potentially coding for enzymes involved in estrogen degradation; 3-
carboxyethylcatechol 2,3-dioxygenase, 2-hydroxymuconic semialdehyde 
hydrolase, 3-alpha-(or 20-beta)-hydroxysteroid dehydrogenase, 3-(3-hydroxy-
phenyl)propionate hydroxylase, 3-oxosteroid 1-dehydrogenase and transcriptional 
regulator IcIR family. Specific primer sets were developed to target these genes, 
and using quantitative reverse transcription PCR (RT-qPCR), gene expression 
when exposed to E2 and EE2, was quantified relative to the control, without 
estrogen, and normalised to the reference genes, malate dehydrogenase and 
arginine deiminase. Gene expression of putative cytochrome P450 
monooxygenase was upregulated initially in the presence of estrogen, therefore 
may be involved in one of the first steps in estrogen degradation. The RT-qPCR 
experiment was complemented by biodegradation studies, however, metabolites 
analysis is required to confirm the postulated estrogen biodegradation pathway. 
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Chapter 1:  General Introduction 
1.1 What is estrogen? 
Since the 1990’s there have been increasing concerns about the concentrations of 
the endocrine disrupting (ED) steroidal estrogens (Fig. 1- 1), estrone (E1) 
C18H22O2, 17β-estradiol (E2) C18H24O2, estriol (E3) C18H24O3, and 17α-
ethinylestradiol (EE2) C20H24O2, in the aquatic environment and their effects upon 
aquatic organisms (Sumpter and Jobling, 1995). The estrogens E1, E2 and E3 are 
naturally occurring steroid hormones derived from cholesterol and released from 
the ovaries, adrenal cortex, testes, adipose tissue, other non-reproductive tissues 
and the placenta in humans (Simpson et al., 1994; Cui et al., 2013; Hanukoglu, 
1992; Nelson and Bulun, 2001; Simoni et al., 2002; Shutt et al., 1974). E1 is 
mainly produced in the adipose tissue derived from the androstenedione 
substrate. E3 is mainly produced in the placenta derived from 16α-
hydroxydehydroisoandrosterone sulfate. E2 is mainly produced in the ovaries 
derived from cholesterol (Simpson et al., 1994; Cui et al., 2013). Although E2 is 
often considered a female hormone, it may have important reproductive functions 
in males (Schulster et al., 2016). Furthermore, the biosynthesis of estrogens is 
also present in animals including mammals (Andaluri et al., 2012; Ray et al., 
2013). However, EE2 is a synthetic derivative of E2 used pharmaceutically as birth 
control (Fig. 1- 1). 
The estrogens E1, E2, E3 and EE2 are one of the five major classes of steroid 
hormones derived from cholesterol, therefore they share a similar structure 
consisting of a phenolic ring (A ring), two cyclohexane ring (B and C rings) and a 
cyclo-pentane ring (D ring) (Fig. 1- 1) (Adeel et al., 2017). Whereas, the A ring in 
progesterone, testosterone, cortisol and aldosterone contain a C-3 ketone, a Δ4 
bond and a C-19 methyl group (Baker, 2013; Berg et al., 2002). The main 
differences between the different estrogens are within the D ring: where E1 has a 
carbonyl group on C17; E2 has a hydroxyl group on C17; E3 has two alcohol 
groups on the C16 and C17; and EE2 has ethinyl groups on the C17α position 
(Fig. 1-1) (Adeel et al., 2017). 
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Figure 1-1: The chemical structures of E1 (top left), E2 (top right), E3 (bottom left), and 
EE2 (bottom right) produced using ChemDrawUltra. The rings beginning from the left of 
each structure are the aromatic A ring, B ring, C ring and the D ring.  
 
In metabolism of estrogen within the body, the cytochrome P450 enzyme 
hydroxylates the ‘A’ ring and leads to its aromatisation (Thomas and Potter, 2013; 
Xu et al., 2005; Simpson, 1994). Cytochrome P450 catalyses the conversion of 
androgens into estrogens such as the aromatisation of testosterone to E2 
(Thomas and Potter 2013). The 17β-hydroxysteriod dehydrogenase type 1 
converts E1 to E2, and type 2 converts E2 to E1 (Thomas and Potter, 2013; Xu et 
al., 2005). Furthermore E1 is aromatised by cytochrome P450 and converted to 
16α-Hydroxyestrone, which is reversibly converted into E3 by 17β-hydroxysteriod 
dehydrogenase. Thus E3 is a metabolite of E1 (Thomas and Potter, 2013, Xu et 
al., 2005; Simpson, 1994). Following hydroxylation, the subsequent eliminations of 
estrogen from the body are through sulfonation, glucuronation or methylation 
(Thomas and Potter, 2013; Xu et al., 2005; Wang et al., 2004; Helton et al., 1977).     
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1.2 Pharmaceutical usage of estrogen 
EE2 is used in birth control such as the combined oral contraceptive pill (COCP), 
combined injectable contraceptives (CIC), contraceptive patches and rings. It is 
also used in hormone replacement therapy (HRT). HRT was first used in the 
1950’s; however in 2002 it was concluded in the Woman’s Health Institute (WHI) 
that the usage of HRT could lead to complications such as blood clots, stroke and 
breast cancer (Manson et al., 2013). Therefore, although there is still some usage 
of HRT, the usage of HRT declined from 2002 to 2010 by 50-77% and usage 
down to lower than 10% in some European countries (Ameye et al., 2014). In 
contrast the usage of the COCP has increased globally, especially in Asia and 
Latin America since its approval by the US Food and Drug Administration (FDA) 
for usage as a contraceptive in 1960 and in 1961 by the House of Commons in the 
United Kingdom (UK) (World Health Oragnisation, 2017). According to the World 
Health Organisation (WHO), the global usage of modern contraceptives, including 
hormonal contraceptives, was 54% in 1990 and 57.4% in 2015. This included 
Africa, Asia and America and the Caribbean with usage of 28.5%, 61.8% and 
66.7% in 2015 respectively (World Health Organisation, 2017). Furthermore, there 
has been increase in the uptake of hormonal contraceptives within the UK with an 
increase of 5.3% between 2002 and 2011 with the COC being the most commonly 
prescribed (Rashed et al., 2015). In 2007 it was reported by the United Nations 
that there are over 100 million users of the COC, mainly within Western Europe, 
the United States of America (USA) and Northern Europe and there are 
approximately 80% of permanent users in the USA (United Nations, 2007; 
Brynhildsen, 2014; Guttmacher Institute, 2013). In 2015/16 the usage of COC was 
the most common method for 45% of women and COC accounted for 5.9% of 
freely dispensed prescriptions in 2015 (NHS, 2016; Prescribing and Medicines 
Team Health and Social Care Information Centre, 2016).  
 
 
 
 
P a g e  | 4 
1.3 The concentration of estrogen detected in the aquatic environment 
Endocrine disrupting steroidal estrogens, E1, E2, E3 and EE2, have been 
detected in the environment worldwide and at various concentrations within 
surface water (Table 1- 1) adapted from (Hassani et al., 2016; Wise et al., 2011; 
Rao et al., 2013; Zhang et al., 2014). 
 
Table 1-1:  Concentrations of estrogens detected within surface water. 
Country Sampling 
area 
Concentration (ng/L) Reference 
E1 E2 E3 EE2 
China Jiulongjiang 
river 
<LOD-
11.23 
<LOD-
52.71 
<LOD-
47.85 
ND Yuan et al., 
2014 
UK Rivers Arun 
and Ouse 
2.9-4.6 0.6 - - Peck et al., 
2004 
The 
Netherlands 
Dutch surface 
water 
0.3-7.2 0.8-1.0 - 0.3-0.4 Vethaak et al., 
2005 
Belgium Scheldt estuary 0.37-10 ND - ND Noppe et al., 
2007 
Germany Rhine Agger 
river 
1.3-9.2 - - 0.3-1.0 Hintemann et 
al., 2006 
China Dagu river 5.0-55.3 0.9-33.4 2.3-46.4 <LOD-
35.6 
Lei et al., 2009 
China Rivers in 
Tianjin 
0.64-
50.7 
<LOD-
31.4 
<LOD-
37.2 
<LOD-
24.4 
Rao et al., 2013 
Taiwan Dan-Shui river 22-66.2 1.4-33.9 12-73.6 7.5-27.4 Zhang et al., 
2014 
China Lake Taihu <LOD-
15.8 
<LOD-
10.8 
- <LOD-
16.4 
Lu et al., 2011 
France Jalle d’Eysines 17.2-
71.4 
<0.1-4.4 <0.1-2.9 ND Labadie and 
Budzinski, 2005 
Austria >400 samples 
from Austria 
<LOD-
4.6 
<LOD-
1.2 
<LOD-
1.9 
<LOD-
0.33 
Hohenblum et 
al., 2004 
Japan Tama River, 
Tokyo 
8.7-19.7 ND - 0.1-5.1 Kawaguchi et 
al., 2004 
China The Pearl River 
Delta 
1.5-11.5 - - - Peng et al., 
2008 
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China The Yangtze 
River, Nanjing 
0.8-1.25 0.8-0.97 5.79 - Lu et al., 2010 
China Yangtze River 0.9-2.98 0.26-1.8 <LOD-
4.37 
<LOD-
2.67 
Jiang et al., 
2012 
China Jiangsu - 5.5-15.5 ND 5.7-30.8 Shen et al., 
2001 
China Shandong 14-180 <LOD-
134 
4-94 7-24 Zhou et al., 
2011 
China Beijing <LOD-
2.3 
- <LOD-
13.9 
5.0-
127.9 
Sun et al., 2009 
China Beijing 1.1 0.2 ND ND Hu et al., 2005 
China The Pearl 
Rivers 
<LOD-
75.0 
<LOD-
7.5 
- - Zhao et al., 
2009 
China Lioaning <LOD-
55.8 
<LOD-
7.4 
- ND Wang et al., 
2011 
China Taiwan 22.4-
66.2 
1.4-33.9 12.4-
73.6 
7.53-
27.4 
Chen et al., 
2007 
Iran Karun river - 13.66 - - Hassani et al., 
2016 
The 
Netherlands 
Coastal 
estuarine and 
freshwater 
0.1-3.4 0.3-5.5 - 0.1-4.3 Belfroid et al., 
1999 
Germany River Danube <0.1-4.1 <0.15-
3.6 
- <0.1-5.1 Kuch and 
Ballschmitter, 
2000 
Germany 3 rivers 0.7-1.6 ND - ND Ternes et al., 
1999 
Canada Thames river 16-49 6-14 - - Lishman et al., 
2006 
Portugal Aveiro district - 85 - - Silva et al., 
2013 
USA 19 surface 
waters 
0.3 17 - 1.4 Benotti et al., 
2009 
China Rivers 
surrounding 
Dianchi Lake 
2-305.8 1.9-58.5 <LOD-
61.5 
<LOD-
206.5 
Huang et al., 
2013 
ND- Not detected or below the limit of detection (<LOD). (-) Some studies did not measure the 
concentrations of all the 4 estrogens so the values were not available. 
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However, the concentrations of estrogens in rivers and surface waters are affected 
by the sources of estrogen located nearby such as hospitals, population sizes, 
farming, wastewater treatment plant (WwTP) effluents, and temperature (Hassani 
et al., 2016). 
Furthermore, estrogens have also been detected in the influent and effluent at 
WwTP, where the effluents are released into rivers (Table 1- 2)  
 
Table 1-2: Example concentrations of estrogens detected in WwTP influent and effluent 
Compound Influent concentrations 
from WwTP (Hamid and 
Eskicioglu, 2012; Huang 
et al., 2013). 
Effluent concentrations in 
WwTP (Hamid and 
Eskicioglu, 2012; Huang et 
al., 2013). 
Lower 
(ng/L) 
Higher (ng/L) Lower 
(ng/L) 
Higher (ng/L) 
Estrone (E1) 2.4 670.0 <0.3 96.0 
17β-estradiol 
(E2) 
2.4 150.0 0.2 30.0 
Estriol (E3) 23.0 660.0 <0.5 275 
17α-
Ethinylestradiol 
(EE2) 
<0.3 70.0 <0.3 26 
 
In addition to detection within surface waters, estrogens have been detected in 
river sediments. In a study of Rivers Ouse and Arun in the UK, the concentrations 
of E1 and E2 were higher within the sediment than in the surface water, with 
concentrations of 24.9-52.5 ng/kg dry weight (dw) and 6.3- 14.6 ng/kg dw, 
respectively (Peck et al., 2004). Also the estrogenicity of the sediment was 532- to 
748- fold higher than in the surface water (Peck et al., 2004). Therefore estrogens 
adsorb to the suspended and bed sediments within rivers due to the partition 
coefficient octanol-water (log Kow) values of 3.1-3.4 and 3.8-4.0 for E1 and E2 
respectively (Peck et al., 2004; Ternes et al., 1999; Lai et al., 2000). Furthermore 
higher concentrations of <40-355 ng/kg dw for E1 were detected in rivers Lea and 
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Nene in the UK, although E2 and EE2 were below the LOD (<100 ng/kg dw) 
(Williams et al., 2003).  
Furthermore estrogens have been detected within soil due to run-off or usage in 
agriculture with amendment of soil by use of broiler litter, leading to estrogenicity 
up to 675 ng/kg dw as E2 equivalent and 50-2300 ng/kg dw as E2 equivalent due 
to surface run-off (Finlay-Moore et al., 2000). 
 
1.4 The sources of estrogen in the environment 
The concentrations of estrogen detected in the environment can vary dependent 
upon the location of the sampling. For example, if it is near a city or rural location 
and the number of WwTP leading into the rivers. Therefore it is important to 
consider the different sources of estrogen which may lead to increased levels of 
estrogen within the environment.  
One of the larger sources of estrogens in WwTP has been attributed to the 
estrogenicity of the natural estrogens being excreted in urine and faeces, with 
excretion rates of estrogen equivalent for the natural estrogens E1, E2 and E3 
accounting for 66-82% (Liu et al., 2009). The excretion rates of estrogen were the 
highest in pregnant women of 4336.8 µgE2/d, followed by premenopausal women, 
postmenopausal women and the lowest in men of 9.937, 4.38, and 3.103 µgE2/d, 
respectively (Liu at al., 2009). Although, according to total population figures of 
2001, the excretion of synthetic EE2 as a fraction of total estrogens is likely to be 
less than 1% in the US. The main contributor of EE2 to the influent at WwTP is 
excretion, as 60% of ingested EE2 is excreted (Wise et al., 2011; Johnson et al., 
2004). Furthermore, 0.21 ng/L of E1 was detected within river water where the 
source of estrogen was attributed to a few scattered dwellings, although this was 
lower in concentration than the rivers upstream and downstream of WwTP (Long 
et al., 2014). 
Estrogens have been detected in the effluent and WwTP influent from a hospital in 
2007 with 9628 patients. The concentrations of estrogen were measured up to 
31.3 ng/L, 4.2 ng/L and 385.5 ng/L for E1, E2 and E3 respectively, but due to the 
high dilution of hospital effluent the impact upon the WwTP influent was 
P a g e  | 8 
considered negligible (Avberšek et al., 2011). Another study also found that there 
was no significant difference between the hospital effluent and the WwTP influent. 
However E2 was only detected once, whereas E1 and EE2 were detected in all of 
the samples, with concentrations ranging up to 58.3, 16.9 and 18.3 ng/L in the 
influent (Pauwels et al., 2008). The average concentrations of E2 detected in the 
hospital effluent of two hospitals in Iranian cities were much higher, with 
concentrations of 93.53 and 83.22 ng/L (Hassani et al.,2016). Furthermore, for 
hospital effluent it is not possible to attribute all the estrogen in the effluent to 
human excretion as there may be other sources in a hospital such as the disposal 
of pharmaceutical wastes and drugs (Avberšek et al., 2011; Pauwels et al., 2008; 
Hassani et al., 2016). 
Discharge of estrogens in the effluent from pathology laboratories in the 
pharmaceutical industry were suggested to be the source of increased E2 
concentrations in urban wastewater of 31.3-69.4 ng/L (Hassani et al., 2016).  
Industrial landfill leachate E2 and EE2 along with bisphenol A were suggested to 
be the major contributors to invitro estrogenicity with concentrations of 2.8 and 17 
ng/L (Svenson et al., 2009). 
Additionally, agricultural livestock excrete the natural estrogens E1, E2 and E3. 
The concentrations of estrogen are higher in some cases than for human 
excretion, with the concentration of E2 being 30-2500ng/L in animals and 0.5-125 
ng/L (Wise et al., 2011; Combalbert et al., 2010). The excretion of all natural 
estrogens by livestock can range from 14-360 µg/d in faeces, 2.5-2000 µg/d in 
urine and 0.07-990 µg/d in total. The largest amount is excreted by larger animals 
such as cows, compared to chickens, and is higher when the animals are 
pregnant (Combalbert et al., 2010). The runoff and effluents from the livestock can 
enter the environment through leaching into the soil, and livestock have more than 
twice the rate of human discharge in the US and Europe at 83000 kg/yr (Kjær et 
al., 2007; Wise et al., 2011). Furthermore, in solid sludge, which can be used in 
agriculture as a fertiliser and conditioner of soil, there are lower concentrations; 
LOD - 63, 22, 13, and 18 µg/kg dry weight for E1, E2, E3, and EE2, respectively 
(Andersen et al. 2003; Braga et al. 2005; Fernandez et al. 2009; Gabet-Giraud et 
al. 2010; Muller et al. 2008; Ternes et al. 2002; Combalbert and Hernandez-
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Raquet, 2010). However, there are also higher concentrations of 50–200 µg/kg dw 
for E1, 272–406 µg/kg dw for E3 and 0.64–7 µg/kg dw for sulfate-conjugated 
forms of E2 and E1 (Nieto et al., 2008). Therefore sludge usage in agriculture is 
another potential source of estrogen in the environment. 
Thus the sources of estrogens include excretion and disposal by humans, 
agriculture and the pharmaceutical industry. 
 
1.5 The environmental fate of estrogens in the environment and their 
effects 
Estrogens E1, E2, E3 and EE2 have been detected at ng/L concentrations within 
the environment (Table 1- 1). There are a number of studies into the persistence 
of E1, E2, E3 and EE2 within the environment, in which the half-lives have been 
found to be 0-1.1 days for E2 (Lee et al., 2003), 2.8-4.9 days for E1 (Lucas and 
Jones, 2006), 0.7-1.7 days for E3 (Carr et al., 2011) and 4-6 days for EE2 (Yin et 
al., 2002). However, there are different half-lives reported under different 
conditions, such as EE2 having a half-life of 36 hours within natural water in the 
laboratory (Zheng et al., 2011). Furthermore under anaerobic conditions the half-
lives are much longer, for example E2 had a half-life of 24 days in soil and little or 
no degradation of other estrogens was observed (Ying and Kookana, 2005). In 
rivers the biodegradation rates may depend upon the seasons and the position of 
the contamination within the river, as the degradation of downstream summer 
samples was fastest due to factors affecting the microbiological community 
(Jȕrgens et al., 2002). Furthermore aerobic degradation of EE2 was much slower 
with a half-life of 17 days, compared to E2 with a half-life of 1.2 days (Jȕrgens et 
al., 2002). Generally the half-life of EE2 is the longest and therefore suggests the 
most persistence of the estrogens, and if compared to the half-life of another 
steroid hormone testosterone of 0.08-0.8 days (Lee et al., 2003), there is a greater 
persistence of estrogens. Therefore the risks associated with the presence of 
estrogens within the environment need to be considered, as some concentrations 
of estrogens detected in the environment (Table 1- 1) are above the predicted-no-
effect concentrations (PNECs) for estrogens for long-term exposure in surface 
water (>60 days); 6, 2, 60 and 0.1 ng/L for E1, E2, E3 and EE2 respectively 
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(Caldwell et al., 2012). In some cases the concentrations are above the PNECs for 
short-term exposure (<60 days); 20, 5, 200 and 0.5 ng/L for E1, E2, E3 and EE2 
are recommended (Caldwell et al., 2012).   
Vitellogenesis is the process in which vitellogin (VTG) is produced by the liver and 
then uptaken by the oocytes during maturation to provide nutrition to a growing 
embryo (Sumpter and Jobling, 1995). Cellular based studies are often used to 
measure the effects of exposure to estrogens. For example the hepatocytes of 
rainbow trout have been used to measure the estrogen receptor-mediated VTG 
synthesis, induced when the cells are exposed to estrogenic substances (Hollert 
et al., 2005). There are many studies into the effects within living aquatic 
organisms. For example, it was found that exposure to estrogenic substances 
within the aquatic environment may lead to the expression of the VTG gene in 
male fish in a concentration-dependent manner, as fish placed in cages closest to 
WwTP effluents along a river had the highest concentrations of VTG (Sumpter and 
Jobling, 1995; Bon et al., 1997; Copeland et al., 1986). A 300-fold increase in the 
concentration of VTG produced in a male trout placed directly into the effluent of a 
WwTP was observed after a short exposure of one week (Sumpter and Jobling, 
1995). In the UK trouts were placed directly into WwTP effluent in 10 different 
water authorities. In 13 of the sites the trouts did not survive the 3 weeks and in 
the other 15 sites the VTG concentrations were increased between 500 to 50000-
fold (Sumpter and Jobling, 1995).  
Furthermore 5% of roach (Rutilus rutilus) in the UK downstream of WwTP have 
been found to be hermaphrodites (Sumpter and Jobling, 1995). The effect has 
been found to be concentration dependent and when exposed to various 
concentrations of effluent, the production of VTG and feminisation of the male 
reproductive ducts was dose-dependent (Rodgers-Gray et al., 2001). Also the 
changes to the male reproductive ducts, observed due to early exposure, were 
permanent. However the concentrations of VTG were reduced when the Rutilus 
rutilus were in water absent of WwTP effluent for 150 days (Rodgers-Gray et al., 
2001). Furthermore, the feminisation of male fish by exposure to WwTP effluent 
contamination, compared to a reference river, led to reduced fertility of Rutilus 
rutilus, as there was a reduction in gamete production leading to a reduction in the 
number of male fish with moderate or severe feminisation that could produce 
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sperm and seminal fluid (milt). Furthermore, of those that could, their production of 
milt was up to 50% less and the motility of sperm was reduced (Jobling et al., 
2002). If the fertility of male fish is reduced, there may be a decline in populations 
of Rutilis rutilus.    
These studies focused mainly on the effects of exposure to WwTP effluents and 
did not specifically measure the concentrations of chemicals present or the 
estrogenicity of the effluent. Therefore these studies demonstrate that there are 
chemicals within WwTP effluents which have effects on the reproductive function 
of male fish and in extreme conditions may be fatal and detrimental to population 
sizes. However these effects are likely attributed to estrogenic activity, as in a 
laboratory based study there was a response to 0.1-0.5 ng/L of EE2 (Purdom et 
al., 1994). Also rainbow trout (Oncorhynchus mykiss) exposed to 100 ng/L EE2 
had increased plasma protein, phosphoprotein and calcium concentrations after 
two weeks exposure (Verslycke et al., 2002), although this is a concentration 
higher than those in detected in the aquatic environment and these studies were 
not within the aquatic environment but within the laboratory. 
Declines in fish populations within the Upper Danube River in Germany may be 
due to estrogen; five of nine sediment extracts had estrogenic activities, of which 
E1 was the main contributor, contributing to 60% of the sum of E2-equivalents, 
although E2 and EE2 were below the limits of detection (Grund et al., 2011). 
However further studies are required to determine if the estrogenic activities are 
the causative factor for the decline in fish populations (Grund et al., 2011). 
Fathead minnow (Pimephales promelas) suffered endocrine disruption, genotoxic 
damage, modulated immune function, and altered metabolism in a sex-specific 
and dose-dependent manner when exposed to a potent estrogenic and a weakly 
estrogenic effluent containing E1, E2 and EE2, and in response to EE2 alone 
(Filby et al., 2007). However fewer of these effects were seen when exposed to a 
weaker estrogenic effluent and the effects were different when exposed to EE2 in 
a mixture compared to when EE2 was alone, suggesting that environmental 
conditions are difficult to replicate within the laboratory (Filby et al., 2007).   
In a whole lake study carried out over 7 years in which Pimephales promelas were 
exposed to environmentally relevant concentrations of 5-6 ng/L of EE2, similar 
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effects were observed to those seen in response to exposure to WwTP effluents 
and exposure to estrogen within laboratory settings (Kidd et al., 2007). By seven 
weeks of exposure to EE2 there was increased concentrations of VTG in both 
male and female fish, but the increase in males was by three orders of magnitude, 
and the VTG messenger RNA (mRNA) was also increased (Kidd et al., 2007). 
Additionally reductions in fertility were observed, with delayed spermatogenesis, 
widespread fibrosis, malformation of tubules and ova-testes in four out of nine 
male fish after 2-3 years exposure (Kidd et al., 2007). In addition some effects of 
chronic exposure were observed in females, such as delayed ovarian 
development and the presence of atretic follicles (Kidd et al., 2007). Overall there 
were observations of population collapse, which suggests that there is a great risk 
to populations of short-lived fish species when chronically exposed to 
concentrations of EE2 detected within the aquatic environment (Kidd et al., 2007). 
The main focus of studies is often the effects of exposure to EE2 and E2, but 
exposure to E1 is rarely investigated. However, exposure to E1 has been 
attributed to undesirable effects in aquatic organisms. In sediments from the 
Upper Danube, Germany, the main contributor to estrogenicity was E1, with E2 
and EE2 being below the limits of detection. Suggesting that more studies into the 
effects of E1 are required (Grund et al., 2011; Ankley et al., 2017). Furthermore 
when Pimephales promelas were exposed to E1 for 4 days at environmentally 
relevant concentrations, this resulted in an increase in the plasma E2 
concentration, in a dose-dependent manner at above 15.6 ng/L of E1, to a level 
comparable to that in females (Ankley et al., 2017). Furthermore VTG mRNA 
expression and concentrations increased in a dose-dependent manner above 41.9 
ng/L and when exposed to C13-E1 lead to C13-E1, β-E2, and α-E2 elevation in the 
plasma, suggesting that fish have the potential to convert E1 to E2 and therefore 
the potential for feminisation through exposure to E1 (Ankley et al., 2017). 
Therefore low concentrations of estrogens (ng/L) detected in the environment 
(Table 1- 1) have been found to produce undesired effects upon aquatic 
organisms, such as vitellogenesis in male fish, endocrine disruption, altered 
embryo and egg production, altered physiology endpoints and subsequently 
reduced population sizes (Segner et al., 2003; Porte et al., 2006; Sumpter and 
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Jobling, 1995; Matozzo et al., 2008; Depledge and Billinghurst, 1999; Jobling et al, 
2004; Souza et al., 2013; Kidd et al., 2007; Jobling and Owen, 2013).  
 
1.6 Legislation 
The effects of endocrine disrupting chemical (ECDs) such as estrogens has led to 
a number of countries and organisations implementing programs or adding ECDs 
to their existing chemical safety strategies. These include the European Union, the 
Joint Working Group on Endocrine Disrupters Testing and Assessment (EDTA) of 
the Organisation for Economic Cooperation and Development (OECD), the 
Endocrine Disruptor Screening Program (EDSP) of the United States 
Environmental Protection Agency (US-EPA), and the Strategic Programs on 
Endocrine Disruptors (SPEED) of the Japan Environment Agency (Hecker and 
Hollert, 2011). 
However there have been no specific legislations implemented for the regulation 
of estrogen in the aquatic environment or in drinking water. However, due to 
increasing concerns, the estrogens, synthetic EE2 and E2 have been 
recommended for monitoring.  In January 2012, the European Commission 
proposed the estrogens, EE2 and E2 as priority substances, with proposed EQS 
of 0.035 ng/L and 0.4 ng/L respectively (Gilbert, 2012; Johnson et al., 2013). 
Furthermore the UK government’s Department for Environment, Food and Rural 
Affairs is proposing an EQS of 0.016 ng/L for EE2 (Gilbert, 2012). Therefore the 
Water Framework Directive (WFD) passed the 2013/39/EU65 directive in August 
2013 in which EE2 and E2 were included in the surveillance list (da Cunha et al., 
2016). Despite this, the regulations have been postponed from implementation 
due opposition by water utilitity companies such as Thames Water, UK which do 
not accept the inclusion of the additional substances to the Priority substances 
directive, as they claim that studies and proposals lack evidence of the risks to 
health, have large economic implications and could lead to increased carbon 
emissions (Water quality, 2013).  
Within the USA, there is only monitoring of EE2 and other endocrine disruptors 
within drinking water. In 2009 a Contaminant Candidate list (CCL) was produced 
containing EE2 and endocrine disruptors for monitoring in the Unregulated 
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Contaminant Monitoring (UCM) program by the US-EPA (da Cunha et al., 2016). 
However estrogen is not currently monitored in the aquatic environment within the 
USA. 
 
1.7 Chemical and physical removal methods of estrogen 
 Sewage treatment plants 
Removal of E1 and E2 at WwTP has been reported at >98 % (Kanda and 
Churchley, 2008). Furthermore, some WwTP can remove EE2 to 0.1 ng l-1, 
concentrations below the PNEC for fish (Lawton et al., 2008). However, removal 
efficiency is dependent upon the treatment processes and operating parameters 
(Andersen et al., 2003; He et al., 2013; Ye et al., 2012; Clara et al., 2005; UKWIR, 
2009). 
Possibilities include advanced oxidation processes (AOP) and physical methods, 
such as sorption and membrane filtration (Silva et al., 2012) (Table. 1- 2), although 
these are often energy-intensive and costly. 
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Table 1-3: Efficiency and disadvantages of estrogen removal methods. 
Method Estrogen removal Disadvantages References 
Sorption  90% E1, E2, E3 and EE2 by granular activated 
carbon (GAC) and powdered activated carbon 
(PAC). 
 80% EE2 by molecularly imprinted polymer 
(MIP). 
 97% E2 by MIP. 
 96.14% to 98.03% E1 by carbon nanotubes 
(CNTs) with MIP. 
 95-98% EE2 by single walled carbon 
nanotubes (SWCNTs). 
 50-75% E1, E2 and EE2 by suspended solids 
(SS). 
 Efficiency affected by the 
presence of natural organic 
matter. 
 pH, temperature and method 
dependent. 
 Numerous studies with removal 
of less than 50%. 
Snyder et al, 2007; Clara et al., 
2004; Neale et al., 2010; Ren et al., 
2007; Yamamoto and Lijestrand, 
2003; Andersen et al., 2005; 
Andersen et al., 2003; Muller et al., 
2008; Ternes et al., 2004; Meng et 
al., 2005; Lai et al., 2010; DeMaleki 
et al., 2010; Gao et al., 2011; 
Joseph et al., 2011. 
Membrane filtration  99-100% E1, E2, E3 and EE2 by nanofiltration 
(NF). 
 98 – 100% E1, E2, E3 and EE2 by reverse 
osmosis or NF. 
 99% E1 and E2 by forward osmosis. 
 ≥99.5% E1 and E2 by direct contact membrane 
distillation (DCMD). 
 Dependent upon equilibrium 
concentration. 
 Dependent on physiochemical 
processes, membrane 
properties, membrane fouling, 
pH, temperature and salinity. 
Silva et al., 2012; Bellona et al., 
2004; Bolong et al., 2009; Liu et al., 
2009; Schäfer et al., 2011; Weber et 
al., 2004; Alturki et al., 2010; 
Cartinella et al., 2006. 
AOP  99-100% E2 and EE2 by Chlorination and 
ozonation. 
 pH dependent. 
 Production of harmful by-
products with estrogenic activity  
Bila et al., 2007; Kim et al., 2004; 
Alum et al., 2004. 
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 Biodegradation of estrogen 
Biodegradation, another removal method, has achieved promising results in some 
instances, including complete mineralisation of EE2 (Yoshimoto et al., 2004). 
Estrogen-degrading bacteria have been isolated from WwTP (Table 1- 3); therefore 
naturally occurring biodegradation processes may provide a sustainable solution not 
entailing excessive costs or energy. Concentrations of estrogen-degrading bacteria 
have been measured by real-time PCR (qPCR) (Roh and Chu, 2010; Hashimoto et 
al., 2009). The concentrations of Sphingomonas sp. KC8 were 2-3 orders higher 
than those of Novosphingobium tardaugens sp. ARI-1 in three WwTP; suggesting 
Sphingomonas sp. KC8 may be ubiquitous in WwTP (Roh and Chu, 2010). 
Additionally, Novosphingobium sp. JEM-1 was generally distributed between two 
WwTP and the cell numbers were correlated with estrogen removal (Hashimoto et 
al., 2009). Furthermore, Sphingomonas sp. AHC-F and Sphingobium sp. AX-B 
immobilised by use of the bacterial cell immobilisation technique degraded 2 mg/L of 
E2 and its metabolite E1 (Ma et al., 2016). Also when using continuous flow with 850 
ng/L of E2 in the influent, the removal efficiency for E2; 94%, and for equivalent 
estrogenic quantities of E2; 87%, with a hydraulic retention time (HRT) of 12 h (Ma et 
al., 2016). When the HRT is increased to 72 h the E2 and E1 are undetected 
suggesting 100% removal efficiency (Ma et al., 2016).    
 
1.8 Known estrogen degrading bacteria 
Few estrogen-degrading bacteria have been identified, with fewer EE2-degrading 
bacteria being identified than other estrogen degrading bacteria (Tables 7 and 8). 
However, it is unclear whether the removal of estrogen is due to growth-linked 
metabolism, or co-metabolism catalysed by enzymes or cofactors existing for 
another function (Yu et al., 2007). Co-metabolism could allow the removal of 
environmental concentrations of estrogen because it is not necessary to meet the 
threshold of energy and carbon required for aerobic and anaerobic biodegradation 
(Hazen, 2010). Co-metabolic estrogen-degrading bacteria have been identified 
(Pauwels et al., 2008; Shi et al., 2004), including autotrophs. Heterotrophic bacteria 
are more likely to remove EE2 than ammonia oxidising bacteria (AOB) via co-
metabolism (Gaulke et al., 2008). Estrogen metabolism by heterotrophs under 
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aerobic conditions has been identified, but some denitrifying bacteria Denitratisoma 
oestradiolicum gen. nov., sp. nov and Steroidobacter denitrificans gen. nov., sp. nov 
are able to degrade E2 under anoxic conditions (Table 3; Fahrbach et al., 2006; 
Fahrbach et al., 2008). However, under anaerobic conditions estrogen degradation is 
absent or has a lower efficiency (Ying et al., 2003; Czajka and Londry, 2006; Sarmah 
and Northcott, 2008; de Mez et al., 2008; Joss et al., 2004; Jürgens et al., 2002).   
In addition to the activated sludge (AS) isolates (Table 1- 3), aquatic bacteria are 
able to remove E1, E2 and incompletely remove EE2 (Matsuoka et al., 2005; 
Jürgens et al., 2002). However, estrogen-degrading bacteria have not been isolated 
from river water, and in river sediment only Escherichia coli has been found to 
degrade estrogen conjugates, although poorly (Duong et al., 2011).  
Bacteria may preferentially degrade abundant substances, such as glucose, rather 
than estrogens present at low environmental concentrations (Thayanukul et al., 
2010). Most studies (Table 1- 3; Matsuoka et al., 2005; Duong et al., 2011) have 
used higher concentrations of estrogen than those found in the environment (Table 
1- 1).
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Table 1-4: List of known estrogen degrading bacteria isolated from AS. 
Bacterial species Degradation of estrogen Starting 
concentration of 
estrogen (mg/L) 
Estrogen removal (%) References 
Novosphingobium 
tardaugens sp. ARI-
1  
Metabolises E1, E2 and E3. 0.3 of E1, E2 and 
E3 
40% E1 in 20 d; 99% E3 in 10 d; 60% E2 
in 14 d. 
Fujii et al., 2002; 
Fujii et al., 2003. 
Aminobacter 
aminovorans sp. 
KC7  
Degrades* E1 and E2. 3 of E2 Transformed E2 to E1 in 7 d; 23-31% E1 
removed in 7 d. 
Yu et al., 2007. 
 
Aminobacter sp. 
KC6  
Degrades* E1 and E2. 3 of E2 Transformed E2 to E1 in 7 d; 16-26% E1 
degraded in 7 d. 
Yu et al., 2007. 
Sphingomonas 
strain KC8  
Metabolises E1 and E2. 3 of E2 Complete mineralisation of E1 and E2 in 7 
d. 
Roh and Chu, 
2010; Yu et al., 
2007; Yu et al., 
2013. 
Brevundimonas 
diminuta strain NK 2 
(EU35276) 
Transforms E2 to E1 3- 4 of E2 The residual concentration of E2 was 
38 ± 1% after 168 h of incubation. 
Muller et al., 
2010. 
Brevundimonas 
vesicularis KC12 
Transforms E2 to E1 3 of E2 Complete transformation within 7 days. Yu et al., 2007. 
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Rhodococcus ruber 
M2 KC4 
Transforms E2 to E1 3 of E2 Complete transformation within 1 day. Yu et al., 2007. 
Microbacterium 
testaceum KC5. 
Transforms E2 to E1 3 of E2 Complete transformation within 1 day. Yu et al., 2007. 
Sphingomonas sp. 
KC9-11 
Transforms E2 to E1 3 of E2 Complete transformation within 1 day. Yu et al., 2007. 
Flavobacterium sp. 
KC1 
Transforms E2 to E1 3 of E2 Complete transformation within 7 days. Yu et al., 2007. 
Bacteroidetes sp. 
KC2 
Transforms E2 to E1 3 of E2 Complete transformation within 7 days. Yu et al., 2007. 
Nocardioides 
simplex sp. KC3 
Transforms E2 to E1 3 of E2 Complete transformation within 7 days. Yu et al., 2007. 
Escherichia coli sp. 
KC13 
Transforms E2 to E1 3 of E2 Complete transformation within 7 days. Yu et al., 2007. 
Sphingomonas sp. 
KC14 
Transforms E2 to E1 3 of E2 Complete transformation within 7 days. Yu et al., 2007. 
Achromobacter 
xylosoxidans  
Degrades* E1, E2 and 
transforms E3. 
0.1- 5.5 Complete transformation within 2 d.  Weber et al., 
2005. 
Ralstonia sp. Degrades* E1, E2 and 
transforms E3. 
0.1 – 5.5 Complete transformation within 2 d. Weber et al., 
2005. 
Pseudomonas 
aeruginosa sp. TJ1  
Metabolises E2. 5 x 10-3 – 1.5 x 10-2  Complete mineralisation of E2 in 2 h. Zeng et al., 
2009. 
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Bacillus subtilis sp. 
E2Y4  
Degrades* E1 and E2. 10 Transformed E2 completely in 4 days; 40% 
E1 within 9 d. 
Jiang et al., 
2010. 
Bacillus sp. E2Y1 Degrades* E1 and E2. 10 Transformed E2 completely in 6 days; 20% 
E1 within 9 d. 
Jiang et al., 
2010. 
Bacillus 
amylonquefaciens 
sp. E2Y2 
Transforms E2 to E1.  10 Transformed E2 to E1 within 4 days. Jiang et al., 
2010. 
Bacillus sp. E2Y3 Transforms E2 to E1. 10 Transformed E2 to E1 within 5 days. Jiang et al., 
2010. 
Bacillus cereus sp. 
E2Y5 
Transforms E2 to E1. 10 Transformed E2 to E1 within 6 days. Jiang et al., 
2010. 
Denitratisoma 
oestradiolicum gen. 
nov., sp. nov 
Metabolises E2 under 
anoxic conditions. 
0.3 Complete mineralisation of E2. Fahrbach et al., 
2006. 
Steroidobacter 
denitrificans gen. 
nov., sp. nov 
Metabolises E2 under 
anoxic conditions. 
0.3 Complete mineralisation of E2. Fahrbach et al., 
2008. 
Nitrosomonas 
europaea 
Co-metabolises E1, E2, E3 
and EE2 under nitrifying 
conditions. 
1 >95-100% E1, E2 and EE2 in 8 days; 
>62.5% E3 in 9 d. 
Shi et al., 2004. 
Sphingobacterium 
sp. JCR5  
Metabolises E1, E2, E3 and 
EE2. 
30 87% EE2 within 10 d. Haiyan et al., 
2007. 
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Novosphingobium 
sp. JEM-1  
Degrades* E1, E2 and EE2. 4.5 x10-5 ± 4.8 x 10-6 
of E1 and 2.0x10-5 ± 
3.0 x10-6 of E2 
99-100% E1 and E2 in <1 h. Hashimoto et al., 
2009. 
Rhodococcus zopfii 
strain Y 50158  
Metabolises E1, E2, E3 and 
EE2. 
100 81% E2 in 2 h; 91% E1 in 3 h; 96% E3 in 4 
h; 70% EE2 in 7 h; Complete 
mineralisation in 24 h. 
Yoshimoto et al., 
2004.  
Rhodococcus equi 
strains Y 50155, Y 
50156, and Y 50157  
Metabolises E1, E2, E3 and 
EE2. 
100 >80% E2 in 5 h; 99% E2 in 24 h; >80% E1 
in 8 h; 99% in 24 h; 72-95% E3 in 24 h; 
>70% EE2 in 8 h; >80-95% in 24 h. 
Yoshimoto et al., 
2004.  
Pseudomonas 
citronellolis SS-2 
Degradation of E1, E2 and 
EE2, but not E3 
4 of EE2 
2 of E2 
93.6% EE2 removal in 168 hours. 
99% E2 in 36 hours. 
Fang-Fang et 
al., 2012 
Pseudomonas 
citronellolis SJTE-3 
Metabolises E1, E2, E3 and 
EE2. 
Unpublished data Unpublished data Zheng et al., 
2016. 
Novosphingobium 
sp. E2S 
Degradation of E2 50 63.29% of E2 was removed within 7 days. Li et al., 2017 
Rhodococcus sp. 
DS201 
Metabolises E2 and E1 0.5 - 10 63.4-100% E2 removed in 3 days, highest 
removal 100% of 1 mg/L E2 in 3 days. 
Lowest 63.4% removal of 10mg/L E2 in 3 
days. 
Yu et al., 2016 
* Where strains were unable to grow upon estrogen as the sole energy or carbon source, but co-metabolism was not confirmed. All strains are aerobic unless 
otherwise stated. 
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Table 1-5: List of known estrogen degrading bacteria from other sources. 
Bacterial species Degradation of estrogen Source of bacteria References 
Phyllobacterium 
myrsinacearum  
Metabolises E1, E2, E3 and co-metabolises 
EE2 in the presence of E1, E2 and E3. 
Compost Pauwels et al.(2008) 
Ralstonia picketti BP2 Metabolises E1, E2, E3 and co-metabolises 
EE2 in the presence of E1, E2 and E3. 
Compost Pauwels et al.(2008) 
Pseudomonas aeruginosa 
BP3 
Metabolises E1, E2, E3 and co-metabolises 
EE2 in the presence of E1, E2 and E3. 
Compost Pauwels et al.(2008) 
Pseudomonas sp. BP7 Metabolises E1, E2, E3 and co-metabolises 
EE2 in the presence of E1, E2 and E3. 
Compost Pauwels et al.,(2008) 
Acinetobacter sp.  Metabolises E1, E2, E3 and co-metabolises 
EE2 in the presence of E1, E2 and E3. 
Compost Pauwels et al., (2008) 
Sphingomonas sp. CYH Degrades E1 (aerobic and anoxic) and 
transforms E2 to E1. 
Artificial sandy 
aquifer 
Ke et al., (2007) 
Agromyces sp. LHJ3 Degrades E3 (aerobic), E2 (anoxic) and 
transforms E2 to E1. 
Artificial sandy 
aquifer 
Ke et al., (2007) 
Acinetobacter sp. LHJ1 Transforms E2 to E1. Artificial sandy 
aquifer 
Ke et al., (2007) 
Sphingomonas ED8 and 
9. 
Metabolises E1 and E2. Soil Kurisu et al., (2010) 
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Rhodococcus ED6, 7 and 
10. 
Metabolises E1 and E2. Soil Kurisu et al., (2010) 
Pseudomonas putida 
strain SJTE-1 
Metabolises E1 and E2 Soil Liang et al., (2012) 
Leptothrix discophora Manganese Mn2+- 
dependent degradation of EE2 
Belgian coordinated 
collections of 
microorganisms. 
Sabirova et al., (2008) 
Pseudomonas putida 
MnB1, 6 and 29. 
Manganese Mn2+- 
dependent degradation of EE2 
Belgian coordinated 
collections of 
microorganisms. 
Sabirova et al., (2008) 
Nitrosomonas europaea 
ATCC 19718  
Co-metabolism and Nitration of EE2  
 
ATCC Gaulke et al.(2008); 
Skotnicka-Pitak et al. 
(2009) 
Buttiauxella Metabolism of E2 and Testosterone Baltic Sea Zhang et al.(2011a) 
Vibrio sp. H5 Metabolism of E2 and Testosterone Baltic Sea Sang et al.(2012) 
Rhodococcus equi ATCC 
13557  
Partial degradation of EE2 in the presence of a 
cosubstrate. EE2 61% ± 1% in 300h. 
ATCC O’Grady et al.(2009); Larcher 
and Yargeau (2013) 
Rhodococcus 
erythropolis ATCC 4277 
Partial degradation of EE2 in the presence of a 
cosubstrate. EE2 46% ± 2% in 300h 
ATCC O’Grady et al.(2009 ); 
Larcher and Yargeau (2013) 
Rhodococcus zopfii 
ATCC 51349 
Partial degradation of EE2 in the presence of a 
cosubstrate. EE2 38% ± 1% in 300h 
ATCC O’Grady et al.(2009); Larcher 
and Yargeau (2013) 
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Bacillus subtilis ATCC 
6051 
Partial degradation of EE2 in the presence of a 
cosubstrate. EE2 27% ± 2% in 300h. 
ATCC Larcher and Yargeau (2013) 
Pseudomonas aeruginosa 
PA01 
Partial degradation of EE2 in the presence of a 
cosubstrate. EE2 34% ± 2% in 300h. 
ATCC Larcher and Yargeau (2013) 
Pseudomonas putida 
ATCC12633 
Partial degradation of EE2 in the presence of a 
cosubstrate. EE2 21% ± 2% in 300h 
ATCC Larcher and Yargeau (2013) 
Rhodococcus 
rhodochrous ATCC13808 
Partial degradation of EE2 in the presence of a 
cosubstrate. No EE2 detected after 48 h 
(possibly co-metabolic) 
ATCC Larcher and Yargeau (2013) 
Bacillus cereus 
Socransky 67  
Conversion of E2 to unknown metabolites Dental plaque Ojanotko-Harri et al (1990) 
Streptococcus mutans 
Ingbritt 
Conversion of E2 to E1 Dental plaque Ojanotko-Harri et al (1990) 
Streptococcus mutans 
NCTC 10449 
Conversion of E2 to E1 Dental plaque Ojanotko-Harri et al (1990) 
Streptococcus mutans 
NCTC 10904 
Conversion of E2 to E1 Dental plaque Ojanotko-Harri et al (1990) 
Rhodococcus sp. P14 Conversion of E2 to E1 Crude oil Ye et al., 2017; Song et al., 
2011. 
Nocardia sp. E110 Degradation of E1 Soil Coombe et al., 1966 
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1.9 The genomic potential of bacteria to degrade estrogen 
The genomic potential of bacteria to degrade estrogen is not well understood, as the 
only whole genome sequences are of the E2 and E1 degrading bacteria 
Sphingomonas sp. KC8 (Hu et al., 2011), Pseudomonas putida strain SJTE-1 (Liang 
et al., 2012) and Rhodococcus sp. P14 which transforms E2 to E1 (Zhang et al., 
2012; Ye et al., 2017). Also the genome of an E1, E2, E3 and EE2 degrader 
Pseudomonas citronellolis SJTE-3 (Zheng et al., 2016). Several genes encoding the 
enzymes suggested to be putatively involved in estrogen degradation, such as 
hydroxysteroid dehydrogenase, 3-ketosteroid-delta1-dehydrogenase, rieske 
dioxygenase, catechol 2,3-dioxygenase, were observed in the genomes of P. putida 
strain SJTE-1 and Sphingomonas sp. KC8 (Liang et al., 2012; Hu et al., 2011). 
Furthermore 17β-hydroxysteriod dehydrogenase was upregulated in Rhodococcus 
sp. P14 when exposed to E2, with increases of 5.35 and 1.68-fold at 6 and 12 hours, 
suggesting that 17β-hydroxysteriod dehydrogenase is responsible for the 
dehydrogenation of the C-17 within the D ring of E2 to produce E1 (Ye et al., 2017). 
Additionally the involvement of the dioxygenase enzyme in the oxidation of the C-4 
and C5 was proposed in the degradation of E1 by Nocardia sp. E110 and in the 
degradation of EE2 and E1 by Sphingobacterium sp. JCR5 (Coombe et al., 1966; 
Haiyan et al., 2007). Furthermore the enzyme 3β,17β-hydroxysteroid dehydrogenase 
was suggested to be responsible for the dehydrogenation of C-17 in the D ring 
leading to the conversion of E2 to E1, and Flavin-dependent monoxygenase is 
responsible for the conversion of E1 to 4-OH-E1 in Sphingomonas sp. KC8 (Chen et 
al., 2017). The enzyme 4-hydroxyestrone 4,5-dioxygenase is suggested to have a 
role in the degradation of 4-OH-E1 (Chen et al., 2017). Genes encoding Flavin-
dependent monooxygenase and 4-hydroxyestrone 4,5-dioxygenase were found 
within two separate gene clusters within the genome of Sphingomonas sp. KC8, 
however the gene encoding 3β,17β-hydroxysteroid dehydrogenase was not found 
clustered with other genes (Chen et al., 2017). 
In mammals and vertebrates, cytochrome P450 enzymes, from the monooxygenase 
family, allow E2 metabolism (Scornaienchi et al., 2010; Nishida et al., 2013). The 
P450 enzymes are also present in bacteria, P450 monooxygenase is required for 
bisphenol A, another benzene-containing pollutant, to be degraded by 
Sphingomonas bisphenolicum strain AO1 (Sasaki et al., 2008). Also non-specific 
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monooxygenase activity may be necessary to degrade E1 (Yu et al., 2007) and 
ammonia monooxygenase was suggested to be involved in estrogen degradation by 
Nitrosomonas europaea (Shi et al., 2004). Therefore, P450 enzymes may have a 
role in estrogen degradation, although P450 enzymes responsible for estrogen 
degradation by bacteria are unidentified. 
 
1.10 Aims 
The main focus of this work will be the degradation of E2, EE2 and their metabolite 
E1, due to the legislative focus being upon E2 and EE2 (Section 1.6). However, E3 
will be included in a potential estrogen degradation pathway for its completeness. In 
a potential estrogen degradation pathway, putative enzymes with the potential for 
estrogen degradation will be identified. The hypothesis is that strains of bacteria 
known to degrade estrogens will contain genes encoding at least some of these 
enzymes. Analysis of their genomes and the use of molecular techniques will confirm 
the presence and expression of those genes during estrogen degradation. Therefore 
RT-qPCR experiments will be carried out using specific primer sets to target these 
genes and measure their expression during a degradation experiment. The 
expression of ribonucleic acid (RNA) during the degradation of estrogen will suggest 
the involvement of the gene and allow the pathway of estrogen degradation to be 
confirmed.  
Therefore the aim of the project is to evaluate the potential estrogen degradation 
pathway through analysis and comparison of the R. equi American Type Culture 
Collection 13557 (ATCC) genome with the genomes of other estrogen degrading 
bacteria, and through measuring the gene expression and metabolite production 
during estrogen degradation. R. equi ATCC 13557 was selected as a model 
organism to study the degradation of estrogen because from the limited number of 
estrogen degrading bacteria (10) available on culture collection websites (Table 1- 
4), R. equi ATCC 13557 had the highest percentage of EE2 degradation reported, 
61% ± 1% in 300h, in the presence of a cosubstrate. (Larcher and Yargeau, 2013). 
Additionally, a large number of other Rhodococcus species (14) and other strains of 
R. equi (3) have been reported as estrogen degrading bacteria (Tables 1- 4 and 1- 
5). Furthermore, R. equi previously known as Nocardia restrictus is a well-studied 
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testosterone, another steroid hormone, degrading organism (Kim et al., 2007; 
Gibson et al., 1966; Sih et al., 1966). To these ends: 
 A hypothetical pathway of estrogen degradation will be proposed using 
existing information from current literature (Chapter 2). 
 The genome of R. equi ATCC 13557 will be assembled and searched for 
genes coding for the enzymes that are potentially involved in estrogen 
degradation (Chapter 3). 
 A comparison of the genomes of potential estrogen degrading bacteria will be 
carried out to localise the genes coding for enzymes that are suggested to be 
involved in estrogen degradation (Chapter 3). 
 An optimised method of estrogen sample preparation and method for the 
addition of estrogen to the growth media will be developed (Chapter 4). 
 Degradation experiments will be carried out to determine estrogen 
degradation by R. equi ATCC13557 under the experimental conditions 
(Chapter 5).  
 New specific sets of primers will be developed to identify and enumerate the 
identified genes coding for enzymes potentially involved in estrogen 
degradation using RT-qPCR (Chapter 6). 
 Gene expression analysis of R.equi ATCC13557, during the degradation of 
estrogen, will be carried out to determine which genes are actively expressed 
(Chapter 6). 
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Chapter 2:  Creating a hypothetical estrogen degradation 
pathway 
2.1 Introduction 
The physiological process of estrogen metabolism is important in understanding the 
fate of estrogen and its metabolites within the environment. The identification of 
genes can help in the use of bacteria as a method of estrogen degradation, 
biodegradation, by potentially enhancing the degradation through bioengineering 
(Van der Geize et al., 2007). Furthermore though genome comparison, genes coding 
for enzymes involved in a metabolic pathway may be identified in the genomes of 
other bacteria, previously unknown to metabolise the compound.  
In 1941, it was proposed that genes control chemical reactions by acting as or 
producing enzymes (Beadle and Tatum, 1941). Later it was postulated that there 
was a relationship between the metabolism of organisms and their genes (Horowitz, 
1945). The Retrograde Hypothesis suggested that due to the depletion of resources, 
organisms which mutated to utilise different resources to produce the depleted 
compound, gained a selective advantage leading to the emergence of metabolic 
pathways (Horowitz, 1945). Another theory is the Patchwork Hypothesis, in which 
early cells contained genes coding for many non-specific enzymes to utilise a broad 
range of compounds. These genes coding for non-specific enzymes went through 
duplication and evolutionary divergence leading to genes coding for more specific 
enzymes. (Ycas, 1974; Jensen, 1976). Therefore, the analysis of metabolic 
pathways can give an understanding of the enzymes involved in each step, thus 
identification of the genes responsible for a metabolic function. The genes of 
organisms, such as bacteria, involved in the production of enzymes with specific 
metabolic functions, may share evolutionary origins, thus there may be a conserved 
core metabolic pathway for steroid degradation. The degradation pathway for 
testosterone by Comamonas testosteroni is well characterised due to the 
identification of metabolites and genes. Confirmation of the gene involvement in 
testosterone degradation was carried out by gene mutation, to stop the activity of 
specific genes, such as TesB, thought to encode dioxygenase, TesD encoding 
hydrolase, and TesEFG (Horinouchi et al., 2001; Horinouchi et al., 2003; Horinouchi 
et al., 2005). In the absence of these genes the metabolism of testosterone was 
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decreased or absent, leading to the accumulation of metabolites which were 
identified. Some of these metabolites were compared to the degradation pathway of 
Androst-4-ene-3,17-dione (4-AD) degradation pathway (Horinouchi et al., 2001; 
Horinouchi et al., 2003; Horinouchi et al., 2005; Sih et al., 1966; Horinouchi et al., 
2012). 
Metabolite detection during the degradation of estrogen, by bacteria, can help to 
elucidate the bacterial degradation pathway of estrogen. In estrogen degradation, 
there have been some metabolites detected, such as E1, 2-hydroxy-2,4-dienevaleric 
acid and 2-hydroxy-2,4-diene-1,6-dioic acid during EE2 degradation by 
Sphingobacterium sp. JCR5 (Haiyan et al., 2007). The production of the metabolites 
E1, pent-4-enoic acid; 5-(4-(2-carboxyethyl)-7a-methyl-1-oxooctahydro-1H-inden-5-
yl)pent-4-enoic acid , 2-ethyl-3-hydroxy-6-methylcyclohexane-1-carboxylic acid; 3-
(7a-methyl-1,5-dioxooctahydro-1H-inden-4-yl) propanoic acid; and 5-hydroxy-4-(3-
hydroxypropyl)-7a-methyloctahydro-1H-inden-1-one during the degradation of E2 by 
Rhodococcus sp. DS201 (Yu et al., 2016). The metabolites 3aα-H-4α-[3’-propanoic 
acid]-5β-[2-ketopropyll-7aβ-methyl-1-indanone, 3aα(-H-4α-[3’-propanoic acid]-5β-[4’-
but-3-enoic acid]-7aβ-methyl-l-indanone, and 2-carboxy-7aβ-methyl-7-keto-9aα-H-
indano-[5,4f]-5aα, 10, 10aβ, ll-tetrahydroquinoline were produced in the degradation 
of E1 by Nocardia sp. E110 (Coombe et al., 1966). Therefore suggesting that E1 is 
degraded by cleavage of the A ring followed by the B ring by the metabolic steps; 1) 
hydroxylation of C-4, 2) Oxidation by dioxygenase between C-4 and C-5, 3) the 
seco- intermediate reacts non-enzymatically with ammonia to produce pyridine 
carboxylic acid (Coombe et al., 1966). The degradation of E1 by Sphingomonas sp. 
KC8 also suggests the A ring is hydroxylated to produce 4-OH-E1, followed by 
cleavage of the A ring by dioxygenase producing a similar metabolite to those 
identified in the degradation by Rhodococcus sp. DS201 and Nocardia sp. E110, 
therefore a common estrogen degradation pathway may occur in both 
Proteobacteria and Actinobacteria (Chen et al., 2017; Coombe et al., 1966; Yu et al., 
2016). Furthermore, the estrogens E1, E2, E3, EE2 and other steroid hormones may 
lie on interconnecting pathways as bacteria can convert EE2 and E2 to E1 
interchangeably, and within soil E2 and E1 were both degraded to E3 
interchangeably (Xuan et al., 2008; Adeel et al., 2017). There have been some 
common metabolites identified within the degradation pathways of estrogen, 
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testosterone and 9,10-Seco steroids, suggesting that there may be a common 
pathway for steroid degradation. For example, the metabolite 2-hydroxy-2,4-
dienevaleric acid identified in EE2 degradation by Sphingobacterium sp. JCR5 is 
analogous to a metabolite produced in the degradation of testosterone by 
Comamonas testosteroni TA441 and the metabolite 2-hydroxy-2,4-diene-1,6-dioic 
acid is also similar to a metabolite in testosterone degradation with a different 
cleavage position (Haiyan et al., 2007; Horinouchi et al., 2003). Also the metabolite 
5-(4-(2-carboxyethyl)-7a-methyl-1-oxooctahydro-1H-inden-5-yl)pent-4-enoic acid 
found in the degradation of E2 by Rhodococcus sp. DS201 is analogous to 3aα-H-
4α-[3’-propanoic acid]-5β-[4’-but-3-enoic acid]-7aβ-methyl-1-indanone dimethyl ester 
found in E1 degradation by Nocardia sp. E110 (Yu et al., 2016; Coombe et al., 
1966). The metabolite 3-(7a-methyl-1,5-dioxooctahydro-1Hinden-4-yl) propanoic acid 
in degradation of E2 is analogous to 9,17-dioxo-1,2,3,4,10,19-hexanorandrostan-5-
oic acid produced in testosterone degradation by Comamonas testosteroni TA441 
(Yu et al., 2016; Horinouchi et al., 2003). Additionally, an intermediate metabolite 
proposed, but not identified as a metabolite in the degradation of E2 by 
Rhodococcus sp. DS201, was proposed in the pathway of Androst-4-ene-3,17-dione 
degradation (Yu et al., 2016; Sih et al., 1966).   
 
However there are suggestions for alternate pathways such as the degradation of 
EE2 to E1 by oxidisation of C17 of the D ring, followed by cleavage of the B ring of 
E1 (Haiyan et al., 2007) compared to the degradation of EE2 beginning with 
electrophilic reactions including hydroxylation and conjugation of the A ring (Yi and 
Harper, 2007). Furthermore the degradation of E2 may follow three pathways; 1) 
dehydrogenation to the intermediate estratetraenol (E0), or E1 by C-17 of the D ring 
followed by hydroxylation of C-4 of the A ring to form 4-hydroxyestrone (4-OH-E1) 
followed by ring cleavage between C-4 and C-5; 2) reduction of the keto-function of 
the D ring at C-17 followed by hydroxylation of C-4 of the A ring to produce 4-
hydroxyestradiol (4-OH-E2); or 3) hydroxylation of C-4 of the A ring followed by 
reduction of the keto-function of the D-ring at C-17 (Kurisu et al., 2010; Nakai et al., 
2011). Also the metabolites keto-E1 and keto-E2 may be due to hydroxylation of the 
saturated rings (Kurisu et al., 2010). However, commonly the first step in E2 
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degradation is conversion to E1 by oxidisation of the C-17 within the D ring to a 
ketone (Yu et al., 2007; Ke et al., 2007; Lee and Liu, 2002).  
Although few studies describe biodegradation pathways, some transient metabolites 
have been reported that suggest the following possible pathways; 
1. EE2 degradation is initiated by either; 
a. Dehydrogenation of C-17 within the saturated D ring to produce E1 (Haiyan 
et al., 2007). 
b. Electrophilic reactions including conjugation and hydroxylation of the 
aromatic A ring (Yi and Harper, 2007). 
2. E2 degradation is initiated by either; 
a. Dehydrogenation of C-17 within the saturated D ring to produce E1 or the 
intermediate E0 (Yu et al., 2007; Ke et al., 2007; Lee and Liu, 2002; Nakai et 
al., 2011). Followed by hydroxylation of the C-4 of the aromatic A ring to 
produce 4-OH-E1 (Kurisu et al., 2010). 
b. Hydroxylation of C-4 of the aromatic A ring followed by reduction of the 
keto-function at C-17 of the saturated D ring to produce 4-OH-E2 (Kurisu et 
al., 2010). 
C. Hydroxylation of the saturated rings B, C or D to produce keto-E1 and keto-
E2 (Kurisu et al., 2010). 
d. Hydroxylation of C-16 within the saturated D ring to produce E3 (Xuan et 
al., 2008).   
3. E1 degradation is initiated by either; 
a. Cleavage of the saturated B ring (Haiyan et al., 2007). 
b. Oxidisation of the saturated D ring to produce a lactone (Lee and Liu, 
2002). 
c. Hydroxylation of the aromatic A ring to produce 4-OH-E1 followed by 
cleavage of the saturated B ring (Kurisu et al., 2010; Coombe et al., 1966). 
d. Hydration of the saturated D ring at positions C-16 and C-17 to produce E3 
(Xuan et al., 2008). 
 
However, a common metabolic pathway for estrogen degradation is unknown. 
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2.2 Materials and methods 
A literature search was conducted using PubMed to find papers using the search 
terms “estrogen degradation,” “bacterial estrogen degradation,” “steroid degradation” 
and other similar search terms. The literature was used to look for a potential 
estrogen degradation pathway using information on estrogen metabolites from 
degradation and gene expression studies. Further literature was searched for steroid 
degradation pathways which were better characterised such as the degradation 
pathway of Comamonas testosteroni. The information was compiled and used to 
produce a hypothetical estrogen degradation pathway by looking at the reported and 
suggested metabolites and combining the pathways with analogous metabolites. 
The software used to produce the potential pathway and all other figures containing 
chemical structures was ChemDrawBio Ultra version 14.0.0.117 (1998-2014).  
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2.3 Results and Discussion 
 
Figure 2-1: The hypothetical estrogen degradation pathway compiled from the information about estrogen degradation (Yu 
et al., 2007; Lee and Liu, 2002; Ke et al., 2007; Kurisu et al., 2010; Haiyan et al., 2007; Yi and Harper, 2007; Yu et al., 2013; 
Yu et al., 2016; Adeel et al., 2017; Xuan et al., 2008) and the testosterone degradation pathway by Comamonas testosteroni 
(Horinouchi et al., 2012). The enzymes or genes coding for enzymes involved in the degradation steps are highlighted in 
purple, the reactions in blue and the parent compounds E1, E2, E3, EE2 and testosterone in red. The dotted arrows 
represent unconfirmed pathways. ChemDrawBio Ultra version 14.0.0.117 
P a g e  | 34 
Combining the existing estrogen degradation pathway information along with the 
better characterised testosterone degradation pathway, we postulated a potential 
estrogen degradation pathway (Fig. 2- 1). There are two possible degradation 
pathways for EE2 (Fig. 2- 2); i) hydroxylation of the aromatic A ring (reaction 1), also 
a common step in the degradation of polycyclic aromatic hydrocarbons (PAH) (Peng 
et al., 2008), suggesting there may be involvement of dioxygenase in the 
degradation of EE2 (Yi and Harper, 2007). ii) Oxidation of the D ring to produce a 
ketone, converting it into E1 (reaction 2), followed by B ring cleavage and then A ring 
hydroxylation and ketonisation, followed by further A ring hydroxylation and meta-
cleavage (Haiyan et al., 2007). 
 
Figure 2- 2:  The two possible pathways for EE2 degradation (Yi and Harper, 2007; Haiyan et al., 2007; Yu et al., 2013) 
 
There are five possible pathways in E2 degradation (Fig. 2- 3); i) A ring hydroxylation 
suggesting the involvement of a dioxygenase enzyme to produce the 4-OH-E2 
metabolite (reaction 6). Followed by either spontaneous cleavage and complete 
metabolism or dehydrogenation of the D ring by a dehydrogenase enzyme to form 
interchangeably 4-OH-E1. The 4-OH-E1 metabolite then undergoes further cleavage 
steps resulting in complete metabolism. ii) Ring hydroxylation of the saturated ring B, 
C or D (reaction 5), producing hydroxy-E2, keto-E2, keto-E1 and 3-(4-
hydroxyphenyl)-2-hydroxyprop-2-enoic acid (Kurisu et al., 2010). iii) Dehydration of 
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D-ring to produce the metabolite E0 (Nakai et al., 2011). iv) Formation of E1 from E2 
by dehydrogenation of the D ring (reaction 7) (Yu et al., 2007). v) Hydroxylation of 
the D ring to produce E3 (reaction 4) (Xuan et al., 2008). 
 
Figure 2-2: The five possible pathways of E2 degradation (Yu et al., 2007; Xuan et al., 2008; Kurisu et al., 2010; Nakai et al., 
2010; Yu et al., 2013; Adeel et al., 2017) 
 
There are four possible pathways for E1 degradation (Fig. 2- 4); i) Dehydrogenation 
of the D ring to form the X1 metabolite, with a lactone at ring D, which is then 
degraded by the tricarboxylic acid (TCA) cycle (Lee and Liu, 2002). ii) Hydroxylation 
at C-4 of the A ring to produce 4-OH-E1 (reaction 8) which then undergoes cleavage 
between C-4 and C-5 of the A ring leading to oxidation, the C-5 is then oxidised to a 
carbonyl group releasing carbon dioxide, then formic acid or carbon dioxide is 
released, then C-9 is hydroxylated to form a keto group and the B ring is cleaved 
(Kurisu et al., 2010; Yu et al., 2016). At this point the pathway is combined with that 
of testosterone degradation by Comamonas testosteroni due to the analogous 
metabolite 4,9-DSHA (Horinouchi et al., 2003; Yu et al., 2016).  iii) Hydration of the D 
ring lead to the production of E3 (reaction 3) (Xuan et al., 2008).  iv) E1 undergoes B 
ring cleavage by hydroxylation to produce 3-HSA (reaction 9) and at this point the 
pathway was combined with the information about the well characterised 
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degradation pathway of testosterone by Comamonas testosteroni, another steroid 
hormone due to the analogous metabolite found in the degradation of EE2 by 
Sphingobacterium sp. JCR5 (Horinouchi et al., 2005; Haiyan et al., 2007). In the 
hypothetical estrogen degradation pathway it is suggested that the degradation of 
the E1 would begin at a later point in the degradation pathway than testosterone due 
to the saturated A ring being more similar to the later point where the B ring is 
cleaved in testosterone. Following this A ring hydroxylation is carried out by C4 
hydroxylase, and metacleavage of the A ring by a dioxygenase enzyme (Coombe et 
al., 1966). Followed by the action of hydrolase and then hydratase for complete 
metabolism (Horinouchi et al., 2005). 
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Figure 2-3: The four possible pathways of E1 degradation (Lee and Liu, 2002; Kurisu et al., 2010; Yu et al., 2016; Horinouchi 
et al., 2003; Xuan et al., 2008; Horinouchi et al., 2005; Haiyan et al., 2007; Coombe et al., 1966; Yu et al., 2013) 
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Therefore, using the potential pathway of estrogen degradation (Fig. 2- 1), the major 
enzymes suggested to be involved in the degradation of estrogen are; dioxygenase, 
hydroxylase, dehydrogenase, hydrolase and hydratase (Table 2- 1). Genes encoding 
some or all of these enzymes are likely to be present in the genomes of estrogen 
degrading bacteria, thus the genome of R. equi ATCC13557 will be evaluated for the 
presence of these genes (Table 2- 1). The proposed hypothetical estrogen pathway 
provides a more comprehensive understanding of the potential metabolites and 
genes coding for the enzymes responsible for each step. There are still multiple 
pathways suggested which may depend on the bacteria and its growth conditions. 
However given that degradation of E1 by Nocardia sp. E110 shares commonalities 
with the degradation of cholesterol by Nocardia restrictus (ATCC 14887) and 
additionally the degradation of E1 by Rhodococcus sp. DS201 and Sphingomonas 
sp. KC8 suggests that the most common pathway for E1 degradation begins with the 
hydroxylation of the A ring by a dioxygenase enzyme to produce 4-OH-E1 (reaction 
10) (Coombe et al., 1966; Sih et al., 1965; Chen et al., 2017; Yu et al., 2016). This is 
further supported by the EAWAG Biocatalysis/Biodegradation database pathway 
prediction for E1 suggests that the hydroxylation of the A ring (rule bt004) is a likely 
first step (Hou et al., 2011). The conversion of EE2 to E1 proposed, is unlikely due to 
the ethinyl group, which is resistant to microbial degradation (García et al., 2011). 
Additionally, bacteria able to degrade EE2 to E1 by the seco pathway, would not be 
able to further degrade E1 (García et al., 2011; Coombe et al., 1966; Wang and Sih, 
1963). Therefore, using the hypothetical estrogen degradation pathway (Fig. 2- 1), 
metabolites detected during estrogen degradation may help to determine the 
pathway of estrogen degradation by bacteria. Additionally, searching for the genes 
coding for enzymes (Table 2- 1), identified in steps within the hypothetical estrogen 
pathway (Fig. 2- 1), within bacterial genomes may also help to identify estrogen 
degrading bacteria and identify which pathway steps are involved in biodegradation 
of estrogen. 
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Table 2-1: The major enzymes potentially involved in estrogen degradation 
Reaction 
number 
Metabolic step Suggested 
enzyme 
EC 
number 
References 
1 EE2 to 2-OH-EE2 Dioxygenase 1.13.11.- Yi and Harper, 2007 
2 EE2 to E1 *Oxygenase 1.13.- 
or 1.14.- 
Haiyan et al., 2007 
3 E1 to E3 Hydratase 4.2.1.- Xuan et al., 2008; Adeel 
et al., 2017 
4 E2 to E3 Hydroxylase 1.14.16.- Xuan et al., 2008; Adeel 
et al., 2017 
5 E2 to keto E2 Hydroxylase 1.14.16.- Kurisu et al., 2010 
6 E2 to 4-OH-E2 Dioxygenase 1.13.11.- Kurisu et al., 2010 
7 E2 to E1 17β-
hydroxysteriod 
dehydrogenase 
1.1.1.51 Yu et al., 2007; Ke et al., 
2007; Lee and Liu, 2002 
8 E1 to 4-hydroxy-E1 Dioxygenase 1.13.11.- Chen et al., 2017; 
Coombe et al., 1966; Yu 
et al., 2016 
9 E1 to 3-HSA Hydroxylase 1.14.16.- Haiyan et al., 2007 
10 3-HSA to 3,4-DHSA  Hydroxylase 1.14.16.- Horinouchi et al., 2004 
11 3,4-DHSA to 4,9-DHSA Dioxygenase 1.13.11.- Horinouchi et al., 2001 
12 4,9-DHSA to 2-
hydroxyhexa-2,4-
dienoic acid and 3-
[(3aS, 7aS)-7a-methyl-
1,5-dioxooctahydro-1H-
inden-4-yl] propanoate 
Hydrolase 3.7.1.- Horinouchi et al., 2003 
13 2-hydroxyhexa-2,4-
dienoic acid to 4-
hydroxy-2-
oxohexanoate 
Hydratase 4.2.1.- Horinouchi et al., 2005 
14 4-hydroxy-2-
oxohexanoate to p-
xylene pathway 
BphI and BphJ 
(Aldolase and 
dehydrogenase 
complex) 
4.1.3.43 Horinouchi et al., 2005; 
Carere et al., 2011 
* Suggested oxygenation of the ethinyl group, however a specific enzyme is unknown. 
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Chapter 3:  Genome assembly and evaluation 
3.1 Introduction 
Whole genome sequencing (WGS) is an important tool in understanding the genomic 
potential of bacteria through the identification of genes coding for enzymes with 
specific functions and through comparative genomics where genomes of bacteria 
with similar functions can be compared to identify common genes. Although the cost, 
speed, average read length and preparation times need to be considered when 
choosing a sequencing platform (Table 3- 1). 
The method of sequencing deoxyribonucleic acid (DNA), termed Sanger sequencing, 
was first developed in 1977 by use of the incorporation of 2',3'-dideoxythymidine 
triphosphate (ddTTP) within DNA polymerase I, leading to chain-termination at the 
positions where thymidylic acid (dT) is replaced. Therefore, when fractionated by 
electrophoresis the band patterns can be observed (Sanger et al., 1977). Although 
widely used, Sanger sequencing, which produced long sequence reads (~1 kb), has 
since been replaced with higher-throughput next-generation sequencing (NGS) 
methods. The first of which was 454 sequencing (Ekblom and Wolf, 2014; Rothberg 
and Leamon, 2008). 454 sequencing miniaturised the pyrosequencing reaction 
which generated short read length and emitted light upon the incorporation of 
nucleotides. This meant that smaller volumes could be used and allowed sequencing 
to be carried out in parallel (Rothberg and Leamon, 2008).  
The use of 454 sequencing was replaced with the use of Illumina HiSeq (Solexa) 
and SOLiD, which produce shorter read lengths and a lower cost-per-base (Ekblom 
and Wolf, 2014; Shendure and Ji, 2008). Illumina uses sequencing by synthesis 
(SBS) bridge-PCR in which forward and reverse primers are tethered to a solid 
substrate by a linker, leading to the clustering of amplicons (Shendure and Ji, 2008). 
SOLiD uses emulsion PCR with use of DNA ligase to ligate octomers, removing the 
fluorescent label and a two-base sequencing method (Shendure and Ji, 2008; Liu et 
al., 2012).  
Furthermore in 2010 and 2011 the compact benchtop sequencers, the Ion Personal 
genome machine (PGM) from Ion Torrent, and MiSeq from Illumina were released 
respectively (Liu et al., 2012).  The Ion PGM uses semiconductor sequencing 
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technology, releasing a proton when polymerase incorporates a nucleotide, thus 
does not require fluorescence (Liu et al., 2012). Therefore the Ion PGM is faster, 
cheaper and smaller in size compared to other NGS, with a higher sequence quality 
and higher mapping rate than the Illumina HiSeq (Liu et al., 2012). The Miseq uses 
SBS but produces higher integrity data and has a broader range of applications 
including amplicon sequencing, clone checking, ChIP-Seq and small genome 
sequencing (Liu et al., 2012). Furthermore the read length is longer and therefore 
contig assembly is better than the HiSeq (Liu et al., 2012). Another benchtop 
sequencer is the Polonator G.007 by Complete Genomics which is a ligation based 
system but is recently introduced and not yet widely used (Liu et al., 2012; Zhang et 
al., 2011b). 
Third-generation sequencers have been newly released and are not yet widely used. 
These include Helicos HeliScope using Single-molecule real-time technology from 
PacBio in which an enzyme incorporates nucleotides into the complementary strand 
and cleaves the fluorescent dye which is captured by a camera in real-time (Liu et 
al., 2012; Zhang et al., 2011b). Its advantages are faster sample preparation, 
reduced error and bias from PCR based methods, fast run time, longer average read 
length (Liu et al., 2012; Zhang et al., 2011b). However, the throughput is lower 
compared to NGS (Liu et al., 2012; Zhang et al., 2011b). 
Another third-generation sequencing technology is Nanopore in which a single-
strand of DNA is threaded into a biopore, which self-assembles to produce a 
heptameric transmembrane channel to which a continuous ionic flow is applied (Liu 
et al., 2012; Zhang et al., 2011b). The current disruption is detected using 
electrophysiological technique based on the size of the deoxyribonucleoside 
monophosphates (dNMP) (Liu et al., 2012; Zhang et al., 2011b). The Nanopore 
produces long read lengths quickly and is less sensitive to temperature than enzyme 
dependent technologies (Liu et al., 2012; Zhang et al., 2011b). 
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Table 3-1: Comparison of genome sequencing platforms (adapted from Shendure and Ji, 2008). 
Platform Read 
length 
(bp) 
per-base 
accuracy 
(%) 
Cost 
per Mb 
($) 
Cost per 
instrument 
($) 
Time taken 
(h) 
SBS Features References 
Sanger 400-
1000 
99.999 500 95000 0.33-3 Polymerase Chain 
termination 
Shendure and Ji, 2008; 
Foundation for Genomics, and 
Population Health, 2011; Liu et 
al., 2012. 
454 250 99.9 60 500000 10 Polymerase 
Pyrosequencing 
Emulsion PCR Margulies et al., 2005; Dressman 
et al., 2003; Liu et al., 2012). 
SOLiD 35 99.99 2 591000 168 Ligase Emulsion PCR Shendure et al., 2005; McKernan 
et al., 2006; Liu et al., 2012 
HiSeq  36 98 2 430000 192 Polymerase Bridge PCR Bentley, 2006; Fedurco et al., 
2006; Liu et al., 2012 
MiSeq 36-300 99.8 0.5 99000 5.25- 29.25 
(incl. prep.) 
Polymerase Bridge PCR Liu et al., 2012; Loman et al., 
2012; Illumina, 2011a 
Ion PGM 200 99 0.63 80490 8 (incl. prep.) Polymerase Semiconductor Liu et al., 2012; Loman et al., 
2012 
Polonator 
G.007 
13 99.999 1 155000 80 Ligase Emulsion PCR Shendure et al., 2005; Dressman 
et al., 2003; Li, 2015. 
Helicos 
HeliScope 
30 99.999 1 1350000 4-6 Polymerase Single molecule Harris et al., 2008; Braslavsky et 
al., 2003; Shendure and Ji, 2008; 
Liu et al., 2012 
Nanopore >5000 N/A <1.5 1000 48 Electrophysiological Biopore Liu et al., 2012; Timp et al., 2010; 
Goodwin et al., 2016 
N/A: Information not available at present. 
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Following genome sequencing the raw sequencing data requires assembly into 
contigs. Genome assembly can be carried out using numerous different assembly 
platforms, which produce genome assemblies of different sizes and qualities, for 
example a guanine-cytosine (GC) rich bacterial genome sequenced using Ilumina 
Miseq SPAdes preformed better compared to other assemblers (Scott and Ely, 
2015). Due to the differences in assembly methods, the performance of an 
assembler can depend on factors such as; GC content, genome size, genome 
sequencing method, and genome target (Ekbolm and Wolf, 2014). Therefore, it is 
important to consider the advantages and disadvantages of different assemblers with 
respect to the requirements of the specific genome assembly project and the 
available resources (Ekbolm and Wolf, 2014). It is difficult to compare between 
different genome assemblers as the validation of each assembler often uses a 
different genome, however Genome Assembly Gold-Standard Evaluation for 
Bacteria (GAGE-B) evaluated eight different bacterial genomes using different 
assemblers to ensure reproducibility (Magoc et al., 2013). In the comparison of some 
genome assemblers; SPAdes, CLC, MaSuRCA and ALLPATHS-LG (Table 3- 2), it 
was considered that in this project the genome of R. equi ATCC13557, likely a GC-
rich bacterial genome (Letek et al., 2010), was sequenced using IIlumina MiSeq 
(Table 3- 2). Genome assembly by SPAdes uses a multisized de Bruijn graph in 
which bubbles and chimeric reads are removed, the software estimates the distance 
between k-mers, constructs a paired assembly graph based upon Paired de Bruijn 
graphs (PDBGs), and constructs the contigs and maps the reads back to the contigs 
using graph simplification (Bankevich et al., 2012). MaSuRCA combines de Bruijn 
graph with overlap-based assembly methods (Zimin et al., 2013). CLC and 
ALLPATHS-LG use the de Bruijn graph approach, but ALLPATHS-LG requires both 
a mate-paired (MP) and paired-ends (PE) libraries and functions to reduce the 
number of errors such as mismatches within the assembly (Butler et al., 2008; 
Gnerre et al., 2011; CLC Genomics Workbench 9.5.3). SPAdes and CLC were 
chosen to assemble the genome of R. equi ATCC13557 due to ease of use and 
availability of CLC and the quality of assembly for PE Illumina data (Table 3- 2; 
Utturkar et al., 2014).  
Both SPAdes and CLC used a de Bruijn graph based assembly method, in which 
sub-sequences of a certain word size found in the reads are tabulated (CLC 
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Genomics Workbench 9.5.3). The table also contains neighboring forwards and 
backwards words, where the starting word shares its first bases with the backwards 
and its last bases with the forward (CLC Genomics Workbench 9.5.3). A graph is 
then produced where the nodes represent the words and neighbouring nodes are 
connected (CLC Genomics Workbench 9.5.3). Branching of the nodes leads to 
separate nodes which overlap, if there is a sequencing error or single nucleotide 
polymorphism (SNP) present a bubble is formed, but bubbles are corrected by the 
assembler choosing the path of highest coverage (CLC Genomics Workbench 
9.5.3). Most of these parameters are within a simple user-interface on CLC where 
the parameters may be set or they can be automatically calculated, additionally 
trimming, quality assessment and genome finishing can all be carried out within the 
assembly software. However, there is a need to use additional programmes to carry 
out additional assembly steps when using SPAdes, for example before assembly the 
quality of the raw sequencing data needs to be assessed using, for example FastQC 
(Andrews, 2010), and then trimming can be carried out using trimming software such 
as Trimmomatic (Bolger et al., 2014). Trimmomatic is a command-line based 
software which removes adapter sequences and carries out quality filtering to 
remove poor quality reads from the sequencing data before assembly (Bolger et al., 
2014). Following SPAdes assembly, unlike CLC which produces the assembly 
statistics, a quality assessment software such as, Quality Assessment Tool for 
Genome Assemblies (QUAST) is required to assess the size of the assembled 
genome, misassemblies and the N50 score, which is the average length of the 
longest 50% of contigs assembled (Gurevich et al., 2013). In order to carry out 
genome finishing in CLC the genome finishing module is required, but once 
purchased can be used within the CLC workbench (CLC Genomics Workbench 
9.5.3). In order to carry out genome finishing for SPAdes assemblies the reads can 
be aligned to the assembled contigs using Mauve which uses algorithmic methods to 
scale the sequence lengths being aligned (Darling, 2004). Following mapping the 
contigs can be reordered using Bowtie2 software which aligns sequence reads to a 
reference genome (Langmead and Salzberg, 2012). Genome analysis can then be 
carried out using Artemis to browse the genome and identify any SNPs, insertions or 
deletions (Rutherford et al., 2000).  
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Table 3-2: Comparing the advantages and disadvantages of different genome assemblers. 
Assembler Advantages Disadvantages 
CLC - User friendly and fast assembly 
- Can be used to design primers and probes using 
graphs and algorithms (CLC Genomics Workbench 
9.5.3). 
- Low memory 4GB RAM recommended 2GB 
required (CLC Genomics Workbench 9.5.3). 
- Tracks to display and compare data. 
- Can be used to find ORFs in a sequence. 
- Cost 
- Difficult to alter algorithms (Ekblom and Wolf, 2014). 
- Poorer assembly statistics compared to SPAdes, MaSuRCA 
and ALLPATHS-LG (Utturkar et al., 2014). 
 
SPAdes -Cost 
- High genome coverage and assembly accuracy 
compared to MaSuRCA and ALLPATHS-LG 
(Utturkar et al., 2014). 
-Identified as one of the best algorithms for bacterial 
genome assemblies using Illumina data (Utturkar et 
al., 2014) 
- The best summary statistics using Illumina PE 
reads (Utturkar et al., 2014) 
 
-Sometimes generates small unaligned contigs indicating that 
they should be discarded (Magoc et al., 2013). 
 - Can handle only one library at a time. 
- Requires preliminary read error correction (e.g. with 
BayesHammer or IonHammer) or the assembly will require 
more time and memory (Bankevich et al., 2012). 
- Other software, such as QUAST, are needed to generate 
summary statistics and for gene finding. 
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MaSuRCA -Cost 
- For B. cereus produced the highest N50 and N50 
corrected contigs compared to SPAdes; N50 was 
twice any other assembler (Magoc et al., 2013). 
- For M. abscessus generated larger contigs than 
SPAdes (Magoc et al., 2013). 
- Produced largest contigs for a 4.75 Mb genome 
measured by either N50 or corrected N50 values, 
for 10 of the 12 experiments (Magoc et al., 2013). 
-Can create good contigs that it labels ‘degenerate’ based on 
internal coverage statistics, which can cause it to omit some 
parts of the genome from the assembly (Magoc et al., 2013). 
- Assembly can be genome and data dependent (Utturkar et 
al., 2014). 
 
ALLPATHS-
LG 
-Cost 
- Outperformed the SPAdes assemblies in terms of 
contig numbers and generated superior hybrid 
assemblies (Nagarajan and Pop, 2013). 
- Requires a lot of memory, 32GB recommended (Ekblom 
and Wolf, 2014). 
- Lower contig numbers than SPAdes  
- Requires high sequence coverage in order to compensate 
for the shortness of the reads. The precise coverage required 
depends on the length and quality of the paired reads, but 
typically is of the order 100x or above (Ekblom and Wolf, 
2014). 
- Requires a short and jumping libraray (Magoc et al., 2013). 
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Exploring the genome may help in understanding the evolution of the estrogen 
degradation pathway and through genome comparison may help with the 
identification of unknown estrogen degrading bacteria and degradation gene 
clusters. For example, a study searched genome databases for gene clusters coding 
enzymes involved in steroid degradation, identifying 8000 taxa containing genes 
coding enzymes involved in steroid degradation, and predicted steroid degradation in 
taxa (Bergstrand et al., 2016). Using genomics the cholate degradation pathway was 
found to be evolutionarily conserved, and that genes encoding enzymes within 
cholate and cholesterol degradation pathways were located on a single gene cluster, 
within the genome of R. equi (Bergstrand et al., 2016). Furthermore, analysis of the 
Rhodococcus sp. RHA1 genome revealed its diverse catabolic potential, including 
the identification of genes coding for enzymes involved in steroid degradation 
(McLeod et al., 2006). 
As mentioned previously in the general introduction (Section 1.9), the only whole 
genome sequences for estrogen degrading bacteria, are of the E2 and E1 degrading 
bacteria Sphingomonas sp. KC8 (Hu et al., 2011) and Pseudomonas putida strain 
SJTE-1 (Liang et al., 2012), Rhodococcus sp. P14 which transforms E2 to E1 
(Zhang et al., 2012; Ye et al., 2017), and Pseudomonas citronellolis SJTE-3 an E1, 
E2, E3 and EE2 degrader (Zheng et al., 2016). Several genes encoding the 
enzymes suggested to be putatively involved in estrogen degradation, such as 
hydroxysteroid dehydrogenase, 3-ketosteroid-delta1-dehydrogenase, rieske 
dioxygenase, catechol 2,3-dioxygenase, were observed in the genomes of P. putida 
strain SJTE-1 and Sphingomonas sp. KC8 (Liang et al., 2012; Hu et al., 2011). 
Furthermore, the gene coding for 17β-hydroxysteriod dehydrogenase was 
upregulated in Rhodococcus sp. P14 when exposed to E2, suggesting that 17β-
hydroxysteriod dehydrogenase is responsible for the dehydrogenation of the C-17 
within the D ring of E2 to produce E1 (Ye et al., 2017).  
There are a limited number of estrogen degrading bacteria (10) available on culture 
collection websites (Table 1- 4). Rhodococcus equi ATCC® 13557TM was identified 
in the literature as an EE2 degrading bacterium (Larcher and Yargeau, 2013; 
O’Grady et al., 2009), and from the bacteria available by culture collection it had the 
highest removal of EE2 (Table 1- 4), therefore it was selected as a model organism 
for the biodegradation studies.  
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The genome of R. equi ATCC13557 will be assembled and evaluated for the genes 
identified as coding for enzymes potentially involved in estrogen degradation from 
the hypothetical estrogen degradation pathway (Fig. 2- 1). Furthermore the genome 
of R. equi ATCC13557 will be compared with the genomes of Sphinomonas sp. KC8 
(Hu et al., 2011) and Pseudomonas putida strain SJTE-1 (Liang et al., 
2012).Therefore the hypotheses are that genes coding for enzymes from the 
hypothetical estrogen degradation pathway (Chapter 2) will be present in the 
genome of R. equi ATCC13557 and there will be genes coding for enzymes 
potentially involved in estrogen degradation shared between the genomes of R. equi 
ATCC13557, P. putida SJTE-1 (Liang et al., 2012) and Sphingomonas sp. KC8 (Hu 
et al., 2011). 
 
3.2 Materials and methods 
 Genome sequencing 
The genome of R. equi ATCC13557 was sequenced and prepared by Dr Lucy Eland, 
School of Computing. 
 
3.2.1.1 Bacterial cultivation and genomic DNA extraction 
The following method was provided from Dr Lucy Eland, School of Computing:  
“Qiagen DNeasy DNA extraction protocol for bacterial cultures 
Adapted from Qiagen DNeasy handbook, July 2006  
A culture of R. equi ATCC13557 was prepared by seeding 10 mL of nutrient broth 
with a single colony taken from a nutrient agar plate. The culture was incubated 
over-night at 26°C. To pellet the bacteria, 1.75 mL of the culture was added to a 
labelled 2 mL spin tube and centrifuged at 20, 000 x g for 3 minutes, the supernatant 
was then removed and discarded. To lyse the bacterial cells, 180 µL of enzymatic 
lysis buffer, prepared using; 20mM Tris-Cl (pH), 2mM Sodium EDTA and 1.2% Triton 
(x100), was added to the spin tube and vortexed for 10-20 seconds. The tube was 
then incubated for 30 minutes at 37°C. Following incubation, 25 µL of proteinase K 
and 200 µL of buffer AL were added to the tube, and vortexed to mix. The tube was 
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then incubated for 30 minutes at 56°C. It was allowed to cool for 2 minutes, before 
adding 200 µL of 100% ethanol to the tube, incubating at room temperature for 2 
minutes, and then vortexing to mix. The contents of the tube (~600 µL) were 
transferred to a labelled 2 mL collection tube and centrifuged at 10,000 x g for 1 
minute. The column was then placed into a new collection tube, and the supernatant 
was discarded. Then 500 µL of buffer AW1 was added to the column, incubated at 
room temperature for 2 minutes, and centrifuged at 10,000 x g for 1 minute. Again 
the column was placed into a new collection tube and the supernatant was 
discarded. Next, 500 µL of buffer AW2 was added to the column and incubated at 
room temperature for 2 minutes, then the tube was centrifuged at 20,000 x g for 3 
minutes. The tube was carefully removed from the centrifuge to ensure the flow-
through did not come into contact with the column. The column was transferred to a 
1.5 mL tube, to which 100 µL of sterile molecular grade water (Sigma Aldrich) was 
added to the column and incubated at room temperature for 5 minutes. The tube was 
then centrifuged at 10,000 x g for 1 minute. The column was transferred to a new 1.5 
mL tube and 100 µL of sterile molecular grade water (Sigma Aldrich) was added to 
the column and incubated at room temperature for 5 minutes. The column was 
centrifuged at 10,000 x g for 1 minute, then the column was discarded. Following 
assessment of the quantity and quality of the two elutions using nanodrop, in which 
the 260/280 = 1.8 and 260/230 = 2.0, the better elution was chosen and the DNA 
was stored at -20°C. 
 
3.2.1.2 Library preparation and Illumina MiSeq sequencing 
The following method was provided by Dr Lucy Eland, School of computing:  
The genomic DNA elution was diluted using molecular-grade water (Sigma Aldrich) 
to a concentration of 1 ng. Sequencing was carried out using the Illumina Nextera XT 
library prep kit using amplicons >300 bp. During the Nextera XT library preparation 
the DNA was quantified using the Qubit (high sensitivity dsDNA kit) and the fragment 
sizes were measured using the Bioanalyser (high sensitivity DNA kit) as quality 
control steps. The Bioanalyser trace from the Illumina Miseq raw sequence data, 
which was carried out after PCR and the first clean-up stage, including the fragment 
and adapter sequence lengths, was provided by Dr Lucy Eland (School of 
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Computing) (Appendix, Fig. 0- 16) (Appendix, Tables 0- 1, 2, 3). The Nextera XT 
library was sequenced using an Illumina MiSeq 300 bp paired-end read run on a V3 
cartridge, on the ‘FASTQ only’ setting to remove the adapter sequences.  
 
 Genome assembly 
Various genome assembly methods were considered (Table  3- 2), however CLC 
and SPAdes were selected due to their low computational requirements, availability 
and ease of use. 
 
3.2.2.1 CLC 
 
Following the workflow (Fig. 3- 1), the genome of R. equi ATCC13557 was 
assembled using CLC. The raw sequence data was imported into CLC workbench 
7.5 as Illumina fastq paired-end data with a minimum distance of 397 and maximum 
distance of 3,520, which were determined by looking at the bioanalyser trace 
information, and with the failed reads removed and the quality assessment was 
created using quality scores using NCBI/Sanger or Illumina 1.8 and later. 
Trimming was carried out using a limit of 0.05 and a maximum number of 
ambiguities of 2, reads below 36 bases were discarded. 
De Novo assembly was carried out with the following parameters; word size of 23, 
bubble size of 228, minimum contig length of 200, perform scaffolding and auto 
detect paired distances. For the read mapping options, “map reads back to contigs 
(slow)” was selected. The following parameters were the default; mismatch cost of 2, 
insertion cost of 3, deletion cost of 3, Length fraction of 0.5 and similarity fraction of 
Data import
Quality 
assessment
Trimming
De Novo 
assembly
Map reads 
back to 
contigs
Contig 
joining
Contig 
analysis
Figure 3-1:  Workflow for the genome assembly of R. equi ATCC13557 using CLC. 
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0.8 with a list of unmapped reads created. Word size and bubble size were 
automatically calculated by CLC. 
Using the genome finishing module, the contigs were joined using Rhodococcus equi 
103S (Letek et al., 2010) as a reference genome. The reference genome was 
selected by submitting the largest contig sequence, contig 5, from the R. equi 
ATCC13557 assembled genome with a size of 598658 bp to Genbank and selecting 
the genome with the highest similarity, which was 99% identity and a 0.0 E value, 
and then the contigs were analysed.  
   
3.2.2.2 SPAdes 
 
Following the workflow (Fig. 3- 2) the genome of R. equi ATCC13557 was 
assembled using SPAdes (Bankevich et al., 2012). The quality of the raw sequence 
data was assessed during the CLC assembly so was not repeated, then the data 
was trimmed using Trimmomatic based on the average quality of 4 bases and to 
remove any reads below the length of 36 bases. SPAdes was then used to assemble 
the paired-end Illumina raw data using the default parameters except “--cov-cutoff 
auto” to remove contigs with lower coverage and "--careful" was used to reduce the 
number of mismatches and short indels within the genome. QUAST (Gurevich, et al., 
2013) was used to evaluate the SPAdes genome assembly. Mauve (Darling, 2004) 
was used to align the original reads back to the assembled genome. Bowtie 2 on the 
usegalaxy.org (Afgan, et al., 2016; Langmead and Salzberg, 2012) was used to 
reorder the contigs. Artemis was used to browse the genome and look for SNPs and 
insertions or deletions (Rutherford, et al., 2000).  
Quality assessment Trimming
De Novo 
assembly
Genome 
assembly 
evaluation
Map reads 
back to 
contigs
Contig 
reordering
Contig 
analysis 
Figure 3-2: Workflow for the genome assembly of R. equi ATCC13557 using SPAdes 
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 Annotation 
Both the CLC and SPAdes genome assemblies were submitted to RAST for 
annotation, and the SEED viewer was used to search for the genes identified in the 
hypothetical estrogen degradation pathway (Chapter 2) (Aziz et al., 2008; Overbeek, 
et al., 2014; Brettin, et al., 2015).     
 
 Creating a graphical map of the genome 
The CGView Comparison Tool (CCT) (Grant et al., 2012) was used to create a 
graphical representation of the genome. As outlined in the CCT website (Grant et al., 
2012), the command “cgview_comparison_tool.pl –p CCT” to create a project, the 
assembled genome the R. equi 103S (Letek et al., 2010) were added to the project 
folders for comparison along with the genes to label and a file containing information 
about the genes. The project settings folder was edited to produce a large map using 
nucleotide sequences. The map was then customised to resize the diagram and text 
using the command “cgview_comparison_tool.pl -p CCT --cct --custom 
useInnerLabels=false featureThickness=150 _cct_blast_thickness=200 
titleFontSize=150 rulerFontSize=70 rulerPadding=100 legendFontSize=70 
backboneRadius=2200 arrowheadLength=20 labelLineLength=80 featureOpacity=1 
labelFontSize=80 maxLabelLength=500 maxLegendLength=400 gene_labels=t 
height=6000”.  
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 Genomic analysis 
A database of genes containing enzymes potentially involved in estrogen 
degradation was compiled using the hypothetical estrogen degradation pathway 
(Fig.2- 1) (Table 2- 1). In addition to these, 3-ketosteriod Δ1-dehydrogenase, also 
named 3-oxosteriod 1-dehydrogenase, responsible for the conversion of 4-AD to 
Androsta-1,4-diene-3,17-dione (ADD) within the testosterone degradation pathway, 
was included in a database of potential estogen degradation genes due to 
upregulation when exposed to E2 (Sang et al., 2011). Genes identified in the 
genome of Comamonas testosteroni (Horinouchi et al., 2003; Horinouchi et al., 2010; 
Horinouchi et al., 2004; Horinouchi et al., 2005) and the two genome sequences of 
the estrogen degrading bacteria Pseudomonas putida SJTE-1 (Liang et al., 2012) 
and Sphingomonas KC8 (Hu et al., 2011), along with the PAH dioxygenase encoding 
genes (Meynet et al., 2015) and dehydrogenase encoding genes (Kisiela et al., 
2012) have been stored in Fasta format. The compiled list was then used to search 
for other genes with at least 85% identity and any Basic Local Alignment Search 
Tool (BLAST) results were added to the list (Appendix Tables 0- 4 and 5), these 
included monoxygenase and isomerase due to their similarities to dioxygenase and 
dehydrogenase, respectively. A RefSeq ID list is provided for some of the genes 
coding for dehydrogenase (Appendix Table 0- 6) (Kisiela et al., 2012).  
Analysis of the R. equi ATCC13557 was carried out using BLAST in BioLinux to 
search the genome for the presence of the genes encoding the enymes within the 
compiled list of gene sequences coding for enzymes which are potentially involved 
estrogen degradation, this was also carried out for the only other two genomes of 
known estrogen degrading bacteria Sphingomonas sp. KC8 and Pseudomonas 
putida SJTE-1 (Hu et al., 2011; Liang et al., 2012). A database was created using 
the command “formatdb -p F Sequence_files/genome.fasta” then the database was 
searched using tblastn, using the command “tblastn -query Protein_files/*.fasta -db 
Sequence_files/genome.fasta -outfmt 7 -out Outputfiles/*.txt” 
Using Rapid Annotation using Subsystem Technology (RAST) (Aziz et al., 2008; 
Overbeek et al., 2014; Brettin et al., 2015), genomes with similarity to R. equi 
ATCC13557 were identified. Furthermore, the genome was compared to the 
genomes of Sphingomonas sp. KC8 and Pseudomonas putida SJTE-1 (Hu et al., 
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2011; Liang et al., 2012) by using The SEED Viewer sequence based comparison 
tool within RAST (Aziz et al., 2008; Overbeek et al., 2014; Brettin et al., 2015).  
 
3.3 Results and Discussion 
 Quality assessment 
The quality distribution of the raw sequencing data produced by CLC workbench 7.5 
(Fig. 3- 3) PHRED-scores of 30 and above are considered high quality, in the raw 
sequencing data over 60% of sequences being observed above 30, however there 
are some being observed below which could lead to false-positive variant calls 
(Illumina. 2011b), thus smaller sequence lengths were discarded in the later 
assembly. 
 
Figure 3-3: The quality of raw sequence data assessed by CLC workbench 7.5. The 
distribution of average sequence quality scores. The quality of a sequence is calculated as 
the average of its base qualities. x: PHRED-score and y: number of sequences observed at 
that quality score normalised to the total number of sequences. 
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 CLC assembly 
The CLC assembly of Rhodococcus equi ATCC13557 was a total size of 3.93 Mb 
and an N50, 50% of the total, contig length of 180.7 Kb and a total of 663 contigs 
assembled (Fig 3- 4; Tables 3- 3). There is a large range of contig lengths, the 
maximum contig length is 598.7 Kb and the minimum is 200 bases, but the average 
length is 8.2 Kb (Table 3- 3). In the mapping there are 159109 unmapped reads, with 
a length of 121.4 bases and 3,018,040 broken paired reads, with a length of 203.49 
bases. When compared to the R. equi 103S reference genome there were a large 
number of BLAST hits above 98%, however the genome size of the CLC assembly 
of 3.93 Mb is much smaller than the 5.04 Mb genome of R. equi 103S (Fig. 3- 4) 
(Letek et al., 2010).  
 
Table 3-3: The assembly statistics for the R. equi genome assembled using CLC. 
 Length Count Total bases 
Reads 228.4 8,884,954 2,029,296,984 
Matched 230.35 8,725,845 2,009,981,356 
Not matched 121.4 159,109 19,315,628 
Contigs 8,183 663  
Reads in pairs 456.56 5,707,774  
Broken paired 
reads 
203.49 3,018,040  
N75 108,697   
N50 180,906   
N25 392,386   
Minimum 200   
Maximum 598,670   
Average 8,184   
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According to the RAST annotation, the CLC assembled R. equi ATCC 13557 
genome (Fig. 3- 4), contains 3748 predicted coding sequences (CDSs) and 354 
subsystems. Furthermore 37% of genes were categorised within a subsystem, whilst 
63% were not categorised within a subsystem. The largest four subsystems are 
amino acids and derivatives (347), carbohydrates (294), cofactors, vitamins, 
prosthetic groups and pigments (248), and fatty acids, lipids, and isoprenoids (200) 
(Fig. 3- 5). A number of CDSs, related to virulence, disease and defense (59), stress 
response (77) and secondary metabolism (77), suggesting there are diverse 
catabolic genes which assist in the adaptation of the bacteria to the environment. 
Furthermore, there are 62 aromatic pathways for the metabolism of aromatic 
compounds of which 13 are peripheral pathways and 47 are involved in the 
metabolism of central aromatic intermediates, which could assist in the degradation 
of steroids.  
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Figure 3-4: The genome map comparing the CLC assembled R. equi ATCC 13557 to the R. equi 103S reference genome. Starting from the outermost ring the feature rings 
depict: 1. Forward strand sequence features of R.equi ATTC 13557; 2. Reverse strand sequence features of R.equi ATCC 13557; 3. The sequence similarity detected by BLAST 
comparisons conducted between nucleotide sequences from R.equi ATCC 13557 and R.equi 103S; 4. The COG features of the reverse strand sequence; 5. The sequence 
similarity detected by BLAST comparisons conducted between nucleotide sequences from R.equi ATCC 13557 and R.equi 103S; The final rings display the GC content and the 
GC skew. A gene cluster of potential estrogen degradation genes is labelled on the outermost ring. Diagram produced using CCT (Grant et al., 2012). 
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Figure 3-5: The subsystem distribution, coverage and counts within the CLC genome assembly of R. equi ATCC13557 as annotated by Rapid 
Annotation System Technology (RAST) server (Aziz, RK et al., 2008; Overbeek, R et al., 2014; Brettin, T et al., 2015). 
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 SPAdes assembly 
3.3.3.1 QUAST assembly statistics 
The SPAdes assembled R. equi ATCC13557 genome had a size of 5.24 Mb with an 
N50 contig length of 196.4 Kb, and a total of 53 contigs (Fig. 3- 5; Table 3- 4). 
Furthermore the length of the longest contig is 715.1 Kb, with the 45 of the contigs 
being over 1000 bp in length (Table 3- 4). Therefore, the size of the SPAdes 
assembly, 5.24 Mb, was of a similar size to the 5.04 Mb genome of R. equi 103S 
(Letek et al., 2010).  
 
Table 3-4: Assembly statistics for the SPAdes assembled R. equi ATCC13557 genome. 
 
 
 
Statistics Contigs 
# contigs 53 
# contigs (>= 0 bp) 55 
# contigs (>=1000 bp) 45 
Largest contig 715095 
Total length 5243649 
Total length (>= 0 bp) 5243905 
Total length (>= 1000 bp) 5238676 
N50 196389 
N75 119737 
L50 7 
L75 15 
GC (%) 68.73 
Mismatches  
# N’s 0 
# N’s per 100 kbp 0 
Predicted genes  
# predicted genes (unique) 4870 
# predicted genes (>= 0 bp) 4873 
# predicted genes (>= 300 bp) 4436 
# predicted genes (>= 1500 bp) 659 
# predicted genes (>= 3000 bp) 69 
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According to the RAST annotation the genome of R. equi ATCC 13557 (Fig. 3- 6), 
assembled using SPAdes, contains 4924 predicted coding sequences (CDSs) and 
414 subsystems. Furthermore 39% of genes were categorised within a subsystem, 
whilst 61% were not categorised within a subsystem. The largest four subsystems 
are Amino Acids and Derivatives (494), Carbohydrates (415), Cofactors, Vitamins, 
Prosthetic Groups, Pigments (355), and Fatty Acids, Lipids, and Isoprenoids (274) 
(Fig. 3- 7).  A large number of CDSs, similar in number to those in the genomes of 
Sphingomonas sp. KC8 (Hu et al., 2011) and Pseudomonas putida SJTE-1 (Liang et 
al., 2010) are found to be related to virulence, disease and defense (81), stress 
response (129) and secondary metabolism (11) which suggest there are diverse 
catabolic genes which assist in the adaptation of the bacteria to the environment. 
Furthermore, there are 75 pathways for the metabolism of aromatic compounds, of 
which 14 are peripheral pathways and 59 are involved in the metabolism of central 
aromatic intermediates, which could assist in the degradation of steroids. 
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Figure 3-6: The genome map comparing the SPAdes assembled R. equi ATCC 13557 to the R. equi 103S reference genome. Starting from the outermost ring the feature rings 
depict: 1. COG features of the forward strand sequence; 2. Forward strand sequence features of R.equi ATTC 13557; 3. Reverse strand sequence features of R.equi ATCC 
13557; 4. The COG features of the reverse strand sequence; 5. The sequence similarity detected by BLAST comparisons conducted between nucleotide sequences from R.equi 
ATCC 13557 and R.equi 103S; The final rings display the GC content and the GC skew. A gene cluster encoding enzymes potentially involved in estrogen degradation is 
labelled on the outermost ring. Diagram produced using CCT (Grant et al., 2012) 
P a g e  | 62 
 
Figure 3-7: The subsystem distribution, coverage and counts within the SPAdes assembly of R. equi ATCC13557 as annotated by Rapid Annotation 
System Technology (RAST) server (Aziz, RK et al., 2008; Overbeek, R et al., 2014; Brettin, T et al., 2015). 
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 Comparison of the SPAdes and CLC assemblies of R. equi ATCC13557 
The genome assembly using SPAdes had a larger genome size of 5.24Mb 
compared to the CLC assembly of 3.93Mb. Furthermore, the N50 score of the 
SPAdes assembly was higher at 196.4Kb than the CLC assembly of 180.7Kb. Also 
there were 53 contigs assembled by the SPAdes compared to 663 assembled by 
CLC. Meaning the SPAdes assembly produced a smaller number of higher quality 
contigs, due to their longer average length, compared to the contigs assembled 
using CLC. Furthermore, in the RAST annotation fewer CDSs were found in the CLC 
assembly (3748), compared to the SPAdes assembly (4924), the numbers of 
subsystems were lower and the percentage of genes classified in a subsystem was 
slightly lower for the CLC assembly (37%) compared to SPAdes assembly (39%). 
The lower number of CDSs and subsystems within the CLC genome assembly 
suggests that the assembly was not as complete compared to the SPAdes 
assembly. The SPAdes assembly, is according to the assembly statistics, a better 
assembly, so the R.equi ATCC13557 genome assembled using SPAdes was used in 
any further analysis and comparisons. 
 
Table 3-5: Comparison of the assembly statistics of R. equi ATCC13557 assembled using CLC 
and SPAdes 
 
Assembly statistic 
Genome assembler 
CLC SPAdes 
Genome size (Mb) 3.93 5.24 
N50 (Kb) 196.4 180.7 
Number of Contigs 663 53 
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 Genome comparison 
According to the functional comparison in the RAST server the closest neighbors of 
R.equi ATCC13557 are Rhodococcus jostii RHA1 (score 504), followed by 
Rhodococcus opacus B4 (score 494), another genome of Rhodococcus jostii RHA1 
(score 489) and Rhodococcus equi 103S (score 449) (Table 3 –6). The neighbor 
score assigned by RAST is the number of top BLAST hits between genes within the 
genome of R.equi ATCC13557 and the neighbor genomes and therefore indicates 
the functional similarities. All of the 30 closest neighbors to R.equi ATCC13557; 
Rhodococcus, Nocardia, Mycobacterium and Gordonia, were all from the 
phylogenetically-related sub-order Corynebacterineae. The closest neighbor, 
Rhodococcus jostii RHA1, is a soil bacterium with a diverse catabolic potential, 
which can degrade aromatic compounds such as biphenyl, chloate and cholesterol 
(McLeod et al., 2006; Bergstrand et al., 2016). Rhodococcus erythropolis (score 
437), although a different strain, is suggested to have the ability to partially degrade 
EE2 in the presence of a cosubstrate (O’Grady et al., 2009; Larcher and Yargeau, 
2013). 
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Table 3-6: The closest neighbours of R. equi ATCC13557 according to RAST 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Score: The number of top blast hits for genes shared between R.equi ATCC13557 and the neighbor 
genome. 
Genome ID Score Genome name 
101510.15 504 Rhodococcus jostii RHA1  
632772.3 494 Rhodococcus opacus B4  
101510.16 489 Rhodococcus jostii RHA1  
685727.3 449 Rhodococcus equi 103S  
234621.6 437 Rhodococcus erythropolis PR4  
596309.3 429 Rhodococcus erythropolis SK121  
247156.1 369 Nocardia farcinica IFM 10152  
247156.8 340 Nocardia farcinica IFM 10152 
745408.3 228 Rhodococcus sp. JVH1 
186196.5 218 Rhodococcus sp. DK17  
525370.3 199 Rhodococcus equi ATCC 33707  
1206729.4 180 Nocardia exalbida NBRC 100660  
246196.19 154 Mycobacterium smegmatis str. MC2 155  
1206721.4 147 Nocardia asiatica NBRC 100129  
1206735.3 143 Nocardia takedensis NBRC 100417  
1165867.3 137 Rhodococcus imtechensis RKJ300  
543736.3 133 Rhodococcus opacus PD630  
1078016.3 130 Rhodococcus erythropolis XP  
1206737.4 129 Nocardia pneumoniae NBRC 100136 
1206730.4 120 Nocardia higoensis NBRC 100133 
1077976.3 119 Gordonia polyisoprenivorans NBRC 16320 
1089454.3 116 Gordonia terrae NBRC 100016 
1206722.4 115 Nocardia araoensis NBRC 100135 
246196.1 115 Mycobacterium smegmatis str. MC2 155 
1214102.3 112 Mycobacterium fortuitum subsp. fortuitum DSM 
46621 
350058.5 108 Mycobacterium vanbaalenii PYR-1 
278137.3 106 Mycobacterium sp. Spyr1 
164756.15 105 Mycobacterium sp. MCS 
350058.8 105 Mycobacterium vanbaalenii PYR-1 
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 Genome evaluation for genes coding for enzymes potentially involved 
in estrogen degradation 
RAST annotation suggested there may be a gene cluster, containing some of genes 
coding for enzymes potentially involved in estrogen degradation, which was present 
in both the CLC and SPAdes genome assemblies (Fig. 3- 8). The presence of the 
genes within a cluster suggests that they are evolutionarily conserved, like the 
cholate and cholesterol degradation pathways which are located on a single gene 
cluster, within the genome of R. equi (Bergstrand et al., 2016). The gene cluster 
contains genes coding for the enzymes identified in the hypothetical estrogen 
degradation pathway (Fig. 2-1; Table 2- 1); 3-carboxyethylcatechol 2,3-dioxygenase 
(EC 1.13.11.16) which catalyses an oxidation reaction by the addition of two oxygen 
molecules, which is likely to be responsible for reactions 1, 6, 8, and 11 (Fig 2- 1; 
Table 2-1); 2-hydroxymuconic semialdehyde hydrolase (EC 3.7.1.9) catalyses the 
hydrolysis of carbon-carbon bonds in ketonic substances, responsible for reaction 12 
(Fig 2- 1; Table 2-1); 3-alpha-(or 20-beta)-hydroxysteroid dehydrogenase is involved 
in steroid degradation by acting on the CH-OH groups with NAD+ or NADP+ as an 
acceptor, responsible for reaction 7 (Fig 2- 1; Table 2-1);  3-(3-hydroxy-
phenyl)propionate hydroxylase (EC 1.14.13.127) is involved in the degradation of 
aromatic compounds by incorporation or reduction of oxygen, responsible for 
reactions 4, 5, 9 and 10 (Fig 2- 1; Table 2-1); 3-oxosteroid 1-dehydrogenase (EC 
1.3.99.4), named 3-ketosteriod Δ1-dehydrogenase within the testosterone 
degradation pathway (Horinouchi et al., 2012) (Fig. 2- 1), by acting upon CH-CH 
groups (Kanehisa et al., 2000; Kanehisa et al., 2016; Kanehisa et al., 2017); and 
transcriptional regulator IcIR family regulates the genes involved in the degradation 
of aromatic compounds (Molina-Henares et al., 2006). Within the hypothetical 
estrogen degradation pathway the genes encoding the enzymes were previously 
stated as the class which contain many enzymes which carry out a similar function; 
dioxygenase, hydroxylase, 17β-hydroxysteriod dehydrogenase, and hydrolase (Fig 
2- 1; Table 2-1). As this study is focused upon the model organism R.equi 
ATCC13557 the enzymes will be henceforth referred to more specifically as their 
annotated name given by RAST of 3-carboxyethylcatechol 2,3-dioxygenase, 3-(3-
hydroxy-phenyl)propionate hydroxylase, 3-alpha-(or 20-beta)-hydroxysteroid 
dehydrogenase, and 2-hydroxymuconic semialdehyde hydrolase respectively. 
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Figure 3-8: A RAST diagram of a chromosomal region around the focus gene coding for  3-carboxyethylcatechol 
2,3-dioxygenase (red, 1). The other genes present code for 2-hydroxymuconic semialdehyde hydrolase (light 
green, 2), 3-alpha-(or 20-beta)-hydroxysteroid dehydrogenase (yellow, 5), 3-(3-hydroxy-phenyl)propionate 
hydroxylase (turquoise, 6), 3-oxosteroid 1-dehydrogenase (dark green, 8) and transcriptional regulator IcIR 
family (blue, 10). The grey arrows are genes with the relative position conserved found in at least four other 
species. 
 
Protein BLAST (BLASTP) comparisons of the R. equi ATCC 13557, Sphingomonas 
KC8 and P. putida SJTE-1 genomes with a database of gene sequences coding for 
enzymes potentially involved in estrogen degradation were carried out in Bio-Linux 
8.0 software (Field et al., 2006). The BLASTP hits above 70% identity are 
summarised and the genes with significant similarity, having a low E-value and large 
coverage are highlighted yellow (Tables 3- 7, 8, 9).  
For Rhodococcus equi there are 11 sequences with identity >70% to 3-ketosteriod 1-
dehydrogenase (3-oxosteriod 1-dehydrogenase), which within the degradation 
pathway of testosterone catalyses the conversion of 4-AD to ADD (Fig. 2- 1), within 
other species of Rhodococcus and also in Mycobacterium ulcerans Agy99, all of 
which are from the phylogenetically-related mycolic-acid containing sub-order 
Corynebacterineae (Table 3- 7). Although other genes showed similarity to genes 
coding for enzymes involved in steroid degradation, such as hydratase (TesD), 
which catalyses the conversion of 4,9-DHSA to 2-hydroxyhexa-2,4-dienoic acid and 
3-[(3aS, 7aS)-7a-methyl-1,5-dioxooctahydro-1H-inden-4-yl] propanoate in reaction 
12 (Fig. 2- 1 and Table 2- 1), the sequence alignment length is very small (14 amino 
acids) suggesting only a small length of the gene had similarity (Horinouchi et al., 
2003). However, this may be important when considering the design of primers to 
target genes coding for enzymes involved in steroid degradation. 
In Sphingomonas KC8, the genes with significant identity, greater than 70% and 0.0 
e-10, to those in the database of genes coding for enzymes potentially involved in 
estrogen degradation were different to those found in Rhodococcus equi; 3-
ketosteriod 5-dehydrogenase (71.14%) was identified in another Sphingomonas 
species, Sphingomas wittichii RW1, and a dioxygenase (84.81%) present in 
Pseudomonas sp. SKA58 (Table 3- 8). All of these genes with significant identity 
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were from Proteobacteria, which is a group phylogenetically distinct and unrelated to 
the sub-order Corynebacterineae, to which Rhodococcus equi belongs. However, 
the gene coding for 3-ketosteriod 1-dehydrogenase of R. equi ATCC13557 shared 
71.14% identity with Sphingomonas sp. KC8 but had an E value of 5.9 over a small 
sequence length of 17 amino acids. 
In Pseudomonas putida SJTE-1, the genes with significant identity, greater than 70% 
and 0.0 e-10, to those in the database of genes encoding enzymes potentially 
involved in estrogen degradation were two genes coding for dioxygenase (100% and 
96.91%) and a genes coding for catechol dioxygenase (98.08%) present in other 
species of Pseudomonas (Table 3- 9). 
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Table 3-7: BLASTP comparisons of the R. equi ATCC 13557 genome with the database of genes coding for enzymes potentially involved in 
estrogen degradation. 
Enzyme BLASTP hit 
Bacteria Accession/ 
Protein Seq ID 
Percentage 
identity (%) 
Alignment 
length 
Mismatches E value 
(e-10) 
3-ketosteriod 5-dehydrogenase Comamonas testosteroni 
CNB-2 
YP_003277400.
1  
71.43 14 4 1.6 
3-ketosteriod 5-dehydrogenase Comamonas testosteroni 
TA441 
AB076368  71.43 14 4 1.7 
3-ketosteriod 1-dehydrogenase (3-
oxosteriod 1-dehydrogenase) 
Rhodococcus erythropolis 
PR4 
NC_012490 87.39 555 66 0 
3-ketosteriod 1-dehydrogenase (3-
oxosteriod 1-dehydrogenase) 
Rhodococcus jostii RHA1 NC_00826  80.04 551 110 0 
3-ketosteriod 1-dehydrogenase (3-
oxosteriod 1-dehydrogenase) 
Rhodococcus jostii RHA1 YP_704476  78.30 553 115 0 
3-ketosteriod 1-dehydrogenase (3-
oxosteriod 1-dehydrogenase) 
Mycobacterium 
smegmatis str. MC2 155 
chromosome 
NC_008596.1 70.05 551 163 0 
3-ketosteriod 1-dehydrogenase (3-
oxosteriod 1-dehydrogenase) 
Rhodococcus jostii RHA1 YP_705733  80.04 551 110 0 
3-ketosteriod 1-dehydrogenase (3-
oxosteriod 1-dehydrogenase) 
Rhodococcus erythropolis 
PR4 
YP_002764184  87.21 555 67 0 
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Enzyme BLASTP hit 
Bacteria Accession/ 
Protein Seq ID 
Percentage 
identity (%) 
Alignment 
length 
Mismatches E value 
(e-10) 
3-ketosteriod 1-dehydrogenase (3-
oxosteriod 1-dehydrogenase) 
Rhodococcus opacus B4 YP_002783051  80.59 546 106 0 
3-ketosteriod 1-dehydrogenase (3-
oxosteriod 1-dehydrogenase) 
Rhodococcus erythropolis 
SK121 
ZP_04388196  87.21 555 67 0 
3-ketosteriod 1-dehydrogenase (3-
oxosteriod 1-dehydrogenase) 
Rhodococcus erythropolis 
PR4 
NC_012490.1 87.39 555 66 0 
3-ketosteriod 1-dehydrogenase (3-
oxosteriod 1-dehydrogenase) 
Rhodococcus jostii RHA1 NC_008268.1 80.04 551 110 0 
3-ketosteriod 1-dehydrogenase (3-
oxosteriod 1-dehydrogenase) 
Mycobacterium ulcerans 
Agy99 
NC_008611.1 67.03 558 178 0 
3-betahydroxysteriod Delta-5 
dehydrogenase 
Mycobacterium abscessus NC_01039 80.30 264 52 3.00E-
132 
Dioxygenase Rhodococcus sp. R04 JF502261 80.00 300 59 4.00E-
147 
Dioxygenase Rhodococcus sp. YK2 AB070456 80.00 15 2 4.8 
Catechol dioxygenase Burkholderia xenovorans 
LB400 
NC_007953 88.24 17 2 0.023 
Hydratase (TesD) Comamonas testosterone LC_010134 78.57 14 3 6.3 
Hydroxylase (3-ketosteriod 9-alpha 
monooxygenase) 
Rhodococcus sp. RD6 CVQP01000005
.1 
70.20 349 104 1.00E-44 
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Table 3-8: BLASTP comparisons of the Sphingomonas sp. KC8 genome with the database of genes coding for enzymes potentially involved in 
estrogen degradation. 
Enzyme BLASTP hit 
Bacteria Accession/ 
Protein Seq ID 
Percentage 
identity (%) 
Alignment 
length 
Mismatches E value 
(e-10) 
3-ketosteriod 5-
dehydrogenase 
Sphingomonas wittichii RW1 YP_001263819.1 71.14 551 159 0 
3-ketosteriod 1-
dehydrogenase (3-
oxosteriod 1-
dehydrogenase) 
Rhodococcus equi ATCC 13557  70.59 17 5 5.9 
3beta Delta5-steroid 
dehydrogenase 
Mycobacterium abscessus NC_010397.1 75.00 12 3 6.3 
Dioxygenase 
(homogentisate 1,2-
dioxygenase) 
Pseudomonas putida SJTE-1 NZ_AKCL010000
92.1 
72.73 11 3 0.71 
 Dioxygenase (taurine 
dioxygenase) 
Pseudomonas putida SJTE-1 NZ_AKCL010000
07.1  
70.59 17 5 1.2 
Dioxygenase Pseudomonas sp. SKA58 AAQG01000001 84.81 441 67 0 
Catechol dioxygenase Bradyrhizobium elkanii USDA 76 NZ_KB900701.1 73.33 15 4 4 
Hydratase Comamonas testosteroni TK102 CP006704 90.91 11 1 8.5 
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Table 3-9: BLASTP comparisons of the P. putida SJTE-1 genome with the database of genes coding for enzymes potentially involved in estrogen 
degradation. 
 
Enzyme 
BLASTP hit 
Bacteria Accession/Protein 
Seq ID 
Percentage 
identity (%) 
Alignment 
length 
Mismatche
s 
E value (e-
10) 
3 or 17-beta hydroxysteriod 
dehydrogenase 
Pseudomonas protegens Pf-5 NC_004129.6  79.69 325 66 7.00E-170 
7-alpha hydroxysteriod 
dehydrogenase 
Acinetobacter radioresistens 
DSM 6976 
NZ_KB849749.1 70.59 17 5 6.5 
12alpha hydroxysteriod 
dehydrogenase 
Bacteriodes pectinophilus ATCC 
43243 
ZP_03463615.1 73.33 15 4 3 
3-ketosteriod delta 4(5alpha) –
dehydrogenase (3-oxosteroid 
1-dehydrogenase) 
Comamonas testosteroni ATCC 
17410 
L23428.1 83.33 12 2 7.1 
Dioxygenase Pseudomonas putida KT2440 AE015451  100 453 0 0 
Dioxygenase Pseudomonas monteilii SB3101 CP006979  84.33 453 71 2.00E-115 
Dioxygenase Pseudomonas putida DOT-T1E CP003734  98.02 202 4 4.00E-89 
Dioxygenase Pseudomonas monteilii SB3078 CP006978  84.33 453 71 2.00E-115 
Dioxygenase Pseudomonas putida F1 CP000712 96.91 453 14 0 
Dioxygenase Sphingomonas sp. LB126 EU024110  71.42 14 4 5.1 
Catechol dioxygenase Pseudomonas putida KT220 NC_002947.3  98.08 312 6 0 
Hydroxylase (3-ketosteroid-9-
alpha-monooxygenase 
oxygenase) 
Mycobacterium chubuense 
strain DSM 44219 
JYNX01000038.1 78.57 14 3 5.7 
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When the genomes of R. equi ATCC13557, Pseudomonas putida SJTE-1 and 
Sphingomonas KC8 were compared to each other, the genes with greater than 70% 
identity coded for the enzymes; malate synthase G, which catalyses the 
condensation of acetyl coenzyme A in the glyoxylate pathway (Roucourt et al., 
2009), with 70.64% identity between R. equi ATCC13557 and P. putida SJTE-1; 
translation elongation factor Tu, which accelerates the binding of aminoacyl-tRNA to 
the ribosome within the elongation phase of protein synthesis (Doerfel and Rodnina, 
2013), with 71.75% identity between Sphingomonas KC8 and P. putida SJTE-1; 
SSU ribosomal protein S12p (S23e), involved in protein synthesis (Restreppo et al., 
2016), with over 70% between all three genomes; alkyl hydroperoxide reductase 
protein F (EC 1.6.4.-), which has a role in oxidative stress response (Rocha and 
Smith, 1999), shared 77.3% identity between R. equi ATCC13557 and P. putida 
SJTE-1; and aliphatic amidase AmiE (EC 3.5.1.4), which has a role in virulence and 
biofilm formation (Clamens et al., 2017), shared 80.47% identity between R. equi 
ATCC13557 and P. putida SJTE-1 (Appendix Table 6).  
There was no presence of genes coding for the following enzymes putatively 
involved in estrogen degradation; hydroxylase, responsible for the conversion of E2 
to E3 in reaction 4, E2 to keto-E2 in reaction 5, E1 to 3-HSA in reaction 9 and 3-HSA 
to 3,4-DHSA in reaction 10 (Fig. 2- 1 and Table 2- 1); monoxygenase, included due 
to similarity to dioxyenase sequences; or cytochrome P450, included as it may have 
a role in the conversion of E1 to 16α-Hydroxyestrone (Thomas and Potter, 2013, Xu 
et al., 2005; Simpson, 1994). However, the presence of genes coding for the 
following enzymes suggested to be involved in estrogen degradation were 
discovered; dioxygenase, catalyses the conversion of EE2 to 2-OH-EE2 in reaction 
1, E2 to 4-OH-E2 in reaction 6, E1 to 4-OH-E1 in reaction 8 (Fig. 2- 1 and Table 2- 
1); dehydrogenase, catalyses the conversion of E2 to E1 in reaction 7 (Fig. 2- 1 and 
Table 2- 1); hydratase, catalyses the conversion of E1 to E3 in reaction 3; hydrolase, 
catalyses the conversion of 4,9-DHSA to 2-hydroxyhexa-2,4-dienoic acid and 3-
[(3aS, 7aS)-7a-methyl-1,5-dioxooctahydro-1H-inden-4-yl] propanoate in reaction 12 
(Fig. 2- 1 and Table 2- 1); and isomerase, included due to similarity to 
dehydrogenase. There are five genes coding for hydratase present in all three 
genomes and seven coding for isomerase present in all three, with one gene coding 
for isomerase being present in R. equi ATCC13557 and P. putida SJTE-1. However, 
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some genes coding for these enzymes are present in two or all three of the genomes 
(Fig. 3- 9, 10, 11).  
 
Figure 3-9: Venn diagram produced using Venny 2.1.0 (Oliveros,  2007-15) showing the presence of genes 
coding for dioxygenase  in the genomes of R. equi ATCC13557, P. putida SJTE-1 and Sphingomonas sp. KC8. 
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Figure 3-10: Venn diagram produced using Venny 2.1.0 (Oliveros,  2007-15) showing the presence of genes 
coding for dehydrogenase in the genomes of R. equi ATCC13557, P. putida SJTE-1 and Sphingomonas sp. KC8. 
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Figure 3-11: Venn diagram produced using Venny 2.1.0 (Oliveros, 2007-15) showing the presence of genes 
encoding hydrolase in the genomes of R. equi ATCC13557, P. putida SJTE-1 and Sphingomonas sp. KC8. 
 
Additionally, when searching for the genes coding for enzymes, in the BLAST 
results, there was a cluster of genes coding for enzymes potentially involved in 
estrogen degradation identified, highlighted yellow (Appendix, Table 0- 7), within R. 
equi ATCC13557 and also present in Sphingomonas KC8. In the cluster, a number 
of the genes coding for enzymes suggested to be involved in estrogen degradation 
were on the same contig. The cluster contained the genes coding for Enoyl-CoA 
hydratase (EC 4.2.1.17), 3-hydroxyisobutyrate dehydrogenase (EC 1.1.1.31), 3-
hydroxyisobutyryl-CoA hydrolase (EC 3.1.2.4), Butyryl-CoA dehydrogenase (EC 
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1.3.99.2), and Methylmalonate-semialdehyde dehydrogenase (EC 1.2.1.27), 
however the function of these enzymes, is suggested to be valine degradation, 
according to RAST (Aziz et al., 2008; Overbeek et al., 2014; Brettin et al., 2015). 
Furthermore, the percentage identity between the gene sequences in the two 
genomes was low (42.18% - 64.26%), suggesting that the sequences don’t match 
very well. 
 
Whilst searching the genomes individually for the genes coding for enzymes 
potentially involved in estrogen degradation using the RAST SEED viewer (Aziz et 
al., 2008; Overbeek et al., 2014; Brettin et al., 2015), a gene cluster, was identified. 
The presence of a gene cluster suggests that the genes are evolutionarily 
conserved, containing genes similar to those identified as coding for enzymes 
potentially involved in estrogen degradation (Fig. 3 – 13). The genome of 
Novosphingobium aromaticivorans (Balkwill et al., 1997) contained a similar cluster 
(Fig. 3 – 13). The gene cluster contained genes coding for 2-hydroxy-6-oxo-6-
phenylhexa-2,4-dienoate hydrolase, which catalyses the conversion of 4,9-DHSA to 
2-hydroxyhexa-2,4-dienoic acid and 3-[(3aS, 7aS)-7a-methyl-1,5-dioxooctahydro-1H-
inden-4-yl] propanoate in reaction 12 (Fig. 2- 1 and Table 2- 1). Also a gene coding 
for dioxygenase was present, which catalyses; EE2 to 2-hydroxy-EE2 in reaction 1, 
E2 to 4-hydroxy-E2 in reaction 6, E1 to 4-hydroxy-E1 in reaction 8 of the potential 
estrogen degradation pathway (Fig 2- 1 and Table 2- 1).A gene coding acyl-CoA 
dehydrogenase within the cluster may have a role in the degradation of estrogen as 
in the degradation of E1 by the lactone pathway, it is degraded via the TCA cycle 
(Fig. 2- 1). The presence of these genes encoding for enzymes within the 
hypothetical estrogen degradation pathway (Fig. 2- 1) suggest that Sphingomonas 
sp. KC8 may be able to metabolise E1, E2 and EE2, furthermore the metabolism of 
E1, E2 and testosterone has been previously confirmed (Roh and Chu, 2010). 
However, the metabolism of EE2 has not been reported in Sphingomonas sp. KC8 
but in a different species Sphingomonas sp. JCR5 (Haiyan et al., 2007) and if 
testosterone and estrogen share a conserved core metabolic pathway then EE2 
degradation may be possible. The metabolism of estrogens by the PAH degrader 
Novosphingobium aromaticivorans (Bell and Wong, 2007) is unreported however, 
Novosphingobium tardaugens sp. AR1 metabolises E1, E2 and E3 (Fujii et al., 2002; 
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Fujii et al., 2003), Novosphingobium sp. JEM-1 degrades E1, E2 and EE2 
(Hashimoto et al., 2009), and Novosphingobium sp. E2S degrades E2 (Li et al., 
2017). Additionally, the presence of dioxygenase within the gene cluster within 
Sphingomonas sp. KC8 and N. aromaticovorans may suggest a conserved 
mechanism of A ring cleavage leading to the complete metabolism of EE2. 
 
 
Figure 3-12: RAST SEED viewer diagram of Sphingomonas KC8 (Hu et al., 2011) gene cluster showing the genes coding for 2-
hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase, annotated as Tes D in N. aromaticivorans (EC 3.7.1.-) (red, 1), Acyl-
CoA dehydrogenase, short-chain specific (EC 1.3.99.2) (Green, 2), 2,3-dihydroxybiphenyl 1,2-dioxygenase (orange, 3), Acyl-
CoA dehydrogenase; probable dibenzothiophene desulfurization enzyme (blue, 4), Rieske (2Fe-2S) domain-containing 
protein (blue, 10), and transcriptional regulator, TetR family (blue, 20). The grey arrows between genes labelled 2 and 20 
are genes where the relative position is conserved in at least four other species and are functionally coupled, these genes 
are coding for the enzymes  Enoyl-[acyl-carrier-protein] reductase [NADPH] (EC 1.3.1.10) and Coenzyme F420-dependent 
N5,N10-methylene tetrahydromethanopterin reductase and related flavin-dependent oxidoreductases; sulfonate 
monooxygenase. In N. aromaticivorans the additional genes code for Probable short-chain type dehydrogenase/reductase 
(EC 1.-.-.-) (yellow, 5), 2-keto-4-pentenoate hydratase (EC 4.2.1.80) (turquoise, 6), fumarate reductase/succinate 
dehydrogenase flavoprotein, N-terminal:FAD dependent oxidoreductase (pink, 7), 4-hydroxy-2-oxovalerate aldolase (EC 
4.1.3.39) (green, 8), Acetaldehyde dehydrogenase, acetylating, (EC 1.2.1.10) in gene cluster for enzymes involved in the 
degradation of phenols, cresols, catechol (brown, 9), putative CoA-transferase subunit alpha Rv3551/MT3655 (EC 2.8.3.-) 
(purple, 17), and 2-nitropropane dioxygenase (EC 1.13.11.32) (yellow, 24). Additionally the grey arrows represent in order 
left to right, genes coding for probable enoyl-CoA hydratase EchA20, Enoyl-CoA hydratase/carnithine racemase, putative 
CoA-transferase subunit beta Rv3552/MT3656, putative oxidoreductase, Sugar phosphate isomerases/epimerases, 
hypothetical protein and Cytochrome P450. 
 
In summary, the genome of R. equi ATCC13557 a known estrogen degrader was 
sequenced and assembled for the first time using both CLC and SPAdes, SPAdes 
produced a better genome assembly using the PE Illumina MiSeq data for the GC 
rich bacterial genome. The genome of R.equi ATCC13557 is slightly larger than that 
of R. equi 103S (5.04 Mb) but smaller than the genome of R. equi sp. P14 (5.68 Mb) 
(Letek et al., 2010; Zhang et al., 2012). Furthermore, the R.equi ATCC13557 
genome contained a greater number of CDs involved in the central aromatic pathway 
(59), compared to the diverse catabolic genome of R. sp. RHA1 (8) (McLeod et al., 
2006). Although less peripheral aromatic pathways (14), compared to R. sp. RHA1 
(26) (McLeod et al., 2006), the percentage relative to the total number of CDSs is the 
same in both genomes (0.28%). The assembled R. equi ATCC13557 genome was 
compared with the genomes of Sphingomonas sp. KC8 and Pseudomonas putida 
SJTE-1 (Hu et al., 2011; Liang et al., 2010), however only a small number of genes, 
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mostly coding for enzymes essential for survival, and none of the genes with above 
70% identity between the genomes were involved in estrogen degradation. When the 
genomes R. equi ATCC13557, Sphingomonas sp. KC8 and Pseudomonas putida 
SJTE-1 (Hu et al., 2011; Liang et al., 2010) were searched using a database of gene 
sequences coding for enzymes potentially involved in estrogen degradation, again 
there were few similarities between the genomes. However, a gene cluster was 
identified within the genome of R. equi ATCC13557 coding for enzymes that may 
catabolise reactions within the potential estrogen degradation pathway. To confirm 
the genes are coding for enzymes involved estrogen degradation, gene expression 
analysis experiments will be required to determine if the genes are active during 
estrogen degradation. If active, the presence of the gene encoding 3-
carboxyethylcatechol 2,3-dioxygenase, suggests that R. equi ATCC13557 may be 
able to degrade; EE2 in reaction 1, E2 in reaction 6, E1 and its metabolites in 
reactions 8 and 11 (Fig 2-1; Table 2- 1). If active, the gene encoding 2-
hydroxymuconic semialdehyde hydrolase, suggests that R. equi ATCC13557 can 
degrade E1 metabolites in reaction 12 (Fig 2-1; Table 2- 1). If active, the presence of 
the gene coding for 3-alpha-(or 20-beta)-hydroxysteroid dehydrogenase, suggests 
that R. equi ATCC13557 can convert E2 to E1 in reaction 7 (Fig 2-1; Table 2- 1). If 
active, the gene encoding 3-(3-hydroxy-phenyl)propionate hydroxylase, suggests 
that R. equi ATCC13557 can convert E2 to E3 or keto E2 in reactions 4 and 5 and 
convert E1 to 3-HSA and further degrade 3-HSA to 3,4-DHSA in reactions 9 and 10 
(Fig 2-1; Table 2- 1). However, the genes coding for hydratase and the aldolase-
dehydrogenase complex were not significantly identified within the genome of R. 
equi ATCC13557 (Fig 2-1; Table 2- 1), therefore the conversion of E1 to E3 in 
reaction 3 is not possible (Fig 2-1; Table 2- 1) and the further degradation of the E1 
metabolites in reactions 13 and 14 are not possible (Fig 2-1; Table 2- 1). Thus it is 
not likely that R. equi ATCC13557 will be able to convert E1 to E3 or completely 
metabolise E1.     
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Chapter 4:  Developing a sample preparation method for 
the quantification of estrogens in degradation experiments 
4.1 Introduction 
Estrogens have a limited aqueous solubility ranging from 0.8-19.1 mg/L and are 
moderately hydrophobic with LogKow’s of 3.1-4.15 (Table 4- 1). Furthermore the 
aqueous solubilities of estrogen vary dependent upon the study conditions and EE2 
has been reported as the estrogen with the lowest solubility in some studies and with 
the highest solubility in others (Table 4- 1). The variations in solubility may be due to 
the pH or ionic strength of the solution, as estrogens have greater solubility in 
alkaline conditions (pH10) and are less soluble within solutions with higher ionic 
strength (Shareef et al., 2006). 
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Table 4-1: The physiochemical properties of estrogens E1, E2 and EE2 (adapted from Shareef et al., 2006) 
E1 E2 EE2 References 
Solubility in 
water (mg/L) 
LogKow 
(octanol-
water 
partition 
coefficient) 
Solubility in 
water (mg/L) 
LogKow 
(octanol-
water 
partition 
coefficient) 
Solubility in 
water (mg/L) 
LogKow 
(octanol-water 
partition 
coefficient) 
0.8-12.4 3.1-3.4 3.9-13.3  3.1-4.0 - - Hanselman et al., 2003 
1.30±0.08 - 1.51±0.04 - 9.20±0.09 - Shareef et al., 2006 
0.8 - 3.9 - 9.7 - Hurwitz and Liu, 1977 
12.4 - 12.96 - 4.83 - Tabak et al., 1981 
1.53 - 3.85 - 19.1 - Yalkowsky, 1999 
2.1 - 3.1 - 3.1 - Yu et al., 2004 
13 3.43 13 3.94 4.8 4.15 Lai et al., 2000 
- - 5 - 10 - Kabasakalian et al., 1966 
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In order to measure the relatively high estrogen concentrations necessary for 
biodegradation studies it is therefore necessary to optimise the sample preparation 
method in order to; i) ensure that the estrogens are added to, and dissolved fully, 
into the aqueous growth media, ii) halt the degradation at a specific time point for 
sample storage prior to sample measurement and iii) reduce and/or account for 
losses to ensure measured estrogen concentrations are reliable. There are different 
methods to remove the bacterial biomass from samples (Table 4- 2), but filtration is 
used most commonly within pure culture degradation experiments. Following 
filtration to remove the bacterial biomass it is assumed that the concentration in the 
filtered sample would remain stable and undegraded until measurement. However, 
the filter material has also shown to retain estrogen and therefore would lead to a 
lower measurement of estrogen in the sample (Han, et al., 2012). Furthermore, there 
are numerous methods of adding estrogen to the growth media by dissolving first in 
an organic solvent and then addition to the aqueous media, which is necessary due 
to the low solubility of estrogen in aqueous solution (Shareef, et al., 2006) (Table 4- 
2). Due to the concerns regarding concentrations of estrogen within the environment 
there are numerous developed methods for the chemical analysis of estrogen within 
environmental samples such as river water for example the sample preparation by 
use of solid phase extraction (SPE) using an Oasis MCX and LiChrolut EN, elution 
with methanol, ethyl acetate followed by analysis using the Luna C8 (Positive-ion 
mode: Solvent A: formic acid 0.1% in Milli-Q water, pH 2 Solvent B: acetonitrile) 
(Negative-ion mode: Solvent A: triethylamine, pH 8, 0.05% in water Solvent B: 
acetonitrile) using high-performance liquid chromatography (HPLC) (Castiglioni et 
al., 2005). However there are fewer methods for detection of estrogens within pure 
culture and the methods differ from each other in both how the samples are prepared 
and how the estrogens are analysed, such as different filter material and size, 
different stock solutions, and different analytical detectors (Table 4- 2). Furthermore 
there is often an absence of the filtration material or sizing.  
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Table 4-2: Methods for sample preparation and estrogen analysis. 
Bacterial removal 
method 
Filter 
size (µm) 
Stock 
solution. 
Chemical 
analysis 
method 
References 
Millex LG13 filter 0.2 Powder 
dissolved 
directly 
into 
media 
GC/MS and 
NMR 
Fujii et al., 2002; 
Fujii et al., 2003 
Ethyl ester 
extraction 
N/A Above 3 
mg/L in 
acetone 
GC/MS and 
YES assay 
Yu et al., 2007 
Schleicher and 
Schuell, Germany 
filter 
0.2 Acetone HPLC-UV/DAD-
FLD 
Weber et al., 
2005. 
Centrifugation and 
methylene chloride 
extraction 
N/A Methanol GC/MS and 
YES assay 
Jiang et al., 
2010. 
Ethyl acetate 
extraction 
N/A Acetone HPLC and 
MS/MS 
Haiyan et al., 
2007. 
 
Microporous 
membrane filter 
0.22 Methanol HPLC Yu et al., 2016 
Solid phase 
extraction, Sep-
Pack plus Florisil 
and NH2 cartiridges 
N/A N/A LC/MS/MS Hashimoto et al., 
2009 
PVDF filter 0.22 100% 
ethanol 
HPLC equipped 
with a Diode 
Array Detector. 
Larcher and 
Yargeau, 2013 
Whatman GF/B filter 
paper 
1 Methanol GC/MS Yoshimoto et al., 
2004 
N/A – information was not provided. Abbreviations: Gas Chromatography mass spectrometry (GC/MS); Yeast estrogen screen 
(YES); Tandem mass spectrometry (MS/MS); Liquid chromatography tandem mass spectrometry (LC/MS/MS).  
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With few studies focusing upon degradation in pure culture and the absence of a 
‘gold’ standard method for chemical analysis, method development will be required 
to overcome issues encountered with estrogen detection within different growth 
media.  
The hypotheses are that different filter materials will lead to different percentage 
retentions of estrogens and that the starting estrogen concentrations will vary 
between the different organic solvents and evaporation times, as with longer 
evaporation times the temperature of the growth media will increase and therefore 
the solubility may increase (Rashid et al., 2014).  
 
4.2 Materials and methods 
 Comparison of different methods to separate bacterial biomass from 
the aqueous phase 
Powdered E1, E2, and EE2 was dissolved using a magnetic stirrer bar into aqueous 
MSM to achieve the known starting concentration of 5 mg/L in 500mL. An aliquot of 
1 mL was taken from this stock solution using a 1.5 mL syringe and was filtered 
through different filters (Table 4- 4), Polytetrafluoroethylene (PTFE) was pre-treated 
by adding 1 mL ethanol followed by 1 mL distilled water to the filter using a syring to 
create a hydrophilic membrane, into amber glass vials in triplicate. Furthermore a set 
of triplicate samples was centrifuged using the Mikro 200R Hettich zentrifugen at 
13,000 x g for 3 minutes and was unfiltered to account for potential losses of 
estrogens during this step. The samples were then measured using HPLC Shimadzu 
VP using a Phenomenex Gemini-NX 5u C18 110A column with the settings of 
flow=1, B = 20%, max. pressure = 4000 psi, low pressure= 200 psi, wavelength= 
230nm, Acquisition = 5, runtime = 13 min, injection volume = 10 µL, and the 
concentration gradients (Table 4- 3). The estrogen samples were quantified relative 
to the standard curve produced for the duplicate standards of known concentrations 
(0.5, 1, 2, 3, 4, 6 and 8 mg/L) of E1, E2 and EE2, which were produced in 50:50 
AcN: MeOH (Appendix Fig. 0- 1, 2 and 3). 
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Table 4-3: HPLC concentration gradient used for the quantification of estrogens 
Concentration of acetonitrile (%) Time (min) 
40 1 
95 7 
95 9 
40 10 
40 13 
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Table 4-4: The different filtration materials assessed for sample preparation for the quantification of estrogens. 
Filter Material description Pore size 
(µm) 
Diameter 
(mm) 
Whatman GD/X Cellulose Acetate 
(CA) 
Hydrophillic, suitable for aqueous and solvent media. For 
biological solutions, high-loading capacity, and low-protein-
binding.a  
0.2 25 
Millex® Durapore® Polyvinylidene 
fluoride (PVDF) 
Hydrophillic, the most suitable membrane for HPLC.a 0.22 13 
NalgeneTM Polyethersulfone (PES) Hydophillic, offers higher flow rates, lower protein binding and 
lower extractables than competitive cellulosic membranes. For 
serum, plasma, and tissue culture solutions.a  
0.2 25 
Sigma Nylon membrane (Nylon) Hydrophillic, for aqueous and aqueous organics. High non-
specific binding, they are not recommended for protein 
solutions.a 
0.2 25 
VWR Polytetrafluoroethylene 
filters (PTFE treated) 
Hydrophillic due to pretreatment. Designed for filtration of 
corrosive gases and organic solvents. Excellent chemical 
resistance. Ultimate compatibility for filtering harsh chemicals.b  
0.2 25 
VWR Polytetrafluoroethylene 
hydrophobic (PTFE hydrophobic) 
Hydrophobic. Designed for filtration of corrosive gases and 
organic solvents. Excellent chemical resistance. Ultimate 
compatibility for filtering harsh chemicals.b  
0.2 13 
Material descriptions taken directly from (a) Sigma Aldrich website, (b) VWR website. 
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 Comparison of methods for dissolving estrogen into aqueous growth 
media 
The aim of this experiment was to improve solubility by; i) experimenting with 
different evaporation times, ii) dissolving estrogen into a solvent either acetonitrile: 
methanol (AcN:MeOH) or acetone, and iii) experimenting with the composition of the 
growth medium to which the estrogen is dissolved due to the possibility that addition 
to a more ionic solution may lead to reduced solubility (Shareef et al., 2006). 
Stock solutions of 1 g/L of mixed estrogen (E1, E2, and EE2) were prepared in 
acetone and 50:50 AcN:MeOH. 50 mL glass flasks were prepared containing 5 mL of 
R. equi ATCC13557 bacterial culture in 40 mL of MSM containing 0.6 g/L of yeast 
extract.  
The time taken to fully evaporate 0.25 mL of Acetone and 0.25 mL of AcN:MeOH, 
within a total volume of 1 mL MSM at 80°C using a LABCONCO RapidVap vertex 
evaportator within a fume hood were measured as 50 and 80 minutes respectively.  
Then the methods of adding the estrogen solutions to the MSM to achieve a 
concentration of 5 mg/L and different evaporation times were varied (Table 4- 5). 
Triplicate samples were taken from each condition and centrifuged using the Mikro 
200R Hettich zentrifugen at 13,000 x g for 3 minutes and filtered through a 0.2 µm 
PVDF filter into amber glass vials using a 1mL syringe and analysed by uHPLC 
(ThermoScientific Dionex Ultimate 3000 RS autosampler, pump, column 
compartment and electrochemical detector) using a ThermoScientific Accucore C18 
100 x 2.1 mm, 2.6µm particle size column with the settings of; flow rate = 0.4 
mL/min, temperature = 40°C, injection volume = 50 – 90 µL, electrochemical 
potential = 1800 mV. The run was isocratic using 62% of mobile phase A and 38% of 
mobile phase B for 4- 6.5 minutes. Mobile phase A contained 95% water, 5% 
acetonitrile and 0.1% formic acid. Mobile phase B contained 95% acetonitrile and 5% 
water with 0.1% formic acid. The detection limit of estrogen was 100ng/L. The 
estrogen samples were quantified relative to the standard curve produced for the 
duplicate standards of known concentrations (1, 2.5, 5, 7.5 and 10 mg/L) of E1, E2 
and EE2, which were produced in 50:50 AcN:MeOH (Appendix Fig. 0- 4, 5 and 6). 
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Table 4-5: The different conditions of the 50 mL flasks. 
Evaporation Stock solvent Composition of media 
1. No evaporation a. Acetone MSM 
b. AcN:MeOH MSM 
2. Half (25 min) c. Acetone MSM 
    Half (40 min) d. AcN:MeOH MSM 
3. Full (50 min) e. Acetone MSM 
    Full (80 min) f. AcN:MeOH MSM 
4. Full (80 min) a. AcN:MeOH 20 mL water 
b. AcN:MeOH Salts solution 
 
The method of adding the estrogen to the flask was further tested to determine if the 
method was valid for use in the 500 mL flasks for the degradation experiments. A 1 
g/L 50:50 AcN:Me 25 mL stock solution was prepared for mixed estrogen (E1, E2, 
and EE2) and for EE2 only. Then 2 mL of the stock solution was evaporated to 0.25 
mL using the LABCONCO RapidVap vertex evaporator at 60°C and then added to 
the 400ml of MSM to produce a concentration of 5 mg/L. Followed by further 
evaporation on a hot plate at 80°c for 80 minutes. Triplicate samples of 1 mL were 
taken from each flask and centrifuged at 13,000 x g for 3 minutes and filtered 
through a 0.2 µm PVDF filter into amber glass vials using a syringe. The 
concentrations of estrogen were analysed using uHPLC (ThermoScientific Dionex 
Ultimate 3000 RS autosampler, pump, column compartment and electrochemical 
detector) using a ThermoScientific Accucore C18 100 x 2.1 mm, 2.6µm particle size 
column with the settings of; flow rate = 0.4 mL/min, temperature = 40°C, injection 
volume = 50 – 90 µL, electrochemical potential = 1800 mV. The run was isocratic 
using 62% of mobile phase A and 38% of mobile phase B for 4- 6.5 minutes. Mobile 
phase A contained 95% water, 5% acetonitrile and 0.1% formic acid. Mobile phase B 
contained 95% acetonitrile and 5% water with 0.1% formic acid. The detection limit 
of estrogen was 100ng/L. The estrogen samples were quantified relative to the 
standard curve produced for the duplicate standards of known concentrations (1, 2.5, 
5, 7.5 and 10 mg/L) of E1, E2 and EE2, which were produced in 50:50 AcN:MeOH 
(Appendix Fig. 0- 7, 8 and 9). 
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 Statistical analysis and graphing software 
Statistical analysis was carried out using Minitab 17: 
The data was determined to be not normal using the Anderson Darling normality 
test. 
Kruskal-Wallis test was used to determine the significance of the losses of estrogen 
due to the different bacterial removal methods, followed by the use of the Games-
Howell method to identify which methods were significantly different to the unfiltered 
control samples. 
Kruskal-Wallis test was used to determine if there was a significant difference 
between the losses of estrogen at different evaporation times. 
Mann-Whitney test was used to determine the significance of the differences in 
estrogen losses due to the different stock solutions prepared with different organic 
solvents. 
Kruskal-Wallis test was used to determine the significance in the losses of estrogens 
due to the addition of estrogen into the different components of MSM. 
All graphs were produced using SigmaPlot version 12.5. 
 
 
4.3 Results 
 Comparison of different methods to separate bacterial biomass from 
the aqueous phase. 
The concentration of EE2 was not quantifiable and was not detected in any samples. 
Estrogen retention varied widely between replicates (n=3) for centrifugation and 
PTFE with average coeffiecients of variation of 35.8% and 35.6% for E1 respectively, 
and 36.6% and 19.5% for E2 respectively. The average retentions of E1 and E2 
were the lowest for the filter material PVDF of 9.09% and 21.44% respectively. 
Furthermore there was less variation between replicates (n=3) for the method using 
PVDF filters with average coefficients of variation of 0.57% and 15.9% for both E1 
and E2 respectively. Losses of E1 and E2 using untreated PTFE were 36.36% and 
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55.56% respectively. There were significant differences for E2 or E1 loss between 
the different biomass removal methods (P=0.038). There was a significant loss of 
estrogen using PTFE (hydrophobic) (P=0.021), but there was no significant loss of 
estrogen, compared to the unfiltered samples, when using PVDF (P=0.159), or 
centrifugation (P=0.284). Estrogens were undetected after filtering with the following 
materials; CA, PES, Nylon and PTFE (treated), indicating that they were removed 
completely by these filters. There were additional losses of estrogen due to 
centrifugation of the samples prior to filtration of 27.27% and 3.33% for E1 and E2 
respectively (Fig. 4- 1). 
 
 Comparison of methods for dissolving estrogen into aqueous growth 
media  
Firstly, considering the effect of evaporation time upon the solubility of estrogens of 
the samples prepared by the addition of the AcN:MeOH mixed estrogen stock 
solution. The average percentage loss of E2 was significantly less when the 
evaporation time was 80 and 50 minutes; 5.13±0.42% and 12.10±0.24% respectively 
(P=0.006) (n=9, Fig. 4- 2 and 3). The average percentage loss of E1 was 
significantly lower when the evaporation time was 80 and 25 minutes; 6.46±0.43% 
and 14.37±0.41% respectively (P=0.002) (n=9, Fig. 4- 2 and 3). Although the 
Figure 4-1: Comparison of the average percentage loss of estrogen (%) resulting from different bacteria removal methods 
from aqueous samples. The methods included the different filter materials; Cellulose Acetate filtration (CA), Polyvinylidene 
fluoride filtration (PVDF), Polyethersulfone filtration (PES), Nylon membrane filtration (Nylon), Polytetrafluoroethylene 
filters treated with ethanol and distilled water to create a hydrophilic membrane (PTFE treated), Polytetrafluoroethylene 
hydrophobic filtration (PTFE hydrophobic), and centrifugation of the aqueous samples (Centrifugation). The error bars 
represent standard deviation of the mean. 
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average percentage loss of EE2 was least at the higher evaporation times, there was 
no significant difference between the different evaporation times (P=0.079) (n=9, Fig. 
4- 2 and 3).   
 
Figure 4-2: Comparison of the average percentage loss of estrogen at different evaporation times; 0, 40 and 80 
minutes, following the addition of the estrogens from a 1g/L AcN:MeOH stock solution. The error bars 
represent standard deviation of the mean. 
 
 
Figure 4-3: Comparison of the average percentage loss of estrogen at different evaporation times; 0, 25 and 50 
minutes, following the addition of the estrogens from a 1g/L Acetone stock solution. The error bars represent 
standard deviation of the mean. 
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In the comparison of the solubility of estrogens when added from stock solutions 
containing different organic solvents, the average percentage loss of E2 was 
significantly lower for added in the AcN:MeOH stock solution with 40 and 80 minutes 
of evaporation; 4.53±0.07% and 5.13±0.42% respectively (P=0.0341) (n=9, Fig. 4- 5 
and 6). The average percentage loss of E1 was significantly lower when the 
estrogen was added in the AcN:MeOH stock solution for 40 and 80 minutes of 
evaporation; 10.10±0.03% and 6.46±0.43% (P=0.0453) (n=6, Fig. 4- 5 and 6). The 
average percentage loss of EE2 was lower for methods when added in AcN:MeOH 
stock without evaporation, but was significantly lower when added in the acetone 
stock solution for 25 and 50 minutes of evaporation; -7.40±0.50% and -0.68±0.22% 
(P=0.0306) (n=6, Fig. 4- 4, 5, 6).  
 
Figure 4-4: Comparison of the average percentage loss of estrogen without evaporation, when the estrogen is 
added to the MSM growth media using the different solvents Acetone and AcN:MeOH. The error bars represent 
standard deviation of the mean. 
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Figure 4-5: Comparison of the average percentage loss of estrogen with half evaporation, when the estrogen is 
added to the MSM growth media using the different solvents Acetone and AcN:MeOH. The error bars represent 
standard deviation of the mean. 
 
 
Figure 4-6: Comparison of the average percentage loss of estrogen with full evaporation, when the estrogen is 
added to the MSM growth media using the different solvents Acetone and AcN:MeOH. The error bars represent 
standard deviation of the mean. 
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Then comparing the addition of estrogen to the different components of the MSM to 
determine if the ionic strength of the salts solution, MSM or water only would affect 
the solubility of estrogens. The percentage loss of E1, E2 and EE2 was significantly 
less for addition of the AcN:MeOH mixed estrogen stock into the MSM growth media 
with 80 min evaporation of 6.46±0.43%, 5.13±0.42% and 5.18±0.4% respectively 
when comparing the addition of estrogen to the different components of the growth 
media (P=0.027) (n=3, Fig. 4- 7).  
 
Figure 4-7: Comparison of the average percentage loss of estrogen when adding a 1g/L mixed estrogen 
AcN:MeOH stock solution into the different components, water, salts and complete MSM growth medium. The 
error bars represent standard deviation of the mean. 
 
Following the method development there was still a difference between the 
quantified estrogen concentrations and the expected concentrations of 5 mg/L. The 
concentration of EE2 was detected at 3.32±0.07 mg/L higher than expected in the 
EE2 only flask. In the mixed estrogen flask there was a higher than expected 
concentration of both E2 and EE2 of 0.17±0.38 mg/L and 0.39±0.47 mg/L 
respectively, and a lower than expected concentration for E1 of 0.28±0.61 mg/L (Fig. 
4- 8).  
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4.4 Discussion 
The filter material with the least retention of estrogen was PVDF so it was chosen as 
the best filter for these experimental conditions. The filter material PVDF has also 
been used previously (Table 4- 2) (Larcher and Yargeau, 2013). The non-detection 
and significant loss of estrogen from the other filters is likely due to adsorption. It has 
been previously reported that estrogens adsorb to various filter materials including 
cellulose containing filters such as CA, paper, and glass fibre at varying amounts 
(Schicksnus and Müller-Goymann, 2000; Walker and Watson, 2010). During this 
experiment it was found that the filter would clog when there was a greater amount 
of bacteria present in samples, therefore it was necessary to first centrifuge the 
samples and filter the supernatant. Centrifugation led to the loss of some estrogen, 
in addition to the loss of estrogen due to filtration. Therefore, these losses of 
estrogen will be considered in the measured estrogen concentrations during the 
degradation experiments. The loss in centrifugation is likely due to sorption of the 
estrogen to the polypropylene centrifuge tubes or to the plastic syringe used during 
filtration. Although, as in these experiments, the losses due to the syringe or plastics 
Figure 4-8: Comparison of the difference between the initial concentration detected and the actual 
concentration of 5 mg/L when the 50:50 AcN:MeOH estrogen stock solution is added to the MSM, and the 
residual organic solvent evaporated off for 80 min. The error bars represent standard deviation of the mean. 
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were determined not significant compared to the losses due to filtration (Walker and 
Watson, 2010). To account for any potential losses of estrogen, however low, the 
standards will be produced by using the same method of preparation as the 
samples, by centrifugation and filtration through PVDF to control for losses of 
estrogen not due to biodegradation. In previous studies, where filtration is the 
method of sample preparation, the use of a control to account for losses of estrogen 
due to filtration is unreported (Table 4- 2). Furthermore, it was shown in these 
experiments that EE2 could not be detected when added in a powder form, like the 
other estrogens, therefore the solubility of EE2 (<5 mg/L) in aqueous media is much 
less than that of the other estrogens under these experimental conditions which has 
been previously reported (Table 4- 1) (Tabak et al., 1981; Lai et al., 2000).  
The method of addition of the estrogen to the growth media (MSM) showed that 
there was a significant difference between the concentrations of estrogen detected 
following addition of estrogen in various different methods, evaporation time, the 
solvent used to produce the stock solution of estrogen and to which component of 
the growth media the estrogen was added. The longest evaporation times of 80 
minutes and 50 minutes led to the significantly lower percentage loss of E2. 
Furthermore the average percentage loss of E1 was significantly lower at 25 minutes 
and 80 minutes evaporation. Solubility of E1 in acetone at 40°C has been reported 
as 20.244 mg/L previously and its solubility in alcohols may be lower due to 
hydrogen-bonding (Ruchelman, 1967). Therefore this may explain the lower 
percentage loss of E1 when using acetone at 25 min evaporation. The difference 
due to the evaporation time was not significant for EE2. The AcN:MeOH stock 
solution led to the lowest percentage loss of E1 and E2 when the evaporation time 
was 80 minutes and 50 minutes. However, the acetone stock solution with at 25 and 
50 minutes evaporation time led to the significantly lower average percentage loss of 
EE2, this was unsurprising as EE2 is soluble in acetone (Veronez et al., 2015). The 
average percentage loss of estrogen was significantly lower when the estrogen stock 
solution was added to the complete MSM, rather than the salts or water components. 
This is likely due to the low solubility of estrogens in water and the increased ionic 
strength of the salts solution alone could have led to reduced solubility (Shareef et 
al., 2006). A single method to add the mixed estrogen to the flask for the degradation 
study was required, therefore it was decided that the method with the overall lower 
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percentage loss of estrogen would be to use the 50:50 AcN:MeOH stock solution 
with an 80 minute evaporation at 80°C into the complete media MSM. Although this 
was the better method, the difference between the expected and quantified 
concentrations; EE2 of 0.39±0.47 mg/L when in mixed stock solution and 3.32±0.07 
mg/L, E2 of 0.17±0.38 mg/L and E1 of -0.28±0.61 mg/L need to be considered in the 
degradation experiments. The losses in estrogen are likely to have been in 
transferring the solution from the test tube into the growth media, because there was 
visible precipitation of the estrogen within the test tube. This may have been due to 
salting out due to the salts solution within the MSM having an ionic effect, hydrogen-
bonding within the water component of the MSM, or due to the pH of the MSM 
(Carter and Sluss, 2013; Shareef et al., 2006; Ruchelman, 1967). Although 
evaporation is carried out it is possible that some residual solvent could remain and 
the addition of organic solvents to the growth media may add an additional carbon 
source during degradation studies, although AcN:MeOH is not known to have an 
effect in enhancing the degradation of estrogens, unlike ethanol (Larcher and 
Yargeu, 2013). Furthermore, dissolving estrogens into solvents and then cystalising 
them out before adding to aqueous media, may effect their physicochemical 
properties, such that the solubility may be altered (Park et al., 2008). For example, 
the solubility of E2 was reduced when crystalised from acetone (Park et al., 2008). 
Therefore, due to these findings it would be recommended that in estrogen 
degradation studies; 1) the filter material should be carefully chosen to reduce the 
retention of estrogen; 2) the loss of estrogen due to filtration and other sample 
preparation should be determined and if these losses are significant a control such 
as processing the standards in the same way or ensuring these losses are 
accounted for in the degradation concentrations; 3) choice of solvent is carefully 
considered to reduce solubility issues if present; 4) the effect upon degradation is 
considered if the solvent remains unremoved. 
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Chapter 5:  Degradation experiments 
5.1 Introduction 
Chromatography techniques are based on the separation of molecules between the 
mobile and stationary phases (Forgács and Cserháti, 2003). Liquid chromatography 
(LC) used a liquid, usually organic solvent mobile phase and a solid stationary phase 
upon the column (Forgács and Cserháti, 2003). The equipment for LC, including 
HPLC which uses pressure to force the mobile phase through the system, and ultra-
high-performance liquid-chromatography (uHPLC) which uses even higher pressure, 
by pumping the mobile phase, which is usually an organic solvent such as methanol 
or acetonitrile, through the system at concentrations specified within the program 
(Pitt, 2009). By using LC, concentrations of chemical compounds, such as 
estrogens, can be quantified by injecting samples into the mobile phase which 
carries the compounds onto the solid phase column where the compounds bind, the 
compound is then eluted from the column as the concentration gradient of the mobile 
phase is increased and the compound passes through the detector producing a peak 
with a peak area relative to the concentration of the compound within the sample 
(Waters, 2017). Monitoring of estrogen concentrations within the environment is of 
increasing importance due to the increasing concerns about the effects of estrogen 
upon aquatic organism and the proposal by the EC of EE2 and E2 as priority 
substances, with EQS of 0.035 ng/L and 0.4 ng/L respectively (Gilbert, 2012; 
Johnson et al., 2013).     
Furthermore, chemical analysis of estrogens by LC has been used in biodegradation 
studies to quantify the concentrations of estrogen in the presence of bacteria to 
study their potential to metabolise estrogens. There have been a number of 
examples in which Rhodococci have been reported to degrade estrogen; 
Rhodococcus sp. P14 was able to convert E2 into E1, Rhodococcus sp. DS201 was 
able to completely metabolise E2 and R. equi ATCC13557 was able to metabolise 
EE2 (Ye et al., 2017; Yu et al., 2016; Larcher and Yargeau, 2013). In order to 
confirm that R. equi ATCC13557 is able to degrade estrogen within my experimental 
conditions it was necessary to carry out degradation experiments in which the 
concentration of estrogen is measured at regular intervals using HPLC for the 
duration of the bacterial growth phase. The hypothesis is that the concentrations of 
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E2 and EE2 would decrease over time and would possibly be completely 
metabolised. 
 
5.2 Materials and methods 
 Bacterial culture 
R. equi ATCC13557 was acclimated to estrogens for 24 hours, by being cultured in 
500 mL Erlenmeyer flasks with vented bungs, containing MSM (See 5.2.1.1) with 0.6 
g/L of yeast extract. The conditions in each of the acclimation flasks were without 
estrogen (control), 5 mg/L of EE2, 5 mg/L of E2, and 5 mg/L mixed estrogen of E1, 
E2 and EE2. R. equi ATCC13557 was previously subcultured numerous times in 
MSM (see 5.2.1.1) containing 5 mg/L of mixed estrogen of E1, E2 and EE2, 5 mg/L 
of EE2, 5 mg/L of E2 and without estrogen (control).  
 
5.2.1.1 Preparing the growth media 
M9, Minimal Salts, 5X MSM (Sigma Aldrich) containing 33.9g/L Na2HPO4, 15g/L 
KH2PO4, 5g/L NH4Cl and 2.5g/L NaCl was prepared by weighing 56.6g into 1L of 
distilled water. Separating the 1L salts solution into 5x 200mL Duran flasks and 
autoclaving at 121°C. The 200 mL salts solutions were the stored at -4°C until 
required. 
To produce the final growth media the 200 mL salts solution was added to 800 mL of 
distilled autoclaved water containing 0.6 g/L of yeast extract. 
  
 Preparation of the experimental flasks 
To add the estrogen to the MSM (containing 0.6 g/L of yeast extract), 2 mL of a stock 
solution of 1g/L of estrogen stock solution (see 5.2.2.3) was evaporated by nitrogen 
gas down to a volume of 0.25 mL. The 0.25 mL estrogen stock was then added to 
the MSM containing 0.6 g/L of yeast extract and evaporated for a further 80 minutes 
on a hot plate to remove the remaining acetonitrile and methanol. The solution was 
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removed from the heat and allowed to cool down, for the 311 hour experiment it was 
left overnight. Next, 40 mL of the acclimated R. equi culture was inoculated into 360 
ml of MSM with 0.6 g/L of yeast extract, containing the estrogen at a concentration of 
5 mg/L. To prepare the abiotic control the method of adding the estrogen into the 
MSM containing 0.6 g/L was the same as above however a 40 mL of a 1% formalin 
solution was added to give a final concentration of 0.1% formalin. The other control 
was prepared without any estrogen solution.  
 
5.2.2.1 Experimental flask conditions for the 45.5 hour experiment 
The conditions were; containing E2; “no estrogen control”; the abiotic control 
containing E1, E2 and EE2; and a mixed estrogen flask containing E1, E2 and EE2. 
 
5.2.2.2 Experimental flask conditions for the 311 hour experiment 
The flasks were set up in triplicate for each condition, the conditions were; containing 
EE2; containing E2; containing mixed E2 and EE2; “no estrogen control;” and the 
abiotic control which contained E2 and EE2.  
 
5.2.2.3 Preparing the estrogen stock solution 
To prepare the 1 g/L mixed estrogen stock solution, 0.025 g of each estrogen 
powder (E1, E2, and EE2) were weighed into an amber glass 25 cm3 volumetric 
flask. A 50:50 solution of acetonitrile: methanol (AcN:MeOH) was prepared and 
mixed in a 500 cm3 volumetric flask, and dispensed into a beaker. The AcN:MeOH 
solution was transferred into the 25 cm3 volumetric using a 25 cm3 Pasteur pipette. 
The solution was then mixed by inversion and stored at 4°C. 
For individual estrogen stock solutions (1g/L) the same protocol was used, however 
only one estrogen powder was added to the solvent. 
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 Monitoring for the degradation experiments 
At each time point the following samples were taken (triplicates of each);  
- 1 mL - to measure bacterial growth  
- 2 mL - for HPLC analysis 
To assess bacterial growth optical density (OD), measured in a Spectrophotomer 
(ATI Unicam 8625 UV/Vis). 
Prior to HPLC analysis, samples were processed through sample preparation 
protocol and stored for estrogen quantification. 
 
5.2.3.1 Monitoring the 45.5 hour degradation experiment 
The flasks were incubated at 25°C for 45.5 hours with 155 rpm rotation. There were 
10 sampling points; an initial sample was taken at 0 hours, then samples were taken 
every 1.5 hours between hours 16 to 24.5, followed by a final sample point at 45.5 
hours. In addition, 100uL samples were taken from each flask to provide colony 
counts, which was done by serial dilutions in Ringer’s solution and plating in 
triplicates onto nutrient agar. 
 
5.2.3.2 Monitoring the 311 hour degradation experiment 
The flasks were incubated at 25°C for 311 hours with 155 rpm rotation. There were 8 
sampling points, which were at every 3 hours for 18 hours and a final sample at 311 
hours. 
 
5.2.3.3 Estrogen sample preparation 
In order to prepare the samples for uHPLC analysis, the samples were immediately 
centrifuged at 13000 x g for 3 min and 1 mL of the supernatant was filtered through 
0.2 µm pore size 13mm EMD Millipore DuraporeTM PVDF membrane syringe filters 
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into a 2 mL wide screw neck 12x32 mm Chromacol™ amber glass vial with 
Chromacol™ Blue screw cap, open top with 6 mm hole and a PTFE septum for 
HPLC analysis. Furthermore standards of known concentrations (1, 2.5, 5, 7.5 and 
10 mg/L) were produced in MSM and were processed in the same way as the 
samples to calculate the concentration of estrogen in the samples (Appendix Fig. 0- 
10-15). 
 
5.2.3.4 uHPLC analysis of estrogen concentration  
Quantification of estrogen concentration was carried out using uHPLC 
(ThermoScientific Dionex Ultimate 3000 RS autosampler, pump, column 
compartment and electrochemical detector) using a ThermoScientific Accucore C18 
100 x 2.1 mm, 2.6µm particle size column with the settings of; flow rate = 0.4 
mL/min, temperature = 40°C, injection volume = 50 – 90 µL, electrochemical 
potential = 1800 mV. The run was isocratic using 62% of mobile phase A and 38% of 
mobile phase B for 4- 6.5 minutes. Mobile phase A contained 95% water, 5% 
acetonitrile and 0.1% formic acid. Mobile phase B contained 95% acetonitrile and 5% 
water with 0.1% formic acid. The detection limit of estrogen was 100ng/L. 
 
 Statistical testing and graphing software 
Statistical analysis was carried out using Minitab 17: 
The data was determined to be not normal using the Anderson Darling normality 
test. 
A Kruskal-Wallis test was carried out to determine if the difference in optical density 
and CFU/mL were significantly different compared to each other and to the control. 
A Pearson’s correlation was carried out to determine if there is a significant 
correlation between time and the concentration of estrogen. Moreover, correlation 
between the concentration of E1 and E2, as the conversion of E2 to E1 was 
identified as a potential pathway step within estrogen degradation (Chapter 2). 
All graphs were produced using SigmaPlot version 12.5. 
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5.3 Results and discussion 
 The 45.5 hour degradation experiment 
5.3.1.1 Bacterial growth 
The average OD at 16 hours for the control flasks is slightly higher at 0.791±0.006 
than for the mixed estrogen flask and the E2 containing flask of 0.061±0.012 and 
0.520±0.015 respectively (Fig. 5-1). The average OD of the control flasks remains 
higher until 45.5 hours where the average OD of the E2 containing flasks is higher at 
0.528±0.007 compared to the control and mixed estrogen flasks of 0.445±0.006 and 
0.424±0.004 respectively. The number of colony forming units per mL (CFU/mL) of 
the control growth was also greater at 6.5x107 ± 4.5x105 CFU/mL than for the mixed 
estrogen flask and the E2 containing flask of 5.1x107 ± 9.6x105 CFU/mL and 4.4x107 
± 1.2x105 CFU/mL respectively (Fig. 5- 2). Furthermore between the hours 16 to 23.5 
the growth is in the stationary phase and after 23.5 hours the bacteria are entering 
the death phase, therefore the bacterial exponential growth phase was identified 
during the first 16 hours. During the whole experiment, the average OD of R. equi 
ATCC13557 in the control flasks is significantly different to the average OD and 
CFU/mL of the mixed flasks (P=0.0173) and the E2 flasks (P=0.0173), however 
there is no significant difference (P=0.0639) in average OD or CFU/ml within the 
mixed estrogen flasks compared to the average OD and CFU/ml of the E2 flasks. 
Furthermore, there was no bacterial growth within the abiotic control.  
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Figure 5-1: The average OD of R. equi ATCC13557 whilst being grown in the different conditions, without 
estrogen (control), exposed to mixed estrogens E1, E2 and EE2 (Mix), exposed to E2 (E2) and 0.1% formalin with 
E1, E2 and EE2 (abiotic).  The error bars represent standard deviation. 
 
 
Figure 5-2: The average CFU/mL of R. equi ATCC13557 whilst being grown in the different conditions, without 
estrogen (control), exposed to mixed estrogens E1, E2 and EE2 (Mix), exposed to E2 (E2) and 0.1% formalin with 
E1, E2 and EE2 (abiotic). The error bars represent standard deviation. 
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5.3.1.2 Estrogen concentrations 
In the mixed estrogen flask there was no change detected in the average 
concentration of EE2 which remained relatively stable. Still, due to slight fluctuation 
between 4.15±0.02 and 4.58±0.04 mg/L, there is a significant positive correlation 
between concentration and time (P=0.005) (Fig. 5- 3). However there was a 
significant decrease (P= 0.001) in the average concentration of E2 from the initial 
4.10±0.05 mg/L, to an average concentration of 0.88±0.01 mg/L at 24.5 hours, and 
not detected by 45.5 hours (Fig. 5- 3). Contrastingly there was a significant increase 
(P=0.01) in the average concentration of E1 from the initial starting concentration of 
4.33±0.11 mg/L to 8.16±0.11 mg/L at 24.5 hours, but it decreased slightly at 45.5 
hours to 7.97±0.10 mg/L (Fig. 5- 3). Furthermore the average decrease in E2 
concentration correlated significantly (P=0.000) with the average increase in E1 
concentration.  
 
  
Figure 5-3: Measuring the average concentrations of mixed estrogens E1, E2 and EE2 over 45.5 hours to 
measure the degradation of estrogen by R. equi ATCC13557. The error bars represent standard deviation. 
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In the E2 containing flask the average concentration of E2 significantly decreased 
(P=0.012) from an initial concentration of 6.57±0.09 mg/L to 0.94±0.04 mg/L at 23.5 
hours and then remained relatively unchanged with a slight decrease in the average 
concentration of 0.86±0.06 mg/L at 45.5 hours (Fig. 5- 4). Furthermore there was a 
significant increase (P=0.003) in the average concentration of E1 with none 
detectable initially to 3.10±0.09 mg/L by 45.5 hours (Fig. 5- 4). Again the decrease in 
the average concentration of E2 significantly correlated (P= 0.000) with an increase 
in the average concentration of E1. 
 
Figure 5-4: Measuring the average concentration of E2 and E1 over 45.5 hours to measure the degradation of 
estrogen by R. equi ATCC13557. The error bars represent standard deviation. 
 
In the abiotic control containing E1, E2 and EE2 there was no significant variation 
(P=0.287, 0.307, 0.207) in the average concentrations, with E1 being 5.19±0.09 
mg/L at the lowest and 5.99±0.09 mg/L at the highest, an increase of 0.80 mg/L (Fig. 
5- 5). The lowest average concentration of E2 was 4.93±0.04 mg/L and 5.56 ±0.12 
mg/L at the highest, an increase of 0.63 mg/L (Fig. 5- 5). Furthermore the lowest 
average concentration of EE2 was 4.99±0.08 mg/L and 5.56±0.06 mg/L at the 
highest, an increase of 0.57 mg/L (Fig. 5- 5).  
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Figure 5-5: Measuring the average concentration of EE2, E2 and E1 over 45.5 hours of the 0.1% formalin 
containing abiotic control. The error bars represent standard deviation. 
 
5.3.1.3 Metabolite analysis 
In the E2 flasks an unknown metabolite peak was present at 16 hours at retention 
time of 1.425 min and a peak area of 50.196nA*min (Fig. 5- 6), which appeared to 
decrease in area at each sampling point for the duration of the 45.5 hours (Fig. 5- 7). 
 
Figure 5-6: Unknown metabolite peak (red) present at 16 hours at retention time 1.425 min and with a peak 
area of 50.196nA*min. 
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Figure 5-7: Peak area of an unknown metabolite at retention time 1.425 min in the E2 only flasks over 45.5 
hours. 
 
 The 311 hour degradation experiment 
5.3.2.1 Bacterial growth 
The average OD between all the experimental conditions remained similar until 12 
hours. At that point, the average OD of the flasks containing E2 was significantly 
higher (P=0.000) than the other conditions at 0.054±0.004 and remained significantly 
higher (P=0.000) at 15 hours at 0.085±0.004 (Fig. 5- 8). At 18 hours the OD of the 
control was significantly higher (P=0.000) at 0.108±0.008, but at 311 hours the 
average OD of the E2 containing flasks was significantly higher (P=0.000) at 
0.156±0.016 (Fig. 5- 8). Furthermore there is no growth of the abiotic control (Fig. 5- 
8).  
When comparing the triplicate flasks for each condition, the average OD is 
significantly different at 12 hours (P=0.016). Flasks A and B at 12 hours, 0.03±0.001, 
have a higher average OD than flask C of 0.02±0.001, but the average OD of the 
control is the highest at 0.043±0.002 in the mixed estrogen flasks (Fig. 5- 9). The 
average OD of flask C increases between 15 and 18 hours, therefore the flasks A, B 
and C have similar OD and there is no significant difference (P=0.060) at 18 hours; 
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0.064 ± 0.002, 0.062 ± 0.001 and 0.047 ± 0.02, respectively. Flask C increases in 
OD between 18 and 311 hours, the average OD; 0.022, is significantly higher 
(P=0.023), than flasks A and B (Fig. 5- 9). 
The average OD of flask C in the EE2 condition is significantly higher (P=0.024) than 
flasks A and B at 12-311 hours (Fig. 5- 10). However, the average OD of the control 
is significantly higher (P=0.020, 0.016) than all the flasks containing EE2 at 15 and 
18 hours, respectively. Again, at 311 hours the EE2 containing flask C has a 
significantly higher (P=0.032) average OD, by 0.02 (Fig. 5- 10). 
The average OD of the flasks containing E2 remain similar until between 18-311 
hours where the average OD of flasks A, B and C; 0.155 ± 0.001, 0.138 ±0.003, and 
0.175 ± 0.005, are significantly higher (P=0.016) than average OD of the control, 
0.129 ±0.006 (Fig. 5- 11).  
 
 
Figure 5-8: The average OD of R. equi ATCC13557 whilst being grown in the different conditions, without 
estrogen (control), exposed to mixed estrogens E2 and EE2 (Mix), exposed to E2 (E2), exposed to EE2 (EE2) and 
0.1% formalin with E2 and EE2 (abiotic).  The error bars represent standard deviation. 
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Figure 5-9: The average OD of R.equi ATCC13557 whilst being grown in mixed estrogen conditions (E2 and EE2), compared 
to the without estrogen (control), and 0.1% formalin with E2 and EE2 (abiotic) 
 
 
Figure 5-10: The average OD of R.equi ATCC13557 whilst being grown in EE2, compared to the without estrogen (control), 
and 0.1% formalin with E2 and EE2 (abiotic) 
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Figure 5-11: The average OD of R.equi ATCC13557 whilst being grown in E2, compared to the without estrogen (control), 
and 0.1% formalin with E2 and EE2 (abiotic) 
 
5.3.2.2 Estrogen concentration 
In all of the three mixed (E2 and EE2) estrogen flasks, there was a significant 
decrease (P=0.028, 0.046, 0.001) in the average concentration of E2 over time and 
with none detectable by 18 hours in flask C (Fig. 5- 12, 13, 14). At 18 hours the 
average concentration of E2 had decreased to 1.6±0.02 mg/L and to 1.5±0.03 mg/L 
in flask A and B respectively (Fig. 5- 12, 13). However a further set of samples was 
taken at 311 hours in which and there was no detectable E2 in flasks A and B. 
Therefore, there was an overall decrease of 5.4±0.02 mg/L in E2 in flask A, 6.6±0.16 
mg/L in flask B and 5.7±0.08 mg/L in flask C. However the average concentration of 
EE2 remained relatively stable in all of the flasks with no significant correlation 
(P=0.384, 0.828, 0.558) over time. Furthermore there was a significant positive 
correlation (P=0.015, 0.039, 0.001) in the average concentration of E1 with time. E1 
was detectable in all of the flasks at 6 hours and the increase significantly correlated 
(P=0.000) with the average concentration of E2 decreasing in all biological 
replicates.  
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The concentration of E1 increased to 4.8±0.02 mg/L, 5.7±0.06, and 6.81±0.05 mg/L 
in flasks A, B and C respectively by 18 hours. Furthermore the average 
concentration of E1 continued to increase in flasks A and B to 7.7±0.15 mg/L at 311 
hours, but the average concentration of E1 in flask C had decreased from 18 hours 
to 6.2±0.02 mg/L at 311 hours.   
 
Figure 5-12: The average concentration of estrogen measured over time in mixed estrogen flask A containing 
E2 and EE2 initially. 
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Figure 5-13: The average concentration of estrogen measured over time in mixed estrogen flask B containing 
E2 and EE2 initially. 
 
 
Figure 5-14: The average concentration of estrogen measured over time in mixed estrogen flask C containing E2 
and EE2 initially. 
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In the three flasks containing only E2, during the first 18 hours there was no 
decrease in the average concentration of E2 or any detectable E1 (Fig. 5- 15). 
However at 311 hours there was no detectable E2 in flasks A, B or C and there was 
a significant increase (0.000) in the average concentration of E1 of 3.2±0.09 mg/L, 
2.2±0.04 mg/L and 3.1±0.02 mg/L in flasks A, B and C respectively. There was a 
significant decrease (P=0.000, 0.000, 0.002) in E2 of 4.2±0.01 mg/L, 6.2±0.02 and 
1.6±0.01 mg/L in flasks A, B and C respectively by 311 hours. The increase in the 
average concentration of E1 significantly correlated (P=0.000, 0.000, 0.001) with the 
decrease in the average concentration of E2 in flasks A, B and C. 
 
 
Figure 5-15: The average concentration of estrogen measured over time in flasks A B and C containing only E2 
initially. 
 
The average concentration of EE2 in flask A showed a gradual increase in 
concentration over time which reached 4.5±0.09 mg/L by 18 hours (Fig. 5- 16). In 
flask B the average concentration of EE2 increased at a faster rate than in flask A, 
reaching 4.5±0.03 mg/L by 15 hours and remaining the same at 18 hours (Fig. 5- 
16). However the average concentration of EE2 in flask C remained relatively 
unchanged for the 18 hours and remained at around 2.3 mg/L between hours 9 until 
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18 (Fig. 5- 16). At 311 hours the average concentration in flask A decreased slightly 
to 4.4±0.03 mg/L, in flask B decreased to 2.7±0.03 mg/L, and in flask C decreased 
slightly to 2.0±0.005 mg/L. The decrease in average concentrations of EE2 in flasks 
B and C correlated significantly (P=0.001, 0.002) with time between 9 and 311 hours, 
however there was no significant positive or negative correlation (P=0.444) with time 
for flask A. 
Figure 5-16: The average concentration of estrogen measured over time in flasks A B and C containing only EE2 
initially. 
 
In the abiotic control the average concentrations for E2 and EE2 increased between 
0 and 3 hours by 1.7 mg/L and 0.4 mg/L respectively, but remained unchanged until 
18 hours (Fig. 5- 17). However at 311 hours there was a decrease in the average 
concentration of E2 and EE2 of 1.3 mg/L and 0.7 mg/L respectively. The decrease in 
average concentration of EE2 significantly correlated (P=0.027) with time, however 
the decrease in E2 did not significantly correlate (P=0.270) with time. The increase in 
the concentrations of E2 and EE2 initially are due to solubility issues, caused by the 
estrogens precipitating out of the solution after being prepared the previous day.  
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Figure 5-17: The average concentration of estrogen measured over time in the abiotic control treated with 0.1% 
Formalin solution and containing E2 and EE2 initially. 
 
In conclusion, in the 45.5 hour experiment there was no significant change in the 
average concentrations of estrogen in the abiotic control for the duration of the 45.5 
hours so therefore the changes in the average concentrations in the E2 only and 
mixed estrogen flasks can be attributed to biotic factors. However in the 311 hour 
experiment, there is a decrease in E2 and EE2 at 311 hours, therefore any changes 
in the concentrations of estrogen between 0 and 18 hours are likely due to biotic 
factors but any change in the EE2 concentration after 18 hours may have been due 
to abiotic factors.  
The time taken for E2 to be completely metabolised was shorter in the presence of 
other estrogens, all E2 was degraded between 18-311 h in the presence of other 
estrogens, however, in the E2 only flasks there was still E2 detectable at 45.5 h but 
were not detected by 311 h. Furthermore in mixed estrogen the conversion from E2 
to E1 was complete, however in the E2 only flasks the amount of E1 detected was 
less than the amount of E2 degraded, therefore there is some complete degradation 
when E2 is the sole estrogen. There was a significant difference in the growth of R. 
equi ATCC13557 in the presence of E2 compared to the control, suggesting that the 
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metabolism of E2 and the degradation of E2 corresponds to an increase in growth, 
therefore the degradation of E2 is growth-linked when E2 is the sole estrogen. The 
degradation of E2 in the mixed estrogen flasks of the 45.5h experiment began after 
the exponential growth phase and during the stationary phase and therefore the 
degradation of E2 within mixed estrogen is not growth-linked. The growth in the 311 
hour experiment of the control is, at the majority of time points, higher than that of 
the experimental flasks, except for the increase in average OD within flask C 
containing mixed estrogen which corresponded with the degradation of E2 which is 
completely metabolised by 18 hours. The faster complete degradation of E2 in the 
presence of other estrogens and non growth-linked degradation suggest that E2 may 
be co-metabolised in the presence of other estrogens (Dalton and Stirling, 1982). 
Co-metabolism has been reported previously in numerous studies (Pauwels et al., 
2008; Shi et al., 2004). This is possibly beneficial as with co-metabolism it is not 
necessary to meet the threshold of energy and carbon required for aerobic and 
anaerobic biodegradation, which may reduce the costs associated with estrogen 
removal (Hazen, 2010). However, the decrease in E2 correlated significantly with the 
increase in E1, meaning E2 was converted into E1. Increased concentration of E1 
within the environment may lead to undesired effects in aquatic organisms (Ankley et 
al., 2017).  
There was no evidence of EE2 degradation by Rhodococcus equi ATCC13557, and 
although the average concentration of EE2 in the EE2 only flasks A and B appeared 
to increase over time, this is likely due to the solubility issues encountered during the 
method development in which the addition of EE2 in an AcN:MeOH stock solution 
appeared to be 3.32±0.07 mg/L lower than the expected concentration of 5 mg/L 
(Fig. 5- 8). There was a decreased in the average concentration of EE2 in flasks A, B 
and C of 0.1 mg/L, 1.8 mg/L and 0.3 mg/L respectively at between 18 and 311 hours 
but the decrease was only significant for flasks B and C. However due to a 
significant reduction of E2 and EE2 in the abiotic control this decrease may have 
been due to abiotic factors. 
In some of the flasks the average increase in E1 is greater than the average 
decrease in E2. The average concentrations of E1 in flasks A, B and C at 311 hours, 
and flask C at 18 hours, were outside the range of the standards and therefore are 
unreliable (Appendix Fig. 0- 13). Thus, it is possible that all the E2 is being converted 
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to E1, but also possible that there may be a lower concentration of E1 than being 
measured as the concentration at 18 hours is not accurate, therefore there is a 
possibility of other metabolites. The elevated concentration of E1 may be due to the 
decrease in flask volume over time due to the number of samples being taken, or an 
issue of separating the peaks during the analysis of the HPLC trace where E2 and 
E1 are overlapping. However, there is no change in the average concentration of 
EE2 in any of the flasks.  
The hypothesis was correct in that the concentration of E2 decreased over time 
within all of the conditions. However, the conversion of E2 to E1 and absence of EE2 
degradation in R. equi ATCC13557 is different than what was reported previously, 
but the presence of 0.5% (v/v) ethanol in the other study may have increased 
estrogen degradation via co-metabolism (Larcher and Yargeu, 2013). Other reasons 
for the difference in degradation may be due to pH, inoculum concentration, and 
temperature which were reported to have effects upon the degradation of E2 by 
Rhodococcus sp. DS201 (Yu et al., 2016). However these findings were similar to 
the conversion of E2 to E1 by Rhodococcus sp. P14 (Ye et al., 2017). Furthermore 
the additional peak with a retention time similar to that of E3, has been reported 
previously however this was under anaerobic conditions using lake sediment and 
sludge (Czajka and Londry, 2006). The conversion of E1 and E2 to E3 has been 
reported in Silt Loam Soil (Xuan et al., 2008).  
Furthermore, the degradation studies combined with the hypothetical degradation 
pathway (Fig. 2-1; Table 2-1) and the gene cluster within the genome of R. equi 
ATCC13557 (Fig. 3- 6), can be used to hypothesize which genes will be expressed 
in R.equi ATCC13557 when exposed to estrogen. The conversion of E2 to E1 is 
present in all of the flasks, with complete conversion occurring in the mixed estrogen 
flasks, which suggests that the gene coding for 3-alpha-(or 20-beta)-hydroxysteriod 
dehydrogenase will be expressed in the presence of estrogen as shown in reaction 7 
of the hypothetical estrogen degradation pathway (Fig. 2- 1; Table 2- 1; Fig. 3- 6). 
However, in the degradation studies with E2 as the sole estrogen, not all the E2 is 
converted to E1, there is evidence of an unknown metabolite (Fig. 5- 6; Fig. 5- 7), 
and there is no decrease in the concentration of E1, suggesting that the genes 
coding for the enzymes catechol 2,3 dioxygenase or putative cytochrome P450 
monooxygenase in reaction 6 and 3-(3-hydroxy-phenyl)proprionate hydroxylase in 
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reactions 4 and 5 (Fig. 2- 1; Table 2- 1; Fig. 3- 6) may be possible. Additionally, the 
decrease in the average peak area of the unknown metabolite (Fig. 5- 6; Fig. 5- 7) 
may suggest a decrease in its concentration and therefore that it is further degraded. 
If the unknown metabolite is 4-OH-E2 and it is converted to 4-OH-E1, then there may 
be expression of the gene coding for 3-alpha-(or 20-beta)-hydroxysteriod 
dehydrogenase after 16 hours, in addition to the initial expression for the conversion 
of E2 to E1. As neither E1 nor EE2 were degraded by R.equi ATCC13557 the genes 
coding for 2-hydroxymuconate-semialdehyde hydrolase shown in reactions 12 of the 
hypothetical estrogen degradation pathway (Fig. 2- 1; Table 2- 1; Fig. 3- 6), is 
unlikely to be expressed in the presence of estrogen. However, if the unknown 
metabolite was 4-OH-E2 and it was converted to 4-OH-E1 then the expression of the 
gene coding for 2-hydroxymuconate-semialdehyde hydrolase in reaction 12 of the 
hypothetical estrogen degradation pathway may be possible (Fig. 2- 1; Table 2- 1; 
Fig. 3- 6). The identity of the unknown metabolite cannot be confirmed without 
further analysis and therefore the concentration cannot be determined from the peak 
area to determine if there is a significant decrease in concentration over time.   
As the conversion of E2 to E1 is observed early within the mixed estrogen flasks it is 
expected that the expression the gene encoding 3-alpha-(or 20-beta)-hydroxysteriod 
dehydrogenase will be early and will decrease as the concentration of E2 decreases. 
However, in the E2 only flasks the expression of 3-alpha-(or 20-beta)-hydroxysteriod 
dehydrogenase is likely to be much later, after 18 hours, due to the delayed 
degradation. Furthermore, in the E2 flasks where the conversion of E2 to E1 was 
incomplete, the genes encoding catechol 2,3 dioxygenase, putative cytochrome 
P450 monooxygenase and 3-(3-hydroxy-phenyl)proprionate hydroxylase are 
expected to be expressed early. If expressed the gene coding for 2-
hydroxymuconate-semialdehyde hydrolase is expected to be expressed much later 
in the degradation.  
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Chapter 6:  Gene expression analysis 
6.1 Introduction 
There have been few studies into the genes coding for enzymes involved in estrogen 
degradation with the focus being mainly upon the metabolites, in a previous study 
using a naphthalene oxidase assay, non-specific monooxygenase activity was 
suggested to be involved in E2 degradation by Sphingomonas sp. KC8 (Yu et al., 
2007). Using RT-qPCR, the 17β-hydroxysteriod dehydrogenase enzyme was 
suggested in the degradation of E2 by Rhodococcus sp. P14 (Ye et al., 2017). In 
order to determine if the genes identified in the genome of R. equi ATCC13557 
(Chapter 3), coding for 2-hydroxymuconate-semialdehyde hydrolase, putative 
cytochrome P450 monoxygenase, 3-oxosteriod 1-dehydrogenase, IcIR family 
transcriptional regulator, catechol 2,3 dioxygenase, 3-(3-hydroxy-phenyl)proprionate 
hydroxylase and 3-alpha-(or 20-beta)-hydroxysteriod dehydrogenase, are involved in 
estrogen degradation, it is necessary to measure their expression over time using 
RT-qPCR when exposed to estrogen and compare this to expression in the absence 
of estrogen. The hypothesis is that there will be an increased expression of the 
genes, coding for enzymes involved in estrogen degradation, identified in R. equi 
ATCC13557 when exposed to estrogen, and that their expression will vary over the 
duration of the degradation study. Following the degradation study, gene expression 
of the genes coding for the enzymes identified in the genome of R. equi ATCC13557 
can be hypothesized for mixed estrogen conditions (Table 6- 1). 
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Table 6-1:  The hypothesized expression of the genes coding for the enzymes identified 
within the genome of R. equi ATCC13557 
 Enzyme Reaction 
number(s) (Fig. 
2-1 & Table 2- 
1) 
Hypothesis 
2-hydroxymuconate-
semialdehyde 
hydrolase 
12 Not expected to be expressed as there was 
no evidence of E1 degradation. 
Putative cytochrome 
P450 monooxygenase 
2 May be expressed in addition to or in place 
of dioxygenase to form 4-OH-E2 or 4-OH-
E1, which were undetectable in the 
degradation studies. Non specific 
monooxygenase activity has been 
previously reported (Yu et al., 2007). 
However, there is no degradation of EE2. 
3-oxosteriod 1-
dehydrogenase 
N/A Although the function within the pathway is 
uncertain there has been a previous study 
that has suggested expression in the 
presence of E2 (Sang et al., 2011). Within 
the context of the hypothesised pathway, 
not expected to be expressed. 
IcIR family 
transcriptional 
regulation 
N/A Transcriptional regulator so expected to be 
expressed where the other genes are 
expressed. 
Catechol 2,3 
dioxygenase 
6 Expression unlikely as all E2 was converted 
to E1, but may have formed undetectable 
metabolites such as 4-OH-E2 or 4-OH-E1. 
3-(3-hydroxy-
phenyl)proprionate 
hydroxylase 
4 & 5 Expression unlikely as all E2 was converted 
to E1, however may be possible if forming 
transient metabolite. 
3-alpha-(or 20-beta)-
hydroxysteriod 
dehydrogenase 
7 Expression expected early due to 
conversion of E2 to E1 beginning at 0-3 
hours. 
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RT-qPCR is the most effective molecular technique in which the gene expression 
(RNA) of specific genes is quantified relative to a control and to reference gene(s) 
due to its detection efficiency and precision (Heid et al., 1996; Rocha et al., 2016). 
During RT-qPCR a fluorescent dye such as SYBR green is incorporated into the 
double-stranded DNA (dsDNA), producing a fluorescent signal directly proportional 
to the number of PCR products within the sample during amplification (Rocha et al., 
2016). RT-qPCR requires the production of complementary DNA (cDNA) by reverse 
transcription of good quality RNA. The stages that follow in RT-qPCR are 
denaturation, where the double-stranded DNA (dsDNA) are separated to single 
stranded DNA (ssDNA), the temperature is reduced to allow binding of the primers, 
and extension where polymerase carries out replication and extension. These steps 
are then repeated to produce many copies of the PCR product and the fluorescence 
is measured in real-time (Rocha et al., 2016). In order for qPCR to be successful, the 
Minimum Information for Publication of Quantitative Real-Time PCR Experiments 
(MIQE) guidelines suggest that there are a number of considerations in the 
production of relevant, accurate, reliable and correct interpretation of RT-QPCR data 
(Bustin et al., 2009). These suggestions include ensuring that; 1) the RNA is of 
sufficient quantity and quality. The quality can be ensured by the 260/280 and 
260/230 ratios between 1.8-2.1 and greater than 1.5 respectively, in addition to gel 
electrophoresis where the ribosomal 23S RNA band which is twice the intensity of 
the 16S RNA band and the absence of smearing, or by use of a bioanalyser 
(ThermoFisher Scientific, 2018); 2) the primers are efficient and specific; 3) there are 
negative reverse transcription (-RT) and no template controls (NTC) on each plate or 
batch of samples; 4) use of standard error bars; 5) appropriate normalisation to 
stable reference gene(s) (Bustin et al., 2009). Furthermore the use of multiple 
reference genes may improve the accuracy of RT-qPCR data. Often studies use a 
single reference gene, without validation to ensure that under their experimental 
conditions that the gene is stably expressed, however reference gene expression 
can vary considerably (Vandesompele et al., 2002). For example, Glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) is the most commonly used reference gene, 
however under different experimental conditions its expression may vary, and 
incorrect normalisation may lead to false interpretations of genes being upregulated 
or downregulated (Kozera and Rapacz, 2013). Therefore the use of geNorm to 
determine the most stable reference genes, genes with the least variation in gene 
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expression, and the minimum number of reference genes required to calculate a 
reliable normalisation factor are recommended (Vandesompele et al., 2002). The 
geNorm assay consists of a number (n=6-12) of commonly used reference genes, 
which are from different functional classes, to reduce the likelihood that they are co-
regulated (Vandesompele et al., 2002). These reference genes are plated along with 
cDNA from all of the experimental and control conditions within the planned 
experiment, RT-qPCR is carried out to measure the gene expression of the 
reference genes. The gene-stability is then determined by the principle that the 
expression ratio of two ideal reference genes is the same in all samples, a lower 
expression ratio suggests the genes are more stable (Vandesompele et al., 2002). 
Therefore, geNorm M is used as a stability measure in which the average pairwise 
variation of a particular reference gene with all the other reference genes as 
standard deviation of the fold change in expression (Vandesompele et al., 2002). In 
order to select the number of reference genes to allow accurate normalisation, and 
to prevent the need for excessive numbers of reference genes, a normalisation 
factor geNorm V is calculated (Vandesompele et al., 2002). The geNormV 
calculation compares the geometric mean of gene expression for the reference 
genes identified as the most stable, with the lowest geNorm M values, by an 
inclusion of reference genes which significantly effect the pair-wise variation 
(Vandesompele et al., 2002).   
 
6.2 Materials and methods 
 Bacterial culture 
R. equi ATCC13557 was acclimated to estrogens for 24 hours, by being cultured in 
500 mL Erlenmeyer flasks with vented bungs, containing MSM (See 6.2.1.1) with 0.6 
g/L of yeast extract. The conditions in each of the acclimation flasks were without 
estrogen (control), 5 mg/L of EE2, 5 mg/L of E2, and 5 mg/L mixed estrogen of E2 
and EE2. R. equi ATCC13557 was previously subcultured numerous times in MSM 
(see 6.2.1.1) containing 5 mg/L of mixed estrogen of E1, E2 and EE2, 5 mg/L of 
EE2, 5 mg/L of E2, and without estrogen (control).  
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6.2.1.1 Preparing the growth media 
M9, Minimal Salts, 5X MSM (Sigma Aldrich) containing 33.9g/L Na2HPO4, 15g/L 
KH2PO4, 5g/L NH4Cl and 2.5g/L NaCl was prepared by weighing 56.6g into 1L of 
distilled water. Separating the 1L salts solution into 5 200mL Duran flasks and 
autoclaving at 121°C. The 200 mL salts solutions were the stored at -4°C until 
required. 
To produce the final growth media the 200 mL salts solution was added to 800 mL of 
distilled autoclaved water containing 0.6 g/L of yeast extract. 
  
 Preparation of the experimental flasks 
To add the estrogen to the MSM (containing 0.6 g/L of yeast extract, 2 mL of a stock 
solution of 1g/L of estrogen in 50:50 acetonitrile:methanol (AcN:MeOH) stock 
solution (see 6.2.2.2) was evaporated using nitrogen gas to a volume of 0.25 mL. 
The 0.25 mL estrogen stock was then added to the MSM containing 0.6 g/L of yeast 
extract and evaporated for a further 80 minutes on a hot plate to remove the 
remaining acetonitrile and methanol. The solution was removed from the heat and 
allowed to cool and then 40 mL of the acclimated R. equi culture was inoculated into 
360 ml of MSM with 0.6 g/L of yeast extract containing the estrogen at a 
concentration of 5 mg/L. The control was prepared without any estrogen solution.  
 
6.2.2.1 Experimental flask conditions 
The flasks were set up in triplicate for each condition, the conditions were containing 
mixed E2 and EE2 and the no estrogen control. 
 
6.2.2.2 Preparing the estrogen stock solution 
To prepare the 1 g/L mixed estrogen stock solution, 0.025 g of each estrogen 
powder (E2 and EE2) were measured into an amber glass 25 cm3 volumetric flask. A 
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50:50 solution of AcN:MeOH was prepared and mixed in a 500 cm3 volumetric flask, 
and dispensed into a beaker. The AcN:MeOH solution was transferred into the 25 
cm3 volumetric using a 25 cm3 Pasteur pipette. The solution was then mixed by 
inversion and stored at 4°C. 
 
 Monitoring for the gene expression experiments 
The flasks were incubated at 25°C for 311 hours with 155 rpm rotation and samples 
were taken every 3 hours for 18 hours and a final sample at 311 hours. However, the 
gene expression analysis will only include samples taken between 0 and 18 hours 
because the bacteria were in stationary/death phase at 311 hours, the growth and 
degradation at 311 hours (Chapter 5, Section 5.3.1).  
At each time point the following samples were taken (triplicates of each);  
- 1 mL - to measure bacterial growth  
- 2 mL - for HPLC analysis 
- 2 mL – for gene expression analysis 
To assess bacterial growth optical density (OD), measured in a Spectrophotomer 
(ATI Unicam 8625 UV/Vis) (Fig. 5- 9). 
Prior to HPLC analysis, samples were processed through sample preparation 
protocol and stored for estrogen quantification (see 6.2.3.1). 
Prior to RNA extraction the samples for gene expression analysis were snap frozen 
at -80°C. 
6.2.3.1 Estrogen sample preparation 
In order to prepare the samples for uHPLC analysis, the samples were immediately 
centrifuged at 13000 x g for 3 min and 1 mL of the supernatant was filtered through 
0.2 µm pore size 13mm EMD Millipore DuraporeTM PVDF membrane syringe filters 
into a 2 mL wide screw neck 12x32 mm Chromacol™ amber glass vial with 
Chromacol™ Blue screw cap, open top with 6 mm hole and a PTFE septum for 
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HPLC analysis. Furthermore standards of known concentrations (1, 2.5, 5, 7.5 and 
10 mg/L) were produced in MSM and were processed in the same way as the 
samples to calculate the concentration of estrogen in the samples (Appendix Fig. 0- 
10 -15). 
 
6.2.3.2 uHPLC analysis of estrogen concentration  
Quantification of estrogen concentration was carried out using uHPLC 
(ThermoScientific Dionex Ultimate 3000 RS autosampler, pump, column 
compartment and electrochemical detector) using a ThermoScientific Accucore C18 
100 x 2.1 mm, 2.6µm particle size column with the settings of; flow rate = 0.4 
mL/min, temperature = 40°C, injection volume = 50 – 90 µL, electrochemical 
potential = 1800 mV. The run was isocratic using 62% of mobile phase A and 38% of 
mobile phase B for 4- 6.5 minutes. Mobile phase A contained 95% water, 5% 
acetonitrile and 0.1% formic acid. Mobile phase B contained 95% acetonitrile and 5% 
water with 0.1% formic acid. The detection limit of estrogen was 100ng/L. 
 
 Extraction of RNA 
The RNA was extracted from the samples for gene expression analysis in a Grade II 
Microbiological cabinet in which all equipment had been cleaned using 70% ethanol 
and RNA erase ® (MP Biomedicals) solution. The extraction method was a 
Phenol:Chloroform extraction with alcohol precipitation modified from (White, 2004). 
1. The samples were thawed on ice and then 1 mL of the sample was added to 
a lysing matrix B tubes (MP Biomedicals) with 1 mL of Phenol:Chloroform, pH 
4.5 (Invitrogen), and ribolysed (MPBio FastPrep®-24) for 30s to disrupt the 
cell walls. 
2. The samples were then incubated on ice for 15 minutes. 
3. Then centrifuged at 8000 x g for 15 min at 4°C. 
4. The aqueous phase was carefully removed and transferred into a fresh 2 mL 
tube and the volume was 500 µL. 
5. 50 µL of 3 M Sodium acetate was added and mixed by vortexing. Sodium 
acetate was added to assist in the ethanol precipitation of the RNA. 
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6. 500 µL of Phenol:Chloroform, pH 4.5 (Invitrogen), was added and mixed by 
vortexing for 1 min and then incubated on ice for 15 min. 
7. Then the homogenate was centrifuged at 8000 x g for 15 min at 4°C. 
8. The 500 µL aqueous phase was transferred to a fresh 2 mL tube. 
9.  500 µL of cold 100% Isopropanol was added and mixed by inversion and 
then incubated at -20°C for 1 hour. 
10. Centrifugation at 8000 x g for 20 min at 4°C until a pellet was formed. 
11.  The supernatant was removed and discarded and the pellet washed in cold 
70% Ethanol by vortexing. 
12. Following centrifugation at 4000 x g for 5 min at 4°C the residual ethanol was 
removed and the pellet air dried for 1 min. 
13. The pellet was then resuspended in 100 µL of RNase free water heated to 
55°C and then stored at -80°C. 
 
6.2.4.1 Quantification of RNA 
Nanodrop was used to assess the quality by the use of the 260/280 and 260/230 
ratios which were expected to be 1.8-2.1 and above 1.5, respectively. Additionally, 
the quality was checked by electrophoresis on 1% agarose gel. 
Furthermore the Qubit® 2.0 Fluorometer (Invitrogen by LifeTechnologies) was used 
along with the Qubit® RNA HS Assay kit to gain a more accurate RNA concentration 
measurement and all the RNA samples were diluted to a concentration of 1 ng/µL 
using Molecular grade water (Sigma Aldrich). 
 
6.2.4.2 Reverse transcription of the RNA 
To generate cDNA from the RNA the QIAGEN® QuantiTect® Reverse Transcription 
kit was used in which the RNA was thawed on ice. Firstly the genomic DNA (gDNA) 
elimination reactions were carried out on a 42°C heat block for 2 min and placed on 
ice until the reverse-transcription reactions were set up. To carry out the reverse-
transcription reactions a PCR machine (Alpha PCR Max) was used with an 
incubation step at 42°C for 30 min, followed by 95°C for 3 min. The reverse-
transcription reactions were then further diluted to 1:200 uL using Molecular grade 
P a g e  | 128 
water (Sigma Aldrich) and stored at -20°C for usage in the geNormTM and RT-qPCR 
experiments. 
 
 geNormTM 
A geNormTM Reference gene selection kit specifically for R. equi was developed by 
Primerdesign using synthetic oligonucleotides for the optimisation. The reference 
gene selection kit was used to compare the expression stability of 12 reference 
genes (Table 6- 2) across the estrogen treated and control samples over time in 
order to select the most stable, the lowest variation in gene expression, gene 
combination over the whole growth period. The 12 reference genes selected, were 
genes identified within gene expression analysis, used commonly within the 
literature, for Rhodococcus. 
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Table 6-2: The 12 reference genes within the geNormTM Reference gene selection kit for R. 
equi ATCC13557 
 REQ number Uniprot gene name Protein 
00090 GyrB DNA gyrase subunit B 
21700 Ihf Integration host factor 
37720 proC Pyrridine-5-carboxylase 
reductase 
17550 atpB ATP synthase subunit A 
11880 arcA Arginine deiminase 
46170 G3P Glyceraldehyde-3-
phosphate 
dehydrogenase 
36840 rplA 50S ribosomal protein L1 
35570 rpoA DNA-directed 
RNApolymerase subunit 
14600 MDH Malate dehydrogenase 
17970 Rim Ribosomal maturation 
factor 
35650 Adk Adenylate kinase 
00010 dnaA Chromosomal replication 
initiator protein 
 
Using the reverse-transcription products produced, the samples were plated in 
triplicate and so that all samples for a given reference gene were within the same 
plate (Hellemans et al., 2007). The BrightWhite Real-Time PCR plates 
(Primerdesign) were set up to have wells containing a total volume of 10 µL, of which 
2.5 µL was template and 7.5 µL of Primerdesign 2x PrecisionPLUSTM Mastermix 
which contained 0.5 µL of the reference gene primer mix, 2 µL of RNase/DNase free 
water, and 5 µL of Primerdesign 2x PrecisionPLUSTM mastermix containing SYBR 
green, per reaction. The plates also contained a no template control (NTC) and no 
reverse transcriptase control (-RT) to ensure there was an absence of contamination 
and no formation of primer dimers. RT-qPCR was carried out using the CFX 96TM 
P a g e  | 130 
Real-Time System C1000TM Thermal cycler BioRad in the CFX Manager TM 3.0 
software with the amplification conditions for 40 cycles (Table 6- 3). 
 
Table 6-3: geNormTM amplification conditions (PrimerDesign, 2016a) 
Step Time (s) Temperature (°C)  
Enzyme activation 120 95 
Denaturation 10 95 
Data collection 60 60 
Melt curve 10 60 
20 95 
 
The data produced was analysed using Biogazelle’s qbasePLUS 3.1 software and 
the optimal number of reference genes was calculated where geNorm V < 0.15 when 
comparing the normalisation factor based on the geometric mean of the reference 
targets. The genes with the highest reference target stability across all the 
experimental conditions was determined where geNorm M ≤ 0.5.  
 
 Selection of gene targets and creation of primers 
The gene sequences of the genes coding for enzymes potentially involved in 
estrogen degradation, which were identified within the genome of R. equi ATCC 
13557, 3-carboxyethylcatechol 2,3-dioxygenase, putative cytochrome P450 
monooxygenase, 2-hydroxymuconic semialdehyde hydrolase, 3-alpha-(or 20-beta)-
hydroxysteroid dehydrogenase, 3-(3-hydroxy-phenyl)propionate hydroxylase, 3-
oxosteroid 1-dehydrogenase and transcriptional regulator IcIR family, were used for 
the design of the primer sets (Table 6- 4). The specific primer sets were developed 
by PrimerDesign as a custom designed real-time PCR assay for use with SYBR 
green.  
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Table 6-4: Primer sets provided by PrimerDesign 
Enzyme Function of enzyme within the 
hypothetical estrogen degradation 
pathway (Table 2- 1 and Fig. 2- 1) 
Primer Sequence Tm GC% Dimer 
2-hydroxymuconate-
semialdehyde 
hydrolase 
Reaction 12 Sense CTACACGACCGACGCCTTC 57.3 63.2 0.0 
Antisense CCGTGCAGGAACAGGATCG 57.6 63.2 -1.2 
Putative cytochrome 
P450 
monooxygenase 
Reactions 6, 8, and/or 11 Sense GCAGTGGTCGAGCTGATGA 56.5 57.9 -0.9 
Antisense CGAGGTGCGAGATGGTGTC 57.3 63.2 0.0 
3-oxosteriod 1-
dehydrogenase 
Function uncertain within estrogen 
degradation pathway 
Sense CCTGTTCATCACATCCAAGGAC 56.5 50 0.0 
Antisense CGACTTCACGGCGTTGAAC 56.6 57.9 -0.2 
IcIR family 
transcriptional 
regulator 
Regulation of the genes Sense CATCAGCTTCGGCGAGGTC 57.6 63.2 -0.9 
Antisense CGATGAGTTCCTTCGATGCG 56.2 55 -0.8 
Catechol 2,3 
dioxygenase 
Reactions 6, 8, and/or 11 Sense GGACCACTTCAACGGGTTCT 56.8 55 0.0 
Antisense AGGTCTTCGGCGATCTCCT 56.7 57.9 -0.1 
3-(3-hydroxy-
phenyl)proprionate 
hydroxylase 
Reactions 5 and/or 9 Sense TCTGTTGCCGCAGGAATCG 57.5 57.9 -0.3 
Antisense CGTCGTCGTCCATGTACTTCT 57.2 52.4 0.0 
3-alpha-(or 20-beta)-
hydroxysteriod 
dehydrogenase 
Reaction 7 Sense GGCAGGTCCTCGACATCAA 56.1 57.9 -0.8 
Antisense AGCGGACGAGATGTTCACG 56.9 57.9 0.0 
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 RT-qPCR 
Using the reverse-transcription products produced, the samples were plated in with 
two biological samples per flask (three flasks experimental, three control) and each 
with triplicate technical replicates. The plate was set up to have wells containing a 
total volume of 10 µL, of which 2.5 µL was template and 7.5 µL of Primerdesign 2x 
PrecisionPLUSTM Mastermix which contained 0.5 µL of the reference gene primer 
mix, 2 µL of RNase/DNase free water, and 5 µL of Primerdesign 2x 
PrecisionPLUSTM mastermix containing SYBR green, per reaction. The plates also 
contained a no template control (NTC) and no reverse transcriptase control (-RT) to 
ensure there was an absence of contamination and no formation of primer dimers. 
RT-qPCR was carried out using the CFX 96TM Real-Time System C1000TM Thermal 
cycler BioRad in the CFX Manager TM 3.0 software with the amplification conditions 
for 40 cycles (Table 6- 5). 
 
Table 6-5: RT-qPCR amplification conditions (PrimerDesign, 2016b) 
Step Time (s) Temperature (°C)  
Enzyme activation 120 95 
Denaturation 10 95 
Data collection 60 60 
Melt curve 10 60 
20 95 
 
To analyse the results the delta delta CT method was used (Equation 6- 1) and then 
fold change was calculated using (Equation 6- 2) (Livak et al., 2001). The arithmetic 
mean of the reference genes and samples were calculated for the experimental and 
control samples, however the geometric mean was taken to combine the average CT 
for the reference genes. 
Equation 6-1: Calculation of delta delta CT normalised to the reference genes. 
ΔΔCT = ((CT(target, control) − CT(reference, control)) − ((CT(target, treated)
− CT(reference, treated)) 
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Equation 6-2: Calculation of the fold change relative to the control. 
fold change = 2ΔΔCT 
 
To produce the standard errors associated with the fold change the variance within 
all six values for CT needed to be included in the final error, therefore the Taylor 
series was used (Equation 6- 3) (Vandesompele et al., 2002). 
Equation 6-3: Calculation of the standard errors associated with the delta delta CT values. 
Error (g(a, b) =  √(a. error (a)2) + (b. error (b2)  
 
The upper and lower standard error was then calculated for the delta delta CT values 
and the standard errors of the upper and lower value were then given to the power of 
2 to calculate the standard error within the fold change. 
 
 Statistical testing and graphing software 
For the geNorm the values of geNorm M ≤ 0.5 and geNorm V < 0.15 are considered 
statistically significant. The graphs were produced using qbase+ software version 3.0 
(Biogazelle, Zwijnaarde, Belgium - www.qbaseplus.com). 
For the RT-qPCR the fold change in expression of a gene must be greater than 2 or 
less than 0.5 to suggest a significant difference in the relative gene expression of a 
gene, because the control fold change is equal to 1 (IRIC., 2017).  Graphs were 
produced using SigmaPlot 12.5. 
Additonally to determine the statistical significance of the difference in gene 
expression over the 18 hour period, the delta CT values of the experimental samples 
were compared to the delta CT values of the control samples, using a two-tailed 
Mann-Whitney test (Minitab 17, 2010). The data was determined to be not normal 
using the Anderson Darling normality test. 
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6.3 Results 
 GeNormTM 
The geNorm V calculation compares the geometric mean of gene expression for the 
reference genes identified as the most stable, by an inclusion of reference genes 
which significantly effect the pair-wise variation (Vandesompele et al., 2002). The 
optimal number of reference gene targets where geNorm V < 0.15 was determined 
to be the two most stably expressed reference gene targets (Fig. 6- 1). All the 
possible numbers of reference genes combinations were < 0.15, however the 
minimal but stable number of two reference genes was selected. 
The geNorm M is used as a stability measure in which the average pairwise variation 
of a particular reference gene with all the other reference genes as standard 
deviation of the fold change in expression (Vandesompele et al., 2002). Although 
there were three genes with geNorm M ≤ 0.5, the optimum number of reference 
gene targets was two, therefore the reference gene targets selected were 11880 
Arginine deiminase (arcA) and 14600 Malate dehydrogenase (MDH) which 
respectively had the lowest average expression stability geNorm M values for the 
whole growth period (Fig. 6- 2).  
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Figure 6-1: geNorm V <0.15 was used to determine the optimal number of reference gene targets. 
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Figure 6-2: geNorm M ≤ 0.5 was used to determine the reference genes with the highest average expression stability. The genes with the highest average stability have the 
lowest geNorm M values (right) and the genes with the lowest average stability have the highest geNorm M values (left). 
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 RT-qPCR 
The average fold change of the gene coding for 3-(3-hydroxy-phenyl)proprionate 
hydroxylase was downregulated in the presence of estrogen at 12 hours and 15 
hours by 3.4 times and 9.6 times respectively (Fig. 6- 3). Overall the gene 
expression of the gene coding for 3-(3-hydroxy-phenyl)proprionate hydroxylase over 
the 18 hours was not significantly different compared to the control (P=0.0967). 
 
Figure 6-3: Fold change in expression of the gene coding for 3-(3-hydroxy-phenyl)proprionate hydroxylase when 
exposed to mixed estrogen relative to the control without estrogen. Normalised to the reference genes Malate 
dehydrogenase and Arginine deiminase. The error bars represent standard error. The dashed line at y=1 
represents the expresson of the control 
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The average fold change of the gene coding for 3-alpha-(or 20-beta)-hydroxysteriod 
dehydrogenase when exposed to estrogen was downregulation between 6 and 18 
hours by 5.3, 17.2, 6.1, 4.6, and 9.3 times respectively, with the expression being the 
lowest compared to the control by 17.2 times at 9 hours (Fig. 6- 4). Furthermore, 
over the 18 hour duration the gene expression compared to the control was 
statistically significant (P=0.0106).  
 
Figure 6-4: Fold change in expression of the gene coding for 3-alpha-(or 20-beta)-hydroxysteriod 
dehydrogenase when exposed to mixed estrogen relative to the control without estrogen. Normalised to the 
reference genes Malate dehydrogenase and Arginine deiminase. The error bars represent standard error. The 
dashed line at y=1 represents the expresson of the control. 
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The gene coding for catechol 2,3-dioxygenase gene was downregulated in the 
presence of estrogen at 12, 15 and 18 hours by 3.9, 2.9 and 2.4 times relative to the 
control (Fig. 6- 5). The expression was therefore lowest compared to the control at 
12 hours by 3.9 times (Fig. 6- 5). However, over the 18 hour duration the gene 
expression was not significantly different when compared to the control (P= 0.0967). 
 
Figure 6-5: Fold change in expression of the gene coding for catechol 2,3-dioxygenase when exposed to mixed 
estrogen relative to the control without estrogen. Normalised to the reference genes Malate dehydrogenase 
and Arginine deiminase. The error bars represent standard error. The dashed line at y=1 represents the 
expresson of the control. 
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The average fold change of the gene coding for the IcIR family transcriptional 
regulator was downregulated at 9, 15 and 18 hours by 3.2, 2.0 and 2.4 times 
respectively (Fig. 6- 6). The lowest expression compared to the control was 3.2 times 
at 9 hours. Furthermore the gene expression over the 18 hours compared to the 
control was significantly different (P= 0.0106). 
 
Figure 6-6: Fold change in expression of the gene coding for the IcIR family transcriptional regulator when exposed to mixed 
estrogen relative to the control without estrogen. Normalised to the reference genes Malate dehydrogenase and Arginine 
deiminase. The error bars represent standard error. The dashed line at y=1 represents the expresson of the control. 
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The gene coding for 3-oxosteriod 1-dehydrogenase was neither upregulated nor 
downregulated in the presence of estrogen compared to the control (Fig. 6- 7). 
Furthermore the gene expression over the 18 hour duration was not significantly 
different compared to the control (P= 0.3067). 
 
Figure 6-7: Fold change in expression of the gene coding for 3-oxosteriod 1-dehydrogenase when exposed to mixed estrogen 
relative to the control without estrogen. Normalised to the reference genes Malate dehydrogenase and Arginine deiminase. 
The error bars represent standard error. The dashed line at y=1 represents the expresson of the control. 
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The gene coding for putative cytochrome P450 monooxygenase was upregulated at 
0 hours by 4.4 times more than the control, however at 18 hours it was 
downregulated by 3.1 times less than the control (Fig. 6- 8). However, the gene 
expression over the 18 hours was not statistically different compared to the control 
(P= 0.6093). 
 
Figure 6-8: Fold change in expression of the gene coding for putative cytochrome P450 monooxygenase when 
exposed to mixed estrogen relative to the control without estrogen. Normalised to the reference genes Malate 
dehydrogenase and Arginine deiminase. The error bars represent standard error. The dashed line at y=1 
represents the expresson of the control. 
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The gene expression of the gene coding for 2-hydroxymuconate-semialdehyde 
hydrolase was downregulated at 15 hours by 2.8 times less than the control (Fig. 6- 
9). Furthermore the gene expression over the 18 hour duration was statistically 
different compared to the control (P= 0.0049). 
 
Figure 6-9: Fold change in expression of the gene coding for 2-hydroxymuconate-semialdehyde hydrolase when exposed to 
mixed estrogen relative to the control without estrogen. Normalised to the reference genes Malate dehydrogenase and 
Arginine deiminase. The error bars represent standard error. The dashed line at y=1 represents the expresson of the control. 
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6.4 Discussion 
The gene expression of the genes coding for enzymes potentially involved in 
estrogen degradation seemed to vary between the experimental flasks and all of the 
genes were expressed lower than the control, with the exception of the genes coding 
for 3-oxosteriod 1-dehydrogenase which was expressed the same as the control for 
the 18 hour duration, and the putative cytochrome P450 monooxygenase gene 
which was expressed higher by 4.4 times more than the control initially. Furthermore 
the average expression of the genes seemed to be decrease relative to the control at 
at the later time points, mostly between 12 and 18 hours. The downregulation of 
these genes corresponds with the time point in the degradation experiment in which 
the growth of R.equi ATCC13557 began to enter the exponential phase and where 
the degradation of E2 began. Therefore, either the increase in E1 or other 
undetectable metabolites, the decrease in concentration of E2, or a combination of 
both led to a reduction in expression of the genes coding for 3-(3-hydroxy-
phenyl)proprionate hydroxylase, 3-alpha-(or 20-beta)-hydroxysteriod 
dehydrogenase, catechol 2,3 dioxygenase, IcIR family transcriptional regulator, 
putative cytochrome P450 monoxygenase, and 2-hydroxymuconate-semialdehyde 
hydrolase, with the exception of 3-oxosteriod 1-dehydrogenase which remained 
unchanged. 
When comparing the gene expression over the full 18 hours and not considering the 
expression at each time point individually, expression of the genes coding for 3-
alpha-(or 20-beta)-hydroxysteriod dehydrogenase, IcIR family transcriptional 
regulator, and 2-hydroxymuconate-semialdehyde hydrolase are different compared 
to the control. However, the only gene upregulated in response to exposure to 
estrogen was the gene coding for putative cytochrome P450 monoxygenase which 
was significantly different than the control at 0 hours. The expression at 0 hours is 
likely due to a delay in taking samples from the flasks due to the large number of 
samples required, and it is likely that due to enrichment, sufficient time had passed 
for expression of genes to begin. The early expression of the gene encoding putative 
cytochrome P450 monoxygenase supports the hypothesis that the first step in 
estrogen degradation by R. equi ATCC13557 is the hydroxylation of the A ring in 
reaction 6 to produce 4-OH-E2 (Table 2- 1; Fig. 2- 1). The hydroxylation of the A ring 
is suggested to be the most common first step in estrogen degradation (Coombe et 
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al., 1966; Sih et al., 1965; Chen et al., 2017; Yu et al., 2016) and supported by the 
EAWAG Biocatalysis/Biodegradation database pathway prediction (Hou et al., 2011). 
However, in all of the experimental flasks the E2 was converted to E1 completely 
with the average concentration of E1 being equal or greater than the average 
decrease in E2, although being greater or equal may be due to issues with the 
standard curve for E1 (Chapter 5). Furthermore, the only metabolite detectable was 
E1, suggesting that the first step in estrogen metabolism involves 3-alpha-(or 20-
beta)-hydroxysteriod dehydrogenase, from reaction 7 of the hypothetical estrogen 
degradation pathway (Table 2- 1; Fig. 2- 1), which has the function of converting E2 
to E1 (Ye et al., 2017). However, there was no upregulation of the gene encoding 3-
alpha-(or 20-beta)-hydroxysteriod dehydrogenase in response to estrogen, so it is 
possible that another gene encoding 3-alpha-(or 20-beta)-hydroxysteriod 
dehydrogenase outside of this gene cluster is responsible for the conversion of E2 to 
E1, as the primers used in this experiment were only specific to the gene identified 
within the gene cluster (Fig. 3- 8). Furthermore, expression of the gene coding for 3-
oxosteriod 1-dehydrogenase was unchanged, despite being identified as one of the 
first enzymes involved in steroid degradation (Sang et al., 2012). However, the 
function within the hypothetical estrogen degradation pathway (Fig. 2- 1) was 
unknown, so the unchanged expression of 3-oxosteriod 1-dehydrogenase in the 
presence of estrogen is unsurprising.  
One of the first possible steps in the degradation of E2 is the conversion of E1 by 
17β-hydroxysteroid dehydrogenase in reaction 7 (Table 2- 1; Fig. 2- 1) therefore 
early expression at 0-3 hours of 3-alpha-(or 20-beta)-hydroxysteriod dehydrogenase 
was expected due to the conversion of E2 to E1 in R. equi ATCC13557. However, 
there was no upregulation of this gene, but another gene within the genome of R. 
equi ATCC13557 may be expressed to produce this enzyme. The other two 
pathways for E2 degradation are the conversion of E2 to keto-E2 by the action of 
hydroxylase (reaction 5) or conversion to 4-OH-E2 by dioxygenase (reaction 6) 
(Table 2- 1; Fig. 2- 1), therefore the genes coding for 2-hydroxymuconate-
semialdehyde hydrolase, catechol 2,3 dioxygenase or putative cytochrome P450 
monooxygenase, were expected to be expressed early at timepoints 0 to 6 hours. 
Initially the expression of the gene coding for catechol 2,3 dioxygenase was 
unchanged relative to the control and then downregulated at 12 to 18 hours as the 
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concentration of E1 increased. Therefore the gene encoding catechol 2,3 
dioxygenase within the gene cluster doesn’t have a role in the degradation of E2 by 
R. equi ATCC13557. However, expression of putative P450 monooxygenase, which 
can function in a similar way to dioxygenase, at 0 hours may suggest conversion to 
4-OH-E2 in reaction 6 or E1 to 4-OH-E1 in reaction 8 (Table 2- 1; Fig. 2- 1), 
however, without metabolite analysis this cannot be confirmed. The gene coding for 
3-(3-hydroxy-phenyl) propionate hydroxylase is suggested to be responsible for 
conversion to keto-E2 by hydroxylase in reaction 5 or conversion of E1 to 3-HSA in 
reaction 9 (Table 2- 1; Fig. 2- 1). However, the gene coding for 3-(3-hydroxy-phenyl) 
proprionate hydroxylase was not changed in response to estrogen exposure until at 
12 and 15 hours where it was downregulated. Therefore 3-(3-hydroxy-phenyl) 
proprionate hydroxylase is unlikely to have a role in the degradation of estrogen by 
R. equi ATCC13557, this was expected as there was no significant reduction in E1 
concentration during the degradation experiments. Furthermore, expression of the 
gene coding for 2-hydroxymuconate-semialdehyde hydrolase enzyme would be 
expected at a later timepoint because within the degradation pathway of E1, reaction 
12 (Table 2- 1; Fig. 2- 1) happens at a later point, and again as there was no 
upregulation of this gene in the presence of estrogen or any significant reduction in 
the concentration of E1 during the degradation studies the gene coding for 2-
hydroxymuconate-semialdehyde hydrolase is not involved in estrogen degradation 
by R. equi ATCC13557. Additonally the function of 3-oxosteriod 1-dehydrogenase is 
unclear in the degradation of E2 as in the degradation of testosterone it functions to 
assist in the cleavage of the A ring by the dehydrogenation leading to a double bond, 
however the double bond already exists within the aromatic A ring of both E1 and E2 
(Horinouchi et al., 2012; Guevara et al., 2017), therefore as expected there was no 
change in expression when exposed to estrogen the gene coding for 3-oxosteriod 1-
dehydrogenase has no role in estrogen degradation by R. equi ATCC13557. The 
IcIR family transcriptional regulator has the function of regulating the genes within 
the cluster involved in specific functions such as carbon metabolism (Fillet et al., 
2011), the IcIR family transcriptional regulator was not expressed differently from the 
control until downregulation at 9, 15 and 18 hours which correspond with the 
timepoints during which the majority of the other genes were downregulated. 
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Although the triplicate flask were set up as biological replicates, the degradation in 
each flask and gene expression were different from each other, for example there 
was complete metabolism of E2 by 18 hours in flask C but E2 was still detected in 
flasks A and B (Fig. 5- 12; 5- 13; 5- 14). The differences in degradation, may be due 
to factors such as differences in the starting concentration in each flask, pH, 
inoculum concentration (Yu et al., 2016). The gene expression experiment used 
samples from the mixed estrogen containing flasks stored from the degradation 
experiments, it is likely that the degradation within the mixed flasks was co-metabolic 
as it was not growth-linked metabolism of estrogen. Therefore, in the future gene 
expression of these genes should be measured within the E2 containing flasks which 
was growth-linked metabolism (Fig. 5- 15).  
If the gene expression experiment is interpreted in the contect of the mixed estrogen 
flask of the 45.5 hour experiment in which the quantification of E1 was much more 
reliable due to a good standard curve, there was 0.46 mg/L of E2 degraded and a 
decrease in the concentration of E1 at 45.5 hours (Fig. 5- 3). There was E2 
degraded which was not converted to E1 and/or the E1 was degraded further, 
therefore the expression of the gene coding for putative cytochrome P450 
monooxygenase within the gene cluster identified within R.equi ATCC13557 is 
involved in estrogen degradation, but these pathway reactions would be more 
strongly confirmed by the use of metabolite detection in addition to the RT-qPCR 
experiment. Further gene expression experiments need to be carried out to confirm 
the involvement of a gene coding for 3-alpha-(or 20-beta)-hydroxysteriod 
dehydrogenase within the genome of R. equi ATCC13557 in the conversion of E2 to 
E1. Additionally, gene expression of these genes should be measured during the 
degradation of E2 as the sole estrogen where the degradation is growth-linked. 
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Chapter 7:  Final discussion 
An updated and comprehensive potential estrogen degradation pathway for bacteria 
has been proposed, which combined the estrogen degradation pathway with that of 
testosterone degradation by Comamonas testosteroni (Horinouchi et al., 2003). 
Using the pathway, a number of enzymes likely necessary in the metabolism of 
estrogen by bacteria were identified including; 17β-hydroxysteriod dehydrogenase, 
dioxygenase, hydroxylase, oxosteroid 1-dehydrogenase, hydratase and hydrolase. 
Some of these enzymes had also been previously implied in the degradation of 
estrogen, such as 17β-hydroxysteriod dehydrogenase, oxosteroid 1-dehydrogenase, 
rieske dioxygenase, catechol 2,3-dioxygenase. Furthermore genes encoding these 
enzymes were identified in the genomes of Sphingomonas sp. KC8 and 
Pseudomonas putida SJTE-1 (Liang et al., 2012; Hu et al., 2011). A gene cluster 
containing genes encoding these enzymes in addition to hydrolase identified within 
the testosterone degradation pathway, which may be a common steroid degradation 
pathway (Horinouchi et al., 2003). Previously, only the gene responsible for 
producing the 17β-hydroxysteriod dehydrogenase enzyme, had been found to be 
upregulated in the presence of estrogen by use of RT-qPCR experiments (Ye et al., 
2017). However, in this work, evidence of upregulation of putative cytochrome P450 
monooxygenase initially in the present of estrogen was presented, therefore the 
enzyme may have a role in estrogen degradation. However, the genes coding for 3-
(3-hydroxy-phenyl)proprionate hydroxylase, catechol 2,3 dioxygenase, IcIR family 
transcriptional regulator, 3-oxosteriod 1-dehydrogenase, 2-hydroxymuconate-
semialdehyde hydrolase, and surprisingly 3-alpha-(or 20-beta)-hydroxysteroid 
dehydrogenase were not upregulated in the presence of estrogen but at later 
timepoints downregulated as the concentration of E2 decreased. However, another 
gene coding for 3-alpha-(or 20-beta)-hydroxysteriod dehydrogenase is likely 
responsible for the conversion of E2 to E1 in reaction 5 of the proposed estrogen 
degradation pathway as E1 was the only detectable metabolite (Fig. 2- 1). Therefore, 
metabolite studies are required in addition to the RT-qPCR experiments to fully 
evaluate the potential estrogen degradation pathway.  
Additionally, the stability of reference genes in measuring the gene expression in the 
presence of estrogens has not been reported previously. In this work, the stability of 
twelve reference genes was compared and the use of multiple reference genes were 
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evaluated (Vandesompele et al., 2002). It was found that the use of reference genes 
coding for malate dehydrogenase and arginine deiminase were the most stably 
expressed reference genes under these experimental conditions. 
Method development of the sample preparation method for the quantification of 
estrogen demonstrated that, as shown previously, choice of filtration is highly 
important in the separation of biomass from estrogen containing samples due to their 
sorption to various filtration materials (Walker and Watson, 2010). Furthermore it is 
important to ensure that estrogen is soluble, and remains soluble, within the 
conditions of an estrogen degradation experiment due to the effects of ionic 
interactions, hydrogen-bonding, and pH (Carter and Sluss, 2013; Shareef et al., 
2006; Ruchelman, 1967). It appears that although dissolved initially in the estogen 
degradation experiments that the estrogen had precipitated out of the MSM and re-
dissolved over time, resulting in the increase in initial estrogen concentrations of E2 
and EE2. Therefore additional measures such as ensuring the pH is constant by use 
of a buffer and beginning the experiment immediately after dissolving the estrogen 
are required. In the degradation experiment R. equi ATCC13557 conversion of E2 
into E1. Although an unknown metabolite was present within the E2 only degradation 
of the 45.5 hour experiments, there was no significant decrease in the concentration 
of E1 suggesting that there is not complete metabolism. Therefore further 
experiments are required to identify the unknown metabolite. The degradation of 
estrogen may not be linked to growth so may be due to co-metabolism in the 
presence of other estrogens, yeast extract or residual solvent within the MSM. The 
co-metabolic conversion of E2 to E1 by R. equi ATCC13557 has not been reported 
previously. There was no degradation of EE2 by R. equi ATCC13557 but this may 
have been due to differences in the pH, inoculum concentration, temperature 
fluctuations or absence of ethanol (Yu et al., 2016; Larcher and Yargeau, 2013). 
Therefore experiments to investigate these effects upon the degradation of R. equi 
ATCC13557 are required.  
Therefore, the findings of this study have successfully explored the study aims 
(Table 7- 1). The findings suggest that there may be more than one estrogen 
degradation pathway present in R. equi ATCC13557 as the conversion of E2 to E1 
suggests that the first step in estrogen degradation is the dehydrogenation of the D 
ring and the upregulation of P450 monooxygenase suggests the first step is 
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hydroxylation of the A ring. Non specific monooxygenase activity has been reported 
previously in the degradation of E1 (Yu et al., 2007) and ammonia monooxygenase 
was suggested to be involved in estrogen degradation by Nitrosomonas europaea 
(Shi et al., 2004), and P450 monoxygenase is involved in E2 degradation within 
mammals (Scornaienchi et al., 2010; Nishida et al., 2013). Therefore, the gene 
coding for putative cytochrome P450 enzyme may have a role in estrogen 
degradation. Therefore, both genes coding for 17β-hydroxysteriod dehydrogenase 
and putative cytochrome P450 monooxygenase are important in estrogen 
degradation within R. equi ATCC13557. However, a bacterium with a greater ability 
to degrade estrogen or an improvement in the degradation experimental conditions 
to enhance the degradation by R. equi ATCC13557 is required to fully evaluate the 
potential estrogen degradation pathways. The current data could be improved if 
metabolite analysis was carried out in addition to RT-qPCR, allowing both the 
identification of the products and the enzymes which catalyse the reactions. 
Additionally, gene expression should be measured in the degradation experiments 
containing E2 as the sole estrogen as the degradation appeared to be growth-linked. 
Although costly, a transciptomic, proteomic and metabolomic approach, may provide 
a more comprehensive understanding of the genomic potential of estrogen 
degrading bacteria. Further primer sets should be developed to target the genes 
coding for the enzymes identified in the hypothetical estrogen degradation pathway 
(Fig. 2- 1; Table 2- 1) as the primers within this study were specific only to the gene 
cluster identified in R. equi ATCC13557 (Fig. 3- 8).    
This research has shown that it is of importance that genome assembly is chosen 
carefully to suit the sequencing data by considering factors such as sequencing 
platform, sequence length and quality. Additionally, in the design of estrogen 
degradation studies there are a number of considerations to ensure the estrogen 
concentrations detected truly represent the losses of estrogen such as; 1) the filter 
material should be carefully chosen to reduce the retention of estrogen; 2) the loss of 
estrogen due to filtration and other sample preparation should be determined and if 
these losses are significant a control such as processing the standards in the same 
way or ensuring these losses are accounted for in the degradation concentrations; 3) 
choice of solvent is carefully considered to reduce solubility issues if present; 4) the 
effect upon degradation is considered if the solvent remains unremoved. Further 
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recommendations are that by searching the genomes of bacteria for genes coding 
for the enzymes necessary for estrogen degradation, using the hypothetical estrogen 
degradation pathway, may allow identification of previously unknown estrogen 
degrading bacteria. Furthemore, in addition to isolating and confirming estrogen 
degradation by biodegradation studies, a greater availability of genome sequences 
of estrogen degrading bacteria, particularly EE2 degraders, within public databases 
would assist in the understanding of estrogen biodegradation through a genomic 
approach.  
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Table 7-1: A table showing how the aims of the project were met. 
Chapter  Aims  Findings 
2 To compile a hypothetical pathway of estrogen 
degradation using existing information from current 
literature on estrogen and testosterone degradation. 
A hypothetical estrogen degradation pathway was compiled (Fig. 2- 1). 
The key steps (reactions) and enzymes involved were summarised into 
a table (Table 2- 1). 
3 To assemble the genome of R. equi ATCC 13557 and 
search it for genes coding for the enzymes that are 
potentially involved in estrogen degradation. 
To compare the genomes of potential estrogen 
degrading bacteria to localise the genes coding for 
enzymes that are suggested to be involved in 
estrogen degradation 
The genome of R. equi ATCC13557 was assembled using both CLC 
and SPAdes. However, the SPAdes assembly was used in further 
analysis due to a better quality assembly and larger genome size. 
A gene cluster was identified within the genome of R. equi ATCC13557 
containing genes from the hypothetical estrogen degradation pathway. 
The genome of R. equi ATCC13557 was compared with the genomes of 
Sphingomonas sp. KC8 and Pseudomonas putida SJTE-1, but the only 
genes with significant similarity were those encoding enzymes essential 
for survival. 
The genomes were searched for genes coding for the enzymes 
identified in the hypothetical estrogen degradation pathway and 3-
oxosteriod 1-dehydrogenase was identified within R. equi ATCC13557. 
In Sphingomonas sp. KC8 3-ketosteriod 5-dehydrogenase, and 
dioxygenase were identified. In P. putida SJTE-1 only dioxygenase was 
identified. 
4 To optimise the method of estrogen sample 
preparation and addition of estrogen to the growth 
media. 
The better sample preparation to remove biomass was determined to be 
centrifugation followed by PVDF filtration. 
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The method to add estrogen to the growth media was determined to be 
producing a stock solution in AcN/Me and adding to the MSM, followed 
by evaporation at 80 ̊C for 80 minutes. 
5 Carry out degradation experiments to determine 
estrogen degradation under the experimental 
conditions. 
R. equi ATCC13557 converted E2 to E1 and the degradation was 
cometabolic in the presence of other estrogens. When E2 was the sole 
estrogen there was production of an unidentified metabolite and some 
E2 may have been converted to this metabolite or possibly degraded as 
not all E2 was converted to E1. There was no degradation of EE2.   
6 Develop new specific primer sets to identify and 
enumerate the identified genes coding for enzymes 
potentially involved in estrogen degradation using RT-
qPCR. 
To quantify gene expression of R. equi ATCC13557 
during degradation to determine the active genes.  
Primers were developed to specifically target the genes within the gene 
cluster of potential estrogen degradation genes found in the genome of 
R. equi ATCC13557. 
RT-qPCR experiments using samples taken from the degradation 
experiment containing mixed estrogen in 5.3.2 (Fig. 5- 9, 5- 12, 5- 13 
and 5- 14). The gene coding for putative cytochrome P450 
monooxygenase was upregulated initially in response to estrogen, 
however the other genes, with the exception of 3-oxosteriod 1-
dehydrogenase which remained unchanged, were downregulated at 
later timepoints as the concentration of E2 decreased and E1 increased. 
Thus, suggesting the first step in estrogen degradation by R. equi 
ATCC13557 is the hydroxylation of the A ring.  
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Appendix 
Figures 
 
Figure Appendix 0-1: The standard curve for E1 used to determine the concentration of the E1 samples of the 
biomass removal experiment. Error bars represent the standard deviation. 
 
 
Figure Appendix 0-2: The standard curve for E2 used to determine the concentration of the E2 samples of the 
biomass removal experiment. Error bars represent the standard deviation. 
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Figure Appendix 0-3: The standard curve for EE2 used to determine the concentration of the EE2 samples of the 
biomass removal experiment. Error bars represent the standard deviation. 
 
 
Figure Appendix 0-4: The standard curve for E1 used to determine the concentration of the E1 samples of the 
methods of dissolving estrogen into MSM. Error bars represent the standard deviation. 
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Figure Appendix 0-5: The standard curve for E2 used to determine the concentration of the E2 samples of the methods of 
dissolving estrogen into MSM. Error bars represent the standard deviation. 
 
 
Figure Appendix 0-6: The standard curve for EE2 used to determine the concentration of the EE2 samples of the methods of 
dissolving estrogen into MSM. Error bars represent the standard deviation. 
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Figure Appendix 0-7: The standard curve for E1 used to determine the concentration of the E1 samples of the initial 
concentrations experiment. Error bars represent the standard deviation. 
 
 
Figure Appendix 0-8: The standard curve for E2 used to determine the concentration of the E2 samples of the 
initial concentrations experiment. Error bars represent the standard deviation. 
y = 17.951x - 3248.5
R² = 0.9921
0
20000
40000
60000
80000
100000
120000
140000
160000
180000
200000
0 2000 4000 6000 8000 10000 12000
A
ve
. p
ea
k 
ar
ea
Concentration (ug/L)
y = 14.579x - 2335.8
R² = 0.9926
0
20000
40000
60000
80000
100000
120000
140000
160000
0 2000 4000 6000 8000 10000 12000
A
ve
. p
ea
k 
ar
ea
Concentration (ug/L)
P a g e  | 193 
 
Figure Appendix 0-9: The standard curve for EE2 used to determine the concentration of the EE2 samples of the 
initial concentrations experiment. Error bars represent the standard deviation. 
 
 
Figure Appendix 0-10: The standard curve for E1 used to determine the concentration of the E1 samples of the 
45.5h degradation experiment. Error bars represent the standard deviation. 
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Figure Appendix  0-11: The standard curve for E2 used to determine the concentration of the E2 samples of the 
45.5 hour degradation experiment. Error bars represent the standard deviation. 
 
 
Figure Appendix 0-12: The standard curve for EE2 used to determine the concentration of the EE2 samples of 
the 45.5 hour degradation experiment. Error bars represent the standard deviation. 
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Figure Appendix 0-13: The standard curve for E1 used to determine the concentration of the E1 samples of the 
311 hour degradation experiment. Error bars represent the standard deviation. 
 
 
Figure Appendix 0-14: The standard curve for E2 used to determine the concentration of the E2 samples of the 
311 hour degradation experiment. Error bars represent the standard deviation. 
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Figure Appendix 0-15:The standard curve for EE2 used to determine the concentration of the EE2 samples of the 311 hour 
degradation experiment. Error bars represent the standard deviation. 
 
 
Figure Appendix 0-16: Bioanalyser trace for R.equi ATCC13557. 
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Tables: 
Table Appendix 0-1: Bioanalyser data overall results 
Number of peaks found 4 
Noise 0.4 
Corr. Area 1 5,629.6 
 
Table Appendix  0-2: Bioanalyser peak data 
Peak Size (bp) Conc. (pg/µL) Molarity 
(pmol/µL) 
Observations 
1 35 125.00 5,411.3 Lower marker 
2 61 19.26 477.2  
3 1,036 4,034.09 5,900.8  
4 1,182 531.78 681.7  
5 1,259 3,137.26 3,775.9  
6 10,380 75.00 10.9 Upper marker 
 
Table Appendix 0-3: Bioanalyser region table 
From 
(bp) 
To (bp) Corr. 
Area 
% of 
Total 
Average 
size 
(bp) 
Size 
distribution 
in CV (%) 
Conc. 
(pg/µL) 
Molarity 
(pmol/L) 
397 3,520 5,629.6 97 1,191 47.9 8,063.36 13,404.1 
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Table Appendix 0-4: Database of genes coding for enzymes potentially involved in estrogen degradation 
Gene/enzyme Accession n. Description Reference/submission information from GenBank 
ORF11  AB063482 a Comamonas testosteroni ORF11, tesA, tesD, tesE, 
tesF, tesG genes, complete cds 
Horinouchi,M Appl. Environ. Microbiol. 69 (4), 2139-
2152 (2003) 
TesA/ORF12 
(hydroxylase) 
AB063482 b Comamonas testosteroni ORF11, tesA, tesD, tesE, 
tesF, tesG genes, complete cds 
Horinouchi, M Appl. Environ. Microbiol. 69 (4), 2139-
2152 (2003) 
TesA2 (hydroxylase of 
3-hydroxy-9, 10-
secoandrosta -1,                      
3, 5(10)-triene-9, 17-
dione, flavin-
dependent                     
monooxygenase 
oxygenase subunit) 
LC010134 Comamonas testosteroni DNA, putative mega-
cluster of steroid degradation genes, strain: T441. 
Horinouchi Microbiology (Reading, Engl.) 147 (PT 12), 
3367-3375 (2001) 
flavin-dependent 
monooxygenase 
oxygenase subunit 
CP006704  Comamonas testosteroni TK102, complete genome. Fukuda Genome Announc 2 (5), e00865-14 (2014) 
ORF17 (3-ketosteroid-
9-alpha-hydroxylase 
reductase) 1a 
(EC(1.14.13.142) 
AB076368  Comamonas testosteroni tesH, tesI, ORF17, ORF18 
genes for 3-ketosteriod-delta1-dehydrogenase, 3-
ketosteriod-delta4(5alpha)-dehydrogenase, 
hypothetical protein, complete cds. 
Horinouchi, M. Appl. Environ. Microbiol. 69 (8), 4421-
4430 (2003) 
3-ketosteroid-9-alpha-
hydroxylase reductase 
subunit 
CP006704 Comamonas testosteroni TK102, complete genome. Fukuda Genome Announc 2 (5), e00865-14 (2014) 
3-(3-hydroxy-
phenyl)proprionate 
hydroxylase 
R.equi 
ATCC13557 
R.equi ATCC13557 rast annotation of spades 
assembly 
This thesis 
Chromosome I LN879547 Comamonas testosteroni P19 genome assembly 
Comamonas testosteroni P19, chromosome : I 
Park,Soo.-Je. Submitted (15-SEP-2015) JEJU NATIONAL 
UNIVERSITY, Lab of Microbial Microbial Ecology and 
Genomics, Dept. of Biology, Jeju National University, 
102 Jejudaehak-ro, Jeju 690-756, Jeju, 690-756, South 
Korea 
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3-ketosteroid 9alpha-
monooxygenase 
(1.14.13.142) 
BCMM010000
37.1 
Streptomyces scabiei DNA, scaffold: 
NODE_037_cov_57.5993, strain: S58, whole genome 
shotgun sequence 
Tomihama,T., Ikenaga,M., Sakai,M., Okubo,T. and 
Ikeda,S. Ecology and Genomics, Dept. of Biology, Jeju 
National University, 102 Jejudaehak-ro, Jeju 690-756, 
Jeju, 690-756, South Korea 
             
3-ketosteroid 9alpha-
monooxygenase 
(1.14.13.142) 
LLWJ0100005
6.1 
Pseudomonas sp. TAA207 contig000056, whole 
genome shotgun sequence 
Submitted (20-OCT-2015) University of Florence, Via 
Madonna del Piano 6, Sesto Fiorentino, Italy 
3-ketosteroid 9alpha-
monooxygenase 
(1.14.13.142) 
LLWI0100006
7.1 
Pseudomonas sp. TAD18 contig000067, whole 
genome shotgun sequence 
Submitted (20-OCT-2015) Dept. of Biology, University 
of Florence, Via Madonna del Piano 6, Sesto Fiorentino, 
Italy 
3-ketosteroid 9alpha-
monooxygenase 
(1.14.13.142) 
BCMK010000
14.1 
Streptomyces acidiscabies DNA, scaffold: 
NODE_014_cov_52.5735, strain: a10, whole genome 
shotgun sequence 
Tomihama et al., Genome Announc 4 (2), e00062-16 
(2016) 
3-ketosteroid 9alpha-
monooxygenase 
(1.14.13.142) 
BCMK010002
00.1 
Streptomyces acidiscabies DNA, scaffold: 
NODE_200_cov_56.898, strain: a10, whole genome 
shotgun sequence 
Tomihama et al., Genome Announc 4 (2), e00062-16 
(2016) 
3-ketosteroid 9alpha-
monooxygenase 
(1.14.13.142) 
BCMN010000
02.1 
Streptomyces turgidiscabies DNA, scaffold: 
NODE_002_cov_60.061, strain: T45, whole genome 
shotgun sequence 
Tomihama et al., Genome Announc 4 (2), e00062-16 
(2016) 
3-ketosteroid 9alpha-
monooxygenase 
(1.14.13.142) 
CP012042.1 Burkholderia pseudomallei strain Bp1651 
chromosome 2, complete sequence 
Bugrysheva et al., Genome Announc. 2015 Dec 3;3(6). 
pii: e01427-15. doi: 10.1128/genomeA.01427-15. 
3-ketosteroid 9alpha-
monooxygenase 
(1.14.13.142) 
CVQP0100000
2.1 
Rhodococcus sp. RD6.2 genome assembly RD6.2, 
scaffold RHCRD62_Contig_10, whole genome 
shotgun sequence 
De Marco Submitted (12-MAY-2015) IINFACTS, R. 
Central de Gandra, 1317 Gandra PRD, Portugal 
3-ketosteroid 9alpha-
monooxygenase 
(1.14.13.142) 
CVQP0100000
5.1 
Rhodococcus sp. RD6.2 genome assembly RD6.2, 
scaffold RHCRD62_Contig_2, whole genome 
shotgun sequence 
De Marco Submitted (12-MAY-2015) IINFACTS, R. 
Central de Gandra, 1317 Gandra PRD, Portugal 
3-ketosteroid 9alpha-
monooxygenase 
(1.14.13.142) 
CVQP0100000
7.1 
Rhodococcus sp. RD6.2 genome assembly RD6.2, 
scaffold RHCRD62_Contig_4, whole genome 
shotgun sequence 
De Marco Submitted (12-MAY-2015) IINFACTS, R. 
Central de Gandra, 1317 Gandra PRD, Portugal 
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Rieske (2Fe-2S) 
domain-containing 
protein 
CP011072.1 Azoarcus sp. CIB, complete genome Martin-Moldes et al Submitted (04-MAR-2015) 
Environmental Biology, Centro de 
            Investigaciones Biologicas (CSIC), Ramiro de 
Maeztu 9, Madrid, 
            Madrid 28040, Spain 
3-ketosteroid 9alpha-
monooxygenase 
(1.14.13.142) 
JYNL01000001
.1 
Mycobacterium chlorophenolicum strain DSM 
43826 MCHLDSM_contig000001, whole genome 
shotgun sequence 
Das et al Genome Biol Evol. 2015 Jun 16;7(7):1871-86. 
doi: 10.1093/gbe/evv111. 
3-ketosteroid-9-alpha-
monooxygenase 
oxygenase subunit 
JYNL01000008
.1 
Mycobacterium chlorophenolicum strain DSM 
43826 MCHLDSM_contig000008, whole genome 
shotgun sequence 
Das et al., Genome Biol Evol. 2015 Jun 16;7(7):1871-86. 
doi: 10.1093/gbe/evv111. 
3-ketosteroid-9-alpha-
monooxygenase 
oxygenase 
JYNU0100000
1.1 
Mycobacterium obuense strain DSM 44075 
MOBUDSM44075_contig000001, whole genome 
shotgun sequence 
Das et al Genome Biol Evol. 2015 Jun 16;7(7):1871-86. 
doi: 10.1093/gbe/evv111. 
3-ketosteroid-9-alpha-
monooxygenase 
oxygenase 
JYNU0100000
2.1 
Mycobacterium obuense strain DSM 44075 
MOBUDSM44075_contig000002, whole genome 
shotgun sequence 
Das et al Genome Biol Evol. 2015 Jun 16;7(7):1871-86. 
doi: 10.1093/gbe/evv111. 
3-ketosteroid-9-alpha-
monooxygenase 
oxygenase 
JYNX0100003
5.1 
Mycobacterium chubuense strain DSM 44219 
MCHUDSM44219_contig000035, whole genome 
shotgun sequence 
Das et al Genome Biol Evol. 2015 Jun 16;7(7):1871-86. 
doi: 10.1093/gbe/evv111. 
3-ketosteroid-9-alpha-
monooxygenase 
oxygenase 
JYNX0100003
8.1 
Mycobacterium chubuense strain DSM 44219 
MCHUDSM44219_contig000038, whole genome 
shotgun sequence. 
Das et al Genome Biol Evol. 2015 Jun 16;7(7):1871-86. 
doi: 10.1093/gbe/evv111. 
3-ketosteroid-9-alpha-
monooxygenase 
oxygenase 
JYNL01000069
.1 
Mycobacterium chlorophenolicum strain DSM 
43826 MCHLDSM_contig000070, whole genome 
shotgun sequence 
Das et al Genome Biol Evol. 2015 Jun 16;7(7):1871-86. 
doi: 10.1093/gbe/evv111. 
3-ketosteroid-9-alpha-
monooxygenase 
oxygenase 
CDHG010000
28.1 
Mycobacterium caprae genome assembly Genome 
assembly of M caprae MB2, contig 28, whole 
genome shotgun sequence 
Manrique Submitted (12-NOV-2014) ERA7, Oh no 
sequences! group, Plaza Campoverde 3 atico, 18001, 
Spain 
3-ketosteroid-9-alpha-
monooxygenase 
oxygenase 
CDHE0100006
5.1 
Mycobacterium bovis genome assembly Assembly 
of Mycobacterium bovis MB4 genome, contig 65, 
whole genome shotgun sequence 
Manrique Submitted (12-NOV-2014) ERA7, Oh no 
sequences! group, Plaza Campoverde 3 atico, 18001, 
Spain 
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3-ketosteroid-9-alpha-
monooxygenase 
oxygenase 
CP006850.1 Nocardia nova SH22a, complete genome Luo et al., Appl Environ Microbiol. 2014 
Jul;80(13):3895-907. doi: 10.1128/AEM.00473-14. Epub 
2014 Apr 18. 
3-ketosteroid-9-alpha-
monooxygenase 
oxygenase 
CDHH010000
76.1 
Mycobacterium bovis genome assembly Assembly 
of the genome MB3, contig 76, whole genome 
shotgun sequence 
Manrique Submitted (12-NOV-2014) ERA7, Oh no 
sequences! group, Plaza Campoverde 3 atico, 18001, 
Spain 
3-ketosteroid-9-alpha-
monooxygenase 
oxygenase 
CDHF0100000
8.1 
Mycobacterium bovis genome assembly Genome 
assembly of Mycobacterium bovis MB1, contig 8, 
whole genome shotgun sequence 
Manrique Submitted (12-NOV-2014) ERA7, Oh no 
sequences! group, Plaza Campoverde 3 atico, 18001, 
Spain 
3-ketosteroid-9-alpha-
monooxygenase 
oxygenase 
HG322950.1 Pseudomonas knackmussii B13 complete genome Miyazaki et al., Submitted (08-MAR-2013) Bielefeld 
University, Center For 
            Biotechnology, Universitaetsstrasse 25, D-33501 
Bielefeld, GERMANY 
3-ketosteroid-9-alpha-
monooxygenase 
oxygenase 
CCSD0100003
2.1 
Rhodococcus ruber genome assembly 
BDK_PRJEB6917_v1, contig 
BDK_RHRU231_Contig_23, whole genome shotgun 
sequence 
Ivshina et al., Genome Announc. 2014 Dec 11;2(6). pii: 
e01297-14. doi: 10.1128/genomeA.01297-14 
3-ketosteroid-9-alpha-
monooxygenase 
oxygenase 
CCSD0100004
3.1 
Rhodococcus ruber genome assembly 
BDK_PRJEB6917_v1, contig 
BDK_RHRU231_Contig_33, whole genome shotgun 
sequence 
Ivshina et al., Genome Announc. 2014 Dec 11;2(6). pii: 
e01297-14. doi: 10.1128/genomeA.01297-14 
3-ketosteroid-9-alpha-
monooxygenase 
oxygenase 
CCSD0100008
9.1 
Rhodococcus ruber genome assembly 
BDK_PRJEB6917_v1, contig 
BDK_RHRU231_Contig_75, whole genome shotgun 
sequence 
Ivshina et al., Genome Announc. 2014 Dec 11;2(6). pii: 
e01297-14. doi: 10.1128/genomeA.01297-14 
3-ketosteroid-9-alpha-
monooxygenase 
oxygenase 
LN482603.1 Rhodococcus ruber genome assembly 
BDK_PRJEB6917_v1, scaffold 
BDK_RHRU231_scaffold13, whole genome shotgun 
sequence 
Ivshina et al., Genome Announc. 2014 Dec 11;2(6). pii: 
e01297-14. doi: 10.1128/genomeA.01297-14 
3-ketosteroid-9-alpha-
monooxygenase 
oxygenase 
LN482615.1 Rhodococcus ruber genome assembly 
BDK_PRJEB6917_v1, scaffold 
Ivshina et al., Genome Announc. 2014 Dec 11;2(6). pii: 
e01297-14. doi: 10.1128/genomeA.01297-14 
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BDK_RHRU231_scaffold25, whole genome shotgun 
sequence 
flavodoxin reductase 
family protein 
JTJI01000003.
1a 
Prauserella sp. Am3 HQ32_scaffold_2.3, whole 
genome shotgun sequence 
Sarkar et al., Submitted (25-NOV-2014) Cellular, 
Molecular and Biomedical Science, University of New 
Hampshire, 46 College Road, Durham, NH 03824, USA 
Rieske (2Fe-2S) 
domain-containing 
JTJI01000003.
1b 
Prauserella sp. Am3 HQ32_scaffold_2.3, whole 
genome shotgun sequence 
Sarkar et al., Submitted (25-NOV-2014) Cellular, 
Molecular and Biomedical Science, University of New 
Hampshire, 46 College Road, Durham, NH 03824, USA 
3-ketosteroid-9-alpha-
monooxygenase 
oxygenase 
CP008953.1 Amycolatopsis japonica strain MG417-CF17, 
complete genome 
Stegmann et al., J Biotechnol. 2014 Nov 10;189:46-7. 
doi: 10.1016/j.jbiotec.2014.08.034. Epub 2014 Sep 3. 
3-ketosteroid-9-alpha-
monooxygenase 
oxygenase 
JNNW010000
40.1 
Mycobacterium tuberculosis strain A4 
Contig_136_len_305152, whole genome shotgun 
sequence 
Liao et al., Genome Announc. 2014 Sep 4;2(5). pii: 
e00672-14. doi: 10.1128/genomeA.00672-14. 
3-ketosteroid-9-alpha-
monooxygenase 
oxygenase 
JNGF0100014
2.1 
Mycobacterium tuberculosis strain A2 Contig_56, 
whole genome shotgun sequence 
Liao et al., Genome Announc. 2014 Sep 4;2(5). pii: 
e00672-14. doi: 10.1128/genomeA.00672-14. 
3-ketosteroid-9-alpha-
monooxygenase 
oxygenase 
AZIN0100000
1.1 
Gammaproteobacteria bacterium MOLA455 
MOLA455_Contig1, whole genome shotgun 
sequence 
Courties et al., Genome Announc. 2014 Jan 30;2(1). pii: 
e01203-13. doi: 10.1128/genomeA.01203-13. 
putative 
oxidoreductase 
FN554889.1a Streptomyces scabiei 87.22 complete genome Bignell et al., Mol. Plant Microbe Interact. 23 (2), 161-
175 (2010) 
putative 
oxidoreductase 
FN554889.1b Streptomyces scabiei 87.22 complete genome Bignell et al., Mol. Plant Microbe Interact. 23 (2), 161-
175 (2010) 
rieske [2Fe-2S] domain 
protein 
CP009160.1 Burkholderia pseudomallei TSV 48 chromosome 2, 
complete sequence 
Johnson et al., Genome Announc 3 (1) (2015) 
Rieske (2Fe-2S) protein CP012577.1 Burkholderia pseudomallei strain 982 chromosome 
2, complete sequence  
Hong Submitted (31-AUG-2015) Institute of Biological 
Sciences University of Malaya, Microbiome Lab, High 
Impact Research, Building, Kuala Lumpur, Kuala 
Lumpur 50603, Malaysia 
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rieske [2Fe-2S] domain 
protein 
CP010066.1 Burkholderia mallei strain 2002721276 chromosome 
2, complete sequence. 
Johnson et al., Genome Announc 3 (2) (2015) 
rieske [2Fe-2S] domain 
protein 
CP009943.1 Burkholderia mallei strain KC_1092 chromosome 2 
sequence. 
Johnson et al., Genome Announc 3 (2) (2015) 
rieske [2Fe-2S] domain 
protein 
CP009898.1 Burkholderia pseudomallei Pasteur 52237 
chromosome 2, complete sequence. 
Johnson et al., Genome Announc 3 (2) (2015) 
rieske [2Fe-2S] domain 
protein 
CP009588.1 Burkholderia mallei strain 11 chromosome II, 
complete sequence. 
Johnson et al., Genome Announc 3 (2) (2015) 
rieske [2Fe-2S] domain 
protein 
CP009537.1 Burkholderia pseudomallei K96243 chromosome II, 
complete sequence. 
Johnson et al., Genome Announc 3 (2) (2015) 
rieske [2Fe-2S] domain 
protein 
CP009484.1 Burkholderia pseudomallei MSHR491 chromosome 
II, complete sequence. 
Johnson et al., Genome Announc 3 (2) (2015) 
rieske [2Fe-2S] domain 
protein 
CP009338.1 Burkholderia mallei strain 2002734299 chromosome 
2, complete 
Johnson et al., Genome Announc 3 (2) (2015) 
rieske [2Fe-2S] domain 
protein 
CP010974.1 Burkholderia pseudomallei strain vgh07 
chromosome 2, complete sequence. 
Chen et al., Genome Announc. 2015 Apr 30;3(2). pii: 
e00345-15. doi: 10.1128/genomeA.00345-15. 
rieske [2Fe-2S] domain 
protein 
CP008731.2 Burkholderia mallei strain 2000031063 chromosome 
2, complete 
Daligault et al., Genome Announc 2 (6) (2014) 
rieske [2Fe-2S] domain 
protein 
CP009156.1 Burkholderia sp. TSV202 chromosome 2, complete 
sequence. 
Johnson et al., Genome Announc 3 (1) (2015) 
rieske [2Fe-2S] domain 
protein 
CP009150.1 Burkholderia pseudomallei B03 chromosome 2, 
complete sequence. 
Johnson et al., Genome Announc 3 (1) (2015) 
rieske [2Fe-2S] domain 
protein 
CP009164.1 Burkholderia pseudomallei A79A chromosome 2, 
complete sequence. 
Johnson et al., Genome Announc 3 (1) (2015) 
rieske [2Fe-2S] domain 
protein 
CP009152.1 Burkholderia pseudomallei MSHR3965 chromosome 
2, complete sequence. 
Johnson et al., Genome Announc 3 (1) (2015) 
rieske [2Fe-2S] domain 
protein 
CP004378.1 Complete genome sequences for 59 burkholderia 
isolates, both pathogenic and near neighbour 
Johnson et al., Genome Announc 3 (2) (2015) 
rieske [2Fe-2S] domain 
protein 
CP008917.1 Burkholderia sp. BGK chromosome 2 sequence. Daligault et al Genome Announc 2 (6) (2014) 
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rieske [2Fe-2S] domain 
protein 
CP007801.1 Burkholderia mallei NCTC 10247 chromosome 2, 
complete sequence. 
Daligault et al Genome Announc 2 (6) (2014) 
rieske [2Fe-2S] domain 
protein 
CP009147.1 Burkholderia mallei strain FMH 23344 chromosome 
2, complete 
Daligault et al Genome Announc 2 (6) (2014) 
rieske [2Fe-2S] domain 
protein 
CP008912.1 Burkholderia pseudomallei HBPUB10134a 
chromosome 2, complete 
Daligault et al Genome Announc 2 (6) (2014) 
rieske [2Fe-2S] domain 
protein 
CP008910.1 Burkholderia pseudomallei MSHR5848 chromosome 
2, complete sequence. 
Daligault et al Genome Announc 2 (6) (2014) 
rieske [2Fe-2S] domain 
protein 
CP008783.1 Burkholderia pseudomallei MSHR5855 chromosome 
2, complete sequence. 
Daligault et al Genome Announc 2 (6) (2014) 
rieske [2Fe-2S] domain 
protein 
CP008754.1 Burkholderia pseudomallei strain 9 chromosome 2, 
complete sequence. 
Daligault et al Genome Announc 2 (6) (2014) 
rieske [2Fe-2S] domain 
protein 
CP008722.1 Burkholderia mallei strain BMQ chromosome 2, 
complete sequence. 
Daligault et al Genome Announc 2 (6) (2014) 
rieske [2Fe-2S] domain 
protein 
CP008710.1 Burkholderia mallei strain 6 chromosome 2, 
complete sequence. 
Daligault et al Genome Announc 2 (6) (2014) 
rieske [2Fe-2S] domain 
protein 
CP008705.1 Burkholderia mallei strain 23344 chromosome 2, 
complete sequence. 
Daligault et al Genome Announc 2 (6) (2014) 
Rieske iron-sulphur 
domain protein 
LK936443.1 Burkholderia pseudomallei genome assembly 
BP_3921g, chromosome : 2. 
Aslett and De Silva Submitted (03-JUL-2014) SC, 
Pathogen Informatics, Wellcome Trust Genome 
Campus, Hinxton, Cambridge, Cambridgeshire., CB10 
1SA, United Kingdom 
iron-sulfur cluster-
binding protein, Rieske 
family 
CP000547.1 Burkholderia mallei NCTC 10247 chromosome II, 
complete sequence. 
DeShazer et al., Submitted (21-OCT-2009) The J. Craig 
Venter Institute, 9704 Medical Center Dr, Rockville, MD 
20850, USA 
iron-sulfur cluster-
binding protein, Rieske 
CP000545.1 Burkholderia mallei NCTC 10229 chromosome II, 
complete sequence. 
DeShazer et al., Submitted (21-OCT-2009) The J. Craig 
Venter Institute, 9704 Medical 
iron-sulfur cluster-
binding protein, rieske 
CP000525.1 Burkholderia mallei SAVP1 chromosome II, complete 
sequence. 
DeShazer et al., Submitted (18-DEC-2006) The Institute 
for Genomic Research, 9712 Medical Center Dr, 
Rockville, MD 20850, USA 
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iron-sulfur cluster-
binding protein, rieske 
CP000125.1 Burkholderia pseudomallei 1710b chromosome II, 
complete sequence. 
Woods and Nierman Submitted (28-SEP-2005) The 
Institute for Genomic Research, 9712 Medical Center 
Dr, Rockville, MD 20850, USA 
iron-sulfur cluster-
binding protein, rieske 
CP000011.2 Burkholderia mallei ATCC 23344 chromosome 2, 
complete sequence. 
Nierman et al., Proc. Natl. Acad. Sci. U.S.A. 101 (39), 
14246-14251 (2004) 
Rieske iron-sulphur 
domain protein 
BX571966.1 Burkholderia pseudomallei strain K96243, 
chromosome 2, complete 
Holden et al., Proc Natl Acad Sci U S A. 2004 Sep 
28;101(39):14240-5. Epub 2004 Sep 17. 
rieske [2Fe-2S] domain 
protein 
CP009546.1 Burkholderia pseudomallei strain MSHR668 
chromosome II, complete 
Johnson et al., Genome Announc. 2015 Apr 30;3(2). pii: 
e00159-15. doi: 10.1128/genomeA.00159-15. 
rieske [2Fe-2S] domain 
protein 
CP009536.1 Burkholderia pseudomallei 7894 chromosome II, 
complete sequence. 
Johnson et al., Genome Announc. 2015 Apr 30;3(2). pii: 
e00159-15. doi: 10.1128/genomeA.00159-15. 
rieske [2Fe-2S] domain 
protein 
CP009477.1 Burkholderia pseudomallei MSHR2543 chromosome 
II, complete 
Johnson et al., Genome Announc. 2015 Apr 30;3(2). pii: 
e00159-15. doi: 10.1128/genomeA.00159-15. 
rieske [2Fe-2S] domain 
protein 
CP009473.1 Burkholderia pseudomallei MSHR840 chromosome 
II, complete sequence. 
Johnson et al., Genome Announc. 2015 Apr 30;3(2). pii: 
e00159-15. doi: 10.1128/genomeA.00159-15. 
rieske [2Fe-2S] domain 
protein 
CP009234.1 Burkholderia pseudomallei MSHR62 chromosome 2, 
complete sequence. 
Johnson et al., Genome Announc. 2015 Feb 12;3(1). pii: 
e01282-14. doi: 10.1128/genomeA.01282-14. 
rieske [2Fe-2S] domain 
protein 
CP009269.1 Burkholderia pseudomallei MSHR2243 chromosome 
2 sequence. 
Bunnell et al., Submitted (26-AUG-2014) Bioscience, 
Los Alamos National Laboratory, P.O. Box 1663, MS 
M888, Los Alamos, NM 87545, US 
rieske [2Fe-2S] domain 
protein 
CP009272.1 Burkholderia pseudomallei MSHR1153 chromosome 
2 sequence 
Bunnell et al., Submitted (26-AUG-2014) Bioscience, 
Los Alamos National Laboratory, 
rieske [2Fe-2S] domain 
protein 
CP009210.1 Burkholderia pseudomallei strain BDP chromosome 
2, complete 
Daligault et al., Genome Announc. 2014 Nov 20;2(6). 
pii: e01106-14. doi: 10.1128/genomeA.01106-14. 
rieske [2Fe-2S] domain 
protein 
CP008891.1 Burkholderia pseudomallei MSHR5858 chromosome 
2, complete sequence. 
Daligault et al., Genome Announc. 2014 Nov 20;2(6). 
pii: e01106-14. doi: 10.1128/genomeA.01106-14. 
rieske [2Fe-2S] domain 
protein 
CP008779.1 Burkholderia pseudomallei strain MSHR1655 
chromosome 2, complete 
Daligault et al., Genome Announc. 2014 Nov 20;2(6). 
pii: e01106-14. doi: 10.1128/genomeA.01106-14. 
rieske [2Fe-2S] domain 
protein 
CP004369.1 Burkholderia pseudomallei MSHR520 chromosome 
2, complete sequence 
Johnson et al., Genome Announc. 2015 Feb 12;3(1). pii: 
e01282-14. doi: 10.1128/genomeA.01282-14. 
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rieske [2Fe-2S] domain 
protein 
CP003977.1 Burkholderia pseudomallei NCTC 13179 
chromosome 2, complete 
Johnson et al., Genome Announc. 2015 Feb 12;3(1). pii: 
e01282-14. doi: 10.1128/genomeA.01282-14. 
rieske [2Fe-2S] domain 
protein 
CP006469.1 Burkholderia pseudomallei MSHR305 chromosome 
2, complete sequence. 
Stone et al., Genome Announc. 2013 Aug 22;1(4). pii: 
e00656-13. doi: 10.1128/genomeA.00656-13. 
iron-sulfur cluster-
binding protein, Rieske 
CP000571.1 Burkholderia pseudomallei 668 chromosome II, 
complete sequence. 
DeShazer et al., Submitted (12-JAN-2010) The Institute 
for Genomic Research, 9712 Medical Center Dr, 
Rockville, MD 20850, USA 
Rieske (2Fe-2S) protein CP012518.1 Burkholderia pseudomallei strain vgh16W 
chromosome 2, complete 
Hsueh et al., Genome Announc. 2015 Oct 15;3(5). pii: 
e01194-15. doi: 10.1128/genomeA.01194-15. 
Rieske (2Fe-2S) protein CP012516.1 Burkholderia pseudomallei strain vgh16R 
chromosome 2, complete 
Hsueh et al., Genome Announc. 2015 Oct 15;3(5). pii: 
e01194-15. doi: 10.1128/genomeA.01194-15. 
Rieske (2Fe-2S) protein CP012093.1 Burkholderia pseudomallei strain 350105 
chromosome 2 sequence. 
Song et al., Genome Announc. 2015 Oct 15;3(5). pii: 
e01162-15. doi: 10.1128/genomeA.01162-15. 
Rieske (2Fe-2S) protein CP009550.1 Burkholderia pseudomallei PB08298010 
chromosome II, complete 
Johnson et al., Genome Announc. 2015 Feb 12;3(1). pii: 
e01282-14. doi: 10.1128/genomeA.01282-14. 
Rieske (2Fe-2S) protein CP009297.1 Burkholderia pseudomallei 406e chromosome 2, 
complete sequence. 
Johnson et al., Genome Announc. 2015 Feb 12;3(1). pii: 
e01282-14. doi: 10.1128/genomeA.01282-14. 
Rieske (2Fe-2S) protein CP004380.1 Burkholderia pseudomallei 1026b chromosome 2, 
complete sequence. 
Johnson et al., Genome Announc. 2015 Feb 12;3(1). pii: 
e01282-14. doi: 10.1128/genomeA.01282-14. 
Rieske (2Fe-2S) protein CP009163.1 Burkholderia pseudomallei K42 chromosome 2, 
complete sequence. 
Johnson et al., Genome Announc. 2015 Feb 12;3(1). pii: 
e01282-14. doi: 10.1128/genomeA.01282-14. 
Rieske (2Fe-2S) protein CP009127.1 Burkholderia pseudomallei strain BSR chromosome 
2, complete 
Daligault et al., Genome Announc. 2014 Nov 20;2(6). 
pii: e01106-14. doi: 10.1128/genomeA.01106-14. 
Rieske (2Fe-2S) protein CP008835.1 Burkholderia pseudomallei strain BGR chromosome 
2, complete 
Daligault et al., Genome Announc. 2014 Nov 20;2(6). 
pii: e01106-14. doi: 10.1128/genomeA.01106-14. 
Rieske (2Fe-2S) protein CP008782.1 Burkholderia pseudomallei strain Mahidol-1106a 
chromosome 2, 
Daligault et al., Genome Announc. 2014 Nov 20;2(6). 
pii: e01106-14. doi: 10.1128/genomeA.01106-14. 
Rieske (2Fe-2S) protein CP008778.1 Burkholderia pseudomallei 576 chromosome 2, 
complete sequence. 
Daligault et al., Genome Announc. 2014 Nov 20;2(6). 
pii: e01106-14. doi: 10.1128/genomeA.01106-14. 
Rieske (2Fe-2S) protein CP008759.1 Burkholderia pseudomallei strain 1106a 
chromosome 2, complete 
Daligault et al., Genome Announc. 2014 Nov 20;2(6). 
pii: e01106-14. doi: 10.1128/genomeA.01106-14. 
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Rieske (2Fe-2S) protein CP004043.1 Burkholderia pseudomallei MSHR146 chromosome 
2, complete sequence. 
Tuanyok et al., Submitted (14-JAN-2013) Genome 
Science, Los Alamos National 
Rieske (2Fe-2S) protein CP004024.1 Burkholderia pseudomallei MSHR511 chromosome 
2, complete sequence. 
Tuanyok et al., Submitted (14-JAN-2013) Genome 
Science, Los Alamos National 
Rieske (2Fe-2S) protein CP004002.1 Burkholderia pseudomallei NCTC 13178 
chromosome 2, complete 
Tuanyok et al., Submitted (18-DEC-2012) Genome 
Science, Los Alamos National 
Rieske (2Fe-2S) protein CP004004.1 Burkholderia pseudomallei NAU20B-16 
chromosome 2, complete 
Tuanyok et al., Submitted (18-DEC-2012) Genome 
Science, Los Alamos National 
Rieske family iron-
sulfur cluster-binding 
CP003782.1 Burkholderia pseudomallei BPC006 chromosome II, 
complete sequence. 
Fang et al J. Bacteriol. 194 (23), 6604-6605 (2012) 
Rieske (2Fe-2S) protein CP002834.1 Burkholderia pseudomallei 1026b chromosome 2, 
complete sequence. 
Hayden et al PLoS ONE 7 (5), E36507 (2012) 
Rieske (2Fe-2S) protein CP000573.1 Burkholderia pseudomallei 1106a chromosome II, 
complete sequence. 
Harkins et al., Submitted (13-FEB-2007) The Institute 
for Genomic Research, 9712 Medical Center Dr, 
Rockville, MD 20850, USA 
Rieske (2Fe-2S) protein CP009586.1 Burkholderia pseudomallei strain PHLS 112 
chromosome II, complete 
Johnson et al., Genome Announc. 2015 Feb 12;3(1). pii: 
e01282-14. doi: 10.1128/genomeA.01282-14. 
Rieske (2Fe-2S) protein CP008893.1 Burkholderia pseudomallei HBPUB10303a 
chromosome 2, complete 
Daligault et al., Genome Announc. 2014 Nov 20;2(6). 
pii: e01106-14. doi: 10.1128/genomeA.01106-14. 
Rieske (2Fe-2S) protein CP008763.1 Burkholderia pseudomallei strain MSHR346 
chromosome 2, complete 
Daligault et al., Genome Announc. 2014 Nov 20;2(6). 
pii: e01106-14. doi: 10.1128/genomeA.01106-14. 
Rieske (2Fe-2S) protein CP002600.1 Burkholderia gladioli BSR3 chromosome 2, complete 
sequence. 
Seo et al., J. Bacteriol. 193 (12), 3149 (2011) 
putative FAD-
dependent 
monooxygenase 
FN563149.1a Rhodococcus equi 103S chromosome. Letek et al., PLoS Genet. 6 (9), E1001145 (2010) 
cytochrome P450 
monooxygenase 
FN563149.1b Rhodococcus equi 103S chromosome. Letek et al., PLoS Genet. 6 (9), E1001145 (2010) 
iron-sulfur binding 
oxidoreductase 
KJ598877.1 Rhodococcus equi strain U-S-A-18 clone S3A2 iron-
sulfur binding oxidoreductase gene, complete cds. 
Yeh et al., Submitted (19-MAR-2014) Graduate Institute 
of Biotechnology, National Chung Hsing University, 250 
Kuo-Kuang Road, Taichung 
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iron-sulfur binding 
oxidoreductase 
FN563149.1c Rhodococcus equi 103S chromosome. Letek et al., PLoS Genet. 6 (9), E1001145 (2010) 
3-ketosteroid-9-alpha-
hydroxylase oxygenase 
subunit 
CP003949.1a Rhodococcus opacus PD630, complete genome. Chen et al Submitted (26-NOV-2012) National 
Laboratory of Macromolecules, Institute of Biophysics, 
Institute of Biophysics, Chinese Academy of Sciences, 
Beijing, 15 Datun Road, Chaoyang District, Beijing, 
Beijing 100101, China 
3-ketosteroid 9alpha-
hydroxylase 
component KshA 
AP011115.1a Rhodococcus opacus B4 DNA, complete genome. Takarada et al., Submitted (30-MAR-2009) 
Contact:Director-General Department of Biotechnology 
National Institute of Technology and Evaluation, NITE 
Genome Analysis Center (NGAC), Department of 
Biotechnology; 2-49-10 Nishihara, Shibuya-ku, Tokyo 
151-0066, Japan URL           :http://www.bio.nite.go.jp/ 
3-ketosteroid-9-alpha-
hydroxylase 
CP011341.1a Rhodococcus aetherivorans strain IcdP1, complete 
genome. 
Qu et al., Genome Announc 3 (4), e00711-15 (2015) 
ketosteroid-9-alpha-
hydroxylase, 
oxygenase 
CP000431.1a Rhodococcus jostii RHA1, complete genome. McLeod et al., Submitted (24-JUL-2006) Microbiology 
and Immunology, University of British Columbia, 1365-
2350 Health Sciences Mall, Vancouver, BC V6T 1Z3, 
Canada 
3-ketosteroid-9-alpha-
hydroxylase 
CP008947.1a Rhodococcus opacus strain R7 sequence. Di Gennaro et al., Genome Announc 2 (4) (2014) 
KshA-like protein CP011269.1a Mycobacterium fortuitum strain CT6, complete 
genome. 
Costa et al., MBio 6 (6), e01520-15 (2015) 
3-ketosteroid-9-alpha-
hydroxylase 
CP014258.1a Mycobacterium fortuitum subsp. fortuitum DSM 
46621 = ATCC 6841 
Singh et al., Submitted (30-NOV-2015) Microbiology, 
CSIR-CDRI, Sitapur Road, Lucknow, Uttar Pradesh 
226021, India 
3-ketosteroid-9-alpha-
hydroxylase oxygenase 
subunit 
CP009914.1a Mycobacterium sp. VKM Ac-1817D, complete 
genome. 
Bragin et al., J. Steroid Biochem. Mol. Biol. 138, 41-53 
(2013 
hypothetical protein FN563149.1 Rhodococcus equi 103S chromosome. Letek et al., PLoS Genet. 2010 Sep 30;6(9):e1001145. 
doi: 10.1371/journal.pgen.1001145. 
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3-ketosteroid-9-alpha-
hydroxylase 
CP011341.1b Rhodococcus aetherivorans strain IcdP1, complete 
genome. 
Qu et al., Genome Announc 3 (4), e00711-15 (2015) 
3-ketosteroid 9alpha-
hydroxylase oxygenase 
HQ425873.1 Rhodococcus rhodochrous strain DSM 43269 
hypothetical protein gene, partial cds; and 3-
ketosteroid 9alpha-hydroxylase oxygenase(kshA1), 
putative ferredoxin (fd1), hypothetical protein, and 
3-ketosteroid 9alpha-hydroxylase reductase (kshB) 
genes, complete cds. 
Petrusma et al., Submitted (22-OCT-2010) Department 
of Microbiology, Groningen Biomolecular Sciences and 
Biotechnology Institute (GBB), Kerklaan 30, Haren 9751 
NN, The Netherlands 
3-ketosteroid-9-alpha-
hydroxylase oxygenase 
subunit 
CP006996.1 Rhodococcus pyridinivorans SB3094, complete 
genome. 
Dueholm et al., Genome Announc 2 (3), e00525-14 
(2014) 
3-ketosteroid-9-alpha-
hydroxylase 
CP011295.1 Rhodococcus erythropolis strain BG43, complete 
genome. 
Ruckert et al., Submitted (17-APR-2015) CeBiTec, 
Bielefeld University, Sequenz 1, Bielefeld, NRW 33615, 
Germany 
3-ketosteroid 9alpha-
hydroxylase 
component KshA 
CP003761.1 Rhodococcus erythropolis CCM2595, complete 
genome. 
Strnad et al., Genome Announc. 2014 Mar 20;2(2). pii: 
e00208-14. doi: 10.1128/genomeA.00208-14. 
probable 3-ketosteroid 
9alpha-hydroxylase 
component KshA 
AP008957.1 Rhodococcus erythropolis PR4 DNA, complete 
genome. 
Sekine et al Environ. Microbiol. 8 (2), 334-346 (2006 
probable dioxygenase 
Rieske iron-sulfur 
component 
CP000431.1b Rhodococcus jostii RHA1, complete genome. McLeod et al., Submitted (24-JUL-2006) Microbiology 
and Immunology, University of British Columbia, 1365-
2350 Health Sciences Mall, Vancouver, BC V6T 1Z3, 
Canada 
3-ketosteroid 9alpha-
hydroxylase 
component KshA2 
AP011115.1b Rhodococcus opacus B4 DNA, complete genome. Takarada et al., Submitted (30-MAR-2009) 
Contact:Director-General Department of Biotechnology 
National Institute of Technology and Evaluation, NITE 
Genome Analysis Center (NGAC), Department of 
Biotechnology; 2-49-10 Nishihara, Shibuya-ku, Tokyo 
151-0066, Japan URL 
            :http://www.bio.nite.go.jp/ 
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3-ketosteroid-9-alpha-
hydroxylase 
CP007255.1 Rhodococcus erythropolis R138, complete genome. Kwasiborski et al Genome Announc 2 (2) (2014) 
3-ketosteroid-9-alpha-
hydroxylase oxygenase 
subunit 
CP003949.1b Rhodococcus opacus PD630, complete genome. Chen et al., Submitted (26-NOV-2012) National 
Laboratory of Macromolecules, Institute of Biophysics, 
Institute of Biophysics, Chinese Academy of Sciences, 
Beijing, 15 Datun Road, Chaoyang District, Beijing, 
Beijing 100101, China 
3-ketosteroid-9-alpha-
hydroxylase 
CP008947.1b Rhodococcus opacus strain R7 sequence. Di Gennaro et al., Genome Announc. 2014 Aug 21;2(4). 
pii: e00827-14. doi: 10.1128/genomeA.00827-14. 
putative iron-sulfur 
binding 
oxidoreductase 
FN563149.1e Rhodococcus equi 103S chromosome. Letek et al., PLoS Genet. 2010 Sep 30;6(9):e1001145. 
doi: 10.1371/journal.pgen.1001145. 
3-ketosteroid 9alpha-
hydroxylase oxygenase 
HQ425877.1 Rhodococcus rhodochrous strain DSM 43269 
hypothetical proteins and 3-ketosteroid 9alpha-
hydroxylase oxygenase (kshA5) genes, complete cds; 
and hypothetical protein gene, partial cds. 
Petrusma et al., Submitted (22-OCT-2010) Department 
of Microbiology, Groningen Biomolecular Sciences and 
Biotechnology Institute (GBB), Kerklaan 30, Haren 9751 
NN, The Netherlands 
3-ketosteroid-9-alpha-
hydroxylase oxygenase 
subunit 
LN868938.1 Nocardia farcinica genome assembly NCTC11134, 
chromosome : 1. 
Submitted (09-MAR-2015) SC, Wellcome Trust Sanger 
Institute, CB10 1SA, United Kingdom 
putative terminal 
oxygenase 
AP006618.1 Nocardia farcinica IFM 10152 DNA, complete 
genome. 
Ishikawa et al., Proc. Natl. Acad. Sci. U.S.A. 101 (41), 
14925-14930 (2004) 
3-ketosteroid 9alpha-
hydroxylase 
component KshA 
AP011115.1c Rhodococcus opacus B4 DNA, complete genome. Takarada et al., Submitted (30-MAR-2009) 
Contact:Director-General Department of Biotechnology 
National Institute of Technology and Evaluation, NITE 
Genome Analysis Center (NGAC), Department of 
Biotechnology; 2-49-10 Nishihara, Shibuya-ku, Tokyo 
151-0066, Japan URL 
            :http://www.bio.nite.go.jp/ 
3-ketosteroid-9-alpha-
hydroxylase 
CP008947.1c Rhodococcus opacus strain R7 sequence. Di Gennaro et al., Genome Announc 2 (4) (2014) 
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Ketosteroid-9-alpha-
hydroxylase, 
oxygenase 
FO082843.1 Nocardia cyriacigeorgica GUH-2 chromosome 
complete genome. 
Zoropogui et al., J. Bacteriol. 194 (8), 2098-2099 (2012) 
probable dioxygenase 
Rieske iron-sulfur 
CP000431.1c Rhodococcus jostii RHA1, complete genome. McLeod et al., Submitted (24-JUL-2006) Microbiology 
and Immunology, University of British Columbia, 1365-
2350 Health Sciences Mall, Vancouver, BC V6T 1Z3, 
Canada 
3-ketosteroid-9-alpha-
hydroxylase oxygenase 
CP003949.1c Rhodococcus opacus PD630, complete genome. Chen et al., Submitted (26-NOV-2012) National 
Laboratory of Macromolecules, Institute of Biophysics, 
Institute of Biophysics, Chinese Academy of Sciences, 
Beijing, 15 Datun Road, Chaoyang District, Beijing, 
Beijing 100101, China 
3-ketosteroid-9-alpha-
hydroxylase 
CP011853.1 Gordonia sp. QH-11, complete genome. Jin et al., Submitted (16-JUN-2015) Key Laboratory of 
Environmental Biotechnology, Research Center for Eco-
Environmental Sciences, Shuangqing Road 18, Beijing 
100085, China 
2Fe-2S)-binding 
protein 
CP014646.1 Thauera humireducens strain SgZ-1, complete 
genome. 
Ma et al., Submitted (28-JUN-2015) Guangdong 
Institute of Eco-Environmental and Soil Science, 
Tianyuan road, Guangzhou 510650, China 
Rieske (2Fe-2S) 
domain protein 
CP000511.1a Mycobacterium vanbaalenii PYR-1, complete 
genome. 
Copeland et al., Submitted (13-DEC-2006) US DOE Joint 
Genome Institute, 2800 Mitchell Drive B100, Walnut 
Creek, CA 94598-1698, USA 
Rieske (2Fe-2S CP002385.1a Mycobacterium gilvum Spyr1, complete genome. Kallimanis et al., Stand Genomic Sci 5 (1), 144-153 
(2011) 
Rieske (2Fe-2S)  CP003053.1 Mycobacterium chubuense NBB4, complete 
genome. 
Lucas et al., Submitted (05-JUN-2012) US DOE Joint 
Genome Institute, 2800 Mitchell Drive B310, Walnut 
Creek, CA 94598-1698, USA 
ring-hydroxylating 
dioxygenase, large 
terminal subunit 
CP003078.1a Mycobacterium sp. JS623, complete genome. Lucas et al., Submitted (07-OCT-2011) US DOE Joint 
Genome Institute, 2800 Mitchell Drive B310, Walnut 
Creek, CA 94598-1698, USA 
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2Fe-2S ferredoxin CP014258.1b Mycobacterium fortuitum subsp. fortuitum DSM 
46621 = ATCC 6841 
Singh et al., Submitted (30-NOV-2015) Microbiology, 
CSIR-CDRI, Sitapur Road, Lucknow, Uttar Pradesh 
226021, India 
Rieske (2Fe-2S) 
domain-containing 
protein 
CP009914.1b Mycobacterium sp. VKM Ac-1817D, complete 
genome. 
Bragin et al., J Steroid Biochem Mol Biol. 2013 
Nov;138:41-53. doi: 10.1016/j.jsbmb.2013.02.016. 
Epub 2013 Mar 6. 
2Fe-2S ferredoxin CP011022.1 Mycobacterium sp. NRRL B-3805, complete genome. Rodriguez-Garcia et al., Submitted (06-MAR-2015) 
Proteomics, INBIOTEC (Instituto de Biotecnologia de 
Leon), Parque Cientifico de Leon. Avda. Real, 1, Leon, 
Leon 24006, Spain 
2Fe-2S ferredoxin CP006936.2 Mycobacterium neoaurum VKM Ac-1815D, 
complete genome. 
Shtratnikova et al., Genome Announc 2 (1) (2014) 
2Fe-2S ferredoxin CP009496.1 Mycobacterium smegmatis strain INHR2, complete 
genome. 
Mohan et al., Genome Announc 3 (1) (2015) 
2Fe-2S ferredoxin CP009495.1 Mycobacterium smegmatis strain INHR1, complete 
genome. 
Mohan et al., Genome Announc 3 (1) (2015) 
2Fe-2S ferredoxin CP009494.1 Mycobacterium smegmatis str. MC2 155, complete 
genome. 
Mohan et al., Genome Announc 3 (1) (2015) 
2Fe-2S ferredoxin CP001663.1 Mycobacterium smegmatis str. MC2 155, complete 
genome. 
Perrodou et al., Nucleic Acids Res. 34 (DATABASE 
ISSUE), D338-D343 (2006) 
2Fe-2S ferredoxin CP000480.1 Mycobacterium smegmatis str. MC2 155, complete 
genome. 
Fleischmann et al., Submitted (19-OCT-2006) The 
Institute for Genomic Research, 9712 Medical Center 
Dr, Rockville, MD 20850, USA 
2Fe-2S ferredoxin LN831039.1 Mycobacterium smegmatis genome assembly 
NCTC8159, chromosome : 1. 
Submitted (09-MAR-2015) SC, Wellcome Trust Sanger 
Institute, CB10 1SA, United Kingdom 
2Fe-2S ferredoxin CP010114.1a Mycobacterium avium subsp. paratuberculosis 
strain E93, complete 
Amin et al., Submitted (28-NOV-2014) Pathobiological 
Sciences, University of Wisconsin-Madison, 1656 
Linden Dr, Madison, WI 53706, USA 
2Fe-2S ferredoxin CP010113.1a Mycobacterium avium subsp. paratuberculosis 
strain E1, complete 
Amin et al., Submitted (28-NOV-2014) Pathobiological 
Sciences, University of Wisconsin-Madison, 1656 
Linden Dr., Madison, WI 53706, USA 
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putative 
oxidoreductase, rieske 
(2Fe-2S 
CP005928.1a Mycobacterium avium subsp. paratuberculosis 
MAP4, complete genome. 
Bannantine et al., Genome Announc 2 (1) (2014) 
hypothetical protein AE016958.1a Mycobacterium avium subsp. paratuberculosis str. 
k10, complete 
Li et al., Proc. Natl. Acad. Sci. U.S.A. 102 (35), 12344-
12349 (2005) 
2Fe-2S ferredoxin CP009614.1a Mycobacterium avium subsp. avium strain DJO-
44271, complete genome. 
Hazbon et al., Submitted (14-OCT-2014) Bacterial 
Collections, BEI Resources/American Type Culture 
Collection (ATCC), 10801 University Blvd., Manassas, 
VA 20110, USA 
2Fe-2S ferredoxin CP009482.1a Mycobacterium avium subsp. avium 2285 (S), 
complete genome. 
Hazbon et al., Submitted (22-SEP-2014) Bacterial 
Collections, BEI 
Resources/American Type Culture Collection (ATCC), 
10801 University Blvd., Manassas, VA 20110, USA 
2Fe-2S ferredoxin CP009493.1a Mycobacterium avium subsp. avium 2285 (R), 
complete genome. 
Hazbon et al., Submitted (22-SEP-2014) Bacterial 
Collections, BEI 
Resources/American Type Culture Collection (ATCC), 
10801 University Blvd., Manassas, VA 20110, USA 
2Fe-2S ferredoxin CP000479.1a Mycobacterium avium 104, complete genome. Fleischmann et al., Submitted (19-OCT-2006) The 
Institute for Genomic Research, 9712 Medical Center 
Dr, Rockville, MD 20850, USA 
hypothetical protein CP011269.1b Mycobacterium fortuitum strain CT6, complete 
genome. 
Costa et al., MBio 6 (6), e01520-15 (2015) 
2Fe-2S ferredoxin AP012555.1a Mycobacterium avium subsp. hominissuis TH135 
chromosomal DNA, 
Uchiya et al., PLoS ONE 8 (8), E71831 (2013) 
2Fe-2S ferredoxin CP002275.1 Mycobacterium indicus pranii MTCC 9506, complete 
genome. 
Ahmed et al., PLoS ONE 2 (10), E968 (2007) 
rieske (2Fe-2S) CP003324.1 Mycobacterium intracellulare MOTT-64, complete 
genome. 
Kim et al., J. Bacteriol. 194 (12), 3268 (2012) 
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3-ketosteroid-9-alpha-
monooxygenase 
oxygenase subunit 
CP014475.1 Mycobacterium phlei strain CCUG 21000, complete 
genome. 
Das et al., Genome Biol Evol (2016) In press 
rieske (2Fe-2S) CP003347.1a Mycobacterium sp. 05-1390, complete genome. Kim et al., Genome Announc 1 (4), e00604-13 (2013) 
rieske (2Fe-2S) CP003323.1 Mycobacterium intracellulare MOTT-02, complete 
genome. 
Kim et al., J. Bacteriol. 194 (10), 2771 (2012) 
rieske (2Fe-2S) CP003322.1 Mycobacterium intracellulare ATCC 13950, 
complete genome. 
Kim et al., J. Bacteriol. 194 (10), 2750 (2012) 
rieske (2Fe-2S) CP012150.1 Mycobacterium goodii strain X7B, complete 
genome. 
Yu et al., Submitted (24-JUL-2015) CAS Key Laboratory 
of Microbial Physiological and Metabolic Engineering, 
Institute of Microbiology, Chinese Academy of 
Sciences, No.1 Beichen West Road, Chaoyang District, 
Beijing 100101, China 
rieske (2Fe-2S) CP003491.1a Mycobacterium sp. MOTT36Y, complete genome. Kim et al., J. Bacteriol. 194 (15), 4141-4142 (2012) 
oxidoreductase CP002329.1 Mycobacterium sinense strain JDM601, complete 
genome. 
Zhang et al., J. Bacteriol. 193 (16), 4300-4301 (2011) 
rieske (2Fe-2S) CP009499.1a Mycobacterium intracellulare 1956, complete 
genome. 
Hazbon et al., Submitted (09-SEP-2014) Bacterial 
Collections, BEI Resources/American Type Culture 
Collection (ATCC), 10801 University        Blvd., 
Manassas, VA 20110, USA 
 
Rieske (2Fe-2S) 
domain-containing 
protein 
CP003053.1 Mycobacterium chubuense NBB4, complete 
genome. 
Lucas et al., Submitted (05-JUN-2012) US DOE Joint 
Genome Institute, 2800 Mitchell Drive B310, Walnut 
Creek, CA 94598-1698, USA 
3-ketosteroid-9-alpha-
hydroxylase 
CP014258.1c Mycobacterium fortuitum subsp. fortuitum DSM 
46621 = ATCC 6841 
Singh et al., Submitted (02-FEB-2016) Microbiology, 
CSIR-CDRI, Sitapur Road, Lucknow, Uttar Pradesh 
226021, India 
Rieske (2Fe-2S) 
domain-containing 
protein 
CP009914.1c Mycobacterium sp. VKM Ac-1817D, complete 
genome. 
Bragin et al., J. Steroid Biochem. Mol. Biol. 138, 41-53 
(2013) 
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KshA-like protein CP011269.1c Mycobacterium fortuitum strain CT6, complete 
genome. 
Costa et al., MBio 6 (6), e01520-15 (2015) 
3-ketosteroid-9-alpha-
hydroxylase 
CP011773.1 Mycobacterium sp. EPa45, complete genome. Kato et al., Genome Announc 3 (4), e00782-15 (2015) 
oxygenase KshA CP003347.1b Mycobacterium sp. 05-1390, complete genome. Kato et al., Genome Announc 1 (4), e00604-13 (2013) 
ring-hydroxylating 
dioxygenase, large 
terminal 
CP002385.1b Mycobacterium gilvum Spyr1, complete genome. Kallimanis et al., Stand Genomic Sci 5 (1), 144-153 
(2011) 
3-ketosteroid-9-alpha-
hydroxylase 
CP009614.1b Mycobacterium avium subsp. avium strain DJO-
44271, complete genome. 
Hazbon et al., Submitted (14-OCT-2014) Bacterial 
Collections, BEI 
Resources/American Type Culture Collection (ATCC), 
10801 University Blvd., Manassas, VA 20110, USA 
3-ketosteroid-9-alpha-
hydroxylase 
CP009482.1b Mycobacterium avium subsp. avium 2285 (S), 
complete genome. 
Hazbon et al., Submitted (22-SEP-2014) Bacterial 
Collections, BEI Resources/American Type Culture 
Collection (ATCC), 10801 University Blvd., Manassas, 
VA 20110, USA 
3-ketosteroid-9-alpha-
hydroxylase 
CP009493.1b Mycobacterium avium subsp. avium 2285 (R), 
complete genome. 
Hazbon et al., Submitted (22-SEP-2014) Bacterial 
Collections, BEI 
Resources/American Type Culture Collection (ATCC), 
10801 University Blvd., Manassas, VA 20110, USA 
oxygenase KshA CP000479.1b Mycobacterium avium 104, complete genome. Fleischmann et al., Submitted (19-OCT-2006) The 
Institute for Genomic Research, 9712 Medical Center 
Dr, Rockville, MD 20850, USA 
Rieske (2Fe-2S) 
domain protein 
CP000656.1 Mycobacterium gilvum PYR-GCK, complete genome. Badejo et al., PLoS ONE 8 (2), E58066 (2013) 
oxygenase KshA CP003491.1b Mycobacterium sp. MOTT36Y, complete genome. Kim et al., J. Bacteriol. 194 (15), 4141-4142 (2012) 
3-ketosteroid-9-alpha-
hydroxylase 
CP010114.1b Mycobacterium avium subsp. paratuberculosis 
strain E93, complete 
Amin et al., Microbiology (Reading, Engl.) 161 (PT 4), 
807-818 (2015) 
3-ketosteroid-9-alpha-
hydroxylase 
CP010113.1b Mycobacterium avium subsp. paratuberculosis 
strain E1, complete 
Amin et al., Microbiology (Reading, Engl.) 161 (PT 4), 
807-818 (2015) 
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oxidoreductase CP005928.1b Mycobacterium avium subsp. paratuberculosis 
MAP4, complete genome. 
Bannantine et al., Genome Announc. 2014 Feb 6;2(1). 
pii: e01252-13. doi: 10.1128/genomeA.01252-13. 
hypothetical protein AE016958.1b Mycobacterium avium subsp. paratuberculosis str. 
k10, complete 
Li et al., Proc Natl Acad Sci U S A. 2005 Aug 
30;102(35):12344-9. Epub 2005 Aug 22. 
3-ketosteroid-9-alpha-
hydroxylase 
CP009499.1b Mycobacterium intracellulare 1956, complete 
genome. 
Hazbon et al., Submitted (09-SEP-2014) Bacterial 
Collections, BEI 
Resources/American Type Culture Collection (ATCC), 
10801 University Blvd., Manassas, VA 20110, USA 
oxygenase KshA AP012555.1b Mycobacterium avium subsp. hominissuis TH135 
chromosomal DNA, 
Uchiya et al., PLoS One. 2013 Aug 21;8(8):e71831. doi: 
10.1371/journal.pone.0071831. eCollection 2013. 
Rieske (2Fe-2S) 
domain protein 
CP000518.1 Mycobacterium sp. KMS, complete genome. Copeland et al., Submitted (18-DEC-2006) US DOE Joint 
Genome Institute, 2800 Mitchell Drive B100, Walnut 
Creek, CA 94598-1698, USA 
Rieske (2Fe-2S) region CP000384.1 Mycobacterium sp. MCS, complete genome. Copeland et al., Submitted (05-JUN-2006) US DOE Joint 
Genome Institute, 2800 Mitchell Drive B100, Walnut 
Creek, CA 94598-1698, USA 
Rieske (2Fe-2S) 
domain protein 
CP000580.1 Mycobacterium sp. JLS, complete genome. Copeland et al., Submitted (20-FEB-2007) US DOE Joint 
Genome Institute, 2800 Mitchell Drive B100, Walnut 
Creek, CA 94598-1698, USA 
Rieske (2Fe-2S) 
domain-containing 
protein 
CP003078.1b Mycobacterium sp. JS623, complete genome. Lucas et al., Submitted (07-OCT-2011) US DOE Joint 
Genome Institute, 2800 Mitchell Drive B310, Walnut 
Creek, CA 94598-1698, USA 
Rieske (2Fe-2S) 
domain protein 
CP000511.1b Mycobacterium vanbaalenii PYR-1, complete 
genome. 
Copeland et al., Submitted (13-DEC-2006) US DOE Joint 
Genome Institute, 2800 Mitchell Drive B100, Walnut 
Creek, CA 94598-1698, USA 
Rieske (2Fe-2S) region CP000656.1b Mycobacterium gilvum PYR-GCK, complete genome. Badejo et al., PLoS ONE 8 (2), E58066 (2013) 
Rieske (2Fe-2S) 
domain-containing 
protein 
CP002385.1c Mycobacterium gilvum Spyr1, complete genome. Kallimanis et al., Stand Genomic Sci. 2011 Oct 
15;5(1):144-53. doi: 10.4056/sigs.2265047. Epub 2011 
Oct 1 
hydroxylase of 3-
hydroxy-9, 10-
LC010134.1b Comamonas testosteroni DNA, putative mega-
cluster of steroid degradation genes, strain: T441. 
Horinouchi et al., Microbiology. 2001 Dec;147(Pt 
12):3367-75. 
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secoandrosta -1, 3, 
5(10)-triene-9, 17-
dione, flavin-
dependent 
monooxygenase 
oxygenase subunit 
Acyl-CoA 
dehydrogenase, type 
2-like protein 
CP001220.2 Comamonas testosteroni CNB-2, complete genome. Ma et al., Appl. Environ. Microbiol. 75 (21), 6812-6819 
(2009) 
flavin-dependent 
monooxygenase 
oxygenase subunit 
CP006704.1 Comamonas testosteroni TK102, complete genome. Fukuda et al., Genome Announc 2 (5), e00865-14 
(2014) 
hydroxylase of 3-
hydroxy-9, 10-
secoandrosta -1, 3, 
5(10)-triene-9, 17-
dione 
LC010134.1c Comamonas testosteroni DNA, putative mega-
cluster of steroid t441 
Horinouchi et al., Microbiology. 2001 Dec;147(Pt 
12):3367-75. 
chromosome I LN879547.1b Comamonas testosteroni P19 genome assembly 
Comamonas testosteroni P19, chromosome : I 
Park Submitted (15-SEP-2015) JEJU NATIONAL 
UNIVERSITY, Lab of Microbial Ecology and Genomics, 
Dept. of Biology, Jeju National University, 102 
Jejudaehak-ro, Jeju 690-756, Jeju, 690-756, South 
Korea 
flavin reductase-like, 
FMN-binding protein 
CP001220.2b Comamonas testosteroni CNB-2, complete genome Fukuda et al., Genome Announc 2 (5), e00865-14 
(2014) 
flavin reductase CP006704.1b Comamonas testosteroni TK102, complete genome. Fukuda et al., Genome Announc. 2014 Sep 11;2(5). pii: 
e00865-14. doi: 10.1128/genomeA.00865-14. 
ORF11 AB063482.1c Comamonas testosteroni ORF11, tesA, tesD, tesE, 
tesF, tesG genes, complete cds. 
Horinouchi et al., Appl. Environ. Microbiol. 69 (4), 
2139-2152 (2003) 
3-ketosteroid-9-alpha-
hydroxylase reductase 
subunit 
LC010134.1d Comamonas testosteroni DNA, putative mega-
cluster of steroid degradation genes, strain: T441. 
Horinouchi et al., Microbiology (Reading, Engl.) 147 (PT 
12), 3367-3375 (2001) 
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chromosome I LN879547.1c Comamonas testosteroni P19 genome assembly 
Comamonas testosteroni P19, chromosome : I. 
Park Submitted (15-SEP-2015) JEJU NATIONAL 
UNIVERSITY, Lab of Microbial Ecology and Genomics, 
Dept. of Biology, Jeju National University, 102 
Jejudaehak-ro, Jeju 690-756, Jeju, 690-756, South 
Korea 
FAD-binding 
oxidoreductase 
CP001220.2c Comamonas testosteroni CNB-2, complete genome Ma et al., Appl. Environ. Microbiol. 75 (21), 6812-6819 
(2009) 
3-ketosteroid-9-alpha-
hydroxylase reductase 
subunit 
CP006704.1d Comamonas testosteroni TK102, complete genome. Fukuda et al., Genome Announc 2 (5), e00865-14 
(2014) 
FAD-binding 
oxidoreductase 
CP001220.2d Comamonas testosteroni CNB-2, complete genome Ma et al., Appl. Environ. Microbiol. 75 (21), 6812-6819 
(2009) 
chromosome i LN879547.1d Comamonas testosteroni P19 genome assembly 
Comamonas testosteroni P19, chromosome : I. 
Park Submitted (15-SEP-2015) JEJU NATIONAL 
UNIVERSITY, Lab of Microbial Ecology and Genomics, 
Dept. of Biology, Jeju National University, 102 
Jejudaehak-ro, Jeju 690-756, Jeju, 690-756, South 
Korea 
Acyl-CoA 
dehydrogenase, type 
2-like protein 
CP001220.2e Comamonas testosteroni CNB-2, complete genome Ma et al., Appl. Environ. Microbiol. 75 (21), 6812-6819 
(2009) 
flavin-dependent 
monooxygenase 
oxygenase subunit 
CP006704.1e Comamonas testosteroni TK102, complete genome. Fukuda et al., Genome Announc 2 (5), e00865-14 
(2014) 
3-ketosteriod 
isomerase 
AB489116 Comamonas testosteroni genes for 3-ketosteroiod 
isomerase, 3-alpha  steroid dehydrogenase, 
complete cds, strain: TA441. 
Horinouchi,M. J. Steroid Biochem. Mol. Biol. 122 (4), 
253-263 (2010) 
ketosteroid isomerase NZ_AKCL0100
0160 
Pseudomonas putida SJTE-1 contig000160, whole 
genome shotgun sequence. 
Liang,R J. Bacteriol. 194 (17), 4781-4782 (2012) 
ketosteroid isomerase NZ_AKCL0100
0166 
Pseudomonas putida SJTE-1 contig000166, whole 
genome shotgun sequence. 
Liang,R J. Bacteriol. 194 (17), 4781-4782 (2012) 
steroid delta-
isomerase 
NZ_AFMP010
00031 
Sphingomonas sp. KC8 contig31, whole genome 
shotgun sequence. 
Liang,R J. Bacteriol. 194 (17), 4781-4782 (2012) 
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steroid delta-
isomerase 
NZ_AFMP010
00031 
Sphingomonas sp. KC8 contig31, whole genome 
shotgun sequence. 
Liang,R J. Bacteriol. 194 (17), 4781-4782 (2012) 
putative 3-ketosteroid-
5-isomerase 
NZ_AFMP010
00031 
Sphingomonas sp. KC8 contig31, whole genome 
shotgun sequence. 
Liang,R J. Bacteriol. 194 (17), 4781-4782 (2012) 
steroid delta-
isomerase 
NZ_AFMP010
00018 
Sphingomonas sp. KC8 contig18, whole genome 
shotgun sequence. 
Liang,R J. Bacteriol. 194 (17), 4781-4782 (2012) 
steroid delta-
isomerase 
LC010134 Comamonas testosteroni DNA, putative mega-
cluster of steroid degradation genes, strain: T441. 
Horinouchi Microbiology (Reading, Engl.) 147 (PT 12), 
3367-3375 (2001) 
conserved 
hypothetical protein 
CP001220 Comamonas testosteroni CNB-2, complete genome. Ma Appl. Environ. Microbiol. 75 (21), 6812-6819 (2009) 
ketosteroid isomerase M22749 Pseudomonas testosteroni ketosteroid isomoerase 
(ksi) gene, complete cds. 
Choi Gene 69 (1), 121-129 (1988) 
delta-5-3-ketosteroid 
isomerase 
J03568 P.testosteroni delta-5-3-ketosteroid isomerase 
gene, complete cds. 
Kuliopulos Proc. Natl. Acad. Sci. U.S.A. 84 (24), 8893-
8897 (1987) 
steroid delta-
isomerase 
CP006704 Comamonas testosteroni TK102, complete genome. Fukuda Genome Announc 2 (5), e00865-14 (2014) 
TesF  AB063482 Comamonas testosteroni ORF11, tesA, tesD, tesE, 
tesF, tesG genes, complete cds. 
Horinouchi et al.,  Appl. Environ. Microbiol. 69 (4), 
2139-2152 (2003) 
TesF (acetaldehyde 
dehydrogenase) 
LC010134 Comamonas testosteroni DNA, putative mega-
cluster of steroid degradation genes, strain: T441. 
Horincouchi Microbiology (Reading, Engl.) 147 (PT 12), 
3367-3375 (2001) 
Acetaldehyde 
dehydrogenase 
CP001220 Comamonas testosteroni CNB-2, complete genome. Ma Appl. Environ. Microbiol. 75 (21), 6812-6819 (2009) 
Acetaldehyde 
dehydrogenase 
CP001220 Comamonas testosteroni CNB-2, complete genome. Ma Appl. Environ. Microbiol. 75 (21), 6812-6819 (2009) 
acetaldehyde 
dehydrogenase 
CP006704 Comamonas testosteroni TK102, complete genome. Fukuda Genome Announc 2 (5), e00865-14 (2014) 
TesG (possibly 4-
hydroxy-2oxovalerate 
aldolase) 
AB063482 Comamonas testosteroni ORF11, tesA, tesD, tesE, 
tesF, tesG genes, complete cds. 
Horinouchi,M Appl. Environ. Microbiol. 69 (4), 2139-
2152 (2003) 
4-hyroxy-2-oxovalerate 
aldolase 
CP006704  Comamonas testosteroni TK102, complete genome. Fukuda Genome Announc 2 (5), e00865-14 (2014) 
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4-hyroxy-2-oxovalerate 
aldolase 
CP006704 Comamonas testosteroni TK102, complete genome. Fukuda Genome Announc 2 (5), e00865-14 (2014) 
4-hyroxy-2-oxovalerate 
aldolase 
LC010134 Comamonas testosteroni DNA, putative mega-
cluster of steroid degradation genes, strain: T441 
Horinouchi Microbiology (Reading, Engl.) 147 (PT 12), 
3367-3375 (2001) 
aphG 4-hydroxy-2-
oxovalerate aldolase 
AB029044 Comamonas testosteroni orfX, orfY, aphT, aphC, 
aphE, aphF, aphG, aphH, orfJ, aphI gene cluster for 
meta-pathway enzymes required for degradation of 
phenol, complete cds 
Arai Microbiology (Reading, Engl.) 146 (PT 7), 1707-
1715 (2000) 
4-hydroxy-2-
oxovalerate aldolase 
(tdnJ) 
NG_035478 Pseudomonas putida UCC22 plasmid pTDN1 genes 
for conversion of aniline to catechol, aniline 
degradation lower-pathway gene cluster, regulatory 
protein and transposase, partial and complete cds 
Fukumori Unpublished 
TadJ 4-hydroxy-2-
oxovalerate aldolase 
AY940090 Delftia tsuruhatensis strain AD9 transposase (tnpA-
L1) gene, partial cds; tad gene cluster, complete 
sequence; transcriptional regulator (orfX), 
hydrolase/acyltransferase (orfY), and muconate 
cycloisomerase (orfZ) genes, complete cds; and 
transposase (tnpA-L2) gene, partial cds 
Liang Microbiology (Reading, Engl.) 151 (PT 10), 3435-
3446 (2005) 
4-hydroxy-2-
oxovalerate aldolase 
CP000539 Acidovorax sp. JS42, complete genome. Copeland unpublished 
4-hydroxy-2-
oxovalerate aldolase 
AF190463 Comamonas sp. JS765 hypothetical CdoX1 (cdoX1), 
hypothetical CmpX-like protein (cdoX2), 
hypothetical CdoFa (cdoFa), hypothetical CdoFb 
(cdoFb), hypothetical CdoR2 (cdoR2), hypothetical 
CdoX3(cdoX3), 2-hydroxymuconic semialdehyde 
dehydrogenase (cdoG), 2-oxo-4-pentenoate 
hydratase (cdoH), acetaldehyde 
dehydrogenase(cdoI), 4-hydroxy-2-oxovalerate 
aldolase (cdoJ), and4-oxalocrotonate decarboxylase 
He J. Ind. Microbiol. Biotechnol. 34 (2), 99-104 (2007) 
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(cdoK) genes, complete cds; and CdoL            (cdoL) 
gene, partial cds. 
4-hydroxy-2-
oxovalerate aldolase 
(pcaJ) 
FJ601374 Diaphorobacter sp. PCA039 pca gene cluster, 
complete sequence. 
Zhang World J. Microbiol. Biotechnol. 26 (4), 665-673 
(2010) 
4-hydroxy-2-
oxovalerate aldolase 
FR687359 Burkholderia rhizoxinica HKI 454, complete genome. Lackner J. Bacteriol. 193 (3), 783-784 (2011) 
TesE AB063482 Comamonas testosteroni ORF11, tesA, tesD, tesE, 
tesF, tesG genes, complete cds. 
Horinouchi,M Appl. Environ. Microbiol. 69 (4), 2139-
2152 (2003) 
2-keto-4-pentenoate 
hydratase 
(hydratase/decarboxyl
ase) 
CP001220 Comamonas testosteroni CNB-2, complete genome. Ma Appl. Environ. Microbiol. 75 (21), 6812-6819 (2009) 
2-keto-4-pentenoate 
hydratase 
CP006704 Comamonas testosteroni TK102, complete genome. Fukuda Genome Announc 2 (5), e00865-14 (2014) 
2-hydroxyhexa-2,4-
dienoate hydratase 
LC010134 Comamonas testosteroni DNA, putative mega-
cluster of steroid degradation genes, strain: T441. 
Horinouchi Microbiology (Reading, Engl.) 147 (PT 12), 
3367-3375 (2001) 
TesD/ORF13 AB063482 Comamonas testosteroni ORF11, tesA, tesD, tesE, 
tesF, tesG genes, complete cds. 
Horinouchi,M Appl. Environ. Microbiol. 69 (4), 2139-
2152 (2003) 
TesD (hydrolase for 4, 
5-9, 10-Diseco-3-
hydroxy-5, 9, 
                     17-
trioxoandrosta-1(10), 
2-dien-4-oic acid) 
LC010134 Comamonas testosteroni DNA, putative mega-
cluster of steroid degradation genes, strain: T441. 
Horinouchi Microbiology (Reading, Engl.) 147 (PT 12), 
3367-3375 (2001) 
alpha/beta hydrolase 
fold protein 
CP001220 Comamonas testosteroni CNB-2, complete genome. Ma Appl. Environ. Microbiol. 75 (21), 6812-6819 (2009) 
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3-oxoacyl-ACP 
reductase 
CP006704 Comamonas testosteroni TK102, complete genome. Fukuda Genome Announc 2 (5), e00865-14 (2014) 
Chromosome I LN879547.1 Comamonas testosteroni P19 genome assembly 
Comamonas testosteroni P19, chromosome : I 
Park,Soo.-Je. 
2-hydroxymuconic 
semialdehyde 
hydrolase 
 
Rhodococcus equi ATCC13557 This thesis 
putative alpha/beta 
hydrolase 
FN563149.1 Rhodococcus equi 103S chromosome Letek et al., PLoS Genet. 2010 Sep 30;6(9):e1001145. 
doi: 10.1371/journal.pgen.1001145. 
hypothetical protein AB117721.1 Rhodococcus rhodochrous orf31, orf32, bphC3 
genes for hypothetical proteins and 2, 3-
dihydroxybiphenyl 1, 2-dioxygenase, partial and 
complete cds. 
Taguchi et al., Biosci Biotechnol Biochem. 2004 
Apr;68(4):787-95. 
Oxosteriod 1-
dehydrogenase 
LGTW010000
00 
Streptomyces scabiei DNA, scaffold: 
NODE_015_cov_67.063, strain: S58, whole genome 
shotgun sequence 
de Man,T.J., Perry,K.A., Coulliette,A.D., Jensen,B., 
Toney,N.C., Limbago,B.M. and Noble-Wang,J. Genome 
Announc 4 (2) (2016) 
 
3- Oxosteriod 1-
dehydrogenase 
BCMM010000
15 
Streptomyces scabiei DNA, scaffold: 
NODE_015_cov_67.063, strain: S58, whole genome 
shotgun sequence 
Submitted (17-NOV-2015) Contact:Tsuyoshi Tomihama 
Kagoshima Prefectural Institute for Agricultural 
Development, Plant Pathology and Entomology; 
Oono2200, Minamisatsuma, Kagoshima 899-3401, 
Japan 
Oxosteriod 1-
dehydrogenase 
BCMM010000
26 
Streptomyces scabiei DNA, scaffold: 
NODE_026_cov_60.1768, strain: S58, whole genome 
shotgun sequence 
Submitted (17-NOV-2015) Contact:Tsuyoshi Tomihama 
Kagoshima Prefectural Institute for Agricultural 
Development, Plant Pathology and Entomology; 
Oono2200, Minamisatsuma, Kagoshima 899-3401, 
Japan 
3- Oxosteriod 1-
dehydrogenase 
LMXT0100003
9.1 
Comamonas testosteroni strain WDL7 contig_68, 
whole genome shotgun sequence 
Submitted (31-OCT-2015) Lab of Soil and Water 
Management, KU Leuven, Kasteelpark Arenberg, 
Heverlee 3001, Belgium 
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3-oxosteroid 1-
dehydrogenase 
LLWJ0100004
5.1 
Pseudomonas sp. TAA207 contig000045, whole 
genome shotgun sequence 
Submitted (20-OCT-2015) University of Florence, Via 
Madonna del Piano 6, Sesto Fiorentino, Italy 
3-oxosteroid 1-
dehydrogenase 
LLWI0100005
5.1 
Pseudomonas sp. TAD18 contig000055, whole 
genome shotgun sequence 
Submitted (20-OCT-2015) Dept. of Biology, University 
of Florence, Via Madonna del Piano 6, Sesto Fiorentino, 
Italy 
3-oxosteroid 1-
dehydrogenase 
BCMK010000
15.1 
Streptomyces acidiscabies DNA, scaffold: 
NODE_015_cov_60.072, strain: a10, whole genome 
shotgun sequence 
Tomihama,T., Ikenaga,M., Sakai,M., Okubo,T. and 
Ikeda,S. Genome Announc 4 (2), e00062-16 (2016) 
3-oxosteroid 1-
dehydrogenase 
BCMN010000
06.1 
Streptomyces turgidiscabies DNA, scaffold: 
NODE_006_cov_57.7002, strain: T45, whole genome 
shotgun sequence 
Tomihama,T., Ikenaga,M., Sakai,M., Okubo,T. and 
Ikeda,S Genome Announc 4 (2), e00062-16 (2016) 
3-oxosteroid 1-
dehydrogenase 
BCMN010000
25.1 
Streptomyces turgidiscabies DNA, scaffold: 
NODE_025_cov_64.0769, strain: T45, whole genome 
shotgun sequence 
Tomihama,T., Ikenaga,M., Sakai,M., Okubo,T. and 
Ikeda,S Genome Announc 4 (2), e00062-16 (2016) 
3-oxosteroid 1-
dehydrogenase 
BCMN010000
34.1 
Streptomyces turgidiscabies DNA, scaffold: 
NODE_034_cov_67.2766, strain: T45, whole genome 
shotgun sequence 
Tomihama,T., Ikenaga,M., Sakai,M., Okubo,T. and 
Ikeda,S Genome Announc 4 (2), e00062-16 (2016) 
3-oxosteroid 1-
dehydrogenase 
CP012901.1 Pseudomonas aeruginosa strain N15-01092, 
complete sequence 
Mataseje et al., Submitted (13-OCT-2015) Antimicrobial 
Resistance and Nosocomial 
            Infections, Public Health Agency of Canada, 1015 
Arlington Street, 
            Winnipeg, MB, Canada 
3-oxosteroid 1-
dehydrogenase 
LOEI01000003
.1 
Klebsiella pneumoniae strain OC511 
AOT23_contig000003, whole genome shotgun 
sequence 
Lopez,L.L., Rusconi,B., Mclaughlin,M., Qi,C., 
Scheetz,M.H., Seshu,J. and Eppinger,M. Genome 
Announc 4 (2) (2016) 
3-oxosteroid 1-
dehydrogenase 
LOEJ0100001
8.1 
Klebsiella pneumoniae strain K1 
AOT20_contig000018, whole genome shotgun 
sequence 
Lopez,L.L., Rusconi,B., Mclaughlin,M., Qi,C., 
Scheetz,M.H., Seshu,J. and Eppinger,M. Genome 
Announc 4 (2) (2016) 
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3-oxosteroid 1-
dehydrogenase 
LOEF0100000
3.1 
Klebsiella pneumoniae strain OC217 
AOT21_contig000003, whole genome shotgun 
sequence 
Lopez,L.L., Rusconi,B., Mclaughlin,M., Qi,C., 
Scheetz,M.H., Seshu,J. and Eppinger,M. Genome 
Announc 4 (2) (2016) 
3-oxosteroid 1-
dehydrogenase 
LOEH0100000
4.1 
Klebsiella pneumoniae strain OC648 
AOT24_contig000004, whole genome shotgun 
sequence 
Lopez,L.L., Rusconi,B., Mclaughlin,M., Qi,C., 
Scheetz,M.H., Genome Announc 4 (2) (2016) 
3-oxosteroid 1-
dehydrogenase 
LOEG0100000
6.1 
Klebsiella pneumoniae strain Z3209 
AOT25_contig000006, whole genome shotgun 
sequence 
Lopez,L.L., Rusconi,B., Mclaughlin,M., Qi,C., 
Scheetz,M.H., Genome Announc 4 (2) (2016) 
3-oxosteroid 1-
dehydrogenase 
CP007255.1 Rhodococcus erythropolis R138, complete genome Kwasiborski,A., Mondy,S., Beury-Cirou,A. and Faure,D. 
Genome Announc 2 (2) (2014) 
 
3-ketosteroid-delta-1-
dehydrogenase 
AZXY0100000
1.1 
Rhodococcus pyridinivorans KG-16 contig00001, 
whole genome shotgun sequence 
Aggarwal,R.K. and Dawar,C. Genome Announc 4 (1), 
e01704-15 (2016) 
3-ketosteroid-delta-1-
dehydrogenase 
LNQH0100000
8.1 
Rhodococcus enclensis strain NIO-1009 contig008, 
whole genome shotgun sequence 
Dastager et al., Int J Syst Evol Microbiol. 2014 
Aug;64(Pt 8):2693-9. doi: 10.1099/ijs.0.061390-0. Epub 
2014 May 22. 
catechol 1,2-
dioxygenase (1a) 
NZ_AKCL0100
0002 
Pseudomonas putida SJTE-1 contig000002, whole 
genome shotgun sequence. 
Liang,R J. Bacteriol. 194 (17), 4781-4782 (2012) 
catechol 1,2-
dioxygenase 
NZ_AKCL0100
0193 
Pseudomonas putida SJTE-1 contig000193, whole 
genome shotgun sequence. 
Liang,R J. Bacteriol. 194 (17), 4781-4782 (2012) 
catechol 2,3-
dioxygenase 
NC_008275 Pseudomonas putida MT53 plasmid pWW53, 
complete sequence 
Miyakoshi, M et al Environ. Microbiol. 14 (11), 2946-
2959 (2012) Yano, H et al J. Mol. Biol. 369 (1), 11-26 
(2007) Tsuda J. Bacteriol. 183 (21), 6215-6224 (2001) 
Sentchilo Appl. Environ. Microbiol. 66 (7), 2842-2852 
(2000) Gallegos J. Bacteriol. 179 (16), 5024-5029 (1997) 
Assinder J. Gen. Microbiol. 139 (3), 557-568 (1993) 
Assinder Nucleic Acids Res. 20 (20), 5476 (1992) 
Osbourne J. Gen. Microbiol. 134 (11), 2965-2975 (1988) 
Keil J. Gen. Microbiol. 133 (5), 1149-1158 (1987) Keil J. 
Bacteriol. 169 (2), 764-770 (1987) Keil J. Bacteriol. 164 
(2), 887-895 (1985) 
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Catechol 2,3 
dioxygenase 
NC_003350 Pseudomonas putida plasmid pWW0, complete 
sequence. 
Greated, A Environ. Microbiol. 4 (12), 856-871 (2002) 
Catechol 2,3 
dioxygenase 
NC_007926 Pseudomonas putida plasmid NAH7, complete 
sequence. 
Sota J. Bacteriol. 188 (11), 4057-4067 (2006) Tsuda 
Mol. Gen. Genet. 223 (1), 33-39 (1990) 
Catechol 2,3 
dioxygenase 
NC_004999 Pseudomonas putida NCIB 9816-4 plasmid pDTG1, 
complete sequence. 
Dennis J. Mol. Biol. 341 (3), 753-768 (2004) 
Catechol 2,3 
dioxygenase 
NC_008275 Pseudomonas putida MT53 plasmid pWW53, 
complete sequence. 
Miyakoshi, M Environ. Microbiol. 14 (11), 2946-2959 
(2012) 
Yano, H et al J. Mol. Biol. 369 (1), 11-26 (2007) 
Tsuda J. Bacteriol. 183 (21), 6215-6224 (2001) 
Sentchilo Appl. Environ. Microbiol. 66 (7), 2842-2852 
(2000) 
Gallegos J. Bacteriol. 179 (16), 5024-5029 (1997) 
Assinder J. Gen. Microbiol. 139 (3), 557-568 (1993) 
Assinder Nucleic Acids Res. 20 (20), 5476 (1992) 
Osbourne J. Gen. Microbiol. 134 (11), 2965-2975 (1988) 
Keil J. Gen. Microbiol. 133 (5), 1149-1158 (1987) 
Keil J. Bacteriol. 169 (2), 764-770 (1987) 
Keil J. Bacteriol. 164 (2), 887-895 (1985) 
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Catechol 2,3 
dioxygenase 
NC_014124 Pseudomonas putida plasmid pDK1, complete 
sequence. 
Mikakoshi Environ. Microbiol. 14 (11), 2946-2959 
(2012) 
Yano, H et al J. Bacteriol. 192 (17), 4337-4347 (2010) 
Assinder J. Gen. Microbiol. 139 (3), 557-568 (1993) 
Assinder Nucleic Acids Res. 20 (20), 5476 (1992) 
Benjamin J. Bacteriol. 173 (8), 2724-2728 (1991) 
Voss SAAS Bull. Biochem. Biotechnol. 3, 54-57 (1990) 
Shaw J. Gen. Microbiol. 134 (9), 2463-2474 (1988) 
Kunz J. Bacteriol. 148 (1), 72-82 (1981) 
Kunz J. Bacteriol. 146 (3), 952-964 (1981) 
Catechol 2,3 
dioxygenase 
NC_010678 Ralstonia pickettii 12J chromosome 2, complete 
sequence. 
Lucas, S Submitted (01-MAY-2008) US DOE Joint 
Genome Institute, 2800 
            Mitchell Drive B100, Walnut Creek, CA 94598-
1698, USA 
Catechol 2,3 
dioxygenase 
NC_007494 Rhodobacter sphaeroides 2.4.1 chromosome 2, 
complete sequence 
Copeland A, Unpublished Kontur Submitted (21-OCT-
2013) US DOE Joint Genome Institute, 2800 
            Mitchell Drive B100, Walnut Creek, CA 94598-
1698, USA 
Catechol 2,3 
dioxygenase 
NC_010175 Chloroflexus aurantiacus J-10-fl chromosome, 
complete genome. 
Copeland A, Unpublished/Submitted (05-DEC-2007) US 
DOE Joint Genome Institute, 2800 
            Mitchell Drive B100, Walnut Creek, CA 94598-
1698, USA 
Catechol 2,3 
dioxygenase 
NC_012674  Pseudomonas fluorescens strain PC20 plasmid 
pNAH20, complete sequence 
Merimaa Arch. Microbiol. 186 (4), 287-296 (2006)  
FEMS Microbiol. Ecol. 31 (3), 195-205 (2000) 
Catechol 2,3 
dioxygenase 
NC_002033 Novosphingobium aromaticivorans plasmid pNL1, 
complete sequence. 
Romine J. Bacteriol. 181 (5), 1585-1602 (1999) 
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Catechol 2,3 
dioxygenase (a) 
NC_002754 Sulfolobus solfataricus P2 chromosome, complete 
genome. 
She Proc. Natl. Acad. Sci. U.S.A. 98 (14), 7835-7840 
(2001) 
Charlebois Genome 43 (1), 116-136 (2000) 
Catechol 2,3 
dioxygenase 
NC_008269 Rhodococcus jostii RHA1 plasmid pRHL1, complete 
sequence. 
McLeod Submitted (24-JUL-2006) Microbiology and 
Immunology, University of 
            British Columbia, 1365-2350 Health Sciences 
Mall, Vancouver, BC V6T 
            1Z3, Canada 
Catechol 2,3 
dioxygenase 
NC_016644  Pseudomonas sp. MC1 plasmid KOPRI126573, 
complete sequence. 
Ahn Unpublished/ Submitted (13-JUL-2011) 
Department of Systems Biology, Yonsei 
            University, 50 Yonsei-Ro, Seodaemun-Gu, Seoul 
120-749, Republic of 
            Korea 
Catechol 2,3 
dioxygenase 
NC_021250  Pseudomonas migulae strain D2RT plasmid pD2RT, 
complete sequence. 
Jutkina Submitted (10-JUL-2012) Department of 
Genetics, Institute of 
            Molecular and Cell Biology, University of Tartu, 
23 Riia Street, 
            Tartu 51010, Estonia 
Catechol 2,3 
dioxygenase 
NC_013446  Comamonas testosteroni CNB-2, complete genome. Ma Appl. Environ. Microbiol. 75 (21), 6812-6819 (2009) 
Catechol 2,3 
dioxygenase 
NC_018028 Pseudomonas stutzeri CCUG 29243, complete 
genome. 
Brunet-Galmes J. Bacteriol. 194 (23), 6642-6643 (2012) 
Catechol 2,3 
dioxygenase 
NC_000964  Bacillus subtilis subsp. subtilis str. 168 chromosome, 
complete genome. 
Barbe, V Microbiology (Reading, Engl.) 155 (PT 6), 
1758-1775 (2009) 
Eichenberger PLoS Biol. 2 (10), E328 (2004)  
Kunst Nature 390 (6657), 249-256 (1997) 
Mizuno Microbiology (Reading, Engl.) 142 (PT 11), 
3103-3111 (1996) 
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Catechol 2,3 
dioxygenase (a) 
NC_008268 Rhodococcus jostii RHA1, complete genome. McLeod Submitted (24-JUL-2006) Microbiology and 
Immunology, University of 
            British Columbia, 1365-2350 Health Sciences 
Mall, Vancouver, BC V6T 
            1Z3, Canada 
Catechol 2,3 
dioxygenase 
NC_012589 Sulfolobus islandicus L.S.2.15 chromosome, 
complete genome. 
Reno Proc. Natl. Acad. Sci. U.S.A. 106 (21), 8605-8610 
(2009) 
Catechol 2,3 
dioxygenase 
NZ_KB900701 Bradyrhizobium elkanii USDA 76 
BraelDRAFT_scaffold1.1, whole genome shotgun 
sequence 
Kyrpides Submitted (16-APR-2013) DOE Joint Genome 
Institute, 2800 Mitchell 
            Drive, Walnut Creek, CA 94598-1698, USA 
Catechol 2,3 
dioxygenase 
NC_006462 Thermus thermophilus HB8 plasmid pTT27, 
complete sequence. 
Masui Submitted (11-NOV-2004) Graduate School of 
Information Science, 
            Nara Institute of Science and Technology, 8916-
5, Takayamacho, 
            Ikoma, Nara 630-0192, Japan 
Catechol 2,3 
dioxygenase 
NC_007973 Cupriavidus metallidurans CH34, complete genome. Copeland A Submitted (18-APR-2006) US DOE Joint 
Genome Institute, 2800 
            Mitchell Drive B100, Walnut Creek, CA 94598-
1698, USA 
Catechol 2,3 
dioxygenase 
NC_012726 Sulfolobus islandicus M.16.4 chromosome, 
complete genome. 
Reno Proc. Natl. Acad. Sci. U.S.A. 106 (21), 8605-8610 
(2009) 
Catechol 2,3 
dioxygenase 
NC_012623 Sulfolobus islandicus Y.N.15.51 chromosome, 
complete genome. 
Reno Proc. Natl. Acad. Sci. U.S.A. 106 (21), 8605-8610 
(2009) 
Catechol 2,3 
dioxygenase 
NC_013769 Sulfolobus islandicus L.D.8.5 chromosome, complete 
genome. 
Reno Unpublished Copeland Submitted (03-SEP-2009) 
US DOE Joint Genome Institute, 2800 
            Mitchell Drive B100, Walnut Creek, CA 94598-
1698, USA 
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Catechol 2,3 
dioxygenase 
NC_012586 Sinorhizobium fredii NGR234 plasmid pNGR234b, 
complete sequence. 
Schmeisser Appl. Environ. Microbiol. 75 (12), 4035-
4045 (2009) 
Streit J. Bacteriol. 186 (2), 535-542 (2004) 
Liesegang Submitted (29-OCT-2007) Institute of 
Microbiology and Genetics, 
            Goettingen Genomics Laboratory, 
Grisebachstrasse 8, Goettingen, 
            Lower Saxony D-37077, Germany 
Catechol 2,3 
dioxygenase 
NC_020995 Enterococcus casseliflavus EC20, complete genome. Russ unpublished 
Russ Submitted (27-MAR-2013) Broad Institute of MIT 
and Harvard, 7 Cambridge Center, Cambridge, MA 
02142, USA 
 
Catechol 2,3 
dioxygenase (b) 
NC_002754 Sulfolobus solfataricus P2 chromosome, complete 
genome. 
She Proc. Natl. Acad. Sci. U.S.A. 98 (14), 7835-7840 
(2001) 
Charlebois Genome 43 (1), 116-136 (2000) 
Catechol 2,3 
dioxygenase 
NC_017276 Sulfolobus islandicus REY15A chromosome, 
complete genome. 
Guo J. Bacteriol. (2011) In press 
Catechol 2,3 
dioxygenase 
NC_017275 Sulfolobus islandicus HVE10/4 chromosome, 
complete genome. 
Guo J. Bacteriol. (2011) In press 
Catechol 2,3 
dioxygenase 
NC_014318  Amycolatopsis mediterranei U32 chromosome, 
complete genome. 
Zhao Cell Res. 20 (10), 1096-1108 (2010) 
Catechol 2,3 
dioxygenase 
NC_007181 Sulfolobus acidocaldarius DSM 639 chromosome, 
complete genome. 
Chen J. Bacteriol. 187 (14), 4992-4999 (2005) 
Catechol 2,3 
dioxygenase 
NC_016978 Comamonas testosteroni plasmid pI2, complete 
sequence. 
Krol Appl. Environ. Microbiol. (2011) In press 
Boon Appl. Environ. Microbiol. 67 (3), 1107-1115 
(2001) 
Catechol 2,3 
dioxygenase 
NC_020247 Sulfolobus acidocaldarius Ron12/I, complete 
genome. 
Mao ISME J 6 (8), 1613-1616 (2012) 
Catechol 2,3 
dioxygenase 
NC_020246 Sulfolobus acidocaldarius N8, complete genome. Mao ISME J 6 (8), 1613-1616 (2012) 
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Catechol 2,3 
dioxygenase 
NC_006270 Bacillus licheniformis ATCC 14580, complete 
genome. 
Rey Genome Biol. 5 (10), R77 (2004) 
Catechol 2,3 
dioxygenase 
NC_003997 Bacillus anthracis str. Ames chromosome, complete 
genome. 
Read Nature 423 (6935), 81-86 (2003) 
Catechol 2,3 
dioxygenase 
NC_014551 Bacillus amyloliquefaciens DSM7 complete genome. Borriss Int. J. Syst. Evol. Microbiol. 61 (PT 8), 1786-1801 
(2011) 
Catechol 1,2 
dioxygenase 
NC_007953 Burkholderia xenovorans LB400 chromosome 3, 
complete sequence. 
Chain Proc. Natl. Acad. Sci. U.S.A. 103 (42), 15280-
15287 (2006) 
Copeland A Submitted (13-MAR-2006) US DOE Joint 
Genome Institute, 2800 
            Mitchell Drive B100, Walnut Creek, CA 94598-
1698, USA 
Catechol 2,3 
dioxygenase 
NC_016047 Bacillus subtilis subsp. spizizenii TU-B-10, complete 
genome. 
Earl J. Bacteriol. 194 (9), 2378-2379 (2012) 
Catechol 2,3 
dioxygenase 
NC_014622 Paenibacillus polymyxa SC2, complete genome. Ma J. Bacteriol. 193 (1), 311-312 (2011) 
Catechol 2,3 
dioxygenase 
NC_005945 Bacillus anthracis str. Sterne chromosome, complete 
genome. 
Brettin Submitted (12-JAN-2004) Joint Genome 
Institute, Department of 
            Energy, 2800 Mitchell Drive, Walnut Creek, CA 
94598, USA 
Catechol 2,3 
dioxygenase 
NZ_CP007640 Bacillus atrophaeus subsp. globigii strain BSS. Daligault Genome Announc 2 (5) (2014) 
Bishop-Lilly Submitted (05-MAY-2014) Bioscience, Los 
Alamos National Laboratory, 
            P.O. Box 1663, MS M888, Los Alamos, NM 
87545, USA 
Catechol 2,3 
dioxygenase (short 
removed) 
NC_005042 Prochlorococcus marinus subsp. marinus str. 
CCMP1375 complete genome 
Dufresne Proc. Natl. Acad. Sci. U.S.A. 100 (17), 10020-
10025 (2003) 
Catechol 1,2 
dioxygenase 
NC_006351 Burkholderia pseudomallei K96243 chromosome 2, 
complete sequence. 
Holden Proc. Natl. Acad. Sci. U.S.A. 101 (39), 14240-
14245 (2004) 
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Catechol 1,2 
dioxygenase (a) 
NC_002947 Pseudomonas putida KT2440 chromosome, 
complete genome. 
Nelson Environ. Microbiol. 4 (12), 799-808 (2002) 
Catechol 1,2 
dioxygenase 
NC_011002 Burkholderia cenocepacia J2315 chromosome 3, 
complete genome. 
Holden J. Bacteriol. 191 (1), 261-277 (2009) 
Catechol 1,2 
dioxygenase (b) 
NC_002947 Pseudomonas putida KT2440 chromosome, 
complete genome. 
Nelson Environ. Microbiol. 4 (12), 799-808 (2002) 
Catechol 1,2 
dioxygenase (a) 
NZ_HG938353 Neorhizobium galegae, complete genome. Osterman BMC Genomics 15, 500 (2014) 
Catechol 1,2 
dioxygenase (a) 
NC_010682 Ralstonia pickettii 12J chromosome 1, complete 
sequence. 
Lucas Submitted (01-MAY-2008) US DOE Joint Genome 
Institute, 2800 
            Mitchell Drive B100, Walnut Creek, CA 94598-
1698, USA 
Catechol 1,2 
dioxygenase 
NZ_KI530699  Acinetobacter gyllenbergii NIPH 230 adfcq-
supercont1.1, whole genome shotgun sequence 
Cerqueira Submitted (04-OCT-2013) Broad Institute of 
MIT and Harvard, 7 
            Cambridge Center, Cambridge, MA 02142, USA 
catechol 1,2-
dioxygenase 
NC_003078 Sinorhizobium meliloti 1021 plasmid pSymB, 
complete sequence. 
Finlan Proc. Natl. Acad. Sci. U.S.A. 98 (17), 9889-9894 
(2001) 
Catechol 1,2 
dioxygenase (a) 
NC_003450  Corynebacterium glutamicum ATCC 13032 
chromosome, complete genome. 
Nagwa (in) PROCEEDINGS OF THE 9TH INTERNATIONAL 
SYMPOSIUM ON THE GENETICS OF INDUSTRIAL 
MICROORGANISMS: 21; Silberbach Appl. Environ. 
Microbiol. 71 (5), 2391-2402 (2005) 
Ikeda Appl. Microbiol. Biotechnol. 62 (2-3), 99-109 
(2003) 
catechol 1,2-
dioxygenase 
NC_004463 Bradyrhizobium japonicum USDA 110 chromosome, 
complete genome. 
Kaneto DNA Res. 9 (6), 225-256 (2002) 
Kaneto DNA Res. 9 (6), 189-197 (2002) 
Gottfert J. Bacteriol. 183 (4), 1405-1412 (2001) 
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catechol 1,2-
dioxygenase 
NZ_KB849655 Acinetobacter junii CIP 64.5 acLZZ-supercont1.3, 
whole genome 
Cerqueira Submitted (19-FEB-2013) Broad Institute of 
MIT and Harvard, 7 Cambridge Center, Cambridge, MA 
02142, USA 
Feldgarden Submitted (19-FEB-2013) Broad Institute of 
MIT and Harvard, 7 
            Cambridge Center, Cambridge, MA 02142, USA 
Catechol 1,2 
dioxygenase 
NC_015663  Enterobacter aerogenes KCTC 2190 chromosome, 
complete genome. 
Shin J. Bacteriol. 194 (9), 2373-2374 (2012) 
Catechol 1,2 
dioxygenase 
NZ_KB851227 Acinetobacter lwoffii NCTC 5866 = CIP 64.10 acLsp-
supercont1.12, whole shotgun sequence. 
Cerqueira Submitted (19-FEB-2013) Broad Institute of 
MIT and Harvard, 7 Cambridge Center, Cambridge, MA 
02142, USA 
Felgarden Submitted (19-FEB-2013) Broad Institute of 
MIT and Harvard, 7 Cambridge Center, Cambridge, MA 
02142, USA  
catechol 1,2 
dioxygenase 
NZ_KB849749 Acinetobacter radioresistens DSM 6976 = NBRC 
102413 = CIP 103788  
            acLrZ-supercont1.9, whole genome shotgun 
sequence. 
Cerqueira Submitted (19-FEB-2013) Broad Institute of 
MIT and Harvard, 7 
            Cambridge Center, Cambridge, MA 02142, USA 
Felgarden Submitted (19-FEB-2013) Broad Institute of 
MIT and Harvard, 7 
            Cambridge Center, Cambridge, MA 02142, USA 
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Catechol 1,2 
dioxygenase (a) 
NZ_KI421499 Bradyrhizobium genosp. SA-4 str. CB756 
BrageDRAFT_scaffold1.1, 
            whole genome shotgun sequence. 
Kyrpides Submitted (23-AUG-2013) DOE Joint Genome 
Institute, 2800 Mitchell Drive, Walnut Creek, CA 94598-
1698, USA 
Catechol 1,2 
dioxygenase 
NC_025133 Sphingobium wenxiniae strain JZ-1 plasmid pPBA, 
complete sequence. 
Wang Appl. Environ. Microbiol. 80 (13), 3811-3818 
(2014) 
Catechol 2,3 
dioxygenase (b) 
NZ_KI421499 Bradyrhizobium genosp. SA-4 str. CB756 
BrageDRAFT_scaffold1.1, whole genome shotgun 
sequence. 
Kyrpides Submitted (23-AUG-2013) DOE Joint Genome 
Institute, 2800 Mitchell 
            Drive, Walnut Creek, CA 94598-1698, USA 
Catechol 1,2 
dioxygenase 
NC_002516 Pseudomonas aeruginosa PAO1 chromosome, 
complete genome. 
Winsor Nucleic acids Res. 37 (DATABASE ISSUE), D483-
D488 (2009) 
Cirz J. Bacteriol. 188 (20), 7101-7110 (2006) 
Palmer J. Bacteriol. 187 (15), 5267-5277 (2005) 
Salunkhe J. Bacteriol. 187 (14), 4908-4920 (2005) 
Filiatrault Infect. Immun. 73 (6), 3764-3772 (2005) 
Rassmussen J. Bacteriol. 187 (5), 1799-1814 (2005) 
Winsor Nucleic acids Res. 33 (DATABASE ISSUE), D338-
D343 (2005) 
Wagner J. Bacteriol. 185 (7), 2080-2095 (2003) 
Schuster J. Bacteriol. 185 (7), 2066-2079 (2003) 
Stover Nature 406 (6799), 959-964 (2000) 
extradiol catechol 
dioxygenase (a) 
NZ_AKCL0100
0023 
Pseudomonas putida SJTE-1 contig000023, whole 
genome shotgun sequence. 
Liang,R J. Bacteriol. 194 (17), 4781-4782 (2012) 
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putative aromatic ring-
opening dioxygenase 
FN563149.1 Rhodococcus equi 103S chromosome. Letek, M et al., PLoS Genet. 2010 Sep 
30;6(9):e1001145. doi: 10.1371/journal.pgen.1001145. 
2, 3-dihydroxybiphenyl 
1, 2-dioxygenase 
AB117721.1 Rhodococcus rhodochrous orf31, orf32, bphC3 
genes for hypothetical proteins and 2, 3-
dihydroxybiphenyl 1, 2-dioxygenase, partial and 
complete cds. 
Taguchi et al., Biosci Biotechnol Biochem. 2004 
Apr;68(4):787-95. 
protocatechuate 4,5-
dioxygenase 
CP003588.1 Pseudomonas putida ND6, complete genome. Li et al., J Bacteriol. 2012 Sep;194(18):5154-5. doi: 
10.1128/JB.01190-12. 
protocatechuate 4,5-
dioxygenase beta 
subunit / 
protocatechuate 4,5-
dioxygenase alpha 
subunit 
CP000712.1 Pseudomonas putida F1, complete genome. Copeland et al., Submitted (25-MAY-2007) US DOE 
Joint Genome Institute, 2800 
            Mitchell Drive B100, Walnut Creek, CA 94598-
1698, USA 
protocatechuate 4,5-
dioxygenase 
CP003734.1 Pseudomonas putida DOT-T1E, complete genome. Udaondo et al., Submitted (04-JUL-2012) 
Environmental Protection, EEZ-CSIC,  Profesor Albareda 
1, Granada, Granada 18008, Spain 
gallate dioxygenase AE015451.2 Pseudomonas putida KT2440 complete genome Nelson et al., Environ Microbiol. 2002 Dec;4(12):799-
808. 
Protocatechuate 4,5-
dioxygenase 
CP002290.1 Pseudomonas putida BIRD-1, complete genome. Matilla et al., J Bacteriol. 2011 Mar;193(5):1290. doi: 
10.1128/JB.01281-10. Epub 2010 Dec 23. 
protocatechuate 4,5-
dioxygenase subunit 
alpha 
CP005976.1 Pseudomonas putida H8234, complete genome. Molina et al Genome Announc. 2013 Jul 18;1(4). pii: 
e00496-13. doi: 10.1128/genomeA.00496-13. 
Protocatechuate 4,5-
dioxygenase 
CP000949.1 Pseudomonas putida W619, complete genome. Copeland et al Submitted (21-FEB-2008) US DOE Joint 
Genome Institute, 2800 
            Mitchell Drive B100, Walnut Creek, CA 94598-
1698, USA 
hydroxyquinol 1,2-
dioxygenase 
CP005959.1 Corynebacterium glutamicum MB001, complete 
genome. 
Baumgart et al., Appl Environ Microbiol. 2013 
Oct;79(19):6006-15. doi: 10.1128/AEM.01634-13. Epub 
2013 Jul 26. 
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putative 
hydroxyquinol/catecho
l 1,2-dioxygenase 
HE802067.1 Corynebacterium glutamicum K051 complete 
genome, strain ATCC 13032, sub-strain K051. 
Binder et al., Genome Biol. 2012 May 28;13(5):R40. doi: 
10.1186/gb-2012-13-5-r40. 
Protocatechuate 3,4-
dioxygenase beta 
subunit 
BA000036.3 Corynebacterium glutamicum ATCC 13032 DNA, 
complete genome. 
Submitted (24-MAY-2002) Contact:Satoshi Nakagawa 
Kyowa Hakko Kogyo Co. Ltd., Tokyo Research 
Laboratories; 3-6-6, Asahi-machi, Machida, Tokyo 194-
8533, Japan 
CATECHOL 1,2-
DIOXYGENASE 
BX927157.1 Corynebacterium glutamicum ATCC 13032, IS 
fingerprint type 4-5,  complete genome; segment 
10/10. 
Kalinowski et al., J Biotechnol. 2003 Sep 4;104(1-3):5-
25. 
hydroxyquinol 1,2-
dioxygenase 
CP012194.1 Corynebacterium glutamicum strain CP, complete 
genome. 
Gui,Y., Ma,Y., Xie,X. and Chen,N. Submitted (30-JUL-
2015) Metabolic Engineering Laboratory, College 
            of Biotechnology, Tianjin University of Science 
and Technology, 13 
            Main Street, Tianjin Economic and Technological 
Development, 
            Tianjin, Tianjin 300457, China 
hydroxyquinol 1,2-
dioxygenase 
CP011309.1 [Brevibacterium] flavum strain ATCC 15168, 
complete genome. 
Ahn,J., Park,G., Jeon,W., Jang,Y., Jang,M., Lee,H. and 
Lee,H. Submitted (22-APR-2015) Biotechnology Process 
Engineering, KRIBB, 
            30 Yenongudanjo-ro, Ochang-eup, Cheongwon-
gu, Cheong-joo 363-883, 
            Republic of Korea 
 
hydroxyquinol 1,2-
dioxygenase 
CP010451.1 Corynebacterium glutamicum strain B253, complete 
genome. 
Wu et al., J Biotechnol. 2015 Aug 10;207:10-1. doi: 
10.1016/j.jbiotec.2015.04.018. Epub 2015 May 4. 
hypothetical protein AP009044.1 Corynebacterium glutamicum R DNA, complete 
genome. 
Yukawa et al., Microbiology. 2007 Apr;153(Pt 4):1042-
58. 
hydroxyquinol 1,2-
dioxygenase 
CP013991.1 Corynebacterium glutamicum strain USDA-ARS-
USMARC-56828, complete 
Harhay et al Submitted (19-JAN-2016) Genetics, 
Breeding, and Animal Health 
            Research Unit, USDA-ARS-USMARC, PO BOX 166, 
Clay Center, NE 68933, 
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            USA 
COG3485 
Protocatechuate 3,4-
dioxygenase beta 
subunit 
CP004048.1 Corynebacterium glutamicum SCgG2, complete 
genome. 
Pei,G., Sun,J. and Zheng,P. Submitted (16-JAN-2013) 
Laboratory of System&Synthetic 
            Biotechnology, Tianjin Institute of Industrial 
Biotechnology, 
            Chinese Academy of Sciences, N0.32,West 7 
Road, Tianjin Airport 
            Economic Park, TianJin, TianJin 300308, China 
Protocatechuate 3,4-
dioxygenase beta 
subunit 
CP004047.1 Corynebacterium glutamicum SCgG1, complete 
genome. 
Pei,G., Sun,J. and Zheng,P. 
Submitted (16-JAN-2013) Laboratory of 
System&Synthetic Biotechnology, Tianjin Institute of 
Industrial Biotechnology, 
            Chinese Academy of Sciences, N0.32,West 7 
Road, Tianjin Airport 
            Economic Park, TianJin, TianJin 300308, China 
hydroxyquinol 1,2-
dioxygenase 
CP007724.1 Corynebacterium glutamicum strain AR1, complete 
genome. 
Park et al Nat Commun. 2014 Aug 5;5:4618. doi: 
10.1038/ncomms5618. 
hydroxyquinol 1,2-
dioxygenase 
CP007722.1 Corynebacterium glutamicum strain ATCC 21831, 
complete genome. 
Park et al., Submitted (13-MAY-2014) BioInformatics 
Research Center, KAIST, 
            Daejeon 305-701, Republic of Korea 
catechol 1,2-
dioxygenase 
CP007569.1 Bradyrhizobium japonicum SEMIA 5079 genome. Siqueira et al BMC Genomics. 2014 Jun 3;15:420. doi: 
10.1186/1471-2164-15-420.  
catechol 1,2-
dioxygenase 
AP014685.1 Bradyrhizobium diazoefficiens DNA, complete 
genome, strain: NK6. 
Lida et al., Appl Environ Microbiol. 2015 Jun 
15;81(12):4143-54. doi: 10.1128/AEM.00741-15. Epub 
2015 Apr 10. 
catechol 1,2-
dioxygenase 
BA000040.2a Bradyrhizobium japonicum USDA 110 DNA, 
complete genome. 
Kaneko et al., DNA Res. 2002 Dec 31;9(6):189-97. 
catechol 1,2-
dioxygenase 
AP012206.1a Bradyrhizobium japonicum USDA 6 DNA, complete 
genome. 
Kaneko et al., Genes (Basel). 2011 Oct 28;2(4):763-87. 
doi: 10.3390/genes2040763. 
catechol 1,2-
dioxygenase 
CP010313.1a Bradyrhizobium japonicum strain E109, complete 
genome. 
Torres et al., Genome Announc. 2015 Feb 19;3(1). pii: 
e01566-14. doi: 10.1128/genomeA.01566-14. 
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catechol 1,2-
dioxygenase 
CP013949.1 Bradyrhizobium sp. CCGE-LA001, complete genome. Servín-Garcidueñas et al., Mol Phylogenet Evol. 2014 
Oct;79:1-11. doi: 10.1016/j.ympev.2014.06.006. Epub 
2014 Jun 18. 
catechol 1,2-
dioxygenase 
CU234118.1 Bradyrhizobium sp. ORS278,complete sequence. Giraud et al., Science. 2007 Jun 1;316(5829):1307-12. 
catechol 1,2-
dioxygenase 
BA000040.2b Bradyrhizobium japonicum USDA 110 DNA, 
complete genome. 
Kaneko et al., DNA Res. 2002 Dec 31;9(6):189-97. 
catechol 1,2-
dioxygenase 
AP012206.1b Bradyrhizobium japonicum USDA 6 DNA, complete 
genome. 
Kaneko et al., Genes (Basel). 2011 Oct 28;2(4):763-87. 
doi: 10.3390/genes2040763. 
catechol 1,2-
dioxygenase 
CP010313.1b Bradyrhizobium japonicum strain E109, complete 
genome. 
Torres et al., Genome Announc. 2015 Feb 19;3(1). pii: 
e01566-14. doi: 10.1128/genomeA.01566-14. 
catechol 1,2-
dioxygenase 
CP000494.1 Bradyrhizobium sp. BTAi1, complete genome. Giraud et al., Science. 2007 Jun 1;316(5829):1307-12. 
catechol 1,2-
dioxygenase 
AP012603.1 Bradyrhizobium oligotrophicum S58 DNA, complete 
genome. 
Okubo et al., Appl Environ Microbiol. 2013 
Apr;79(8):2542-51. doi: 10.1128/AEM.00009-13. Epub 
2013 Feb 8. 
catechol 1,2-
dioxygenase 
AP014704.1 Methylobacterium aquaticum DNA, complete 
genome, strain: MA-22A. 
Tani et al., Genome Announc 3 (2), e00266-15 (2015) 
TesB (meta-cleavage 
enzyme, 2,3-
Dihydroxybiphenyl-
1,2-dioxygenase) 
AB040808 Comamonas testosteroni tesB, ORF1, ORF2, ORF3 
genes, complete cds. 
Horinouchi,M Microbiology (Reading, Engl.) 147 (PT 
12), 3367-3375 (2001) 
homogentisate 1,2-
dioxygenase (1) 
NZ_AKCL0100
0092 
Pseudomonas putida SJTE-1 contig000092, whole 
genome shotgun sequence. 
Liang,R J. Bacteriol. 194 (17), 4781-4782 (2012) 
protocatechuate 3,4-
dioxygenase alpha 
chain (2) 
NZ_AKCL0100
0092 
Pseudomonas putida SJTE-1 contig000092, whole 
genome shotgun sequence. 
Liang,R J. Bacteriol. 194 (17), 4781-4782 (2012) 
protocatechuate 3,4-
dioxygenase subunit 
beta (3) 
NZ_AKCL0100
0092  
Pseudomonas putida SJTE-1 contig000092, whole 
genome shotgun sequence. 
Liang,R J. Bacteriol. 194 (17), 4781-4782 (2012) 
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benzoate 1,2-
dioxygenase subunit 
beta 
NZ_AKCL0100
0002 
Pseudomonas putida SJTE-1 contig000002, whole 
genome shotgun sequence. 
Liang,R J. Bacteriol. 194 (17), 4781-4782 (2012) 
benzoate 1,2-
dioxygenase subunit 
alpha 
NZ_AKCL0100
0002  
Pseudomonas putida SJTE-1 contig000002, whole 
genome shotgun sequence. 
Liang,R J. Bacteriol. 194 (17), 4781-4782 (2012) 
taurine dioxygenase NZ_AKCL0100
0007 
Pseudomonas putida SJTE-1 contig000007, whole 
genome shotgun sequence. 
Liang,R J. Bacteriol. 194 (17), 4781-4782 (2012) 
4-
hydroxyphenylpyruvat
e dioxygenase 
NZ_AKCL0100
0201 
Pseudomonas putida SJTE-1 contig000201, whole 
genome shotgun sequence. 
Liang,R J. Bacteriol. 194 (17), 4781-4782 (2012) 
quercetin 2,3-
dioxygenase 
NZ_AKCL0100
0201 
Pseudomonas putida SJTE-1 contig000201, whole 
genome shotgun sequence. 
Liang,R J. Bacteriol. 194 (17), 4781-4782 (2012) 
alpha-ketoglutarate-
dependent 
dioxygenase 
NZ_AKCL0100
0201 
Pseudomonas putida SJTE-1 contig000201, whole 
genome shotgun sequence. 
Liang,R J. Bacteriol. 194 (17), 4781-4782 (2012) 
protocatechuate 4,5-
dioxygenase subunit 
alpha 
NZ_AKCL0100
0023  
Pseudomonas putida SJTE-1 contig000023, whole 
genome shotgun sequence. 
Liang,R J. Bacteriol. 194 (17), 4781-4782 (2012) 
Extradiol ring-cleavage 
dioxygenase III subunit 
B. 
NZ_AKCL0100
0055 
Pseudomonas putida SJTE-1 contig000055, whole 
genome shotgun sequence. 
Liang,R J. Bacteriol. 194 (17), 4781-4782 (2012) 
4-
hydroxyphenylpyruvat
e dioxygenase 
NZ_AKCL0100
0022 
Pseudomonas putida SJTE-1 contig000022, whole 
genome shotgun sequence. 
Liang,R J. Bacteriol. 194 (17), 4781-4782 (2012) 
2-nitropropane 
dioxygenase 
NZ_AKCL0100
0190 
Pseudomonas putida SJTE-1 contig000190, whole 
genome shotgun sequence. 
Liang,R J. Bacteriol. 194 (17), 4781-4782 (2012) 
2-nitropropane 
dioxygenase 
NZ_AKCL0100
0135  
Pseudomonas putida SJTE-1 contig000135, whole 
genome shotgun sequence. 
Liang,R J. Bacteriol. 194 (17), 4781-4782 (2012) 
taurine dioxygenase NZ_AKCL0100
0081 
Pseudomonas putida SJTE-1 contig000081, whole 
genome shotgun sequence. 
Liang,R J. Bacteriol. 194 (17), 4781-4782 (2012) 
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DOPA 4,5-dioxygenase NZ_AKCL0100
0071 
Pseudomonas putida SJTE-1 contig000071, whole 
genome shotgun sequence. 
Liang,R J. Bacteriol. 194 (17), 4781-4782 (2012) 
taurine dioxygenase NZ_AKCL0100
0071  
Pseudomonas putida SJTE-1 contig000071, whole 
genome shotgun sequence. 
Liang,R J. Bacteriol. 194 (17), 4781-4782 (2012) 
ring-cleaving 
dioxygenase 
NZ_AKCL0100
0205 
Pseudomonas putida SJTE-1 contig000205, whole 
genome shotgun sequence. 
Liang,R J. Bacteriol. 194 (17), 4781-4782 (2012) 
phytanoyl-CoA 
dioxygenase 
NZ_AFMP010
00051 
Sphingomonas sp. KC8 contig50, whole genome 
shotgun sequence. 
Hu,A. J. Bacteriol. 193 (16), 4266-4267 (2011) 
dioxygenase NZ_AFMP010
00051 
Sphingomonas sp. KC8 contig50, whole genome 
shotgun sequence. 
Hu,A. J. Bacteriol. 193 (16), 4266-4267 (2011) 
dioxygenase NZ_AFMP010
00044  
Sphingomonas sp. KC8 contig43, whole genome 
shotgun sequence. 
Hu,A. J. Bacteriol. 193 (16), 4266-4267 (2011) 
dioxygenase NZ_AFMP010
00039 
Sphingomonas sp. KC8 contig38, whole genome 
shotgun sequence. 
Hu,A. J. Bacteriol. 193 (16), 4266-4267 (2011) 
4-
hydroxyphenylpyruvat
e dioxygenase 
NZ_AFMP010
00011 
Sphingomonas sp. KC8 contig11, whole genome 
shotgun sequence. 
Hu,A. J. Bacteriol. 193 (16), 4266-4267 (2011) 
homogentisate 1,2-
dioxygenase 
NZ_AFMP010
00011 
Sphingomonas sp. KC8 contig11, whole genome 
shotgun sequence. 
Hu,A. J. Bacteriol. 193 (16), 4266-4267 (2011) 
2-nitropropane 
dioxygenase 
NZ_AFMP010
00011 
Sphingomonas sp. KC8 contig11, whole genome 
shotgun sequence. 
Hu,A. J. Bacteriol. 193 (16), 4266-4267 (2011) 
phytanoyl-CoA 
dioxygenase 
NZ_AFMP010
00016 
Sphingomonas sp. KC8 contig16, whole genome 
shotgun sequence. 
Hu,A. J. Bacteriol. 193 (16), 4266-4267 (2011) 
phytanoyl-CoA 
dioxygenase 
NZ_AFMP010
00016 
Sphingomonas sp. KC8 contig16, whole genome 
shotgun sequence. 
Hu,A. J. Bacteriol. 193 (16), 4266-4267 (2011) 
taurine dioxygenase NZ_AFMP010
00016 
Sphingomonas sp. KC8 contig16, whole genome 
shotgun sequence. 
Hu,A. J. Bacteriol. 193 (16), 4266-4267 (2011) 
2-nitropropane 
dioxygenase 
NZ_AFMP010
00016 
Sphingomonas sp. KC8 contig16, whole genome 
shotgun sequence. 
Hu,A. J. Bacteriol. 193 (16), 4266-4267 (2011) 
2-nitropropane 
dioxygenase 
NZ_AFMP010
00031 
Sphingomonas sp. KC8 contig31, whole genome 
shotgun sequence. 
Hu,A. J. Bacteriol. 193 (16), 4266-4267 (2011) 
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2-nitropropane 
dioxygenase 
NZ_AFMP010
00031 
Sphingomonas sp. KC8 contig31, whole genome 
shotgun sequence. 
Hu,A. J. Bacteriol. 193 (16), 4266-4267 (2011) 
glyoxalase/bleomycin 
resistance/protein/dio
xygenase 
NZ_AFMP010
00031 
Sphingomonas sp. KC8 contig31, whole genome 
shotgun sequence. 
Hu,A. J. Bacteriol. 193 (16), 4266-4267 (2011) 
biphenyl 2,3-
dioxygenase 
NZ_AFMP010
00036 
Sphingomonas sp. KC8 contig35, whole genome 
shotgun sequence. 
Hu,A. J. Bacteriol. 193 (16), 4266-4267 (2011) 
Rieske-type ring 
hydroxylating 
dioxygenase beta 
subunit 
NZ_AFMP010
00026 
Sphingomonas sp. KC8 contig26, whole genome 
shotgun sequence. 
Hu,A. J. Bacteriol. 193 (16), 4266-4267 (2011) 
aromatic ring-cleaving 
dioxygenase 
NZ_AFMP010
00004 
Sphingomonas sp. KC8 contig04, whole genome 
shotgun sequence. 
Hu,A. J. Bacteriol. 193 (16), 4266-4267 (2011) 
2-nitropropane 
dioxygenase 
NZ_AFMP010
00059 
Sphingomonas sp. KC8 contig58, whole genome 
shotgun sequence. 
Hu,A. J. Bacteriol. 193 (16), 4266-4267 (2011) 
glyoxalase/bleomycin 
resistance/protein/dio
xygenase 
NZ_AFMP010
00009 
Sphingomonas sp. KC8 contig09, whole genome 
shotgun sequence. 
Hu,A. J. Bacteriol. 193 (16), 4266-4267 (2011) 
tryptophan 2 3-
dioxygenase 
NZ_AFMP010
00035 
Sphingomonas sp. KC8 contig70, whole genome 
shotgun sequence. 
Hu,A. J. Bacteriol. 193 (16), 4266-4267 (2011) 
alpha-ketoglutarate-
dependent 
dioxygenase 
NZ_AFMP010
00032 
Sphingomonas sp. KC8 contig32, whole genome 
shotgun sequence. 
Hu,A. J. Bacteriol. 193 (16), 4266-4267 (2011) 
dioxygenase beta 
subunit 
NZ_AFMP010
00019 
Sphingomonas sp. KC8 contig19, whole genome 
shotgun sequence. 
Hu,A. J. Bacteriol. 193 (16), 4266-4267 (2011) 
glyoxalase/bleomycin 
resistance/protein/dio
xygenase 
NZ_AFMP010
00040 
Sphingomonas sp. KC8 contig39, whole genome 
shotgun sequence. 
Hu,A. J. Bacteriol. 193 (16), 4266-4267 (2011) 
3-hydroxyanthranilate 
3,4-dioxygenase 
NZ_AFMP010
00040 
Sphingomonas sp. KC8 contig39, whole genome 
shotgun sequence. 
Hu,A. J. Bacteriol. 193 (16), 4266-4267 (2011) 
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glyoxalase/bleomycin 
resistance/protein/dio
xygenase 
NZ_AFMP010
00013 
Sphingomonas sp. KC8 contig13, whole genome 
shotgun sequence. 
Hu,A. J. Bacteriol. 193 (16), 4266-4267 (2011) 
protocatechuate 3,4-
dioxygenase 
NC_008314 Ralstonia eutropha H16 chromosome 2. Pohlmann, A Nat. Biotechnol. 24 (10), 1257-1262 
(2006) 
protocatechuate 3,4-
dioxygenase 
NC_008313  Ralstonia eutropha H16 chromosome 1. Pohlmann, A Nat. Biotechnol. 24 (10), 1257-1262 
(2006) 
hydroxyquinol 1,2-
dioxygenase 
NZ_KI421499 Bradyrhizobium genosp. SA-4 str. CB756 
BrageDRAFT_scaffold1.1, 
Kyrpides Submitted (23-AUG-2013) DOE Joint Genome 
Institute, 2800 Mitchell 
            Drive, Walnut Creek, CA 94598-1698, USA 
protocatechuate 
dioxygenase 
NC_008268 Rhodococcus jostii RHA1, complete genome. McLeod Submitted (24-JUL-2006) Microbiology and 
Immunology, University of British Columbia, 1365-2350 
Health Sciences Mall, Vancouver, BC V6T 
            1Z3, Canada 
TesB LC010134 Comamonas testosteroni DNA, putative mega-
cluster of steroid degradation genes, strain: T441 
Hourinochi Microbiology (Reading, Engl.) 147 (PT 12), 
3367-3375 (2001) 
biphenyl-2,3-diol-1,2-
dioxygenase 
CP001220 Comamonas testosteroni CNB-2, complete genome. Ma Appl. Environ. Microbiol. 75 (21), 6812-6819 (2009) 
biphenyl-2,3-diol-1,2-
dioxygenase 
AF493052 Comamonas testosteroni biphenyl-2,3-diol-1,2-
dioxygenase gene, complete cds. 
Skowasch Biochem. Biophys. Res. Commun. 294 (3), 
560-566 (2002) 
biphenyl 2,3-
dioxygenase 
CP006704 Comamonas testosteroni TK102, complete genome. Fukuda Genome Announc 2 (5), e00865-14 (2014) 
Dioxygenase JF502261 Rhodococcus sp. R04 dioxygenase gene, complete 
cds. 
Yang Submitted (27-FEB-2011) Department of 
Biotechnology, Institution of 
            Enzyme, Wucheng Road, Taiyuan, Shanxi 
030006, China 
protocatechuate 3,4-
dioxygenase 
NC_013446 Comamonas testosteroni CNB-2, complete genome. Ma  Appl. Environ. Microbiol. 75 (21), 6812-6819 (2009) 
protocatechuate 3,4-
dioxygenase subunit 
beta 
NC_013446  Comamonas testosteroni CNB-2, complete genome. Ma Appl. Environ. Microbiol. 75 (21), 6812-6819 (2009) 
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protocatechuate 4,5-
dioxygenase subunit 
alpha 
NC_010002 Delftia acidovorans SPH-1, complete genome. Schleheck Appl. Environ. Microbiol. 70 (7), 4053-4063 
(2004) 
protocatechuate 3,4-
dioxygenase subunit 
beta 
NC_010002 Delftia acidovorans SPH-1, complete genome. Schleheck Appl. Environ. Microbiol. 70 (7), 4053-4063 
(2004) 
protocatechuate 3,4-
dioxygenase subunit 
beta 
NC_003450 Corynebacterium glutamicum ATCC 13032 
chromosome, complete genome. 
Silberbach Appl. Environ. Microbiol. 71 (5), 2391-2402 
(2005) 
Ikeda Appl. Microbiol. Biotechnol. 62 (2-3), 99-109 
(2003) 
protocatechuate 3,4-
dioxygenase subunit 
beta 
NC_010002  Delftia acidovorans SPH-1, complete genome. Schleheck Appl. Environ. Microbiol. 70 (7), 4053-4063 
(2004) 
protocatechuate 3,4-
dioxygenase subunit 
beta 
NC_012586  Sinorhizobium fredii NGR234 plasmid pNGR234b, 
complete sequence. 
Schmeisser Appl. Environ. Microbiol. 75 (12), 4035-
4045 (2009) 
Streit J. Bacteriol. 186 (2), 535-542 (2004) 
protocatechuate 3,4-
dioxygenase 
NC_008314 Ralstonia eutropha H16 chromosome 2. Pohlmann, A Nat. Biotechnol. 24 (10), 1257-1262 
(2006) 
protocatechuate 3,4-
dioxygenase subunit 
alpha 
NC_020800 Xanthomonas axonopodis Xac29-1, complete 
genome. 
Chen Submitted (15-MAR-2013) School of Agriculture 
and Biology, Shanghai 
            Jiao Tong University, 800 Dongchuan Road, 
Shanghai, Shanghai 
            200240, China 
protocatechuate 3,4-
dioxygenase subunit 
beta 
NC_020800 Xanthomonas axonopodis Xac29-1, complete 
genome. 
Chen Submitted (15-MAR-2013) School of Agriculture 
and Biology, Shanghai 
            Jiao Tong University, 800 Dongchuan Road, 
Shanghai, Shanghai 
            200240, China 
protocatechuate 3,4-
dioxygenase subunit 
beta 
NC_006834 Xanthomonas oryzae pv. oryzae KACC 10331, 
complete genome. 
Park  Submitted (23-SEP-2004) National Institute of 
Agricultural 
            Biotechnology, Rural Development 
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Administration, 225 Seodundong, 
            Suwon 441-707, Republic of Korea 
protocatechuate 3,4-
dioxygenase 
NZ_HG938353 Neorhizobium galegae, complete genome. Osterman BMC Genomics 15, 500 (2014) 
protocatechuate 3,4-
dioxygenase 
NC_013446 Comamonas testosteroni CNB-2, complete genome. Ma  Appl. Environ. Microbiol. 75 (21), 6812-6819 (2009) 
protocatechuate 4,5-
dioxygenase subunit 
alpha 
NC_010002 Delftia acidovorans SPH-1, complete genome. Schleheck Appl. Environ. Microbiol. 70 (7), 4053-4063 
(2004) 
protocatechuate 3,4-
dioxygenase subunit 
beta 
NC_010002 Delftia acidovorans SPH-1, complete genome. Schleheck Appl. Environ. Microbiol. 70 (7), 4053-4063 
(2004) 
protocatechuate 3,4-
dioxygenase subunit 
beta 
NC_003450 Corynebacterium glutamicum ATCC 13032 
chromosome, complete genome. 
Silberbach Appl. Environ. Microbiol. 71 (5), 2391-2402 
(2005) 
protocatechuate 3,4-
dioxygenase subunit 
beta 
NC_010002  Delftia acidovorans SPH-1, complete genome. Schleheck Appl. Environ. Microbiol. 70 (7), 4053-4063 
(2004) 
protocatechuate 3,4-
dioxygenase subunit 
beta 
NC_012586  Sinorhizobium fredii NGR234 plasmid pNGR234b, 
complete sequence. 
Schmeisser Appl. Environ. Microbiol. 75 (12), 4035-
4045 (2009) 
protocatechuate 3,4-
dioxygenase 
NC_008314 Ralstonia eutropha H16 chromosome 2. Pohlmann, A Nat. Biotechnol. 24 (10), 1257-1262 
(2006) 
protocatechuate 3,4-
dioxygenase subunit 
alpha 
NC_020800 Xanthomonas axonopodis Xac29-1, complete 
genome. 
Chen Submitted (15-MAR-2013) School of Agriculture 
and Biology, Shanghai 
            Jiao Tong University, 800 Dongchuan Road, 
Shanghai, Shanghai 
            200240, China 
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protocatechuate 3,4-
dioxygenase subunit 
beta 
NC_020800 Xanthomonas axonopodis Xac29-1, complete 
genome. 
Chen Submitted (15-MAR-2013) School of Agriculture 
and Biology, Shanghai 
            Jiao Tong University, 800 Dongchuan Road, 
Shanghai, Shanghai 
            200240, China 
protocatechuate 3,4-
dioxygenase subunit 
beta 
NC_006834 Xanthomonas oryzae pv. oryzae KACC 10331, 
complete genome. 
Park  Submitted (23-SEP-2004) National Institute of 
Agricultural 
            Biotechnology, Rural Development 
Administration, 225 Seodundong, 
            Suwon 441-707, Republic of Korea 
protocatechuate 3,4-
dioxygenase 
NZ_HG938353 Neorhizobium galegae, complete genome. Osterman BMC Genomics 15, 500 (2014) 
reductase  U49504 Pseudomonas sp. Parales et al., Gene 181 (1-2), 57-61 (1996) 
Dioxygenase AF252550 Comamonas testosteroni Moser and Stahl Appl. Microbiol. Biotechnol. 55 (5), 
609-618 (2001) 
dox operon 
(doxABCDEFGHIJ) 
genes 
M60405 Pseudomonas sp. Denome et al., J. Bacteriol. 175 (21), 6890-6901 (1993) 
naphthalene 
dioxygenase  
U49496 Pseudomonas sp Parales et al., Gene 181 (1-2), 57-61 (1996) 
naphthalene 
dioxygenase  
AF004284 Pseudomonas putida  Hamann Submitted (14-MAY-1997) Biologie, 
Universitat Bremen, Leobener 
            Strasse, Bremen 28359, Germany 
naphthalene 
dioxygenase (nahAc) 
gene 
AY048759 Pseudomonas fluorescens Min and Ji Submitted (26-OCT-2001) Biological Science, 
Sookmyung Women's 
            University, Chungpa-Dong 2-Ka, Yongsan-Ku, 
Seoul 140-742, Korea 
Dioxygenase AB004059 Pseudomonas putida Takizawa et al., J. Bacteriol. 176 (8), 2444-2449 (1994) 
naphthalene 
dioxygenase 
M83949 Pseudomonas putida Simon et al., Gene 127 (1), 31-37 (1993) 
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naphthalene 
dioxygenase 
AF039533 Pseudomonas stutzeri Bosch et al., Submitted (19-DEC-1997) Microbiology, 
Universitat Illes Balears,             Carretera Valldemossa 
km. 7.5, Palma de Mallorca, Balearic Islands 07071, 
Spain 
naphthalene 
dioxygenase 
M23914 Pseudomonas putida Kurkela et al., Gene 73 (2), 355-362 (1988) 
naphthalene 
dioxygenase 
AB255564 uncultured bacterium Ono et al., Appl. Microbiol. Biotechnol. 74 (2), 501-510 
(2007) 
naphthalene 
dioxygenase 
AF004283 Pseudomonas fluorescens Hamann Submitted (14-MAY-1997) Biologie, 
Universitat Bremen, Leobener 
            Strasse, Bremen 28359, Germany 
naphthalene 
dioxygenase 
D84146 Pseudomonas aeruginosa Takizawa et al., Submitted (21-MAR-1996) Noboru 
TAKIZAWA, Okayama University of 
            Science, Applied Chemistry; 1-1 Ridai-cho, 
Okayama, Okayama 700,  JAPAN  
nitrobenzene 
dioxygenase  
AF379638 Comamonas sp. JS765 Lessner et al., Appl. Environ. Microbiol. 68 (2), 634-641 
(2002) 
naphthalene 
dioxygenase 
DQ846881 Rhodococcus opacus  Di Gennaro et al., Appl. Microbiol. Biotechnol. 87 (1), 
297-308 (2010) 
aromatic dioxygenase AF121905 Rhodococcus sp. I24 Treadway et al., Submitted (21-JAN-1999) Department 
of Biology, Massachusetts 
            Institute of Technology, 77 Massachusetts Ave., 
Bldg 68-370, Cambridge, MA 02139, USA 
naphthalene 
dioxygenase 
AY392424 Rhodococcus sp. P200 Kulakov et al., Appl. Environ. Microbiol. 71 (4), 1754-
1764 (2005) 
naphthalene 
dioxygenase 
AY392423 Rhodococcus sp. P400 Kulakov et al., Appl. Environ. Microbiol. 71 (4), 1754-
1764 (2005) 
o-xylene oxygenase 
gene 
AB206671 Rhodococcus opacus TKN14 Maryuma et al., Appl. Environ. Microbiol. 71 (12), 7705-
7715 (2005) 
NidA (nidA) gene AY330100 Mycobacterium sp. KMS Miller et al., Microb. Ecol. 48 (2), 230-238 (2004) 
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dioxygenase large 
alpha subunit (nidA) 
gene 
DQ537942 Mycobacterium gilvum strain czh-101  Hennessee and Li Submitted (10-MAY-2006) MBBE, UH, 
1955 East-West Rd #402, Honolulu, 
            HI 96822, USA 
dioxygenase large 
alpha subunit (nidA) 
gene 
AF548343 Mycobacterium flavescens strain PYR-GCK  Brezna et al., Submitted (25-SEP-2002) Microbiology 
Division, USFDA/NCTR, 3900 
            NCTR Rd., Jefferson, AR 72079, USA 
Iron-sulfur protein 
large subunit 
AB017794 Nocardioides sp. Saito et al., Chemosphere 38 (6), 1331-1337 (1999) 
dioxygenase EF026099 Mycobacterium sp. SNP11 Pagnaut et al., Res. Microbiol. 158 (2), 175-186 (2007) 
dioxygenase DQ358754 Mycobacterium sp. CH-1 Morgan and Churchill Submitted (10-JAN-2006) 
Biological Sciences, University of Alabama, 
            Hackberry Lane, Tuscaloosa, AL 35487-0344, 
USA 
extradiol dioxygenase DQ157862 Mycobacterium sp. CH-2  Morgan and Churchill Submitted (08-AUG-2005) 
Department of Biology, University of 
            Alabama, Hackberry Lane, Tuscaloosa, AL 35487-
0344, USA 
biphenyl dioxygenase AB113649 Bacillus sp. JF8 Mukerjee-Dhar et al., Microbiology (Reading, Engl.) 151 
(PT 12), 4139-4151 (2005) 
Ring hydroxylating 
dioxygenase 
AJ494743 Mycobacterium sp. 6PY1 Krivobok et al., J. Bacteriol. 185 (13), 3828-3841 (2003) 
extradiol dioxygenase AB031319 Nocardioides sp. KP7  Saito et al., J. Bacteriol. 182 (8), 2134-2141 (2000) 
NidB DQ157863 Mycobacterium sp. CH-2  Morgan and Churchill Submitted (08-AUG-2005) 
Department of Biology, University of 
            Alabama, Hackberry Lane, Tuscaloosa, AL 35487-
0344, USA 
NidA (nidA) gene AF548345 Mycobacterium frederiksbergense strain FAn9T Brezna et al.,  Submitted (25-SEP-2002) Microbiology 
Division, USFDA/NCTR, 3900 
            NCTR Rd., Jefferson, AR 72079, USA 
phthalate dioxygenase  AY365117 Mycobacterium vanbaalenii strain PYR-1 Stingley et al., Biochem. Biophys. Res. Commun. 322 
(1), 133-146 (2004) 
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naphthalene inducible 
dioxygenase 
AF249301 Mycobacterium sp. PYR-1 Khan et al., Appl. Environ. Microbiol. 67 (8), 3577-3585 
(2001) 
NidA (nidA) gene DQ537941 Mycobacterium pallens strain czh-8 Hennessee and Li Int. J. Syst. Evol. Microbiol. 59 (PT 2), 
378-387 (2009) 
dioxygenase DQ358753 Mycobacterium sp. CH-1  Morgan and Churchill Submitted (10-JAN-2006) 
Biological Sciences, University of Alabama, Hackberry 
Lane, Tuscaloosa, AL 35487-0344, USA 
NidA and NidB AY330098 Mycobacterium sp. JLS Miller et al., Microb. Ecol. 48 (2), 230-238 (2004) 
NidA AB179737 Mycobacterium sp. MHP-1 Habe et al J. Biosci. Bioeng. 98 (4), 306-308 (2004) 
nidA AF548347 Mycobacterium gilvum strain BB1 Brezna et al., Submitted (25-SEP-2002) Microbiology 
Division, USFDA/NCTR, 3900 
            NCTR Rd., Jefferson, AR 72079, USA 
pdoA1 AJ494745 Mycobacterium sp. 6PY1  Krivobok et al., J. Bacteriol. 185 (13), 3828-3841 (2003) 
NidA AY330102 Mycobacterium sp. MCS Miller et al., Microb. Ecol. 48 (2), 230-238 (2004) 
dioxygenase AF546905 Mycobacterium sp. S65 Sho et al., FEMS Microbiol. Ecol. 48 (2), 209-220 (2004) 
dioxygenase AJ536756 Ralstonia oxalatica transposon Tn4371. Toussaint et al., Appl. Environ. Microbiol. 69 (8), 4837-
4845 (2003) 
biphenyl dioxygenase AB086835 Comamonas testosteroni  Hiraoka et al., Appl. Environ. Microbiol. 68 (10), 5104-
5112 (2002) 
biphenyl dioxygenase U47637 Pandoraea pnomenusa strain B-356 Sylvestre et al., Gene 174 (2), 195-202 (1996) 
biphenyl dioxygenase M83673 Pseudomonas pseudoalcaligenes KF707 Taira et al., J. Biol. Chem. 267 (7), 4844-4853 (1992) 
biphenyl dioxygenase AY027651 Pseudomonas sp. Cam-1  Master and Mohn Appl. Environ. Microbiol. 67 (6), 
2669-2676 (2001) 
biphenyl dioxygenase M86348 Paraburkholderia xenovorans LB400 Erickson and Mondello J. Bacteriol. 174 (9), 2903-2912 
(1992) 
biphenyl dioxygenase U95054 Pseudomonas sp. B4  Ducrocq and Truffaut Submitted (25-MAR-1997) 
Laboratoire de Genetique Microbienne,            
Universite de Technologie de Compiegne, Centre de 
Recherche de Royallieu BP529, Compiegne 60205, 
France 
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biphenyl dioxygenase AF049345 Pseudomonas pseudoalcaligenes Taira et al., J. Biol. Chem. 267 (7), 4844-4853 (1992) 
biphenyl dioxygenase AJ010057 Burkholderia sp. JB1  Dignum Submitted (04-AUG-1998) Dignum M., 
Laboratory of Microbiology, 
            University of Amsterdam, Nieuwe Achtergracht 
127, Amsterdam, 
            NL-1018 WS, THE NETHERLANDS 
terpA EF527236 Rhodococcus sp. L4 Suttinun and Luepromchai Submitted (28-MAR-2007) 
Department of Microbiology, Faculty of Science, 
Chulalongkorn University, Bangkok 10330, Thailand 
dioxygenase Y18245 Pseudomonas putida Mosqueda et al., Gene 232 (1), 69-76 (1999) 
benzene dioxygenase M17904 Pseudomonas putida Irie et al., J. Bacteriol. 169 (11), 5174-5179 (1987) 
biphenyl dioxygenase AJ251217 Pseudomonas sp. B4  Rodarie et al., Submitted (03-DEC-1999) Rodarie D., 
DBMS / BBSI, CEA Grenoble, 17 avenue des Martyrs, 
38054 Grenoble cedex 09, FRANCE 
dioxygenase AY831463 Pseudomonas putida strain GJ31 Kunze et al., Microbiology (Reading, Engl.) 155 (PT 12), 
4069-4083 (2009) 
toluene dioxygenase J04996 Pseudomonas putida Zylstra and Gibson J. Biol. Chem. 264 (25), 14940-14946 
(1989) 
dioxygenase AJ006307 Ralstonia sp. JS705 van der Meer Appl. Environ. Microbiol. 64 (11), 4185-
4193 (1998) 
dioxygenase  U15298 Pseudomonas sp. Werlen et al., J. Biol. Chem. 271 (8), 4009-4016 (1996) 
chlorobenzene 
dioxygenase 
U78099 Burkholderia sp. PS12 Beil et al., Eur. J. Biochem. 247 (1), 190-199 (1997) 
cumene dioxygenase D37828 Pseudomonas fluorescens Aoki et al., J. Ferment. Bioeng. 81, 187-196 (1996) 
ethylbenzene 
dioxygenase 
AF049851 Pseudomonas fluorescens Corkery and Dobson FEMS Microbiol. Lett. 166 (2), 171-
176 (1998) 
dioxygenase U53507 Pseudomonas JR1 Pflugmacher et al., Appl. Environ. Microbiol. 62 (11), 
3967-3977 (1996) 
dioxygenase AJ293587 Pseudomonas putida Chablain et al., Res. Microbiol. 148 (2), 153-161 (1997) 
dioxygenase AF006691 Pseudomonas putida Eaton and Timmis J. Bacteriol. 168 (1), 123-131 (1986) 
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dioxygenase AB048707 Rhodococcus sp. RHA1 Kitagawa et al., Biosci. Biotechnol. Biochem. 65 (8), 
1907-1911 (2001) 
dioxygenase AB120955 Rhodococcus sp. RHA1 Iwasaki et al., Submitted (24-SEP-2003) Takumi Iwasaki, 
Nagaoka University of Technology, Department of 
Bioengineering; Kamitomioka, Nagaoka, 
Niigata 940-2188, Japan  
dioxygenase AB120956 Rhodococcus sp. RHA1 Iwasaki et al., Submitted (24-SEP-2003) Takumi Iwasaki, 
Nagaoka University of Technology, Department of 
Bioengineering; Kamitomioka, Nagaoka, Niigata 940-
2188, Japan 
dioxygenase AB048708 Rhodococcus sp. RHA1 Kitagawa et al., Biosci. Biotechnol. Biochem. 65 (8), 
1907-1911 (2001) 
terminal dioxygenase U27591 Rhodococcus sp. M5 Wang et al., Gene 164 (1), 117-122 (1995) 
dioxygenase X80041 Rhodococcus globerulus Asturias et al., Gene 156 (1), 11-18 (1995) 
dioxygenase D32142 Rhodococcus sp. RHA1 Masai et al., Appl. Environ. Microbiol. 61 (6), 2079-2085 
(1995) 
isopropylbenzene 2,3-
dioxygenase 
U24277 Rhodococcus erythropolis Kesseler et al., Microbiology (Reading, Engl.) 142 (PT 
11), 3241-3251 (1996) 
terminal dioxygenase D88020 Rhodococcus erythropolis  Kosono et al., Appl. Environ. Microbiol. 63 (8), 3282-
3285 (1997) 
biphenyl dioxygenase EF152282 Sphingobium yanoikuyae Chadhain et al., J. Ind. Microbiol. Biotechnol. 34 (9), 
605-613 (2007) 
oxidoreductase AF380367 Burkholderia sp. DBT1 Di Gregorio et al., Biodegradation 15 (2), 111-123 
(2004) 
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dioxygenase AB024945 Alcaligenes faecalis Kiyohara et al., Submitted (14-MAR-1999) Noboru 
Takizawa, Okayama University of 
            Science, Applied Chemistry; 1-1, Ridai-cho, 
Okayama 700-0005, Japan 
dioxygenase DQ501245 Cycloclasticus sp. P1  Wang et al., Submitted (19-APR-2006) The Third 
Institute of Oceanography, State 
            of Oceanic Administration (SOA), Room 329, 
Daxue Road 184#, Xiamen, 
            Fujian 361005, P.R. China 
Ring hydroxylating 
dioxygenase 
AJ633551 Sphingomonas sp. CHY-1  Demaneche et al., Appl. Environ. Microbiol. 70 (11), 
6714-6725 (2004) 
extradiol dioxygenase AF169302 Burkholderia cepacia  Johnson et al., Arch. Microbiol. 173 (2), 86-90 (2000) 
dioxygenase CP000511 Mycobacterium vanbaalenii PYR-1 Copeland et al., Submitted (13-DEC-2006) US DOE Joint 
Genome Institute, 2800 
            Mitchell Drive B100, Walnut Creek, CA 94598-
1698, USA 
dioxygenase CP000479 Mycobacterium avium 104 Fleischmann et al., Submitted (19-OCT-2006) The 
Institute for Genomic Research, 9712 
            Medical Center Dr, Rockville, MD 20850, USA 
dioxygenase CP000509 Nocardioides sp. JS614, Coleman et al., J. Bacteriol. 193 (13), 3399-3400 (2011) 
dioxygenase CP000656 Mycobacterium gilvum PYR-GCK Badejo et al., PLoS ONE 8 (2), E58066 (2013) 
dioxygenase AB091693 Sphingomonas sp. P2  Pinyakong et al., Biochem. Biophys. Res. Commun. 301 
(2), 350-357 (2003) 
dioxygenase AAXZ0100000
3 
Rhodobacteraceae bacterium HTCC2150 Kang et al., J. Bacteriol. 192 (23), 6315-6316 (2010) 
dioxygenase AB272984 Rhodococcus rhodochrous Taguchi et al., Biosci. Biotechnol. Biochem. 68 (4), 787-
795 (2004) 
dioxygenase CH482384 Pseudomonas aeruginosa 2192 Mathee et al., Proc. Natl. Acad. Sci. U.S.A. 105 (8), 
3100-3105 (2008) 
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dioxygenase EU024110 Sphingomonas sp. LB126 fluorene/dibenzofuran 
degradation operon, 
Schuler et al., Appl. Environ. Microbiol. 74 (4), 1050-
1057 (2008) 
dioxygenase AF060489 Sphingomonas sp. CB3  Shepherd and Lloyd-Jones Biochem. Biophys. Res. 
Commun. 247 (1), 129-135 (1998) 
dioxygenase AAQG010000
01 
Sphingomonas sp. SKA58  Hagstrom et al., Submitted (17-MAR-2006) J Craig 
Venter Institute, 9704 Medical 
            Center Drive, Rockville, MD 20850, USA 
dioxygenase AB201843 Paenibacillus sp. YK5 Iida et al., Arch. Microbiol. 184 (5), 305-315 (2006) 
dioxygenase U51165 Cycloclasticus oligotrophus XYLX  Wang et al.,  Appl. Environ. Microbiol. 62 (6), 2169-
2173 (1996) 
dioxygenase AB161232 Sphingomonas sp. A4 Pinyakong et al., FEMS Microbiol. Lett. 238 (2), 297-305 
(2004) 
dioxygenase AB240454 Sphingomonas sp. A4  Kouzuma et al., Microbiology (Reading, Engl.) 152 (PT 
8), 2455-2467 (2006) 
dioxygenase AB121977 Xanthobacter polyaromaticivorans  Hirano et al., Appl. Microbiol. Biotechnol. 69 (6), 672-
681 (2006) 
dioxygenase AF157565 Sphingopyxis macrogoltabida strain TFA Andujar et al., J. Bacteriol. 182 (3), 789-795 (2000) 
dioxygenase AB070456 Rhodococcus sp. YK2 Iida et al., Biosci. Biotechnol. Biochem. 66 (7), 1462-
1472 (2002) 
dioxygenase AF061751 Burkholderia sp. strain RP007 Laurie and Lloyd-Jones J. Bacteriol. 181 (2), 531-540 
(1999) 
dioxygenase CP000089 Dechloromonas aromatica RCB Salinero et al., Submitted (04-AUG-2005) US DOE Joint 
Genome Institute, 2800 
            Mitchell Drive B100, Walnut Creek, CA 94598-
1698, USA 
dioxygenase D89064 Pseudomonas sp. Sato et al., J. Bacteriol. 179 (15), 4841-4849 (1997) 
dioxygenase U18133 Conidiobolus coronatus Nakatsu et al., Proc. Natl. Acad. Sci. U.S.A. 88 (19), 
8312-8316 (1991) 
pobA and pobB genes X78823  P.pseudoalcaligenes (POB310)  Dehmel et al., Arch. Microbiol. 163 (1), 35-41 (1995) 
phthalate dioxygenase  AF095748 Burkholderia cepacia Chang and Zylstra J. Bacteriol. 180 (24), 6529-6537 
(1998) 
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2-halobenzoate 1,2-
dioxygenase 
X79076 Burkholderia cepacia Haak et al., J. Bacteriol. 177 (3), 667-675 (1995) 
dioxygenase AF009224 Acinetobacter sp. ADP1  Neidle et al., J. Bacteriol. 170 (10), 4874-4880 (1988) 
dioxygenase AF071556 Acinetobacter sp. ADP1  Bundy et al., J. Bacteriol. 180 (17), 4466-4474 (1998) 
dioxygenase AB084235 Terrabacter sp. DBF63 Habe et al., Appl. Microbiol. Biotechnol. 61 (1), 44-54 
(2003) 
dioxygenase X72850 Sphingomonas sp. Happe et al., J. Bacteriol. 175 (22), 7313-7320 (1993) 
dioxygenase D17319 Pseudomonas sp. KKS102 Kimbara et al., J. Bacteriol. 171 (5), 2740-2747 (1989) 
napthalene 
dioxygenase 
AF082663 Rhodococcus sp. NCIMB12038 Larkin et al., J. Bacteriol. 181 (19), 6200-6204 (1999) 
putative cis-
naphthalene 1,2-
dioxygenase 
AJ401612 Rhodococcus sp. 1BN  Andreoni et al., Environ. Microbiol. 2 (5), 572-577 
(2000) 
benzene dioxygenase AF148496 Pseudomonas putida Tan et al., Gene 130 (1), 33-39 (1993) 
dioxygenase EF600714 Pandoraea pnomenusa Jiang et al., Arch. Microbiol. 191 (6), 485-492 (2009) 
dioxygenase AP011117 Rhodococcus opacus B4  Na et al., J. Biosci. Bioeng. 99 (4), 378-382 (2005) 
dioxygenase AF452376 Rhodococcus aetherivorans strain I24 Priefert et al., Appl. Microbiol. Biotechnol. 65 (2), 168-
176 (2004) 
dioxygenase BA000007 Escherichia coli O157:H7 str Makino et al., Genes Genet. Syst. 74 (5), 227-239 
(1999) 
dioxygenase AE005174 Escherichia coli O157:H7 str. EDL933 Perna et al., Nature 409 (6819), 529-533 (2001) 
dioxygenase Z37966 Escherichia coli K-12 Turlin et al., Submitted (22-SEP-1994) Antoine Danchin, 
Biochimie et genetique 
            moleculaire, Institut, Pasteur, 28 rue du Docteur 
Roux, PARIS CEDEX 
            15, F-75724, FRANCE 
dioxygenase U00096 Escherichia coli str. K-12 substr. MG1655 Blattner et al.,  Science 277 (5331), 1453-1462 (1997) 
dioxygenase AP009048 Escherichia coli str. K-12 substr. W3110 Musso et al., Proc. Natl. Acad. Sci. U.S.A. 74 (1), 106-
110 (1977) 
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dioxygenase CP000038 Shigella sonnei Ss046 Yang et al., Nucleic Acids Res. 33 (19), 6445-6458 
(2005) 
dioxygenase CP000802 Escherichia coli HS Rasko et al., J. Bacteriol. 190 (20), 6881-6893 (2008) 
dioxygenase CP000036 Shigella boydii Sb227 Yang et al., Nucleic Acids Res. 33 (19), 6445-6458 
(2005) 
dioxygenase CP000266 Shigella flexneri 5 str. 8401 Nie et al., BMC Genomics 7, 173 (2006) 
dioxygenase ACLI01000099 Corynebacterium efficiens YS-314 Qin et al., Submitted (10-APR-2009) Human Genome 
Sequencing Center, Baylor College of Medicine, One 
Baylor Plaza, Houston, TX 77030, USA 
dioxygenase BX571866 Photorhabdus luminescens subsp. laumondii TTO1 Duchaud et al., Nat. Biotechnol. 21 (11), 1307-1313 
(2003) 
dioxygenase AB237655 Pseudomonas putida plasmid NAH7 Tsuda and Iino Mol. Gen. Genet. 223 (1), 33-39 (1990) 
dioxygenase AY887963 Pseudomonas fluorescens strain PC20 plasmid 
pNAH20 
Heinaru et al., FEMS Microbiol. Ecol. 31 (3), 195-205 
(2000) 
dioxygenase AY125981 Pseudomonas fluorescens plasmid pLP6a McFarlane and Foght Submitted (25-JUN-2002) 
Biological Sciences, University of Alberta, 
            Edmonton, AB T6G 2E9, Canada 
dioxygenase AF491307 Pseudomonas putida NCIB 9816-4 plasmid pDTG1 Simon et al., Gene 127 (1), 31-37 (1993) 
dioxygenase BX640437 Bordetella bronchiseptica strain RB50 Parkhill et al., Nat. Genet. 35 (1), 32-40 (2003) 
dioxygenase AE005674 Shigella flexneri 2a str. 301 Jin et al., Nucleic Acids Res. 30 (20), 4432-4441 (2002) 
dioxygenase AE014073 Shigella flexneri 2a str. 2457T Wei et al., Infect. Immun. 71 (5), 2775-2786 (2003) 
dioxygenase AY208917 Pseudomonas sp. ND6 plasmid pND6-1 Li et al., Gene 336 (2), 231-240 (2004) 
dioxygenase AF036940  Ralstonia sp. U2 Fuenmayor et al., J. Bacteriol. 180 (9), 2522-2530 
(1998) 
dioxygenase DQ167474  Polaromonas naphthalenivorans CJ2 Jeon et al., Appl. Environ. Microbiol. 72 (2), 1086-1095 
(2006) 
dioxygenase CP000529 Polaromonas naphthalenivorans CJ2 Copeland et al., Submitted (21-DEC-2006) US DOE Joint 
Genome Institute, 2800 
            Mitchell Drive B100, Walnut Creek, CA 94598-
1698, USA 
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dioxygenase CP000539 Acidovorax sp. JS42 Copeland et al., Submitted (21-DEC-2006) US DOE Joint 
Genome Institute, 2800 
            Mitchell Drive B100, Walnut Creek, CA 94598-
1698, USA 
dioxygenase CP000077 Sulfolobus acidocaldarius DSM 639 Chen et al., J. Bacteriol. 187 (14), 4992-4999 (2005) 
dioxygenase CP000520 Mycobacterium sp. KMS plasmid pMKMS02 Copeland et al., Submitted (18-DEC-2006) US DOE Joint 
Genome Institute, 2800 
            Mitchell Drive B100, Walnut Creek, CA 94598-
1698, USA 
dioxygenase CP000456 Arthrobacter sp. FB24 Copeland et al., Submitted (28-AUG-2006) US DOE Joint 
Genome Institute, 2800 
            Mitchell Drive B100, Walnut Creek, CA 94598-
1698, USA 
dioxygenase CP000518 Mycobacterium sp. KMS Copeland et al., Submitted (18-DEC-2006) US DOE Joint 
Genome Institute, 2800 
            Mitchell Drive B100, Walnut Creek, CA 94598-
1698, USA 
dioxygenase CP000519 Mycobacterium sp. KMS plasmid pMKMS01 Copeland et al., Submitted (18-DEC-2006) US DOE Joint 
Genome Institute, 2800 
            Mitchell Drive B100, Walnut Creek, CA 94598-
1698, USA 
dioxygenase CP000580 Mycobacterium sp. JLS Copeland et al., Submitted (20-FEB-2007) US DOE Joint 
Genome Institute, 2800 
            Mitchell Drive B100, Walnut Creek, CA 94598-
1698, USA 
dioxygenase CP000384 Mycobacterium sp. MCS Copeland et al., Submitted (05-JUN-2006) US DOE Joint 
Genome Institute, 2800 
            Mitchell Drive B100, Walnut Creek, CA 94598-
1698, USA 
dioxygenase CP000385 Mycobacterium sp. MCS Copeland et al., Submitted (05-JUN-2006) US DOE Joint 
Genome Institute, 2800 
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            Mitchell Drive B100, Walnut Creek, CA 94598-
1698, USA 
dioxygenase AF331043 Arthrobacter keyseri plasmid pRE1 Eaton J. Bacteriol. 183 (12), 3689-3703 (2001) 
dioxygenase AP008980 Terrabacter sp. DBF63 plasmid pDBF1 Kasuga J. Ferment. Bioeng. 84, 387-399 (1997) 
dioxygenase EF494237 Rhodococcus sp. DK17 plasmid pDK2 Choi et al., Biochem. Biophys. Res. Commun. 357 (3), 
766-771 (2007) 
dioxygenase AB048709 Rhodococcus sp. RHA1 Kitagawa et al., Biosci. Biotechnol. Biochem. 65 (8), 
1907-1911 (2001) 
dioxygenase AB154536 Rhodococcus sp. RHA1 Kitagawa et al., Submitted (17-DEC-2003) Keisuke 
Miyauchi, Nagaoka University of 
            Technology, Department of Bioengineering; 
1603-1 Kamitomioka, 
            Nagaoka, Niigata 940-2188, Japan  
        
dioxygenase AB154537 Rhodococcus sp. RHA1 Kitagawa et al., Submitted (17-DEC-2003) Keisuke 
Miyauchi, Nagaoka University of 
            Technology, Department of Bioengineering; 
1603-1 Kamitomioka, 
            Nagaoka, Niigata 940-2188, Japan  
        
putative phthalate 
dioxygenase 
AAR90178 Rhodococcus sp. RHA1 Choi et al., Submitted (16-DEC-2003) Department of 
Biology, Yonsei University, 
            134 Shinchon-dong, Seoul 120-749, Korea 
dioxygenase DQ007994 Rhodococcus sp. TFB Tomas-Gallardo et al Proteomics 6 (SUPPL 1), S119-
S132 (2006) 
dioxygenase AF546904 Mycobacterium sp. S65  Sho et al., FEMS Microbiol. Ecol. 48 (2), 209-220 (2004) 
dioxygenase DQ028634 Mycobacterium vanbaalenii PYR-1 Kim et al., Appl. Environ. Microbiol. 72 (2), 1045-1054 
(2006) 
biphenyl dioxygenase EF151283 Sphingobium yanoikuyae strain B1 Chadhain et al., J. Ind. Microbiol. Biotechnol. 34 (9), 
605-613 (2007) 
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dioxygenase CP000676 Novosphingobium aromaticivorans DSM 12444  Copeland et al., Submitted (12-APR-2007) US DOE Joint 
Genome Institute, 2800 
            Mitchell Drive B100, Walnut Creek, CA 94598-
1698, USA 
dioxygenase AY502075 Rhodococcus sp. DK17  Kim et al., Appl. Environ. Microbiol. 70 (12), 7086-7092 
(2004) 
dioxygenase AF079317 Sphingomonas aromaticivorans plasmid pNL1 Romine et al., J. Bacteriol. 181 (5), 1585-1602 (1999) 
dioxygenase AB272985 Rhodococcus erythropolis Taguchi et al., Biosci. Biotechnol. Biochem. 71 (5), 
1136-1144 (2007) 
dioxygenase AB272986 Rhodococcus sp. HA99 Taguchi et al., Biosci. Biotechnol. Biochem. 71 (5), 
1136-1144 (2007) 
dioxygenase DQ403247 Rhodococcus sp. R04  Yang et al., J. Appl. Microbiol. 103 (6), 2214-2224 
(2007) 
dioxygenase AF119621 Pseudomonas abietaniphila BKME-9  Mohn et al., Syst. Appl. Microbiol. 22 (1), 68-78 (1999) 
dioxygenase CP000272 Paraburkholderia xenovorans LB400  Chain et al., Proc. Natl. Acad. Sci. U.S.A. 103 (42), 
15280-15287 (2006) 
dioxygenase CP000699 Sphingomonas wittichii RW1 Miller et al., J. Bacteriol. 192 (22), 6101-6102 (2010) 
dioxygenase AJ223219 Sphingomonas sp. Armengaud et al., J. Bacteriol. 180 (15), 3954-3966 
(1998) 
dioxygenase AJ223220 Sphingomonas sp. Armengaud et al., J. Bacteriol. 180 (15), 3954-3966 
(1998) 
dioxygenase CP000701 Sphingomonas wittichii RW1  Miller et al., J. Bacteriol. 192 (22), 6101-6102 (2010) 
dioxygenase D88021 Rhodococcus erythropolis Kosono et al., Appl. Environ. Microbiol. 63 (8), 3282-
3285 (1997) 
dioxygenase AB270530 Sphingomonas sp. KA1  Habe et al., FEMS Microbiol. Lett. 211 (1), 43-49 (2002) 
dioxygenase AB110633 Rhodococcus opacus Kimura et al., Appl. Microbiol. Biotechnol. (2006) In 
press 
dioxygenase AB102786 Cycloclasticus sp. A5 Kasai et al., Appl. Environ. Microbiol. 69 (11), 6688-
6697 (2003) 
dioxygenase AB075242 Terrabacter sp. YK3 Tida et al., Appl. Environ. Microbiol. 68 (8), 3716-3723 
(2002) 
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dioxygenase AE015451 Pseudomonas putida KT2440 Nelson et al., Environ. Microbiol. 4 (12), 799-808 (2002) 
dioxygenase CP000432 Rhodococcus jostii RHA1 plasmid pRHL1 McLeod Submitted (24-JUL-2006) Microbiology and 
Immunology, University of 
            British Columbia, 1365-2350 Health Sciences 
Mall, Vancouver, BC V6T 
            1Z3, Canada 
dioxygenase CP000433 Rhodococcus jostii RHA1 plasmid pRHL2 Takeda et al., J. Bacteriol. 192 (18), 4741-4751 (2010) 
dioxygenase AY502076 Rhodococcus sp. DK17 plasmid pDK3 Choi et al., Submitted (16-DEC-2003) Department of 
Biology, Yonsei University, 
            134 Shinchon-dong, Seoul 120-749, Korea 
dioxygenase AB257758 Plasmid pFKY4 Ono et al., Appl. Microbiol. Biotechnol. 74 (2), 501-510 
(2007) 
dioxygenase AB257757 Plasmid pFKY1 Ono et al., Appl. Microbiol. Biotechnol. 74 (2), 501-510 
(2007) 
dioxygenase NG_034878 Pseudomonas putida plasmid NPL1 Boronin et al., Genetika 25 (2), 226-237 (1989) 
napthalene 
dioxygenase 
NG_041567 Pseudomonas putida plasmid pAK5 Izmalkova et al., Res. Microbiol. 164 (3), 244-253 (2013) 
dioxygenase HM623873 Pseudomonas chlororaphis strain SY-02 Zhang et al., Submitted (02-JUL-2010) College of 
Resources and Environmental 
            Engineering, East China University of Science and 
Technology, 130 
            Meilong Road, Shanghai 200237, China 
dioxygenase JN248563 Pseudomonas sp. MC1 Ahn et al., Submitted (13-JUL-2011) Department of 
Systems Biology, Yonsei 
            University, 50 Yonsei-Ro, Seodaemun-Gu, Seoul 
120-749, Republic of 
            Korea 
Naphtalene 
dioxygenase 
HM368649 Pseudomonas sp. N1 Bianchi Submitted (28-MAY-2010) Department of 
Structural and Functional 
            Biology, University of Insubria, Via J.H. Dunant 3, 
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Varese 21100, 
            Italy 
dioxygenase CP007510 Pseudomonas stutzeri strain 19SMN4  Brunet-Galmes et al., Submitted (24-MAR-2014) 
Microbiology, Department of Biology, 
            Univesitat de les Illes Balears (UIB), Carretera de 
Valldemossa km 
            7.5, Palma de Mallorca, Illes Balears 07122, 
Spain 
dioxygenase CP003677 Pseudomonas stutzeri CCUG 29243 Brunet-Galmes et al., J. Bacteriol. 194 (23), 6642-6643 
(2012) 
dioxygenase HM204990 Pseudomonas stutzeri strain NJ  Chakraborty et al., Submitted (06-MAY-2010) 
Microbiology, Bose Institute, P-1/12 C.I.T. 
            Scheme VII M, Kolkata, West Bengal 700054, 
India 
dioxygenase NG_036701 Rhodococcus sp. TFB Tomas-Gallardo et al Microb Biotechnol 2 (2), 262-273 
(2009) 
dioxygenase CP008952 Rhodococcus opacus strain R7  Di Gennaro et al., Genome Announc 2 (4) (2014) 
dioxygenase CP008951 Rhodococcus opacus strain R7  Di Gennaro et al., Genome Announc 2 (4) (2014) 
dioxygenase AB024936 Rhodococcus sp. CIR2  Takizawa et al., Submitted (12-MAR-1999) Noboru 
Takizawa, Okayama University of 
            Science, Applied Chemistry; 1-1, Ridai-cho, 
Okayama 700-0005, Japan 
dioxygenase NG035928 Rhodococcus opacus plasmid pWK301 Kimura et al., Appl. Microbiol. Biotechnol. (2006) In 
press 
dioxygenase GQ848233 Gordonia sp. CC-NAPH129-6  Lin et al., Microbiol. Res. 167 (7), 395-404 (2012) 
napthalene 
dioxygenase 
GQ503240 Rhodococcus sp. B13  Anan et al., Antonie Van Leeuwenhoek 100 (2), 309-
316 (2011) 
napthalene 
dioxygenase 
GQ503241 Rhodococcus sp. B2-1  Anan et al., Antonie Van Leeuwenhoek 100 (2), 309-
316 (2011) 
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napthalene 
dioxygenase 
GQ503239 Rhodococcus sp. DB11  Anan et al., Antonie Van Leeuwenhoek 100 (2), 309-
316 (2011) 
dioxygenase CP002385 Mycobacterium gilvum Spyr1 Kallimanis et al., Stand Genomic Sci 5 (1), 144-153 
(2011) 
NidA HM049723 Mycobacterium sp. py142 DeBruyn et al., Submitted (31-MAR-2010) Center for 
Environmental Biotechnology, The 
            University of Tennessee, 676 Dabney Hall, 
Knoxville, TN 37996, USA 
NidA HM049719 Mycobacterium sp. py137 DeBruyn et al., Submitted (31-MAR-2010) Center for 
Environmental Biotechnology, The 
            University of Tennessee, 676 Dabney Hall, 
Knoxville, TN 37996, USA 
NidA HM049714 Bacterium py120  DeBruyn et al., Submitted (31-MAR-2010) Center for 
Environmental Biotechnology, The 
            University of Tennessee, 676 Dabney Hall, 
Knoxville, TN 37996, USA 
NidA HM049725 Mycobacterium sp. py145  DeBruyn et al., Submitted (31-MAR-2010) Center for 
Environmental Biotechnology, The 
            University of Tennessee, 676 Dabney Hall, 
Knoxville, TN 37996, USA 
NidA HM049713 Bacterium py114 DeBruyn et al., Submitted (31-MAR-2010) Center for 
Environmental Biotechnology, The 
            University of Tennessee, 676 Dabney Hall, 
Knoxville, TN 37996, USA 
NidA HM049726 Mycobacterium sp. py146 DeBruyn et al., Submitted (31-MAR-2010) Center for 
Environmental Biotechnology, The 
            University of Tennessee, 676 Dabney Hall, 
Knoxville, TN 37996, USA 
dioxygenase CP003169 Mycobacterium rhodesiae NBB3 Lucas et al., Submitted (08-DEC-2011) US DOE Joint 
Genome Institute, 2800 
            Mitchell Drive B310, Walnut Creek, CA 94598-
1698, USA 
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dioxygenase AB626849 Mycobacterium sp. NJS-P Zeng et al., Submitted (20-APR-2011) Contact:Jun Zeng 
Institute of Soil Science, 
            Chinese Academy of Sciences, Soil Biology and 
Biochemistry; No. 71 
            Beijing East Road, Nanjing 210008, China 
dioxygenase JQ916945 Pseudomonas sp. Jpyr-1 Ma Submitted (10-APR-2012) School of Life Science and 
Biotechnology, 
            Dalian Technology of Technology, No. 2, Ling 
Gong Road, Gan Jing Zi 
            District, Dalian, Liao Ning 116024, China 
dioxygenase CP003872 Acidovorax sp. KKS102 Ohtsubo et al., J. Bacteriol. 194 (24), 6970-6971 (2012) 
dioxygenase AB706355 Comamonas testosteroni genomic DNA Hara and Takatsuka Submitted (28-MAR-2012) 
Contact:Tomijiro Hara Yamagata University, 
            Graduate School of Science and Engineering; 4-
3-16 Jonan, Yonezawa, 
            Yamagata 992-8510, Japan 
dioxygenase AB546270 Acidovorax sp. KKS102  Ohtsubo et al., J. Biol. Chem. 276 (39), 36146-36154 
(2001) 
dioxygenase CP006704 Comamonas testosteroni TK102 Fukuda et al., Genome Announc 2 (5), e00865-14 
(2014) 
dioxygenase CP008761 Burkholderia xenovorans LB400 Bishop-Lilly et al., Submitted (19-JUN-2014) Bioscience, 
Los Alamos National Laboratory, 
            P.O. Box 1663, MS M888, Los Alamos, NM 
87545, USA 
dioxygenase JN874407 Cupriavidus sp. SK-4  Ilori et al., J. Basic Microbiol. (2013) In press 
dioxygenase FJ715926 Pseudomonas putida strain B6-2 Li et al., Environ. Sci. Technol. 43 (22), 8635-8642 
(2009) 
dioxygenase CP003093 Pseudoxanthomonas spadix BD-a59 Lee et al., J. Bacteriol. 194 (2), 544 (2012) 
dioxygenase CP000530 Polaromonas naphthalenivorans CJ2  Copeland et al., Submitted (21-DEC-2006) US DOE Joint 
Genome Institute, 2800 
P a g e  | 261 
Gene/enzyme Accession n. Description Reference/submission information from GenBank 
            Mitchell Drive B100, Walnut Creek, CA 94598-
1698, USA 
biphenyl dioxygenase JQ015309 Alcanivorax sp. HA03  Hassan Submitted (09-NOV-2011) Environmental 
Biotechnology Department, 
            GEBRI Menoufiya Uni., P.O. Box 79, Sadat City, 
Egypt 
biphenyl dioxygenase AB733643 Janibacter sp. TYM3221 Nguyen et al., J. Biosci. Bioeng. 116 (1), 91-100 (2013) 
biphenyl dioxygenase AB609317 Janibacter sp. TYM3221 Nguyen et al., Enzyme Microb. Technol. 49 (6-7), 532-
539 (2011) 
dioxygenase EF635855 Pseudomonas nitroreducens strain J5-1 Jiang and Wang Submitted (29-MAY-2007) Department 
of Environmental Science and 
            Engineering, Tsinghua University, Beijing 
100084, China 
dioxygenase EU825676 Bordetella sp. IITR02 Pathak et al., Submitted (30-MAY-2008) Environmental 
Biotechnology Division, 
            Indian Institute of Toxicology Research, 
Mahatma Gandhi Marg, P.O. 
            Box-80, Lucknow, Uttar Pradesh 226 001, India 
dioxygenase AM902716 Bordetella petrii strain DSM 12804 Gross et al., BMC Genomics 9, 449 (2008) 
dioxygenase CP006979 Pseudomonas monteilii SB3101 Dueholm et al., Submitted (11-DEC-2013) 
Biotechnology, Chemistry, and Environmental 
            Engineering, Aalborg University, 
Sohngaardsholmsvej 49, Aalborg 
            9000, Denmark 
dioxygenase CP006978 Pseudomonas monteilii SB3078 Dueholm et al., Genome Announc 2 (3), e00524-14 
(2014) 
dioxygenase CP003734 Pseudomonas putida DOT-T1E Udaondo et al., Submitted (04-JUL-2012) 
Environmental Protection, EEZ-CSIC, 
            Profesor Albareda 1, Granada, Granada 18008, 
Spain 
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dioxygenase CP000712 Pseudomonas putida F1 Copeland et al., Submitted (25-MAY-2007) US DOE 
Joint Genome Institute, 2800 
            Mitchell Drive B100, Walnut Creek, CA 94598-
1698, USA 
dioxygenase AB828709 Pseudomonas putida Faizal et al., J. Ind. Microbiol. Biotechnol. 32 (11-12), 
542-547 (2005) 
dioxygenase NC_010002 Delftia acidovorans SPH-1 Schleheck et al., Appl. Environ. Microbiol. 70 (7), 4053-
4063 (2004) 
dioxygenase NC_020800 Xanthomonas axonopodis Xac29-1 Chen et al., Submitted (15-MAR-2013) School of 
Agriculture and Biology, Shanghai Jiao Tong University, 
800 Dongchuan Road, Shanghai, Shanghai           
200240, China 
dioxygenase NC_006834 Xanthomonas oryzae pv. oryzae KACC 10331 Lee et al., Nucleic Acids Res. 33 (2), 577-586 (2005) 
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2017) 
Accession n. Description Reference/submission information 
from GenBank 
TesH (3-ketosteroid-
delta1-dehydrogenase) 
3-oxosteroid 1-
dehydrogenase,  
AB076368  Comamonas testosteroni TA441 tesH, tesI, 
ORF17, ORF18 genes for 3-ketosteriod-
delta1-dehydrogenase, 3-ketosteriod-
delta4(5alpha)-dehydrogenase, hypothetical 
protein, complete cds. 
Horinouchi, M. Appl. Environ. 
Microbiol. 69 (8), 4421-4430 (2003) 
TesI (3-ketosteroid-
delta4(5alpha)-
dehydrogenase) 
3-oxo-5alpha-
steroid 4-
dehydrogenase 
AB076368 Comamonas testosteroni TA441  tesH, tesI, 
ORF17, ORF18 genes for 3-ketosteriod-
delta1-dehydrogenase, 3-ketosteriod-
delta4(5alpha)-dehydrogenase, hypothetical 
protein, complete cds. 
Horinouchi, M. Appl. Environ. 
Microbiol. 69 (8), 4421-4430 (2003) 
3-beta-hydroxysteroid 
dehydrogenase ORF62 
3beta-hydroxy-
DELTA5-steroid 
dehydrogenase 
AB474240 Comamonas testosteroni TA441 O genes for 
hypothetical proteins, 3-beta-hydroxysteriod 
dehydrogenase, hypothetical protein, partial 
and complete cds, strain:TA441. 
Horinouchi,M. J. Steroid Biochem. Mol. 
Biol. 122 (4), 253-263 (2010) 
3-alpha steroid 
dehydrogenase (acts as 
17β-dehydrogenase) 
3alpha-
hydroxysteroid 
3-
dehydrogenase 
AB489116 Comamonas testosteroni TA441 genes for 3-
ketosteroiod isomerase, 3-alpha  steroid 
dehydrogenase, complete cds, strain: TA441. 
Horinouchi,M. J. Steroid Biochem. Mol. 
Biol. 122 (4), 253-263 (2010) 
3-beta hydroxysteroid 
dehydrogenase 
3(or 17)beta-
hydroxysteroid 
dehydrogenase 
NZ_AKCL01000092 Pseudomonas putida SJTE-1 contig000092, 
whole genome shotgun sequence 
Liang,R., J. Bacteriol. 194 (17), 4781-
4782 (2012) 
3-beta hydroxysteroid 
dehydrogenase 
3(or 17)beta-
hydroxysteroid 
dehydrogenase 
NZ_AKCL01000160 Pseudomonas putida SJTE-1 contig000160, 
whole genome shotgun sequence 
Liang,R., J. Bacteriol. 194 (17), 4781-
4782 (2012) 
3-beta hydroxysteroid 
dehydrogenase 
3(or 17)beta-
hydroxysteroid 
dehydrogenase 
NZ_AFMP01000007 Sphingomonas sp. KC8 contig07, whole 
genome shotgun sequence. 
Hu,A. J. Bacteriol. 193 (16), 4266-4267 
(2011) 
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7-alpha-hydroxysteroid 
dehydrogenase 
7alpha-
hydroxysteroid 
dehydrogenase 
NZ_AFMP01000007 Sphingomonas sp. KC8 contig07, whole 
genome shotgun sequence. 
Hu,A. J. Bacteriol. 193 (16), 4266-4267 
(2011) 
3-alpha-hydroxysteroid 
dehydrogenase 
3alpha-
hydroxysteroid 
3-
dehydrogenase 
NZ_AFMP01000031 Sphingomonas sp. KC8 contig31, whole 
genome shotgun sequence. 
Hu,A. J. Bacteriol. 193 (16), 4266-4267 
(2011) 
3-ketosteroid-delta-1-
dehydrogenase 
3-oxosteroid 1-
dehydrogenase 
NZ_AFMP01000031 Sphingomonas sp. KC8 contig31, whole 
genome shotgun sequence. 
Hu,A. J. Bacteriol. 193 (16), 4266-4267 
(2011) 
3-beta-hydroxysteroid 
dehydrogenase 
3(or 17)beta-
hydroxysteroid 
dehydrogenase 
NC_005027 Rhodopirellula baltica SH 1 chromosome, 
complete genome. 
Wecker BMC Genomics 10, 410 (2009) 
3-keto-5alpha-steroid 
delta(1)-dehydrogenase 
KstD3 
3-oxosteroid 1-
dehydrogenase 
NC_012490 Rhodococcus erythropolis PR4 DNA, 
complete genome. 
Sekine Environ. Microbiol. 8 (2), 334-
346 (2006) 
3-ketosteroid delta(1)-
dehydrogenase KstD2 
3-oxosteroid 1-
dehydrogenase 
NC_012490  Rhodococcus erythropolis PR4 DNA, 
complete genome. 
Sekine Environ. Microbiol. 8 (2), 334-
346 (2006) 
3-ketosteroid-delta-1-
dehydrogenase 
3-oxosteroid 1-
dehydrogenase 
NC_012490  Rhodococcus erythropolis PR4 DNA, 
complete genome. 
Sekine Environ. Microbiol. 8 (2), 334-
346 (2006) 
3-ketosteroid delta(1)-
dehydrogenase 
3-oxosteroid 1-
dehydrogenase 
NC_012490 Rhodococcus erythropolis PR4 DNA, 
complete genome. 
Sekine Environ. Microbiol. 8 (2), 334-
346 (2006) 
3-ketosteroid-delta-1-
dehydrogenase 
3-oxosteroid 1-
dehydrogenase 
NC_008269 Rhodococcus jostii RHA1 plasmid pRHL1, 
complete sequence. 
McLeod Submitted (24-JUL-2006) 
Microbiology and Immunology, 
University of 
            British Columbia, 1365-2350 
Health Sciences Mall, Vancouver, BC 
V6T 
            1Z3, Canada 
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3-ketosteroid-delta-1-
dehydrogenase 
3-oxosteroid 1-
dehydrogenase 
NC_008269 Rhodococcus jostii RHA1 plasmid pRHL1, 
complete sequence. 
McLeod Submitted (24-JUL-2006) 
Microbiology and Immunology, 
University of 
            British Columbia, 1365-2350 
Health Sciences Mall, Vancouver, BC 
V6T 
            1Z3, Canada 
3-ketosteroid-delta-1-
dehydrogenase 
3-oxosteroid 1-
dehydrogenase 
NC_008268 Rhodococcus jostii RHA1, complete genome. McLeod Submitted (24-JUL-2006) 
Microbiology and Immunology, 
University of 
            British Columbia, 1365-2350 
Health Sciences Mall, Vancouver, BC 
V6T 
            1Z3, Canada 
3-ketosteroid-delta-1-
dehydrogenase 
3-oxosteroid 1-
dehydrogenase 
NC_008268 Rhodococcus jostii RHA1, complete genome. McLeod Submitted (24-JUL-2006) 
Microbiology and Immunology, 
University of 
            British Columbia, 1365-2350 
Health Sciences Mall, Vancouver, BC 
V6T 
            1Z3, Canada 
3-ketosteroid-delta-1-
dehydrogenase 
3-oxosteroid 1-
dehydrogenase 
NC_008268 Rhodococcus jostii RHA1, complete genome. McLeod Submitted (24-JUL-2006) 
Microbiology and Immunology, 
University of 
            British Columbia, 1365-2350 
Health Sciences Mall, Vancouver, BC 
V6T 
            1Z3, Canada 
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3-ketosteroid-delta-1-
dehydrogenase 
3-oxosteroid 1-
dehydrogenase 
NC_002944 Mycobacterium avium subsp. 
paratuberculosis str. k10, complete genome 
Li Proc. Natl. Acad. Sci. U.S.A. 102 (35), 
12344-12349 (2005) 
3-ketosteroid-delta-1-
dehydrogenase 
3-oxosteroid 1-
dehydrogenase 
NC_002944 Mycobacterium avium subsp. 
paratuberculosis str. k10, complete genome 
Li Proc. Natl. Acad. Sci. U.S.A. 102 (35), 
12344-12349 (2005) 
3-ketosteroid-delta-1-
dehydrogenase 
3-oxosteroid 1-
dehydrogenase 
NC_002944 Mycobacterium avium subsp. 
paratuberculosis str. k10, complete genome 
Li Proc. Natl. Acad. Sci. U.S.A. 102 (35), 
12344-12349 (2005) 
3-ketosteroid-delta-1-
dehydrogenase 
3-oxosteroid 1-
dehydrogenase 
NC_002944 Mycobacterium avium subsp. 
paratuberculosis str. k10, complete genome 
Li Proc. Natl. Acad. Sci. U.S.A. 102 (35), 
12344-12349 (2005) 
3-ketosteroid-delta-1-
dehydrogenase 
3-oxosteroid 1-
dehydrogenase 
NC_016946 Mycobacterium intracellulare ATCC 13950, 
complete genome. 
Kim J. Bacteriol. 194 (10), 2750 (2012) 
3-ketosteroid-delta-1-
dehydrogenase 
3-oxosteroid 1-
dehydrogenase 
NC_016946 Mycobacterium intracellulare ATCC 13950, 
complete genome. 
Kim J. Bacteriol. 194 (10), 2750 (2012) 
3-ketosteroid-delta-1-
dehydrogenase 
3-oxosteroid 1-
dehydrogenase 
NC_016946 Mycobacterium intracellulare ATCC 13950, 
complete genome. 
Kim J. Bacteriol. 194 (10), 2750 (2012) 
3-ketosteroid-delta-1-
dehydrogenase 
3-oxosteroid 1-
dehydrogenase 
NC_016946 Mycobacterium intracellulare ATCC 13950, 
complete genome. 
Kim J. Bacteriol. 194 (10), 2750 (2012) 
3-ketosteroid-delta-1-
dehydrogenase 
3-oxosteroid 1-
dehydrogenase 
NC_008596 Mycobacterium smegmatis str. MC2 155 
chromosome, complete genome. 
Fleischmann Submitted (19-OCT-2006) 
The Institute for Genomic Research, 
9712 
            Medical Center Dr, Rockville, MD 
20850, USA 
3-ketosteroid-delta-1-
dehydrogenase 
3-oxosteroid 1-
dehydrogenase 
NC_008596 Mycobacterium smegmatis str. MC2 155 
chromosome, complete genome. 
Fleischmann Submitted (19-OCT-2006) 
The Institute for Genomic Research, 
9712 
            Medical Center Dr, Rockville, MD 
20850, USA 
3-ketosteroid-delta-1-
dehydrogenase 
3-oxosteroid 1-
dehydrogenase 
NC_008596 Mycobacterium smegmatis str. MC2 155 
chromosome, complete genome. 
Fleischmann Submitted (19-OCT-2006) 
The Institute for Genomic Research, 
9712 
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            Medical Center Dr, Rockville, MD 
20850, USA 
3-ketosteroid-delta-1-
dehydrogenase 
3-oxosteroid 1-
dehydrogenase 
NC_008596 Mycobacterium smegmatis str. MC2 155 
chromosome, complete genome. 
Fleischmann Submitted (19-OCT-2006) 
The Institute for Genomic Research, 
9712 
            Medical Center Dr, Rockville, MD 
20850, USA 
3-ketosteroid-delta-1-
dehydrogenase 
3-oxosteroid 1-
dehydrogenase 
NC_008611 Mycobacterium ulcerans Agy99 
chromosome, complete genome. 
Stinear Genome Res. 17 (2), 192-200 
(2007) 
3-ketosteroid-delta-1-
dehydrogenase 
3-oxosteroid 1-
dehydrogenase 
NC_008611 Mycobacterium ulcerans Agy99 
chromosome, complete genome. 
Stinear Genome Res. 17 (2), 192-200 
(2007) 
3-beta-hydroxy-delta(5)-
steroid dehydrogenase 
3beta-hydroxy-
DELTA5-steroid 
dehydrogenase 
NC_013209 Acetobacter pasteurianus IFO 3283-01 DNA, 
complete genome. 
Azuma Nucleic Acids Res. 37 (17), 5768-
5783 (2009) 
3-beta-hydroxy-delta(5)-
steroid dehydrogenase 
3beta-hydroxy-
DELTA5-steroid 
dehydrogenase 
NZ_AFSD01000001  Agrobacterium tumefaciens F2 chromosome 
C c1, whole genome shotgun sequence. 
Li J. Bacteriol. 193 (19), 5531 (2011) 
3-beta-hydroxy-delta(5)-
steroid dehydrogenase 
3beta-hydroxy-
DELTA5-steroid 
dehydrogenase 
NC_009667  Ochrobactrum anthropi ATCC 49188 
chromosome 1, complete sequence. 
Chain J. Bacteriol. 193 (16), 4274-4275 
(2011) 
3-beta-hydroxy-delta(5)-
steroid dehydrogenase 
3beta-hydroxy-
DELTA5-steroid 
dehydrogenase 
 NC_007761  Rhizobium etli CFN 42, complete genome. Gonzalez Proc. Natl. Acad. Sci. U.S.A. 
103 (10), 3834-3839 (2006) 
3-beta-hydroxy-delta(5)-
steroid dehydrogenase 
3beta-hydroxy-
DELTA5-steroid 
dehydrogenase 
NC_010505 Methylobacterium radiotolerans JCM 2831, 
complete genome. 
Copeland  Submitted (19-MAR-2008) 
US DOE Joint Genome Institute, 2800 
            Mitchell Drive B100, Walnut 
Creek, CA 94598-1698, USA 
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3-beta-hydroxy-delta(5)-
steroid dehydrogenase 
3beta-hydroxy-
DELTA5-steroid 
dehydrogenase 
NZ_KB900701  Bradyrhizobium elkanii USDA 76 
BraelDRAFT_scaffold1.1, whole genome 
shotgun sequence. 
Kyrpides Submitted (16-APR-2013) DOE 
Joint Genome Institute, 2800 Mitchell 
            Drive, Walnut Creek, CA 94598-
1698, USA 
3-beta-hydroxy-delta(5)-
steroid dehydrogenase 
3beta-hydroxy-
DELTA5-steroid 
dehydrogenase 
NC_008783 Bartonella bacilliformis KC583, complete 
genome. 
Hendrix  Submitted (18-DEC-2006) The 
Institute for Genomic Research, 9712 
            Medical Center Dr, Rockville, MD 
20850, USA 
KsdD-like steroid 
dehydrogenase 
3-oxosteroid 1-
dehydrogenase 
NC_000962  Mycobacterium tuberculosis H37Rv, 
complete genome. 
Lew Tuberculosis (Edinb) 91 (1), 1-7 
(2011) 
3-beta-hydroxy-delta(5)-
steroid dehydrogenase 
3beta-hydroxy-
DELTA5-steroid 
dehydrogenase 
NC_007643 Rhodospirillum rubrum ATCC 11170 
chromosome, complete genome. 
Munk Stand Genomic Sci 4 (3), 293-302 
(2011) 
3-oxo-5-alpha-steroid 4-
dehydrogenase 
3-oxo-5alpha-
steroid 4-
dehydrogenase 
(NADP+) 
NC_009614 Bacteroides vulgatus ATCC 8482, complete 
genome. 
Xu PLoS Biol. 5 (7), E156 (2007) 
delta 4, 5-alpha steroid 
dehydrogenase 
3-oxo-5alpha-
steroid 4-
dehydrogenase 
(NADP+) 
NZ_JH604622 Pseudomonas fragi B25 Scaffold1, whole 
genome shotgun sequence. 
Mei J. Bacteriol. 194 (12), 3276-3277 
(2012) 
3-oxo-5-alpha-steroid 4-
dehydrogenase 
3-oxo-5alpha-
steroid 4-
dehydrogenase 
(NADP+) 
NC_006347 Bacteroides fragilis YCH46 DNA, complete 
genome. 
Kuwahara Proc. Natl. Acad. Sci. U.S.A. 
101 (41), 14919-14924 (2004) 
NAD(P)H steroid 
dehydrogenase 
3alpha-
hydroxysteroid 
3-
dehydrogenase  
NC_003902 Xanthomonas campestris pv. campestris str. 
ATCC 33913 chromosome, complete 
genome. 
da Silva Nature 417 (6887), 459-463 
(2002) 
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NAD(P)H steroid 
dehydrogenase 
3alpha-
hydroxysteroid 
3-
dehydrogenase  
NC_003902 Xanthomonas campestris pv. campestris str. 
ATCC 33913 chromosome, complete 
genome. 
da Silva Nature 417 (6887), 459-463 
(2002) 
3-oxo-5-alpha-steroid 4-
dehydrogenase 
3-oxo-5alpha-
steroid 4-
dehydrogenase 
(NADP+) 
NC_004663 Bacteroides thetaiotaomicron VPI-5482 
chromosome, complete genome. 
Xu Science 299 (5615), 2074-2076 
(2003) 
Putative steroid 
dehydrogenase 
3beta-hydroxy-
DELTA5-steroid 
dehydrogenase 
(possibly) 
NC_010397 Mycobacterium abscessus chromosome, 
complete sequence. 
Ripoll unsubmitted 
3-beta hydroxysteroid 
dehydrogenase 
3(or 17)beta-
hydroxysteroid 
dehydrogenase 
NC_004129 Pseudomonas protegens Pf-5, complete 
genome. 
Paulsen Nat. Biotechnol. 23 (7), 873-
878 (2005) 
7-alpha-hydroxysteroid 
dehydrogenase 
Recommended 
names 
(BRENDA) 
NC_002695 Escherichia coli O157:H7 str. Sakai 
chromosome, complete genome. 
Bergholz BMC Microbiol. 7, 97 (2007) 
3-beta hydroxysteroid 
dehydrogenase/isomerase 
family protein 
3(or 17)beta-
hydroxysteroid 
dehydrogenase 
NC_003997 Bacillus anthracis str. Ames chromosome, 
complete genome. 
Read Nature 423 (6935), 81-86 (2003) 
3-ketosteroid-delta-1-
dehydrogenase 
3-oxosteroid 1-
dehydrogenase 
NC_010382 Lysinibacillus sphaericus C3-41, complete 
genome. 
Hu J. Bacteriol. 190 (8), 2892-2902 
(2008) 
7-alpha-hydroxysteroid 
dehydrogenase 
7alpha-
hydroxysteroid 
dehydrogenase 
NC_007618  Brucella melitensis biovar Abortus 2308 
chromosome I, complete sequence, strain 
2308. 
Chain Infect. Immun. 73 (12), 8353-
8361 (2005) 
7-alpha-hydroxysteroid 
dehydrogenase 
7alpha-
hydroxysteroid 
dehydrogenase 
NC_009850 Arcobacter butzleri RM4018, complete 
genome. 
Kaakoush Antonie Van Leeuwenhoek 
92 (4), 429-441 (2007) 
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enzyme names 
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Accession n. Description Reference/submission information 
from GenBank 
7-alpha-hydroxysteroid 
dehydrogenase 
7alpha-
hydroxysteroid 
dehydrogenase 
NC_011751  Escherichia coli UMN026 chromosome, 
complete genome. 
Touchon PLoS Genet. 5 (1), E1000344 
(2009) 
7-alpha-hydroxysteroid 
dehydrogenase 
7alpha-
hydroxysteroid 
dehydrogenase 
NC_011750 Escherichia coli IAI39 chromosome, complete 
genome. 
Touchon PLoS Genet. 5 (1), E1000344 
(2009) 
7-alpha-hydroxysteroid 
dehydrogenase 
7alpha-
hydroxysteroid 
dehydrogenase 
NC_012039 Campylobacter lari RM2100, complete 
genome. 
Miller Foodborne Pathog. Dis. 5 (4), 
371-386 (2008) 
7-alpha-hydroxysteroid 
dehydrogenase 
7alpha-
hydroxysteroid 
dehydrogenase 
NZ_CP007181 Campylobacter coli RM4661, complete 
genome. 
Wright Submitted (06-FEB-2014) 
Agricultural Research Service, US 
            Department of Agriculture, 800 
Buchanan Street, Albany, CA 94710, 
            USA 
7-alpha-hydroxysteroid 
dehydrogenase 
7alpha-
hydroxysteroid 
dehydrogenase 
NZ_KB849749  Acinetobacter radioresistens DSM 6976 = 
NBRC 102413 = CIP 103788 acLrZ-
supercont1.9, whole genome shotgun 
sequence. 
Unpublished 
7-alpha-hydroxysteroid 
dehydrogenase 
7alpha-
hydroxysteroid 
dehydrogenase 
NC_008599 Campylobacter fetus subsp. fetus 82-40, 
complete genome. 
Fouts unpublished 
7-alpha-hydroxysteroid 
dehydrogenase 
7alpha-
hydroxysteroid 
dehydrogenase 
NC_000915  Helicobacter pylori 26695 chromosome, 
complete genome. 
Raymond PLoS ONE 3 (5), E2259 (2008) 
ORF18 (likely 3alpha-
dehydrogenase ) 1b 
3alpha-
hydroxysteroid 
3-
dehydrogenase 
AB076368  Comamonas testosteroni TA441 tesH, tesI, 
ORF17, ORF18 genes for 3-ketosteriod-
delta1-dehydrogenase, 3-ketosteriod-
delta4(5alpha)-dehydrogenase, hypothetical 
protein, complete cds. 
Horinouchi, M. Appl. Environ. 
Microbiol. 69 (8), 4421-4430 (2003) 
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enzyme names 
(BRENDA, 
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Accession n. Description Reference/submission information 
from GenBank 
TesR (regulator gene for 
degradation)  (likely 
Delta1-dehydrogenase ) 
3-oxosteroid 1-
dehydrogenase 
AB186487 Comamonas testosteroni TA441 degradation 
gene cluster (ORF genes and tesR gene), 
complete cds. 
Horinouchi,M. Biochem. Biophys. Res. 
Commun. 324 (2), 597-604 (2004) 
3-ketosteroid-delta 4(5 
alpha)-dehydrogenase 
3-oxosteroid 1-
dehydrogenase 
L23428 Comamonas testosteroni ATCC 17410 delta 
4, 5-alpha steroid dehydrogenase gene, 
complete cds. 
Florin J. Bacteriol. 178 (11), 3322-3330 
(1996) 
3-oxosteriod 1-
dehydrogenase node-1 
length 715095-cov-
155.621-id-1 
3-oxosteriod 1-
dehydrogenase 
R. equi ATCC13557 
unsubmitted 
R.equi ATCC13557 (rast output for spades 
assembly) 
This thesis  
17beta hydroxysteriod 
dehydrogenase 
17beta 
hydroxysteriod 
dehydrogenase 
FN563149.1 Rhodococcus equi 103S chromosome. Letek et al., PLoS Genet. 2010 Sep 
30;6(9):e1001145. doi: 
10.1371/journal.pgen.1001145. 
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Table Appendix 0-6: Gene sequences coding for dehydrogenase taken from Kisiela et al., (2012). 
Gene/enzyme RefSeq ID Description Reference/submission information 
3-ketosteroid-Δ1-dehydrogenase YP_907615 Mycobacterium ulcerans Agy99 Stinear et al., Genome Res. 17 (2), 192-200 (2007) 
3-ketosteroid-Δ1-dehydrogenase ZP_04751485 Mycobacterium kansasii ATCC 
12478 
Veyrier et al., Submitted (08-DEC-2008) Department of Medicine, 
McGill University, A5.156, 1650 Cedar Avenue, Montreal, Quebec 
H3G 1A4, Canada 
3-ketosteroid-Δ1-dehydrogenase YP_001073300 Mycobacterium sp. JLS Copeland et al., Submitted (20-FEB-2007) US DOE Joint Genome 
Institute, 2800 Mitchell Drive B100, Walnut Creek, CA 94598-1698, 
USA 
3-ketosteroid-Δ1-dehydrogenase YP_641822 Mycobacterium sp. MCS Copeland et al., Submitted (12-JUN-2006) National Center for 
Biotechnology Information, NIH, Bethesda, MD 20894, USA 
3-ketosteroid-Δ1-dehydrogenase YP_940731 Mycobacterium sp. KMS Copeland et al., Submitted (22-DEC-2006) National Center for 
Biotechnology        Information, NIH, Bethesda, MD 20894, USA 
3-ketosteroid-Δ1-dehydrogenase YP_890167 Mycobacterium smegmatis str. 
MC2 155 
Fleischmann et al., Submitted (19-OCT-2006) The Institute for 
Genomic Research, 9712 Medical Center Dr, Rockville, MD 20850, 
USA 
3-ketosteroid-Δ1-dehydrogenase YP_956014 Mycobacterium vanbaalenii 
PYR-1 
Copeland et al., Submitted (28-DEC-2006) National Center for 
Biotechnology Information, NIH, Bethesda, MD 20894, USA 
3-ketosteroid-Δ1-dehydrogenase YP_001132789 Mycobacterium gilvum PYR-GCK Copeland et al., Submitted (13-APR-2007) National Center for 
Biotechnology Information, NIH, Bethesda, MD 20894, USA 
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Probable dehydrogenase YP_001701374 Mycobacterium abscessus Ripoll et al., PLoS ONE 4 (6), E5660 (2009) 
3-ketosteroid-Δ1-dehydrogenase YP_116669 Nocardia farcinica IFM 10152 Ishikawa et al., Proc. Natl. Acad. Sci. U.S.A. 101 (41), 14925-14930 
(2004) 
3-ketosteroid-Δ1-dehydrogenase YP_704476 Rhodococcus jostii RHA1 McLeod et al., Proc. Natl. Acad. Sci. U.S.A. 103 (42), 15582-15587 
(2006) 
3-ketosteroid-Δ1-dehydrogenase YP_002781639 Rhodococcus opacus B4 Takarada et al., Submitted (02-APR-2009) National Center for 
Biotechnology Information, NIH, Bethesda, MD 20894, USA 
3-ketosteroid-Δ1-dehydrogenase ZP_04388196 Rhodococcus erythropolis SK121 Sebastian et al., Submitted (20-APR-2009) J. Craig Venter Institute, 
9704 Medical Center Drive, Rockville, MD 20850, USA 
3-ketosteroid-Δ1-dehydrogenase YP_002764184 Rhodococcus erythropolis PR4 Sekine et al., Environ. Microbiol. 8 (2), 334-346 (2006) 
3-ketosteroid-Δ1-dehydrogenase ZP_05478502 Streptomyces sp. AA4 Fischbach et al., Submitted (09-FEB-2009) Broad Institute of MIT 
and Harvard, 7         Cambridge Center, Cambridge, MA 02142, USA 
3-ketosteroid-Δ1-dehydrogenase YP_923969 Nocardioides sp. JS614 Coleman et al., J. Bacteriol. 193 (13), 3399-3400 (2011) 
3-ketosteroid-Δ1-dehydrogenase ZP_06607635 Aeromicrobium marinum DSM 
15272 
Qin et al., Submitted (10-APR-2009) Human Genome Sequencing 
Center, Baylor            College of Medicine, One Baylor Plaza, 
Houston, TX 77030, USA 
3-ketosteroid-Δ1-dehydrogenase YP_001413067 Parvibaculum lavamentivorans 
DS-1 
Schleheck et al., Arch. Microbiol. 183 (6), 369-377 (2005) 
3-ketosteroid-Δ1-dehydrogenase YP_001696275 Lysinibacillus sphaericus C3-41 Hu et al., J. Bacteriol. 190 (8), 2892-2902 (2008) 
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3-ketosteroid-Δ1-dehydrogenase ZP_01725238 Bacillus sp. B14905 Edwards et al., Submitted (12-JUN-2006) J Craig Venter Institute, 
9704 Medical            Center Drive, Rockville, MD 20850, USA 
putative FAD binding domain 
protein 
ZP_05095058 marine gamma 
proteobacterium HTCC2148 
Amann et al., Submitted (16-JUL-2008) J. Craig Venter Institute, 
9704 Medical Center Drive, Rockville, MD 20850, USA 
Fumarate reductase/succinate 
dehydrogenase flavoprotein 
subunit 
ZP_01626281 marine gamma 
proteobacterium HTCC2080 
Thrash et al., J. Bacteriol. 192 (14), 3842-3843 (2010) 
putative FAD binding domain 
protein 
ZP_05094533 marine gamma 
proteobacterium HTCC2148 
Amann et al., Submitted (16-JUL-2008) J. Craig Venter Institute, 
9704 Medical Center Drive, Rockville, MD 20850, USA 
fumarate reductase/succinate 
dehydrogenase flavoprotein 
domain protein 
ZP_03544409 Comamonas testosteroni KF-1 Schleheck et al., Appl. Environ. Microbiol. 70 (7), 4053-4063 (2004) 
hypothetical protein ZP_03607292 Methanobrevibacter smithii 
DSM 2375 
Sudarsanam et al., Submitted (27-OCT-2008) Genome Sequencing 
Center, Washington 
University School of Medicine, 4444 Forest Park, St. Louis, MO 
63108, USA 
short chain dehydrogenase YP_447755 Methanosphaera stadtmanae 
DSM 3091 
Fricke et al., J. Bacteriol. 188 (2), 642-658 (2006) 
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hypothetical protein ZP_03636608 Holdemania filiformis DSM 
12042 
Sudarsanam et al., Submitted (19-DEC-2008) Genome Sequencing 
Center, Washington 
University School of Medicine, 4444 Forest Park, St. Louis, MO 
63108, USA 
short-chain 
dehydrogenase/reductase SDR  
YP_003182859 Eggerthella lenta DSM 2243 Lucas et al., Submitted (02-SEP-2009) US DOE Joint Genome 
Institute, 2800 Mitchell Drive, Walnut Creek, CA 94598-1698, USA 
hypothetical protein ZP_03759971 Clostridium asparagiforme DSM 
15981 
Sudarsanam et al., Submitted (14-JAN-2009) Genome Sequencing 
Center, Washington            University School of Medicine, 4444 
Forest Park, St. Louis, MO 63108, USA 
short chain 
dehydrogenase/reductase 
ZP_04672086 Clostridiales bacterium 
1_7_47_FAA 
Allen-Vercoe et al., Submitted (13-AUG-2008) Broad Institute of 
MIT and Harvard, 7          Cambridge Center, Cambridge, MA 02142, 
USA 
hypothetical protein ZP_03777187 Clostridium hylemonae DSM 
15053 
Sudarsanam et al., Submitted (02-FEB-2009) Genome Sequencing 
Center, Washington             University School of Medicine, 4444 
Forest Park, St. Louis, MO 63108, USA 
hypothetical protein ZP_02432210 Clostridium scindens ATCC 
35704 
Sudarsanam et al.,Submitted (07-NOV-2007) Genome Sequencing 
Center, Washington           University School of Medicine, 4444 
Forest Park, St. Louis, MO 63108, USA 
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hypothetical protein ZP_03293133 Clostridium hiranonis 
DSM13275 
Sudarsanam et al.,  Submitted (03-FEB-2007) Genome Sequencing 
Center, Washington            University School of Medicine, 4444 
Forest Park, St. Louis, MO 63108, USA 
hypothetical protein ZP_02236388 Dorea formicigenerans ATCC 
27755 
Sudarsanam et al., Submitted (08-OCT-2007) Genome Sequencing 
Center, Washington University School of Medicine, 4444 Forest 
Park, St. Louis, MO 63108, USA 
hypothetical protein ZP_03463615 [Bacteroides] pectinophilus 
ATCC43243 
Sudarsanam et al., Submitted (13-NOV-2008) Genome Sequencing 
Center, Washington University School of Medicine, 4444 Forest 
Park, St. Louis, MO 63108, USA 
Oxidoreductase, short chain 
dehydrogenase/reductase family 
protein 
ZP_01772477 Collinsella aerofaciens ATCC 
25986 
Sudarsanam et al., Submitted (25-APR-2007) Genome Sequencing 
Center, Washington  University School of Medicine, 4444 Forest 
Park, St. Louis, MO 63108, USA 
hypothetical protein ZP_03296838 Collinsella stercoris DSM 13279 Sudaranam et al., Submitted (01-OCT-2008) Genome Sequencing 
Center, Washington University School of Medicine, 4444 Forest 
Park, St. Louis, MO 63108, USA 
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hypothetical protein ZP_03799118 Coprococcus comes ATCC 27758 Sudaranam et al., Submitted (18-FEB-2009) Genome Sequencing 
Center, Washington  University School of Medicine, 4444 Forest 
Park, St. Louis, MO 63108, USA 
hypothetical protein ZP_02027406 Eubacterium ventriosum 
ATCC27560 
Sudaranam et al., Submitted (27-MAR-2007) Genome Sequencing 
Center, Washington University School of Medicine, 4444 Forest 
Park, St. Louis, MO 63108, USA 
short chain dehydrogenase ZP_05744752 Lactobacillus antri DSM 16041 Qin et al., Submitted (10-APR-2009) Human Genome Sequencing 
Center, Baylor            College of Medicine, One Baylor Plaza, 
Houston, TX 77030, USA 
oxidoreductase, short chain 
dehydrogenase/reductase family 
protein 
ZP_03682514 Catenibacterium mitsuokai DSM 
15897 
Fulton et al., Submitted (16-DEC-2008) Genome Sequencing 
Center, Washington           University School of Medicine, 4444 
Forest Park, St. Louis, MO 63108, USA 
hypothetical protein ZP_02075484 Clostridium sp. L2-50 Sudaranam et al., Submitted (08-AUG-2007) Genome Sequencing 
Center, Washington University School of Medicine, 4444 Forest 
Park, St. Louis, MO 63108, USA 
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hypothetical protein ZP_02205767 Coprococcus eutactus ATCC 
27759 
Sudaranam et al., Submitted (11-SEP-2007) Genome Sequencing 
Center, Washington  University School of Medicine, 4444 Forest 
Park, St. Louis, MO 63108, USA 
3-oxoacyl-(acyl-carrier-protein) 
reductase  
ZP_06113400 Clostridium hathewayi DSM 
13479 
Weinstock et al., Submitted (28-APR-2009) Genome Sequencing 
Center, Washington  University School of Medicine, 4444 Forest 
Park, St. Louis, MO 63108, USA 
hypothetical protein ZP_02429777 Clostridium ramosum DSM 1402 Sudaranam et al., Submitted (09-NOV-2007) Genome Sequencing 
Center, Washington             University School of Medicine, 4444 
Forest Park, St. Louis, MO 63108, USA 
short-chain dehydrogenase ZP_04565678 Coprobacillus sp. D7 Ward et al., Submitted (05-FEB-2009) Broad Institute of MIT and 
Harvard, 7             Cambridge Center, Cambridge, MA 02142, USA 
short chain 
dehydrogenase/reductase 
YP_001274304 Methanobrevibacter smithii 
ATCC 35061 
Samuel et al., Proc. Natl. Acad. Sci. U.S.A. 104 (25), 10643-10648 
(2007) 
short-chain dehydrogenase ZP_05976067 Methanobrevibacter smithii 
DSM 2374 
Weinstock et al., Submitted (30-SEP-2009) Genome Sequencing 
Center, Washington             University School of Medicine, 4444 
Forest Park, St. Louis, MO 63108, USA 
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hypothetical protein YP_637479 Mycobacterium sp. MCS Copeland et al., Submitted (05-JUN-2006) US DOE Joint Genome 
Institute, 2800            Mitchell Drive B100, Walnut Creek, CA 94598-
1698, USA  
hypothetical protein YP_936319 Mycobacterium sp. KMS Copeland et al., Submitted (22-DEC-2006) National Center for 
Biotechnology             Information, NIH, Bethesda, MD 20894, USA 
hypothetical protein YP_001537700 Salinispora arenicola CNS-205 Penn et al., ISME J 3 (10), 1193-1203 (2009) 
hypothetical protein YP_001159497 Salinispora tropica CNB-440 Eustaquio et al., Proc. Natl. Acad. Sci. U.S.A. 106 (30), 12295-12300 
(2009) 
hypothetical protein ZP_05478503 Streptomyces sp. AA4 Fischbach et al., Submitted (09-FEB-2009) Broad Institute of MIT 
and Harvard, 7             Cambridge Center, Cambridge, MA 02142, 
USA 
hypothetical protein YP_116670 Nocardia farcinica IFM 10152 Ishikawa et al., Proc. Natl. Acad. Sci. U.S.A. 101 (41), 14925-14930 
(2004) 
Probable dehydrogenase YP_001701375 Mycobacterium abscessus Ripoll et al., PLoS ONE 4 (6), E5660 (2009) 
hypothetical protein YP_908262 Mycobacterium ulcerans Agy99 Stinear et al., Genome Res. 17 (2), 192-200 (2007) 
hypothetical protein YP_001848529 Mycobacterium marinum M Stinear et al., Genome Res. 18 (5), 729-741 (2008) 
hypothetical protein ZP_04747468 Mycobacterium kansasii 
ATCC12478 
Veyrier et al., Submitted (08-DEC-2008) Department of Medicine, 
McGill University,             A5.156, 1650 Cedar Avenue, Montreal, 
Quebec H3G 1A4, Canada 
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putative 3-ketosteroid 
delta(4)(5alpha)-dehydrogenase 
YP_002764185 Rhodococcus erythropolis PR4 Sekine et al., Environ. Microbiol. 8 (2), 334-346 (2006) 
3-ketosteroid-delta4 
dehydrogenase 
ZP_04388024 Rhodococcus erythropolis SK121 Sebastian et al., Submitted (20-APR-2009) J. Craig Venter Institute, 
9704 Medical            Center Drive, Rockville, MD 20850, USA 
fumarate reductase/succinate 
dehydrogenase 
YP_003277400 Comamonas testosteroni CNB-2 Ma et al., Appl. Environ. Microbiol. 75 (21), 6812-6819 (2009) 
fumarate reductase/succinate 
dehydrogenase flavoprotein 
domain     protein 
ZP_03544408 Comamonas testosteroni KF-1 Schleheck et al., Submitted (02-JAN-2009) US DOE Joint Genome 
Institute, 2800            Mitchell Drive B100, Walnut Creek, CA 94598-
1698, USA 
hypothetical protein YP_728803 Ralstonia eutropha H16 Pohlmann et al., Nat. Biotechnol. 24 (10), 1257-1262 (2006) 
hypothetical protein YP_001796921 Cupriavidus taiwanensis LMG 
19424 
Amadou et al., Genome Res. 18 (9), 1472-1483 (2008) 
hypothetical protein YP_001166106 Novosphingobium  
aromaticivorans DSM 12444 
Copeland et al., Submitted (08-MAY-2007) National Center for 
Biotechnology             Information, NIH, Bethesda, MD 20894, USA 
hypothetical protein YP_001263819 Sphingomonas wittichii RW1 Miller et al., J. Bacteriol. 192 (22), 6101-6102 (2010) 
hypothetical protein YP_001262358 Sphingomonas wittichii RW1 Miller et al., J. Bacteriol. 192 (22), 6101-6102 (2010) 
fumarate reductase/succinate 
dehydrogenase flavoprotein 
domain 
ZP_03265787 Burkholderia sp. H160 Ormeno-Orrillo et al., J. Bacteriol. 194 (24), 6927 (2012) 
hypothetical protein YP_713249 Frankia alni ACN14a Normand et al., Genome Res. 17 (1), 7-15 (2007) 
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hypothetical protein YP_001135820 Mycobacterium gilvum PYR-GCK Copeland et al., Submitted (13-APR-2007) National Center for 
Biotechnology             Information, NIH, Bethesda, MD 20894, USA 
hypothetical protein YP_887193 Mycobacterium smegmatis str. 
MC2 155 
Fleischmann et al., Submitted (29-NOV-2006) National Center for 
Biotechnology             Information, NIH, Bethesda, MD 20894, USA 
hypothetical protein YP_001068597 Mycobacterium sp. JLS Copeland et al., Submitted (20-FEB-2007) US DOE Joint Genome 
Institute, 2800             Mitchell Drive B100, Walnut Creek, CA 
94598-1698, USA 
fumarate reductase/succinate 
dehydrogenase  
YP_003277399 Comamonas testosteroni CNB-2 Ma et al., Appl. Environ. Microbiol. 75 (21), 6812-6819 (2009) 
3-ketosteroid-delta1-
dehydrogenase 
YP_340631 Pseudoalteromonas 
haloplanktis TAC125 
Medigue et al., Genome Res. 15 (10), 1325-1335 (2005) 
fumarate reductase/succinate 
dehydrogenase flavoprotein 
domain-containing protein 
YP_001674315 Shewanella halifaxensis HAW-
EB4 
Copeland et al., Submitted (12-FEB-2008) National Center for 
Biotechnology             Information, NIH, Bethesda, MD 20894, USA 
fumarate reductase/succinate 
dehydrogenase flavoprotein 
domain-containing protein 
YP_001501980 Shewanella pealeana ATCC 
700345 
Copeland et al., Submitted (09-OCT-2007) National Center for 
Biotechnology            Information, NIH, Bethesda, MD 20894, USA 
fumarate reductase/succinate 
dehydrogenase flavoprotein, N-
YP_295753 Ralstonia eutropha JMP134 Copeland et al., Submitted (18-AUG-2005) National Center for 
Biotechnology             Information, NIH, Bethesda, MD 20894, USA 
P a g e  | 282 
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terminal:FAD dependent 
oxidoreductase 
3-oxosteroid 1-dehydrogenase YP_728801 Ralstonia eutropha H16 Pohlmann et al., Nat. Biotechnol. 24 (10), 1257-1262 (2006) 
3-oxosteroid 1-dehydrogenase YP_001796919 Cupriavidus taiwanensis LMG 
19424 
Amadou et al., Genome Res. 18 (9), 1472-1483 (2008) 
fumarate reductase/succinate 
dehydrogenase flavoprotein 
domain protein 
ZP_02893600 Burkholderia ambifaria IOP40-
10 
Copeland et al., Submitted (03-MAR-2008) US DOE Joint Genome 
Institute, 2800            Mitchell Drive B100, Walnut Creek, CA 94598-
1698, USA 
fumarate reductase/succinate 
dehydrogenase flavoprotein 
subunit 
YP_372172 Burkholderia lata Copeland et al., Submitted (11-OCT-2005) US DOE Joint Genome 
Institute, 2400            Mitchell Drive B100, Walnut Creek, CA 94598-
1698, USA 
putative FAD-binding component 
for oxidoreductase 
YP_002234257 Burkholderia cenocepacia J2315 Holden et al., J. Bacteriol. 191 (1), 261-277 (2009) 
3-oxosteroid 1-dehydrogenase YP_001262337 Sphingomonas wittichii RW1 Miller et al., J. Bacteriol. 192 (22), 6101-6102 (2010) 
fumarate reductase/succinate 
dehydrogenase flavoprotein 
domain-containing protein  
YP_001262329 Sphingomonas wittichii RW1 Miller et al., J. Bacteriol. 192 (22), 6101-6102 (2010) 
fumarate reductase/succinate 
dehydrogenase flavoprotein 
domain-containing protein 
YP_001166117 Novosphingobium 
aromaticivorans DSM 12444 
Copeland et al., Submitted (08-MAY-2007) National Center for 
Biotechnology             Information, NIH, Bethesda, MD 20894, USA 
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fumarate reductase/succinate 
dehydrogenase flavoprotein 
domain-containing protein 
YP_001263842 Sphingomonas wittichii RW1 Miller et al., J. Bacteriol. 192 (22), 6101-6102 (2010) 
fumarate reductase/succinate 
dehydrogenase flavoprotein 
domain-containing protein 
YP_001166011 Novosphingobium 
aromaticivorans DSM 12444 
Copeland et al., Submitted (08-MAY-2007) National Center for 
Biotechnology             Information, NIH, Bethesda, MD 20894, USA 
3-ketosteroid-delta-1-
dehydrogenase 
YP_640946 Mycobacterium sp. MCS Copeland et al., Submitted (12-JUN-2006) National Center for 
Biotechnology             Information, NIH, Bethesda, MD 20894, USA 
3-ketosteroid-delta-1-
dehydrogenase 
YP_939840 Mycobacterium sp. KMS Copeland et al., Submitted (22-DEC-2006) National Center for 
Biotechnology             Information, NIH, Bethesda, MD 20894, USA 
fumarate reductase/succinate 
dehydrogenase flavoprotein 
domain-containing protein 
YP_003301095 Thermomonospora curvata DSM 
43183 
Chertkov et al., Stand Genomic Sci 4 (1), 13-22 (2011) 
3-ketosteroid-delta-1-
dehydrogenase 
YP_002783051 Rhodococcus opacus B4 Takarada et al., Submitted (02-APR-2009) National Center for 
Biotechnology             Information, NIH, Bethesda, MD 20894, USA 
3-ketosteroid-delta-1-
dehydrogenase 
YP_705733 Rhodococcus jostii RHA1 McLeod et al., Proc. Natl. Acad. Sci. U.S.A. 103 (42), 15582-15587 
(2006) 
3-oxosteroid 1-dehydrogenase ZP_04387793 Rhodococcus erythropolis SK121 Sebastian et al., Submitted (20-APR-2009) J. Craig Venter Institute, 
9704 Medical             Center Drive, Rockville, MD 20850, USA 
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3-ketosteroid-delta-1-
dehydrogenase 
YP_702446 Rhodococcus jostii RHA1 McLeod et al., Proc. Natl. Acad. Sci. U.S.A. 103 (42), 15582-15587 
(2006) 
3-ketosteroid-delta-1-
dehydrogenase 
YP_002779402 Rhodococcus opacus B4 Takarada et al., Submitted (02-APR-2009) National Center for 
Biotechnology             Information, NIH, Bethesda, MD 20894, USA 
3-ketosteroid-delta-1-
dehydrogenase 
YP_001159498 Salinispora tropica CNB-440 Eustaquio et al., Proc. Natl. Acad. Sci. U.S.A. 106 (30), 12295-12300 
(2009) 
3-ketosteroid-delta-1-
dehydrogenase 
YP_001537701 Salinispora arenicola  CNS-205 Penn et al., ISME J 3 (10), 1193-1203 (2009) 
3-ketosteroid-delta-1-
dehydrogenase 
YP_001159451 Salinispora tropica CNB-440 Eustaquio et al., Proc. Natl. Acad. Sci. U.S.A. 106 (30), 12295-12300 
(2009) 
3-ketosteroid-delta-1-
dehydrogenase 
YP_001537652 Salinispora arenicola CNS-205 Penn et al., ISME J 3 (10), 1193-1203 (2009) 
3-ketosteroid-delta-1-
dehydrogenase 
NP_822771 Streptomyces avermitilis MA-
4680 = NBRC 14893 
Ikeda et al., Nat. Biotechnol. 21 (5), 526-531 (2003) 
3-ketosteroid-delta-1-
dehydrogenase 
ZP_05016500 Streptomyces sviceus ATCC 
29083 
Fischbach et al., Submitted (25-FEB-2008) Broad Institute of MIT 
and Harvard, 7 Cambridge Center, Cambridge, MA 02142, USA 
3-ketosteroid-delta-1-
dehydrogenase 
ZP_05533430 Streptomyces 
viridochromogenes DSM 40736 
Fischbach et al., Submitted (09-FEB-2009) Broad Institute of MIT 
and Harvard, 7             Cambridge Center, Cambridge, MA 02142, 
USA 
oxidoreductase YP_003491889 Streptomyces scabiei 87.22 Bignell et al., Mol. Plant Microbe Interact. 23 (2), 161-175 (2010) 
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3-ketosteroid-delta-1-
dehydrogenase 
YP_003115795 Catenulispora acidiphila Copeland et al., Stand Genomic Sci 1 (2), 119-125 (2009) 
3-ketosteroid-delta-1-
dehydrogenase 
ZP_05001264 Streptomyces sp. Mg1 Fischbach et al., Submitted (25-FEB-2008) Broad Institute of MIT 
and Harvard, 7 Cambridge Center, Cambridge, MA 02142, USA 
3-ketosteroid-delta-1-
dehydrogenase 
ZP_05504907 Streptomyces sp. C Fischbach et al., Submitted (09-FEB-2009) Broad Institute of MIT 
and Harvard, 7             Cambridge Center, Cambridge, MA 02142, 
USA 
succinate dehydrogenase/fumarate 
reductase flavoprotein subunit 
ZP_04025274 Tsukamurella paurometabola 
DSM 20162 
Lucas et al., Submitted (26-FEB-2009) US DOE Joint Genome 
Institute, 2800             Mitchell Drive, Walnut Creek, CA 94598-
1698, USA 
succinate dehydrogenase/fumarate 
reductase flavoprotein subunit 
YP_003272100 Gordonia bronchialis DSM 
43247 
Ivanova et al., Stand Genomic Sci 2 (1), 19-28 (2010) 
succinate dehydrogenase/fumarate 
reductase flavoprotein subunit 
ZP_04387329 Rhodococcus erythropolis SK121 Sebastian et al., Submitted (20-APR-2009) J. Craig Venter Institute, 
9704 Medical             Center Drive, Rockville, MD 20850, USA 
3-ketosteroid delta(1)-
dehydrogenase 
YP_002766394 Rhodococcus erythropolis PR4 Sekine et al., Environ. Microbiol. 8 (2), 334-346 (2006) 
3-ketosteroid-delta-1-
dehydrogenase 
NP_959464 Mycobacterium avium subsp. 
paratuberculosis K-10 
Li et al., Proc. Natl. Acad. Sci. U.S.A. 102 (35), 12344-12349 (2005) 
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3-ketosteroid-delta-1-
dehydrogenase 
YP_879904 Mycobacterium avium 104 Fleischmann et al., Submitted (19-OCT-2006) The Institute for 
Genomic Research, 9712             Medical Center Dr, Rockville, MD 
20850, USA 
3-ketosteroid-delta-1-
dehydrogenase 
ZP_05215097 Mycobacterium avium subsp. 
avium ATCC 25291 
Turenne et al., Submitted (22-JAN-2009) Medicine, McGill 
University Health Centre,             1650 Cedar Ave, Montreal, 
Quebec H3G 1A4, Canada 
3-ketosteroid-delta-1-
dehydrogenase 
ZP_05227620 Mycobacterium intracellulare 
ATCC 13950 
Turenne et AL., Submitted (30-NOV-2007) McGill University and 
Genome Quebec             Innovation Centre, 740 Avenue Docteur 
Penfield, Montreal, Quebec H3A 1A4, Canada 
3-ketosteroid-delta-1-
dehydrogenase 
YP_001853283 Mycobacterium marinum M Stinear et al., Genome Res. 18 (5), 729-741 (2008) 
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Table Appendix 0-7: BLAST comparison of the genomes R. equi ATCC13557, Sphingomonas sp. KC8 and P. putida SJTE-1. 
Gene Length Function Contig Gene percent 
identity 
(%) 
Contig Gene percent 
identity (%) 
R. equi 
ATCC13557  
 
P. putida SJTE-1 Sphingomonas sp. KC8 
1 451 Translation initiation factor 2 60 2037 54.93 30 1481 48.35 
5 457 putative DNA-damage-inducible protein F 97 3044 29.44 39 2200 25.44 
8 309 tRNA pseudouridine synthase B (EC 4.2.1.70) 60 2035 43.38 30 1477 43.95 
11 315 Riboflavin kinase (EC 2.7.1.26) / 
 FMN adenylyltransferase (EC 2.7.7.2) 
97 3078 35.89 57 3343 37.67 
12 90 SSU ribosomal protein S15p (S13e) 60 2034 55.06 30 1476 51.69 
15 447 FIG007959: peptidase, M16 family 73 2479 27.69 30 1384 36.07 
18 253 4-hydroxy-tetrahydrodipicolinate reductase (EC 
1.17.1.8) 
60 2051 33.21 18 695 31.79 
26 303 4-hydroxy-tetrahydrodipicolinate synthase (EC 
4.3.3.7) 
111 3698 35.58 39 2192 35.84 
31 906 Cell division protein FtsK 126 4245 44.36 54 3066 44.38 
36 163 C-terminal domain of CinA type S 145 4833 33.6 59 3449 40.16 
47 297 Diacylglycerol kinase-related protein 30 930 29.21 26 1114 24.58 
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(%) 
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R. equi 
ATCC13557  
 
P. putida SJTE-1 Sphingomonas sp. KC8 
48 543 Alkyldihydroxyacetonephosphate synthase (EC 
2.5.1.26) 
134 4415 35.88 14 505 35.85 
54 346 RecA protein 51 1506 68.11 39 2197 68.75 
61 506 tRNA-i(6)A37 methylthiotransferase 110 3657 30.63 59 3417 40.56 
66 309 tRNA dimethylallyltransferase (EC 2.5.1.75) 65 2229 35.78 20 834 36.17 
67 290 Diaminopimelate epimerase (EC 5.1.1.7) 77 2597 29.33 62 3632 29.83 
72 382 Butyryl-CoA dehydrogenase (EC 1.3.99.2) 122 4194 36.86 42 2378 52.66 
73 243 SOS-response repressor and protease LexA 
(EC 3.4.21.88) 
30 913 37.5 39 2167 35.59 
75 163 Ribonucleotide reductase transcriptional 
regulator NrdR 
94 2981 44.9 34 1818 44.09 
76 1314 ATP-dependent helicase hrpA 114 3775 48.34 66 3891 37.61 
77 410 Adenosylmethionine-8-amino-7- 
oxononanoate aminotransferase (EC 2.6.1.62) 
13 473 38.27 66 3822 35.39 
79 325 Ribokinase (EC 2.7.1.15) 16 575 44.41 68 3929 32.69 
86 310 Hydrogen peroxide-inducible genes activator 79 2677 38.38 42 2448 36.08 
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(%) 
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identity (%) 
R. equi 
ATCC13557  
 
P. putida SJTE-1 Sphingomonas sp. KC8 
96 318 UDP-glucose 4-epimerase (EC 5.1.3.2) 3 41 47.68 40 2366 45.83 
99 389 NAD-independent protein deacetylase AcuC 79 2709 33.57 51 2906 32.93 
100 899 possible acetyl-CoA synthetase 146 4868 28.41 7 155 33.33 
110 402 putative transmembrane transport protein 99 3174 30.58 42 2424 29.84 
111 460 RNA polymerase sigma factor RpoD 90 2851 59.41 62 3599 57.98 
117 103 Deoxyuridine 5'-triphosphate 
nucleotidohydrolase  
(EC 3.6.1.23) 
79 2655 44.29 39 2097 41.18 
125 423 23S rRNA (Uracil-5-) -methyltransferase  
RumA (EC 2.1.1.-) 
60 1975 29.73 43 2479 30.65 
130 608 Glutaminase (EC 3.5.1.2) 14 543 39.86 19 746 38.09 
131 657 1-deoxy-D-xylulose 5-phosphate  
synthase (EC 2.2.1.7) 
94 2994 39.65 6 80 39.88 
139 404 Ribonuclease D (EC 3.1.26.3) 112 3729 30.69 68 3926 31.98 
143 356 Uroporphyrinogen III decarboxylase (EC 
4.1.1.37) 
73 2439 43.18 66 3850 39.77 
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ATCC13557  
 
P. putida SJTE-1 Sphingomonas sp. KC8 
147 117 Transcriptional regulator, GntR family 79 2711 42.67 30 1528 46.55 
150 147 Peptide methionine sulfoxide reductase  
MsrB (EC 1.8.4.12) 
34 1162 45.8 66 3833 52.07 
160 684 Threonyl-tRNA synthetase (EC 6.1.1.3) 16 568 41.68 66 3779 41.18 
164 376 Phosphatidylinositol alpha- 
mannosyltransferase (EC 2.4.1.57) 
66 2268 34.33 8 253 30.26 
170 251 FIG000859: hypothetical protein 110 3674 44.98 27 1222 41.53 
171 192 Crossover junction endodeoxyribonuclease 
 RuvC (EC 3.1.22.4) 
110 3675 39.74 27 1223 39.29 
172 202 Holliday junction DNA helicase RuvA 110 3676 37.16 27 1224 47.33 
173 378 Holliday junction DNA helicase RuvB 110 3677 56.11 27 1226 52.48 
175 552 Protein-export membrane protein  
SecD (TC 3.A.5.1.1) 
105 3299 26.95 26 972 36 
176 392 Protein-export membrane protein  
SecF (TC 3.A.5.1.1) 
105 3300 29.01 26 971 25.56 
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ATCC13557  
 
P. putida SJTE-1 Sphingomonas sp. KC8 
178 198 Adenine phosphoribosyltransferase  
(EC 2.4.2.7) 
78 2634 44.44 8 207 45.75 
179 779 GTP pyrophosphokinase (EC 2.7.6.5),  
(p)ppGpp synthetase I 
79 2670 40.2 27 1204 36.47 
183 427 Histidyl-tRNA synthetase (EC 6.1.1.21) 106 3319 42.73 66 3783 44.18 
186 335 Malate dehydrogenase (EC 1.1.1.37) 99 3116 23.79 26 1000 23.83 
198 519 Multicopper oxidase 93 2958 41.41 18 625 45.35 
202 154 Bona fide RidA/YjgF/TdcF/RutC subgroup 139 4603 30.97 40 2371 39.62 
203 342 Radical SAM domain protein 45 1271 35.6 39 2340 36.53 
207 310 YpfJ protein, zinc metalloprotease superfamily 60 1978 41.7 26 1016 38.64 
208 594 Aspartyl-tRNA synthetase (EC 6.1.1.12)  
@ Aspartyl-tRNA(Asn) synthetase (EC 6.1.1.23) 
110 3673 49.06 39 2188 43.41 
222 469 ATPase, AAA family 126 4247 44.32 26 1138 40.36 
223 891 Alanyl-tRNA synthetase (EC 6.1.1.7) 115 3855 41.76 40 2370 42.75 
224 147 Putative Holliday junction resolvase YqgF 68 2331 31.68 39 2125 29.23 
225 484 FIG004453: protein YceG like 34 1114 35.33 42 2406 24.93 
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P. putida SJTE-1 Sphingomonas sp. KC8 
227 379 Chorismate synthase (EC 4.2.3.5) 40 1205 33.05 45 2595 37.61 
228 185 Shikimate kinase I (EC 2.7.1.71) 73 2444 42.5 51 2920 41.1 
229 370 3-dehydroquinate synthase (EC 4.2.3.4) 73 2443 42.33 51 2919 42.36 
230 141 3-dehydroquinate dehydratase II (EC 4.2.1.10) 17 633 46.32 6 42 45.45 
233 188 Translation elongation factor P 35 1177 30.39 18 569 35.91 
234 168 Transcription termination protein NusB 94 2986 41.89 38 2057 35.87 
236 314 Aspartate carbamoyltransferase (EC 2.1.3.2) 68 2333 50.99 62 3589 53.31 
237 460 Dihydroorotase (EC 3.5.2.3) 68 2334 34.07 61 3558 50 
239 387 Carbamoyl-phosphate synthase  
small chain (EC 6.3.5.5) 
60 2050 44.16 62 3595 43.73 
240 1116 Carbamoyl-phosphate synthase  
large chain (EC 6.3.5.5) 
60 2049 57.58 62 3593 56.08 
243 169 Guanylate kinase (EC 2.7.4.8) 79 2663 40.91 54 3114 45.45 
245 429 Phosphopantothenoylcysteine  
decarboxylase (EC 4.1.1.36)  
79 2654 41.5 39 2099 43.77 
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P. putida SJTE-1 Sphingomonas sp. KC8 
/ Phosphopantothenoylcysteine synthetase (EC 
6.3.2.5) 
246 404 S-adenosylmethionine synthetase (EC 2.5.1.6) 68 2298 56.37 26 1090 50 
249 339 Magnesium and cobalt transport protein CorA 36 1191 37.35 66 3766 23.98 
253 308 Methionyl-tRNA formyltransferase (EC 2.1.2.9) 42 1228 41.33 39 2179 39.47 
254 496 Ribosomal RNA small subunit methyltransferase 
B (EC 2.1.1.-) 
42 1227 32.87 51 2828 37.25 
263 224 Ribulose-phosphate 3-epimerase (EC 5.1.3.1) 90 2879 46.82 30 1471 49.49 
264 337 Diaminohydroxyphosphoribosylaminopyrimidine  
deaminase (EC 3.5.4.26)  
/ 5-amino-6-(5-phosphoribosylamino)uracil 
reductase (EC 1.1.1.193) 
94 2982 38.63 54 3124 45.68 
265 204 Riboflavin synthase eubacterial/eukaryotic (EC 
2.5.1.9) 
94 2983 47.98 54 3123 40.1 
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P. putida SJTE-1 Sphingomonas sp. KC8 
266 416 3,4-dihydroxy-2-butanone 4-phosphate 
synthase (EC 4.1.99.12) 
 / GTP cyclohydrolase II (EC 3.5.4.25) 
94 2990 56.29 54 3063 52.38 
267 154 6,7-dimethyl-8-ribityllumazine synthase (EC 
2.5.1.78) 
94 2985 44.14 54 3121 38.4 
269 695 Excinuclease ABC subunit C 122 4184 35.14 21 901 35.99 
270 300 FIG000506: Predicted P-loop-containing kinase 108 3415 37.98 51 2816 43.6 
273 340 NAD-dependent glyceraldehyde-3-phosphate  
dehydrogenase (EC 1.2.1.12) 
109 3473 53.03 18 562 52.41 
274 409 Phosphoglycerate kinase (EC 2.7.2.3) 68 2294 41.69 18 564 44.58 
275 262 Triosephosphate isomerase (EC 5.3.1.1) 60 2040 47.62 39 2176 45.35 
280 932 Phosphoenolpyruvate carboxylase (EC 
4.1.1.31) 
59 1677 36.03 54 3149 47.54 
284 250 6-phosphogluconolactonase (EC 3.1.1.31), 
eukaryotic type 
109 3487 29.65 30 1618 28.32 
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P. putida SJTE-1 Sphingomonas sp. KC8 
286 484 Glucose-6-phosphate 1-dehydrogenase (EC 
1.1.1.49) 
124 4212 42.04 30 1617 41.06 
288 703 Transketolase (EC 2.2.1.1) 68 2296 42.79 18 561 43.5 
290 330 Heme O synthase, protoheme IX 
farnesyltransferase  
(EC 2.5.1.-) COX10-CtaB 
45 1284 39.69 30 1391 39.16 
304 421 Cysteine desulfurase (EC 2.8.1.7), SufS 
subfamily 
59 1655 40.15 66 3883 47.39 
306 135 PaaD-like protein (DUF59) involved in Fe-S 
cluster assembly 
146 4883 38.14 7 152 36.27 
312 544 ABC transporter ATP-binding protein 53 1528 35.93 54 3183 36.54 
317 934 Aconitate hydratase (EC 4.2.1.3)  
@ 2-methylisocitrate dehydratase (EC 4.2.1.99) 
30 942 55.8 66 3798 54.59 
320 377 COG0714: MoxR-like ATPases 33 1027 47.68 30 1407 43.65 
321 319 hypothetical protein PA3071 33 1028 30.94 30 1408 28.64 
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P. putida SJTE-1 Sphingomonas sp. KC8 
323 241 3-oxoacyl-[acyl-carrier protein] reductase (EC 
1.1.1.100) 
34 1118 47.9 42 2403 42.02 
358 452 FIG016551: Putative peptidase 59 1659 26.01 59 3368 28.99 
360 357 Dihydroorotate dehydrogenase (EC 1.3.3.1) 30 960 43.24 66 3876 44.97 
362 289 Heme ABC transporter, ATPase component 
HmuV 
60 2011 45.7 30 1492 42.53 
367 283 Undecaprenyl-diphosphatase (EC 3.6.1.27) 9 275 35.9 56 3289 31.97 
373 386 L-cysteine:1D-myo-inosityl 2-amino-2 
-deoxy-alpha-D-glucopyranoside ligase MshC 
9 232 38.57 42 2471 32.01 
383 384 FIG00995179: hypothetical protein 32 993 30.52 6 97 35.29 
385 1193 5-methyltetrahydrofolate-- 
homocysteine methyltransferase (EC 2.1.1.13) 
17 667 32.73 26 1112 35.94 
387 284 Rhodanese domain protein UPF0176,  
Actinobacterial subgroup 
47 1375 32.55 6 53 31.01 
390 284 ATP phosphoribosyltransferase (EC 2.4.2.17) 108 3432 30.41 38 2059 32.35 
397 342 possible transcriptional regulator 97 3060 41.79 51 2788 42.65 
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P. putida SJTE-1 Sphingomonas sp. KC8 
404 473 possible diacylglycerol kinase 62 2150 33.08 19 780 39.02 
409 318 Twin-arginine translocation protein TatC 68 2353 32.86 21 862 37.36 
425 245 Transcriptional regulator, GntR family 60 2060 36.23 54 3119 48.15 
433 1199 CobN component of cobalt chelatase involved  
in B12 biosynthesis 
140 4674 38.57 30 1436 38.07 
440 401 putative integrase 147 4937 29.18 50 2775 32.36 
445 517 TldD family protein, Actinobacterial subgroup 66 2280 31.22 54 3163 27.59 
452 544 Apolipoprotein N-acyltransferase (EC 2.3.1.-)  
in lipid-linked oligosaccharide synthesis cluster 
86 2843 38.46 26 1089 28.4 
458 712 Para-aminobenzoate synthase,  
 
amidotransferase component (EC 2.6.1.85)  
/ Para-aminobenzoate synthase, aminase 
component (EC 2.6.1.85) 
90 2883 42.64 39 2172 49.46 
470 147 Transcriptional regulator, AraC family 17 658 38.54 39 2338 37.76 
483 632 alkyl sulfatase (EC 3.1.6.-) 33 1013 51.05 34 1720 28.09 
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P. putida SJTE-1 Sphingomonas sp. KC8 
493 759 DEAD-box ATP-dependent RNA helicase CshA 
(EC 3.6.4.13) 
60 1890 41.59 66 3786 45.76 
494 487 6-phosphogluconate dehydrogenase, 
decarboxylating (EC 1.1.1.44) 
124 4211 37.03 22 914 32.48 
498 342 Pirin, N-terminal:Pirin, C-terminal 142 4770 41.18 54 3111 40.82 
507 724 Malate synthase G (EC 2.3.3.9) 86 2819 70.64 56 3221 62.01 
514 947 Glycine dehydrogenase [decarboxylating] 
 (glycine cleavage system P protein) (EC 
1.4.4.2) 
109 3452 60.78 59 3409 39.4 
521 135 Glycine cleavage system H protein 77 2561 50.39 59 3406 46.36 
525 204 CDP-diacylglycerol--glycerol-3-phosphate  
3-phosphatidyltransferase (EC 2.7.8.5) 
122 4185 35.16 51 2916 39.77 
527 211 Hypothetical nudix hydrolase YeaB 109 3529 52.78 45 2600 42.57 
532 231 Cytidylate kinase (EC 2.7.4.25) 46 1362 41.82 39 2157 42.08 
533 322 Pseudouridine synthase family protein 115 3828 43.25 38 2075 38.57 
534 238 Segregation and condensation protein B 115 3826 37.06 21 859 38.18 
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P. putida SJTE-1 Sphingomonas sp. KC8 
535 274 Segregation and condensation protein A 115 3825 30.5 21 858 32.91 
536 310 Chromosome (plasmid) partitioning protein ParA 81 2779 47.24 66 3861 44.98 
539 555 CTP synthase (EC 6.3.4.2) 59 1629 53.48 26 1156 51.64 
542 592 DNA repair protein RecN 60 2055 31.8 26 968 34.97 
543 314 NAD kinase (EC 2.7.1.23) 33 1047 36.36 56 3215 36.17 
557 491 Aldehyde dehydrogenase (EC 1.2.1.3) 135 4443 41.75 59 3392 53.09 
558 250 3-oxoacyl-[acyl-carrier protein]  
reductase (EC 1.1.1.100) 
33 1075 39.52 47 2643 41.04 
563 395 CAIB/BAIF family protein 45 1336 37.97 60 3513 41.14 
579 566 Fumarate hydratase class I, aerobic (EC 
4.2.1.2) 
108 3361 31.54 20 808 31.24 
580 340 Alcohol dehydrogenase (EC 1.1.1.1) 132 4338 32.9 63 3711 34.12 
584 159 3-demethylubiquinone-9 3-methyltransferase 136 4503 46.79 56 3267 53.75 
603 360 GTP-binding and nucleic acid-binding  
protein YchF 
99 3180 50.55 30 1466 51.09 
609 144 Transcriptional regulator, MarR family 45 1354 35.42 68 3917 36.36 
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P. putida SJTE-1 Sphingomonas sp. KC8 
613 414 FIG00761799: membrane protein 122 4121 28.66 30 1400 26.79 
617 335 4-hydroxy-3-methylbut-2-enyl diphosphate 
 
 reductase (EC 1.17.1.2) 
97 3082 49.68 59 3402 52.94 
619 398 Exodeoxyribonuclease VII large subunit (EC 
3.1.11.6) 
109 3493 33.1 30 1591 35.13 
620 77 Exodeoxyribonuclease VII small subunit (EC 
3.1.11.6) 
94 2997 41.82 49 2763 39.29 
623 469 Fumarate hydratase class II (EC 4.2.1.2) 108 3410 51.85 54 3029 51.78 
629 437 Serine hydroxymethyltransferase (EC 2.1.2.1) 80 2760 54.39 34 1819 54.4 
647 165 Transcription elongation factor GreA 60 2047 36.51 62 3592 36.03 
650 385 Cystathionine gamma-lyase (EC 4.4.1.1) 112 3726 43.68 66 3800 37.03 
652 461 Cystathionine beta-synthase (EC 4.2.1.22) 114 3750 42.77 62 3675 40.66 
658 409 Ribosomal RNA small subunit  
methyltransferase C (EC 2.1.1.52) 
100 3217 33.73 66 3785 40.22 
667 319 Exopolyphosphatase (EC 3.6.1.11) 77 2586 34.5 30 1627 34.37 
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P. putida SJTE-1 Sphingomonas sp. KC8 
670 429 Enolase (EC 4.2.1.11) 126 4267 58.5 20 813 61.79 
672 303 Ferrous iron transport permease EfeU 53 1512 29.41 44 2498 28.33 
675 536 ABC transporter ATP-binding protein 140 4670 34.87 61 3532 36.81 
676 229 Nucleoside triphosphate pyrophosphohydrolase 
 MazG (EC 3.6.1.8) 
51 1478 35.62 59 3439 33.04 
677 1226 Transcription-repair coupling factor 30 908 46.25 26 1027 39.31 
679 490 N-acetylglucosamine-1-phosphate 
 uridyltransferase (EC 2.7.7.23) 
 / Glucosamine-1-phosphate N-
acetyltransferase (EC 2.3.1.157) 
81 2769 44.35 42 2463 39.87 
680 327 Ribose-phosphate pyrophosphokinase (EC 
2.7.6.1) 
99 3183 40.58 54 3061 44.73 
688 393 Cysteine desulfurase (EC 2.8.1.7) 29 845 33.11 62 3688 38.89 
691 198 LSU ribosomal protein L25p 99 3182 32.29 30 1463 35.64 
692 193 Peptidyl-tRNA hydrolase (EC 3.1.1.29) 99 3181 42.16 30 1465 37.57 
722 431 sensor histidine kinase 108 3367 31.19 29 1288 34.48 
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P. putida SJTE-1 Sphingomonas sp. KC8 
740 266 SSU rRNA (adenine(1518)-N(6)/adenine 
(1519)-N(6))-dimethyltransferase (EC 2.1.1.182) 
90 2865 36.36 51 2830 39.69 
745 280 Putative deoxyribonuclease YcfH 34 1111 37.92 62 3604 34.51 
746 529 Methionyl-tRNA synthetase (EC 6.1.1.10) 62 2131 27.32 62 3605 62.4 
750 277 rRNA small subunit methyltransferase I 60 1858 36.4 26 1175 37.14 
757 97 Arsenate reductase (EC 1.20.4.1) 51 1490 45.92 6 39 51.04 
759 133 Redox-sensitive transcriptional activator SoxR 32 998 52.34 30 1527 53.91 
770 210 Ribosomal-protein-S5p-alanine 
acetyltransferase 
105 3276 27.27 34 1826 27.84 
772 269 UTP--glucose-1-phosphate uridylyltransferase 
(EC 2.7.7.9) 
132 4355 34.8 66 3768 38.02 
777 146 Large-conductance mechanosensitive channel 60 1966 35.66 30 1473 37.74 
779 159 Molybdenum cofactor biosynthesis protein 
MoaB 
30 933 36.03 29 1298 36.89 
780 462 Heat shock protein HtrA 59 1751 42.11 57 3327 42.58 
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P. putida SJTE-1 Sphingomonas sp. KC8 
781 456 Osmosensitive K+ channel histidine 
 kinase KdpD (EC 2.7.3.-) 
59 1761 35 51 2818 33.13 
783 204 FIG00996993: hypothetical protein 65 2235 31.68 26 1093 32.12 
788 55 LSU ribosomal protein L33p @ LSU ribosomal  
protein L33p, zinc-independent 
78 2650 46.94 35 1931 59.09 
790 85 SSU ribosomal protein S18p @ SSU ribosomal 
 protein S18p, zinc-independent 
65 2214 45.61 42 2398 46.15 
801 129 Lactoylglutathione lyase and related lyases 13 489 62.9 66 3801 33.66 
806 523 IMP cyclohydrolase (EC 3.5.4.10)  
/ Phosphoribosylaminoimidazolecarboxamide  
formyltransferase (EC 2.1.2.3) 
62 2159 44.78 30 1469 47.97 
812 301 Succinyl-CoA ligase [ADP-forming] alpha chain 
(EC 6.2.1.5) 
121 4083 53.36 26 1001 50.66 
813 390 Succinyl-CoA ligase [ADP-forming] beta chain 
(EC 6.2.1.5) 
121 4082 41.48 54 3050 38.86 
816 825 ATP-dependent DNA helicase UvrD/PcrA 79 2721 39.46 42 2439 38 
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820 531 Glucose-6-phosphate isomerase (EC 5.3.1.9) 60 2026 46.55 59 3430 40.53 
842 161 Dihydrofolate reductase (EC 1.5.1.3) 74 2498 37.66 57 3344 40.99 
852 330 Rod shape-determining protein MreB 108 3399 37.5 29 1321 36.73 
860 406 Flavohemoprotein (Hemoglobin-like protein) ( 
Flavohemoglobin) 
 (Nitric oxide dioxygenase) (EC 1.14.12.17) 
104 3266 35.87 25 950 32.44 
871 117 HspR, transcriptional repressor of DnaK operon 100 3195 43.1 39 2198 40.54 
878 198 FIG00998616: hypothetical protein 7 125 61.24 6 82 37.31 
879 352 Transposase 7 130 68.21 44 2573 33.54 
881 326 Quinone oxidoreductase (EC 1.6.5.5) 7 132 68.62 66 3854 45.4 
882 343 Transcriptional regulator, AraC family 7 126 40 37 1968 26.47 
884 455 Transporter, MFS superfamily 7 129 52.8 47 2642 29.52 
895 266 alginate biosynthesis regulatory protein AlgR 
(lytT) 
109 3533 38.84 54 3157 37.09 
896 410 Autolysis histidine kinase LytS 116 3940 32.73 54 3158 38.94 
903 793 Beta-glucosidase (EC 3.2.1.21) 59 1780 29.41 37 1973 35.28 
P a g e  | 305 
Gene Length Function Contig Gene percent 
identity 
(%) 
Contig Gene percent 
identity (%) 
R. equi 
ATCC13557  
 
P. putida SJTE-1 Sphingomonas sp. KC8 
912 341 ATPase 17 690 42.77 51 2869 34.65 
920 308 putative oxidoreductase 33 1055 43.96 26 1018 43.69 
921 271 Enoyl-CoA hydratase (EC 4.2.1.17) 134 4429 37.9 37 1962 39.63 
926 193 Copper metallochaperone, bacterial analog of 
Cox17 protein 
63 2173 33.02 26 1182 38.89 
930 300 ABC transporter, ATP-binding protein 77 2576 40.99 68 3933 39.62 
932 502 Acetyl-coenzyme A carboxyl transferase 
 alpha chain (EC 6.4.1.2)  
/ Acetyl-coenzyme A carboxyl transferase beta 
chain (EC 6.4.1.2) 
33 1081 39.06 42 2384 37.97 
935 335 Putative oxidoreductase YncB 43 1240 39.22 21 903 48.33 
944 400 NADH:flavin oxidoreductases, Old Yellow 
Enzyme family 
7 154 32.68 39 2212 38.54 
947 458 Deoxyribodipyrimidine photolyase (EC 4.1.99.3) 100 3194 36.4 51 2910 39.66 
949 221 Transcriptional regulator, GntR family 8 229 32.09 44 2560 38.35 
950 282 Fumarylacetoacetate hydrolase family protein 50 1428 31.25 44 2559 43.63 
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956 242 FKBP-type peptidyl-prolyl cis-trans isomerase 116 3964 42.34 30 1402 37.96 
957 433 Citrate synthase (si) (EC 2.3.3.1) 121 4074 57.25 51 2855 55.97 
960 217 Pyridoxamine 5'-phosphate oxidase (EC 1.4.3.5) 110 3593 48.95 45 2588 42.02 
962 373 Phosphoserine aminotransferase (EC 2.6.1.52) 46 1365 21.56 26 1144 23.28 
974 301 NADH pyrophosphatase (EC 3.6.1.22) 125 4225 36.73 26 1149 36.53 
996 483 Nitrate/nitrite transporter 30 963 29.19 62 3702 29.17 
1000 393 Sulfur carrier protein adenylyltransferase ThiF 100 3190 45.34 39 2096 45.16 
1006 546 putative ATP-dependent RNA helicase 68 2313 45.29 14 508 41.71 
1017 225 RNA polymerase sigma-E factor 9 248 32.72 21 869 35.45 
1018 167 Cys-tRNA(Pro) deacylase YbaK 109 3544 51.57 13 491 42.41 
1019 342 luciferase family protein 147 4946 50.32 7 119 53.27 
1032 946 Protein export cytoplasm protein SecA  
ATPase RNA helicase (TC 3.A.5.1.1) 
60 1840 46.95 61 3560 48.93 
1040 484 Adenosylhomocysteinase (EC 3.3.1.1) 68 2308 49.81 61 3573 62.21 
1045 509 Amino acid permease 13 475 26.64 54 3037 40.76 
1048 461 Phosphomannomutase (EC 5.4.2.8) 79 2656 35.45 54 3128 36.53 
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1060 396 4-carboxymuconolactone decarboxylase (EC 
4.1.1.44) 
60 1802 44.92 54 3127 42.86 
1061 277 Pca regulon regulatory protein PcaR 60 1808 42.11 26 1129 26.85 
1062 404 Acetyl-CoA acetyltransferase (EC 2.3.1.9) 146 4878 47.45 39 2280 42.14 
1063 274 possible sugar phosphate isomerase/ 
epimerase 
13 467 44.72 52 2955 29.5 
1065 365 FIG00995642: hypothetical protein 13 468 30.17 44 2542 25.85 
1066 268 oxidoreductase of aldo/keto reductase family, 
subgroup 1 
135 4458 38.1 52 2951 38.57 
1068 297 Quinate/shikimate 5-dehydrogenase I delta (EC 
1.1.1.25) 
17 634 49.64 66 3847 33.7 
1076 428 benzoate MFS transporter BenK 2 5 36.3 30 1539 32.54 
1079 301 dTDP-Rha:A-D-GlcNAc-diphosphoryl  
polyprenol, A-3-L-rhamnosyl transferase WbbL 
3 35 29.68 54 2981 28.99 
1080 282 dTDP-4-dehydrorhamnose reductase (EC 
1.1.1.133) 
94 2968 26.69 54 2985 42.51 
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1087 170 Phosphoribosylaminoimidazole carboxylase 
 catalytic subunit (EC 4.1.1.21) 
79 2703 59.74 54 3053 64.63 
1088 422 Phosphoribosylaminoimidazole carboxylase  
ATPase subunit (EC 4.1.1.21) 
79 2702 35.21 54 3052 34.81 
1100 304 Thiosulfate sulfurtransferase, rhodanese (EC 
2.8.1.1) 
65 2241 31.02 57 3333 33 
1123 503 Glycerol kinase (EC 2.7.1.30) 109 3542 56.54 26 965 51.75 
1125 401 Transcriptional regulator, GntR family domain  
/ Aspartate aminotransferase (EC 2.6.1.1) 
78 2644 31.87 54 2990 30.84 
1145 584 Succinate dehydrogenase flavoprotein subunit 
(EC 1.3.99.1) 
121 4077 48.44 51 2872 49.05 
1146 259 Succinate dehydrogenase iron-sulfur protein 
(EC 1.3.99.1) 
121 4078 42.74 51 2871 39.52 
1147 445 D-alanyl-D-alanine carboxypeptidase (EC 
3.4.16.4) 
132 4381 30.43 62 3608 32.22 
1149 348 Tryptophanyl-tRNA synthetase (EC 6.1.1.2) 60 1873 35.33 39 2107 48.35 
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1155 438 O-acetylhomoserine sulfhydrylase (EC 2.5.1.49)  
/ O-succinylhomoserine sulfhydrylase (EC 
2.5.1.48) 
14 536 54.44 51 2812 57.31 
1158 290 Methylenetetrahydrofolate dehydrogenase 
(NADP+) (EC 1.5.1.5)  
/ Methenyltetrahydrofolate cyclohydrolase (EC 
3.5.4.9) 
29 786 46.5 35 1947 45.36 
1161 182 tRNA (cytidine(34)-2'-O)-methyltransferase (EC 
2.1.1.207) 
70 2386 51.97 8 212 36.42 
1163 346 Putative membrane protein YeiH 135 4469 37.29 62 3678 32.38 
1171 103 rhodanese-related sulfurtransferase 70 2389 30.49 65 3739 38.3 
1173 1094 DNA polymerase III alpha subunit (EC 2.7.7.7) 4 54 42.17 46 2640 39.11 
1194 526 GMP synthase [glutamine-hydrolyzing] (EC 
6.3.5.2) 
109 3498 51.81 30 1581 54.21 
1197 489 Inosine-5'-monophosphate dehydrogenase (EC 
1.1.1.205) 
109 3497 56.2 51 2827 58.2 
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1207 101 Heat shock protein 60 family co-chaperone 
GroES 
60 1824 40.62 26 1095 51.04 
1210 446 Large subunit naph/bph dioxygenase 80 2752 32.5 44 2530 30.49 
1211 123 3-phenylpropionate dioxygenase ferredoxin 
subunit 
7 127 32.89 31 1655 43.4 
1213 190 Biphenyl dioxygenase subunit beta (EC 
1.14.12.18)  
(Biphenyl 2,3-dioxygenase) 
2 8 25.64 44 2529 34.13 
1230 347 TsaD/Kae1/Qri7 protein, required for 
threonylcarbamoyladenosine 
 t(6)A37 formation in tRNA 
90 2854 44.54 54 3107 43.38 
1231 166 Ribosomal-protein-S18p-alanine 
acetyltransferase (EC 2.3.1.-) 
99 3156 32.26 59 3422 44.74 
1232 225 TsaB protein, required for 
threonylcarbamoyladenosine 
 (t(6)A) formation in tRNA 
59 1675 33.52 59 3423 52.63 
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1234 182 TsaE protein, required for 
threonylcarbamoyladenosine  
t(6)A37 formation in tRNA 
65 2232 43.37 61 3571 35 
1236 409 Alanine racemase (EC 5.1.1.1) 78 2638 35.43 6 48 35.56 
1237 488 NAD(P)HX epimerase / NAD(P)HX dehydratase 65 2233 36.46 43 2478 39.66 
1240 621 Glucosamine--fructose-6-phosphate 
aminotransferase  
[isomerizing] (EC 2.6.1.16) 
81 2767 44.71 42 2464 45.66 
1244 443 Phosphoglucosamine mutase (EC 5.4.2.10) 60 2041 45.62 34 1832 46.36 
1245 169 SSU ribosomal protein S9p (S16e) 60 1868 54.55 6 73 50 
1246 148 LSU ribosomal protein L13p (L13Ae) 60 1869 52.82 6 74 45.86 
1258 381 Butyryl-CoA dehydrogenase (EC 1.3.99.2) 140 4684 44.62 12 384 38.74 
1259 297 tRNA pseudouridine synthase A (EC 4.2.1.70) 33 1083 34.75 62 3616 35.71 
1260 181 LSU ribosomal protein L17p 90 2943 50.52 56 3231 47.27 
1261 355 DNA-directed RNA polymerase alpha subunit 
(EC 2.7.7.6) 
90 2942 42.99 56 3232 45.42 
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1262 202 SSU ribosomal protein S4p (S9e) 90 2941 47.09 34 1815 41.01 
1263 138 SSU ribosomal protein S11p (S14e) 90 2940 60.63 56 3233 62.1 
1264 123 SSU ribosomal protein S13p (S18e) 90 2939 57.26 56 3234 56.56 
1266 86 Translation initiation factor 1 126 4242 69.01 19 744 58.9 
1269 182 Adenylate kinase (EC 2.7.4.3) 59 1676 42.47 3 22 43.98 
1270 441 Preprotein translocase secY subunit (TC 
3.A.5.1.1) 
90 2937 43.25 19 750 41.83 
1271 147 LSU ribosomal protein L15p (L27Ae) 90 2936 39.46 19 751 44.67 
1272 60 LSU ribosomal protein L30p (L7e) 90 2935 38.6 19 752 43.86 
1273 214 SSU ribosomal protein S5p (S2e) 90 2934 53.01 19 753 51.95 
1274 136 LSU ribosomal protein L18p (L5e) 90 2933 54.26 19 754 61.29 
1275 180 LSU ribosomal protein L6p (L9e) 90 2932 47.68 19 755 52.84 
1276 133 SSU ribosomal protein S8p (S15Ae) 90 2931 50 19 756 46.21 
1278 189 LSU ribosomal protein L5p (L11e) 90 2929 58.52 19 758 59.22 
1279 106 LSU ribosomal protein L24p (L26e) 90 2928 38.83 19 759 42.59 
1280 123 LSU ribosomal protein L14p (L23e) 90 2927 68.03 19 760 64.23 
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1281 91 SSU ribosomal protein S17p (S11e) 90 2926 63.51 19 761 52.05 
1282 79 LSU ribosomal protein L29p (L35e) 90 2925 42.37 19 762 49.12 
1283 139 LSU ribosomal protein L16p (L10e) 90 2924 54.87 19 763 57.46 
1284 266 SSU ribosomal protein S3p (S3e) 90 2923 53.54 19 764 52.38 
1285 135 LSU ribosomal protein L22p (L17e) 90 2922 57.14 19 765 45.54 
1286 94 SSU ribosomal protein S19p (S15e) 90 2921 64.13 19 766 61.96 
1287 278 LSU ribosomal protein L2p (L8e) 90 2920 64.6 19 767 49.82 
1288 102 LSU ribosomal protein L23p (L23Ae) 90 2919 48.1 19 768 43.33 
1289 222 LSU ribosomal protein L4p (L1e) 90 2918 46.72 19 769 32.67 
1290 218 LSU ribosomal protein L3p (L3e) 90 2917 53.4 19 770 48.54 
1291 102 SSU ribosomal protein S10p (S20e) 90 2916 60 19 771 56.44 
1306 352 Probable phenylacetic acid degradation  
NADH oxidoreductase paaE (EC 1.-.-.-) 
80 2753 32.86 22 907 32.63 
1308 196 Transcriptional regulator, TetR family 97 3069 41.94 62 3681 50.88 
1309 256 Glutamate racemase (EC 5.1.1.3) 100 3191 35.35 34 1823 36.87 
1320 397 Translation elongation factor Tu 90 2903 66.75 19 772 71.75 
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1321 701 Translation elongation factor G 122 4169 58.61 19 773 61.77 
1322 157 SSU ribosomal protein S7p (S5e) 90 2913 62.6 19 774 56.41 
1323 125 SSU ribosomal protein S12p (S23e) 90 2912 71.54 19 775 73.98 
1331 533 Methylcrotonyl-CoA carboxylase 
 carboxyl transferase subunit (EC 6.4.1.4) 
122 4193 51.95 38 2022 49.16 
1338 319 Alcohol dehydrogenase (EC 1.1.1.1) 77 2579 45.28 26 1071 37 
1343 1320 DNA-directed RNA polymerase  
beta' subunit (EC 2.7.7.6) 
90 2911 50.7 11 378 51.77 
1344 1163 DNA-directed RNA polymerase  
beta subunit (EC 2.7.7.6) 
90 2910 56.95 11 379 58.35 
1354 257 Conserved hypothetical integral  
membrane protein YrbE1A 
108 3426 31.71 54 3144 34.72 
1355 349 Methionine ABC transporter  
ATP-binding protein 
108 3425 38.93 39 2279 40.73 
1356 129 LSU ribosomal protein L7/L12 (P1/P2) 90 2909 52.8 6 25 54.47 
1357 186 LSU ribosomal protein L10p (P0) 90 2908 33.93 6 26 36.42 
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1358 238 LSU ribosomal protein L1p (L10Ae) 90 2907 52 6 27 57.4 
1359 145 LSU ribosomal protein L11p (L12e) 90 2906 55.14 6 28 57.45 
1360 266 Transcription antitermination protein NusG 90 2905 43.68 6 29 42.02 
1366 302 Probable protease htpX homolog (EC 3.4.24.-) 35 1165 29.74 26 994 40.36 
1369 233 2-heptaprenyl-1,4-naphthoquinone  
methyltransferase MenG (EC 2.1.1.163) 
68 2346 39.83 59 3407 37.86 
1381 540 ATP-dependent DNA helicase RecQ 115 3807 38.9 66 3776 42.94 
1389 393 Probable low-affinity inorganic phosphate 
transporter 
122 4179 38.84 57 3318 41.88 
1414 325 Cytochrome c-type biogenesis protein 
CcsA/ResC 
116 3956 34.65 28 1265 31.76 
1434 326 Porphobilinogen synthase (EC 4.2.1.24) 8 223 48.75 13 410 53.68 
1436 335 Porphobilinogen deaminase (EC 2.5.1.61) 53 1519 40.97 54 3108 42.57 
1445 267 Pyrroline-5-carboxylate reductase (EC 1.5.1.2) 73 2460 43.17 20 839 35.34 
1457 95 hypothetical protein 60 1983 40 28 1258 35.82 
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1460 445 Glycosyltransferase MshA involved  
in mycothiol biosynthesis (EC 2.4.1.-) 
66 2273 38.16 49 2760 36.84 
1479 368 UDP-N-acetylenolpyruvoylglucosamine  
reductase (EC 1.1.1.158) 
34 1129 34.76 38 2095 36.22 
1487 296 Formyltetrahydrofolate deformylase (EC 
3.5.1.10) 
60 1817 59.65 56 3206 47.54 
1498 287 UDP-galactose-lipid carrier transferase (EC 2.-.-
.-) 
48 1380 33.78 39 2189 37.24 
1511 231 Urea ABC transporter, ATPase protein UrtE 63 2182 42.99 54 3022 35.45 
1512 1196 Urea carboxylase (EC 6.3.4.6) 122 4191 48.97 54 2996 49.08 
1520 295 probable 3-oxoacyl-(acyl carrier protein) 
reductase 
60 1910 36.65 59 3489 39.78 
1527 468 Dihydrolipoamide dehydrogenase (EC 1.8.1.4) 121 4081 41.2 19 781 44.99 
1533 316 Transcriptional regulator, AsnC family 77 2556 41.24 6 49 40.43 
1539 542 Heat shock protein 60 family chaperone GroEL 60 1823 61.64 26 1096 58.79 
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1545 263 CDP-diacylglycerol--serine O- 
phosphatidyltransferase (EC 2.7.8.8) 
60 2000 32.12 8 205 42.99 
1548 726 FIG00999703: hypothetical protein 60 2043 40.35 29 1294 42.61 
1565 206 Peptide deformylase (EC 3.5.1.88) 42 1229 39.33 62 3613 40.94 
1567 267 Exodeoxyribonuclease III (EC 3.1.11.2) 11 393 35.96 21 877 38.43 
1573 284 Hydroxymethylpyrimidine phosphate kinase  
 
ThiD (EC 2.7.4.7) 
62 2119 32.92 34 1833 39.92 
1578 331 transcriptional regulator, AraC family 78 2613 37.5 52 2956 37.27 
1582 250 Thiazole biosynthesis protein ThiG 73 2469 51.56 6 43 53.04 
1584 356 Glycine oxidase ThiO (EC 1.4.3.19) 97 3088 30.47 12 400 26.21 
1585 231 Thiamin-phosphate pyrophosphorylase (EC 
2.5.1.3) 
62 2120 30.69 18 567 31.1 
1590 963 DNA topoisomerase I (EC 5.99.1.2) 30 917 43.99 34 1827 37.49 
1601 273 Phosphoserine phosphatase (EC 3.1.3.3) 49 1416 35.19 54 3143 29.27 
1608 663 Acetyl-coenzyme A synthetase (EC 6.2.1.1) 60 2027 51.57 39 2224 53.07 
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1612 468 L-Proline/Glycine betaine transporter ProP 59 1722 52.07 42 2442 46.75 
1613 403 Na+/H+ antiporter NhaA type 110 3596 41.36 54 3046 40.41 
1618 223 Possible membrane-anchored thioredoxin-like 
protein 
116 3957 39.39 61 3566 40.48 
1619 227 Endonuclease III (EC 4.2.99.18) 110 3560 43.88 18 694 38.34 
1623 225 cAMP-binding proteins - catabolite gene 
activator and  
regulatory subunit of cAMP-dependent protein 
kinases 
90 2887 30.48 30 1537 29.3 
1625 311 Chromosome initiation inhibitor 10 304 32.38 30 1557 40.78 
1630 153 Bona fide RidA/YjgF/TdcF/RutC subgroup 29 805 34.09 30 1560 61.84 
1631 260 4-oxalocrotonate decarboxylase (EC 4.1.1.77) 138 4561 30.29 30 1559 48.68 
1645 774 Multimodular transpeptidase-transglycosylase 
 (EC 2.4.1.129) (EC 3.4.-.-) 
73 2472 36.97 30 1621 35.71 
1648 188 ThiJ/PfpI family protein 11 376 42.13 39 2098 24.43 
1655 459 FAD dependent oxidoreductase 76 2522 32.97 14 506 43.88 
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1669 489 Catalase (EC 1.11.1.6) 90 2944 55.56 54 3117 54.26 
1680 628 Acylamino-acid-releasing enzyme 86 2837 28.18 34 1814 29.18 
1686 133 Arsenate reductase (EC 1.20.4.1) 11 383 32.33 44 2512 28.44 
1701 344 Aspartate-semialdehyde dehydrogenase (EC 
1.2.1.11) 
33 1085 36.02 28 1249 45.43 
1702 422 Aspartokinase (EC 2.7.2.4) 115 3856 49.39 59 3388 47.87 
1713 568 2-isopropylmalate synthase (EC 2.3.3.13) 109 3490 55.48 11 313 25.56 
1717 253 3-oxoacyl-[acyl-carrier protein] reductase (EC 
1.1.1.100) 
33 1059 40.4 1 2 43.31 
1745 207 Transcriptional regulator, GntR family 135 4481 40 47 2693 42.86 
1754 195 Recombination protein RecR 118 4014 48.44 62 3614 41.67 
1755 108 FIG000557: hypothetical protein co-occurring 
with RecR 
117 4013 39.81 62 3683 31.19 
1759 433 Cyclopropane-fatty-acyl-phospholipid synthase 
(EC 2.1.1.79) 
79 2734 36.99 51 2911 38.58 
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1768 213 regulatory protein, LuxR:Response regulator 
receiver 
122 4183 35.45 22 915 33.77 
1772 314 transcriptional regulator, AraC family 135 4465 38.57 51 2879 38.95 
1777 718 DNA polymerase III subunits gamma and tau 
(EC 2.7.7.7) 
117 4012 37.58 62 3684 38.34 
1805 305 glutamyl-Q-tRNA synthetase 60 2018 43.21 30 1566 47.47 
1806 406 UDP-N-acetylglucosamine 1- 
carboxyvinyltransferase (EC 2.5.1.7) 
108 3431 46.19 68 3923 45.74 
1807 167 ATP:Cob(I)alamin adenosyltransferase (EC 
2.5.1.17) 
60 1836 37.8 30 1568 47.62 
1809 123 ATP synthase epsilon chain (EC 3.6.3.14) 81 2770 33.67 39 2288 37.78 
1810 483 ATP synthase beta chain (EC 3.6.3.14) 81 2771 61.42 39 2289 61.52 
1811 327 ATP synthase gamma chain (EC 3.6.3.14) 81 2772 38.56 39 2290 32.82 
1812 548 ATP synthase alpha chain (EC 3.6.3.14) 81 2773 53.02 39 2291 56.78 
1813 275 ATP synthase delta chain (EC 3.6.3.14) 81 2774 39.02 39 2292 39.74 
1816 260 ATP synthase F0 sector subunit a 81 2776 27.91 21 896 32.14 
P a g e  | 321 
Gene Length Function Contig Gene percent 
identity 
(%) 
Contig Gene percent 
identity (%) 
R. equi 
ATCC13557  
 
P. putida SJTE-1 Sphingomonas sp. KC8 
1819 220 TsaC protein (YrdC domain) required for  
threonylcarbamoyladenosine t(6)A37 
modification in tRNA 
115 3824 30.05 59 3436 35.78 
1822 360 Peptide chain release factor 1 100 3188 46.81 66 3784 47.7 
1823 78 LSU ribosomal protein L31p @ LSU ribosomal 
protein L31p, zinc-dependent 
73 2452 56.94 8 191 39.13 
1824 681 Transcription termination factor Rho 77 2584 56.99 66 3852 55.86 
1827 438 Homoserine dehydrogenase (EC 1.1.1.3) 59 1710 38.44 54 3089 42.14 
1829 551 Arginyl-tRNA synthetase (EC 6.1.1.19) 73 2454 26.74 21 855 40.11 
1838 618 Sulfate adenylyltransferase subunit 1 (EC 
2.7.7.4) 
60 1879 47.52 51 2945 48.9 
1839 309 Sulfate adenylyltransferase subunit 2 (EC 
2.7.7.4) 
60 1880 50.83 51 2944 49.83 
1850 259 Enoyl-CoA hydratase (EC 4.2.1.17) 29 836 66.67 30 1531 58.17 
1851 304 3-hydroxyisobutyrate dehydrogenase (EC 
1.1.1.31) 
60 1989 46.26 30 1530 54.36 
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1852 359 3-hydroxyisobutyryl-CoA hydrolase (EC 3.1.2.4) 140 4685 39.88 30 1532 42.18 
1853 383 Butyryl-CoA dehydrogenase (EC 1.3.99.2) 29 837 43.28 30 1533 57.07 
1855 502 Methylmalonate-semialdehyde dehydrogenase 
(EC 1.2.1.27) 
97 3072 57.46 30 1534 64.26 
1865 416 N-acetyl-L,L-diaminopimelate deacetylase (EC 
3.5.1.47) 
4 67 48.82 26 997 42.96 
1873 343 putative phosphotransferase 130 4319 33.22 13 408 33.44 
1874 208 Transcriptional regulator, AsnC family 135 4476 36 62 3669 33.54 
1875 366 Pyruvate dehydrogenase E1 component alpha 
subunit (EC 1.2.4.1) 
116 3868 35.09 42 2418 34.97 
1876 334 Pyruvate dehydrogenase E1 component beta 
subunit (EC 1.2.4.1) 
116 3867 46.99 42 2419 45.1 
1879 477 NAD(P) transhydrogenase subunit beta (EC 
1.6.1.2) 
45 1331 45.76 34 1843 47.59 
1880 109 NAD(P) transhydrogenase alpha subunit (EC 
1.6.1.2) 
45 1332 45.35 34 1841 39.22 
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1881 372 NAD(P) transhydrogenase alpha subunit (EC 
1.6.1.2) 
45 1333 49.45 34 1840 43.94 
1899 460 Glycolate dehydrogenase (EC 1.1.99.14), 
subunit GlcD 
134 4416 39.25 56 3217 39.01 
1950 293 Predicted L-lactate dehydrogenase, Fe-S 
oxidoreductase subunit YkgE 
134 4414 21.77 56 3219 24.8 
1969 260 Alkanesulfonates transport system permease 
protein 
53 1566 52.87 30 1546 26.83 
1972 455 nitrilotriacetate monooxygenase component A 11 355 37.16 49 2739 26.51 
1977 710 Protease II (EC 3.4.21.83) 113 3738 45.06 8 162 40.88 
1995 226 Phosphoribosylformylglycinamidine synthase, 
 glutamine amidotransferase subunit (EC 
6.3.5.3) 
109 3504 29.26 18 551 59.02 
1998 476 C4-dicarboxylate-transport transmembrane 
protein DctA 
110 3648 48.05 20 784 45.05 
2008 527 Amidophosphoribosyltransferase (EC 2.4.2.14) 33 1077 35.93 26 1075 44.69 
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2009 360 Phosphoribosylformylglycinamidine cyclo-ligase 
(EC 6.3.3.1) 
50 1470 44.67 39 2180 43.14 
2014 506 Cytochrome d ubiquinol oxidase subunit I (EC 
1.10.3.-) 
60 1972 31.84 39 2265 32.11 
2015 341 Cytochrome d ubiquinol oxidase subunit II (EC 
1.10.3.-) 
60 1971 32.65 39 2266 35.4 
2031 302 Phosphate transport system permease protein 
PstA (TC 3.A.1.7.1) 
79 2695 35.04 42 2458 36.54 
2032 259 Phosphate transport ATP-binding protein PstB 
(TC 3.A.1.7.1) 
138 4569 57.65 42 2457 58.59 
2035 222 Phosphate transport system regulatory protein 
PhoU 
79 2692 28.23 42 2456 31.67 
2039 381 tRNA dihydrouridine synthase B (EC 1.-.-.-) 62 2157 38.34 59 3446 37.95 
2051 69 Mobile element protein 59 1712 59.26 26 1171 68.29 
2057 403 POSSIBLE OXIDOREDUCTASE 53 1549 25.96 34 1690 42.03 
2079 305 Methylisocitrate lyase (EC 4.1.3.30) 28 750 42.35 29 1315 33.33 
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2098 404 Serine phosphatase RsbU, regulator of sigma 
subunit 
45 1307 37.14 11 368 36.27 
2110 339 transcriptional regulator, AraC family protein 134 4408 30.52 17 545 33.51 
2111 395 Aspartate aminotransferase (EC 2.6.1.1) 106 3323 40.21 6 64 43.4 
2145 351 ABC transporter (iron.B12.siderophore.hemin) , 
permease component 
17 623 43.75 30 1493 39.46 
2156 637 Methionine ABC transporter ATP-binding protein 66 2265 35.28 54 3186 37.08 
2157 145 Transcriptional regulator, MarR family 128 4298 36.11 25 937 39.24 
2161 393 Valine--pyruvate aminotransferase (EC 
2.6.1.66) 
60 2016 34.97 6 51 44.09 
2162 418 Phosphoribosylamine--glycine ligase (EC 
6.3.4.13) 
62 2161 46.59 30 1592 45.5 
2168 465 Two-component system response phosphate 
sensor kinase, PhoR 
79 2688 38.05 61 3572 38.74 
2170 105 Quaternary ammonium compound-resistance 
protein SugE 
50 1436 39.22 34 1760 42.31 
P a g e  | 326 
Gene Length Function Contig Gene percent 
identity 
(%) 
Contig Gene percent 
identity (%) 
R. equi 
ATCC13557  
 
P. putida SJTE-1 Sphingomonas sp. KC8 
2204 255 Conserved hypothetical integral membrane 
protein YrbE1A 
45 1317 31.67 39 2278 34.65 
2216 254 3-hydroxyacyl-CoA dehydrogenase (EC 
1.1.1.35)  
@ 17hydroxysteroid dehydrogenase type 10 
(HSD10)-like 
29 839 54.9 51 2892 60.94 
2245 530 Long-chain fatty-acid-CoA ligase (EC 6.2.1.3), 
Mycobacterial subgroup FadD3 
122 4196 35.34 39 2335 44.68 
2286 410 CDP-4-dehydro-6-deoxy-D-glucose 3-
dehydratase (EC 4.2.1.-) 
116 3894 32.91 8 268 47.74 
2304 153 Histone acetyltransferase HPA2 and related 
acetyltransferases 
79 2713 30.94 35 1939 45.05 
2306 333 Glycerol-3-phosphate dehydrogenase 
[NAD(P)+] (EC 1.1.1.94) 
122 4114 41.92 54 3106 44.04 
2307 369 D-alanine--D-alanine ligase (EC 6.3.2.4) 60 1846 32.49 21 848 34.46 
2310 322 Thiamine-monophosphate kinase (EC 2.7.4.16) 94 2987 36.54 38 2055 35.14 
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2312 226 Uracil-DNA glycosylase, family 1 59 1769 42.53 26 1086 45.74 
2319 176 Ribosomal RNA small subunit methyltransferase 
D (EC 2.1.1.-) 
100 3189 38.1 42 2443 42.5 
2320 153 Phosphopantetheine adenylyltransferase (EC 
2.7.7.3) 
73 2490 39.74 49 2765 40.14 
2324 232 Ribonuclease III (EC 3.1.26.3) 59 1748 40.47 43 2481 38.16 
2327 567 Potassium-transporting ATPase A chain (EC 
3.6.3.12) (TC 3.A.3.7.1) 
122 4122 47.16 20 823 48.29 
2328 699 Potassium-transporting ATPase B chain (EC 
3.6.3.12) (TC 3.A.3.7.1) 
122 4123 61.07 20 822 61.57 
2329 217 Potassium-transporting ATPase C chain (EC 
3.6.3.12) (TC 3.A.3.7.1) 
122 4124 36.65 20 821 37.5 
2331 227 DNA-binding response regulator KdpE 122 4126 50.23 20 820 42.86 
2332 477 Amino-acid carrier protein AlsT 94 2962 42.83 34 1831 34.21 
2338 1201 Chromosome partition protein smc 116 4006 45.73 26 1154 41.38 
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2340 498 Signal recognition particle receptor protein FtsY 
(=alpha subunit) (TC 3.A.5.1.1) 
73 2476 46.43 62 3634 46.74 
2342 113 Nitrogen regulatory protein P-II 77 2603 59.82 6 59 63.39 
2343 846 [Protein-PII] uridylyltransferase (EC 2.7.7.59) 59 1650 26.49 56 3229 27.04 
2344 527 Signal recognition particle, subunit Ffh SRP54 
(TC 3.A.5.1.1) 
59 1719 47.36 28 1255 48.53 
2348 294 Inner membrane protein translocase component 
YidC, long form 
81 2783 36.78 39 2119 38.37 
2350 312 Aldo-keto reductase 144 4798 31.08 51 2902 42.05 
2356 263 probable ABC drug resistance transporter, 
permease component 
12 442 27.52 51 2890 30.17 
2361 157 Thiol peroxidase, Bcp-type (EC 1.11.1.15) 111 3696 40.3 21 872 37.86 
2367 535 ATPase component BioM of energizing module 
of biotin ECF transporter 
60 1812 43.94 57 3328 48.64 
2368 373 Alcohol dehydrogenase (EC 1.1.1.1) 59 1623 37.37 33 1678 37.87 
P a g e  | 329 
Gene Length Function Contig Gene percent 
identity 
(%) 
Contig Gene percent 
identity (%) 
R. equi 
ATCC13557  
 
P. putida SJTE-1 Sphingomonas sp. KC8 
2383 449 NADP-specific glutamate dehydrogenase (EC 
1.4.1.4) 
99 3133 56.5 51 2790 30.08 
2387 375 Xanthine and CO dehydrogenases maturation 
factor, XdhC/CoxF family 
128 4294 47.25 39 2267 35.26 
2400 558 ABC transporter ATP-binding protein 99 3132 56.43 59 3453 55.95 
2402 1622 NAD-specific glutamate dehydrogenase (EC 
1.4.1.2), large form 
31 978 41.58 30 1334 38.86 
2421 862 Membrane alanine aminopeptidase N (EC 
3.4.11.2) 
33 1042 28.14 45 2586 28.83 
2430 457 Cell division trigger factor (EC 5.2.1.8) 29 784 30.52 62 3630 31.18 
2433 426 ATP-dependent Clp protease ATP-binding 
subunit ClpX 
29 782 63.29 62 3626 62.06 
2437 275 Formate dehydrogenase chain D (EC 1.2.1.2) 53 1585 29.64 13 409 34.43 
2450 688 Phosphate acetyltransferase (EC 2.3.1.8) 101 3228 37.62 54 3136 31.83 
P a g e  | 330 
Gene Length Function Contig Gene percent 
identity 
(%) 
Contig Gene percent 
identity (%) 
R. equi 
ATCC13557  
 
P. putida SJTE-1 Sphingomonas sp. KC8 
2460 408 O-acetylhomoserine sulfhydrylase (EC 2.5.1.49)  
/ O-succinylhomoserine sulfhydrylase (EC 
2.5.1.48) 
33 1076 44.94 8 247 50.13 
2467 405 Phosphoribosylglycinamide formyltransferase 2 
(EC 2.1.2.-) 
59 1723 65.38 56 3284 55.74 
2476 422 transcriptional regulator, LuxR family 51 1500 42.19 29 1325 45.76 
2491 430 Adenylosuccinate synthetase (EC 6.3.4.4) 65 2223 54.01 26 1141 43.93 
2500 309 Cobalt-zinc-cadmium resistance protein CzcD 23 711 39.12 21 906 31.87 
2505 239 DedA protein 94 3012 38.3 26 1172 25.95 
2529 140 Ribosome-associated heat shock protein 
implicated  
in the recycling of the 50S subunit (S4 paralog) 
53 1578 33.08 56 3241 34.48 
2534 851 ClpB protein 97 3102 57.49 30 1414 57.02 
2541 526 O-succinylbenzoic acid--CoA ligase (EC 
6.2.1.26) 
114 3771 36.94 24 925 40.4 
2556 263 Short chain oxidoreductase 14 522 34.72 47 2667 38.7 
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2564 299 Luciferase-like monooxygenase superfamily 11 336 32.61 38 2041 41.61 
2572 190 Heat shock protein GrpE 60 2054 32.35 26 980 29.59 
2573 614 Chaperone protein DnaK 60 2053 55.97 26 1181 59.97 
2587 495 Uncharacterized iron-regulated membrane 
protein; Iron-uptake factor PiuB 
63 2176 28.78 30 1585 27.35 
2598 368 Peptide chain release factor 2 59 1687 48.31 57 3348 44.41 
2603 158 tmRNA-binding protein SmpB 60 2059 46.81 39 2193 48.61 
2607 334 Proline iminopeptidase (EC 3.4.11.5) 69 2363 44.86 39 2158 36.49 
2612 538 Phosphoglucomutase (EC 5.4.2.2) 139 4596 61.51 62 3682 28.86 
2621 358 Putative metal chaperone, involved in Zn 
homeostasis,  
GTPase of COG0523 family 
60 1960 29.55 30 1435 29.21 
2622 210 Cobalamin biosynthesis protein BluB @ 5,6-
dimethylbenzimidazole 
 synthase, flavin destructase family 
50 1462 41.21 30 1495 36.32 
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2624 138 Molybdenum cofactor biosynthesis protein 
MoaE 
60 1891 33.83 51 2918 34.35 
2625 337 Molybdenum cofactor biosynthesis protein 
MoaC /  
Molybdenum cofactor biosynthesis protein 
MoaB 
60 1893 51.97 39 2169 51.33 
2627 350 Molybdenum cofactor biosynthesis protein 
MoaA 
34 1109 35.74 56 3214 38.8 
2630 269 NAD synthetase (EC 6.3.1.5) 63 2207 51.75 54 3060 27.38 
2639 215 (2Fe-2S)-binding domain protein 116 4004 47.48 66 3903 41.22 
2648 188 NADPH:quinone oxidoreductase 122 4142 50.44 8 296 40.87 
2652 729 Ribonucleotide reductase of class Ib (aerobic), 
alpha subunit (EC 1.17.4.1) 
110 3638 28.04 20 806 26.32 
2653 336 Ribonucleotide reductase of class Ib (aerobic), 
beta subunit (EC 1.17.4.1) 
110 3636 22.38 20 804 24.12 
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2659 550 Cytochrome c oxidase polypeptide I (EC 
1.9.3.1) 
45 1277 47.35 30 1392 46.01 
2660 390 Phosphoserine phosphatase (EC 3.1.3.3) 65 2243 40.1 20 833 42.4 
2674 267 Electron transfer flavoprotein, beta subunit 121 4064 31.43 54 3049 31.17 
2675 319 Electron transfer flavoprotein, alpha subunit 121 4065 43.71 54 3048 43.69 
2678 250 1-acyl-sn-glycerol-3-phosphate acyltransferase 
(EC 2.3.1.51) 
108 3388 31.47 59 3418 33.56 
2680 373 tRNA-specific 2-thiouridylase MnmA 125 4235 35.26 66 3765 42.02 
2682 704 DNA ligase (EC 6.5.1.2) 116 4008 39.57 39 2100 40.81 
2686 100 Aspartyl-tRNA(Asn) amidotransferase subunit C 
(EC 6.3.5.6) 
 @ Glutamyl-tRNA(Gln) amidotransferase 
subunit C (EC 6.3.5.7) 
108 3398 31.18 39 2128 35.63 
2687 495 Aspartyl-tRNA(Asn) amidotransferase subunit A 
(EC 6.3.5.6) 
108 3397 48.85 39 2129 49.09 
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 @ Glutamyl-tRNA(Gln) amidotransferase 
subunit A (EC 6.3.5.7) 
2692 223 Putative two-component system response 
regulator 
90 2874 33.33 34 1771 38.1 
2694 505 Aspartyl-tRNA(Asn) amidotransferase subunit B 
(EC 6.3.5.6)  
@ Glutamyl-tRNA(Gln) amidotransferase 
subunit B (EC 6.3.5.7) 
108 3396 41.72 39 2130 39.52 
2701 650 Acetolactate synthase large subunit (EC 2.2.1.6) 60 2003 45.24 20 835 46.09 
2702 168 Acetolactate synthase small subunit (EC 
2.2.1.6) 
60 2002 42.04 20 836 38.36 
2703 338 Ketol-acid reductoisomerase (EC 1.1.1.86) 60 2001 56.88 20 837 59.39 
2704 531 D-3-phosphoglycerate dehydrogenase (EC 
1.1.1.95) 
51 1486 37.45 26 1143 39.88 
2705 338 3-isopropylmalate dehydrogenase (EC 1.1.1.85) 33 1088 38.95 8 245 40.56 
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2712 478 3-isopropylmalate dehydratase large subunit 
(EC 4.2.1.33) 
33 1091 60.09 26 1068 58.95 
2713 204 3-isopropylmalate dehydratase small subunit 
(EC 4.2.1.33) 
33 1090 47.12 26 1070 44.04 
2714 243 DNA-binding protein HU / low-complexity, AKP-
rich domain 
16 562 40.23 62 3622 43.1 
2716 740 Polyphosphate kinase (EC 2.7.4.1) 77 2587 41.02 39 2183 45.05 
2719 229 Dihydrolipoamide acyltransferase component of  
branched-chain alpha-keto acid dehydrogenase 
complex (EC 2.3.1.168) 
121 4080 43.28 26 1003 45.56 
2721 507 Cytosol aminopeptidase PepA (EC 3.4.11.1) 109 3445 38.24 51 2834 43.52 
2722 372 Aminomethyltransferase (glycine cleavage 
system T protein) (EC 2.1.2.10) 
77 2562 40.06 59 3405 36.93 
2723 368 Branched-chain amino acid aminotransferase 
(EC 2.6.1.42) 
140 4669 38.53 62 3611 55.65 
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2725 370 Nicotinate-nucleotide--dimethylbenzimidazole  
phosphoribosyltransferase (EC 2.4.2.21) 
50 1457 40.53 26 1012 42.51 
2729 117 probable iron binding protein from the 
HesB_IscA_SufA family 
90 2896 41.38 21 876 40.74 
2732 333 Cytochrome c oxidase polypeptide II (EC 
1.9.3.1) 
45 1276 26.42 30 1393 26.07 
2735 551 Ubiquinol--cytochrome c reductase, cytochrome 
B subunit (EC 1.10.2.2) 
60 1866 27.19 8 210 25 
2738 181 Cytochrome c oxidase polypeptide III (EC 
1.9.3.1) 
45 1279 35.42 30 1388 36.46 
2740 352 Anthranilate phosphoribosyltransferase (EC 
2.4.2.18) 
90 2884 38.37 39 2171 40.88 
2758 463 2-keto-3-deoxy-D-arabino-heptulosonate-7- 
phosphate synthase II (EC 2.5.1.54) 
35 1170 52.5 29 1314 51.95 
2764 345 Geranylgeranyl pyrophosphate synthetase (EC 
2.5.1.29) 
94 2996 35 49 2764 32.35 
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2765 327 5,10-methylenetetrahydrofolate reductase (EC 
1.5.1.20) 
68 2309 35.42 26 1111 36.39 
2775 335 rRNA small subunit methyltransferase H 60 1856 42.55 38 2084 37.8 
2777 588 Cell division protein FtsI [Peptidoglycan 
synthetase] (EC 2.4.1.129) 
60 1854 31.53 38 2086 27.61 
2778 548 UDP-N-acetylmuramoylalanyl-D-glutamate- 
-2,6-diaminopimelate ligase (EC 6.3.2.13) 
60 1853 37.58 38 2087 42.23 
2779 507 UDP-N-acetylmuramoylalanyl-D-glutamyl- 
2,6-diaminopimelate--D-alanyl-D-alanine ligase 
(EC 6.3.2.10) 
60 1852 36 38 2088 35.76 
2780 365 Phospho-N-acetylmuramoyl-pentapeptide-
transferase (EC 2.7.8.13) 
60 1851 36.54 38 2089 38.1 
2781 504 UDP-N-acetylmuramoylalanine--D-glutamate 
ligase (EC 6.3.2.9) 
60 1850 34.55 38 2090 34.64 
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2783 382 UDP-N-acetylglucosamine--N-acetylmuramyl- 
(pentapeptide) pyrophosphoryl-undecaprenol N-
acetylglucosamine transferase (EC 2.4.1.227) 
60 1848 32.81 38 2092 30.89 
2784 499 UDP-N-acetylmuramate--alanine ligase (EC 
6.3.2.8) 
60 1847 36.46 38 2093 37.93 
2786 410 Cell division protein FtsZ (EC 3.4.24.-) 60 1843 50 21 851 52.26 
2787 242 COG1496: Uncharacterized conserved protein 97 3100 38.56 20 797 41.61 
2788 207 Hypothetical protein YggS, proline synthase co-
transcribed bacterial homolog PROSC 
73 2459 39.71 66 3870 35.82 
2800 303 Ribosomal large subunit pseudouridine 
synthase D (EC 4.2.1.70) 
97 3099 37.01 62 3661 40.39 
2804 311 RarD protein 86 2821 36.59 26 991 39.54 
2811 451 Threonine dehydratase (EC 4.3.1.19) 142 4726 38.69 39 2162 35.28 
2840 189 Carbonic anhydrase (EC 4.2.1.1) 45 1272 45.26 25 944 35.58 
2849 552 Exoenzymes regulatory protein AepA precursor 78 2620 28.01 39 2246 34.59 
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2850 538 Dipeptide-binding ABC transporter,  
periplasmic substrate-binding component (TC 
3.A.1.5.2) 
128 4284 26.23 39 2142 29.63 
2859 454 Glutamine synthetase type I (EC 6.3.1.2) 114 3774 31.34 66 3827 31.06 
2882 236 Transcriptional regulator, GntR family 108 3436 38.1 42 2431 43.4 
2917 269 Monoglyceride lipase (EC 3.1.1.23) 76 2529 31.25 49 2735 35.78 
2919 115 PhnB protein 114 3766 33.05 51 2854 34.15 
2935 344 Transcription termination protein NusA 60 2038 36.31 30 1483 42.65 
2936 182 FIG000325: clustered with transcription 
termination protein NusA 
60 2039 35.71 30 1484 34.44 
2940 204 transcriptional regulator, TetR family 116 3988 43.28 38 1985 41.18 
2942 529 NADH-ubiquinone oxidoreductase chain N (EC 
1.6.5.3) 
122 4149 38.98 18 586 40.17 
2943 527 NADH-ubiquinone oxidoreductase chain M (EC 
1.6.5.3) 
122 4150 36.51 18 585 37.12 
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2944 644 NADH-ubiquinone oxidoreductase chain L (EC 
1.6.5.3) 
122 4151 43.39 18 584 41.18 
2945 100 NADH-ubiquinone oxidoreductase chain K (EC 
1.6.5.3) 
122 4152 36.84 18 583 44.79 
2946 277 NADH-ubiquinone oxidoreductase chain J (EC 
1.6.5.3) 
122 4153 32.89 18 582 30.94 
2947 182 NADH-ubiquinone oxidoreductase chain I (EC 
1.6.5.3) 
122 4154 43.94 18 581 37.5 
2948 435 NADH-ubiquinone oxidoreductase chain H (EC 
1.6.5.3) 
122 4155 37.42 18 580 45.99 
2950 689 NADH-ubiquinone oxidoreductase chain F (EC 
1.6.5.3) 
122 4157 46.5 18 578 50.63 
2952 252 NADH-ubiquinone oxidoreductase chain C (EC 
1.6.5.3) 
122 4159 43.37 18 574 37.66 
2953 191 NADH-ubiquinone oxidoreductase chain B (EC 
1.6.5.3) 
122 4160 50 18 573 56.64 
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2954 123 NADH ubiquinone oxidoreductase chain A (EC 
1.6.5.3) 
122 4161 36.45 18 572 36.59 
2965 582 Prolyl-tRNA synthetase (EC 6.1.1.15), bacterial 
type 
110 3663 43.24 43 2484 41.87 
2969 494 Multidrug efflux pump P55 7 144 32.65 7 128 35.38 
2970 409 Siroheme synthase /  
Precorrin-2 oxidase (EC 1.3.1.76)  
/ Sirohydrochlorin ferrochelatase (EC 4.99.1.4) / 
 Uroporphyrinogen-III methyltransferase (EC 
2.1.1.107) 
30 965 40.17 39 2220 40.66 
2973 197 Cob(I)alamin adenosyltransferase (EC 2.5.1.17) 50 1464 39.01 30 1437 40.93 
2988 511 Cobyric acid synthase (EC 6.3.5.10) 50 1459 45.57 38 1974 45.75 
2989 286 Methionine aminopeptidase (EC 3.4.11.18) 59 1649 50.2 6 61 48.75 
3001 263 2-aminoethylphosphonate ABC transporter 
permease protein II (TC 3.A.1.9.1) 
74 2502 34.93 14 518 36.69 
3007 620 Flp pilus assembly protein TadB 33 1030 27.18 30 1457 29.28 
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3008 457 Type II/IV secretion system ATP hydrolase  
TadA/VirB11/CpaF, TadA subfamily 
141 4694 40.16 39 2285 49.61 
3016 388 1-hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate 
synthase (EC 1.17.7.1) 
106 3318 50.44 35 1937 48.26 
3017 411 Membrane-associated zinc metalloprotease 59 1641 28.07 8 196 27.69 
3018 386 1-deoxy-D-xylulose 5-phosphate 
reductoisomerase (EC 1.1.1.267) 
59 1642 43.83 8 197 46.72 
3020 355 Ribosomal RNA large subunit methyltransferase 
N (EC 2.1.1.-) 
106 3315 38.07 54 3021 39.7 
3026 287 Phosphatidate cytidylyltransferase (EC 2.7.7.41) 59 1643 42.61 8 198 38.94 
3027 186 Ribosome recycling factor 59 1645 43.78 8 200 42.53 
3028 243 Uridine monophosphate kinase (EC 2.7.4.22) 59 1646 47.66 8 201 52.12 
3029 275 Translation elongation factor Ts 59 1647 35.13 8 202 39.6 
3030 277 SSU ribosomal protein S2p (SAe) 59 1648 50 8 203 53.39 
3037 374 Rossmann fold nucleotide-binding protein  
Smf possibly involved in DNA uptake 
42 1230 36.27 34 1825 37.26 
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3038 503 MG(2+) CHELATASE FAMILY PROTEIN / 
ComM-related protein 
78 2607 46.05 39 2123 41.68 
3042 213 Ribonuclease HII (EC 3.1.26.4) 59 1634 46.63 34 1834 49.73 
3043 258 Signal peptidase I (EC 3.4.21.89) 59 1749 29.06 30 1399 28.35 
3044 114 LSU ribosomal protein L19p 59 1715 58.49 28 1251 55.08 
3046 325 Sulfatase modifying factor 1 precursor 
 (C-alpha-formyglycine- generating enzyme 1) 
121 4093 30.99 38 1984 57.42 
3047 813 Transcription accessory protein (S1 RNA-
binding domain) 
53 1572 62.79 30 1475 44.05 
3050 233 tRNA (Guanine37-N1) -methyltransferase (EC 
2.1.1.31) 
59 1716 44.4 28 1252 43.17 
3051 189 16S rRNA processing protein RimM 59 1717 26.88 28 1253 25.32 
3053 149 SSU ribosomal protein S16p 59 1718 40 28 1254 44.44 
3068 407 L-lactate dehydrogenase (EC 1.1.2.3) 60 2062 38.86 39 2245 50 
3083 107 4Fe-4S ferredoxin, iron-sulfur binding 59 1615 52.73 56 3242 49.38 
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3085 261 Ribulose-5-phosphate 4-epimerase and related 
epimerases and aldolases 
33 1022 35.75 30 1404 32.46 
3094 435 Vanillate O-demethylase oxygenase subunit 
(EC 1.14.13.82) 
134 4425 30.18 47 2651 32.2 
3125 389 FIG01001855: hypothetical protein 11 346 24.47 49 2736 41.37 
3131 272 FIG003003: hypothetical protein 147 4894 50.7 56 3265 46.82 
3150 314 LysR-family transcriptional regulator 8 218 36.55 25 940 44.68 
3153 185 Ribonuclease HI (EC 3.1.26.4) 122 4138 36.36 59 3400 37.14 
3156 348 2,3-butanediol dehydrogenase, R-alcohol 
 forming, (R)- and (S)-acetoin-specific (EC 
1.1.1.4) 
97 3027 40.45 19 719 37.5 
3159 254 3-oxoacyl-[acyl-carrier protein] reductase (EC 
1.1.1.100) 
79 2739 40.56 20 791 44.49 
3162 479 Aldehyde dehydrogenase (EC 1.2.1.3);  
Probable coniferyl aldehyde dehydrogenase 
(EC 1.2.1.68) 
73 2486 44.18 33 1675 36.53 
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3180 426 Tyrosyl-tRNA synthetase (EC 6.1.1.1) 90 2899 29.64 26 1029 42.68 
3186 475 Argininosuccinate lyase (EC 4.3.2.1) 53 1516 43.08 66 3771 44.81 
3187 400 Argininosuccinate synthase (EC 6.3.4.5) 110 3556 41.52 54 3081 43.19 
3189 313 Ornithine carbamoyltransferase (EC 2.1.3.3) 109 3546 45.54 8 223 54.38 
3190 407 Acetylornithine aminotransferase (EC 2.6.1.11) 115 3848 46.45 8 224 42.37 
3191 308 Acetylglutamate kinase (EC 2.7.2.8) 79 2657 46.05 35 1950 45.49 
3192 413 Glutamate N-acetyltransferase (EC 2.3.1.35)  
/ N-acetylglutamate synthase (EC 2.3.1.1) 
60 1839 38.96 61 3563 37.75 
3193 342 N-acetyl-gamma-glutamyl-phosphate reductase 
(EC 1.2.1.38) 
90 2895 41.79 11 341 32.86 
3196 830 Phenylalanyl-tRNA synthetase beta chain (EC 
6.1.1.20) 
16 563 33.22 27 1195 33.92 
3197 357 Phenylalanyl-tRNA synthetase alpha chain (EC 
6.1.1.20) 
16 564 46.47 27 1196 43.84 
3198 267 FIG011178: rRNA methylase 65 2216 28.57 51 2813 34.03 
3199 130 LSU ribosomal protein L20p 16 565 56.41 27 1198 48.31 
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3200 65 LSU ribosomal protein L35p 16 566 35.94 27 1199 44.07 
3201 174 Translation initiation factor 3 16 567 52.52 54 3140 51.8 
3205 991 Excinuclease ABC subunit A 90 2946 57.2 40 2344 57.45 
3215 711 Excinuclease ABC subunit B 34 1103 55.89 54 3044 55.1 
3217 420 Dephospho-CoA kinase (EC 2.7.1.24) 97 3109 35.82 66 3846 27.32 
3227 913 DNA polymerase I (EC 2.7.7.7) 45 1297 38.43 54 3168 34.61 
3236 445 Pyruvate kinase (EC 2.7.1.40) 116 3980 41.53 27 1215 42.53 
3237 493 Glutamate synthase [NADPH] small chain (EC 
1.4.1.13) 
73 2440 36.62 56 3288 39.87 
3238 1546 Glutamate synthase [NADPH] large chain (EC 
1.4.1.13) 
73 2441 42.28 56 3286 43.5 
3240 315 Prolipoprotein diacylglyceryl transferase (EC 
2.4.99.-) 
75 2510 24.89 20 795 24.73 
3241 268 Tryptophan synthase alpha chain (EC 4.2.1.20) 45 1254 39.33 42 2385 35.82 
3242 388 Tryptophan synthase beta chain (EC 4.2.1.20) 45 1255 61.1 42 2386 62.63 
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3243 270 Indole-3-glycerol phosphate synthase (EC 
4.1.1.48) 
90 2885 41.73 39 2170 43.68 
3245 534 Anthranilate synthase, aminase component (EC 
4.1.3.27) 
90 2881 44.62 39 2174 42.08 
3246 327 FIG074102: hypothetical protein 35 1167 43.83 66 3905 39.83 
3262 269 UDP-glucose dehydrogenase (EC 1.1.1.22) 8 211 39.15 66 3793 43.81 
3271 245 3-oxoacyl-[acyl-carrier protein] reductase (EC 
1.1.1.100) 
127 4269 38.07 44 2556 36.03 
3279 291 Aldo-keto reductase 66 2262 30.9 38 2028 30.46 
3282 293 N-formylglutamate deformylase (EC 3.5.1.68) 60 1943 40 30 1514 37.29 
3304 418 tRNA-guanine transglycosylase (EC 2.4.2.29) 105 3297 38.44 8 305 40.93 
3313 388 Glutaryl-CoA dehydrogenase (EC 1.3.99.7) 45 1335 46.48 38 2038 46.61 
3319 153 Predicted transcriptional regulator of 
 sulfate adenylyltransferase, Rrf2 family 
106 3306 30.51 28 1272 31.82 
3320 321 C-5 sterol desaturase (EC 1.3.-.-) 77 2588 37.67 54 3101 39.07 
3323 444 putative integral membrane efflux protein 78 2619 32.21 34 1902 32.09 
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3331 344 Ribonuclease BN (EC 3.1.-.-) 114 3761 37 45 2593 26.98 
3343 145 tRNA-specific adenosine-34 deaminase (EC 
3.5.4.-) 
109 3502 50.78 38 2068 48.06 
3345 317 Arogenate dehydrogenase (EC 1.3.1.43) 46 1363 38.72 54 3038 31.97 
3361 142 putative phenylacetic acid degradation protein 53 1571 33.33 26 974 32.33 
3369 701 Periplasmic aromatic aldehyde oxidoreductase 
, molybdenum binding subunit YagR 
145 4834 39.62 20 793 33.33 
3392 1162 helicase (Snf2/Rad54 family) 110 3606 31.46 13 477 37.58 
3399 420 Quinone oxidoreductase (EC 1.6.5.5) 49 1417 44.62 39 2299 46.99 
3409 315 Glycosyltransferase 23 718 34.2 54 3068 40.85 
3411 332 dTDP-glucose 4,6-dehydratase (EC 4.2.1.46) 108 3383 30.16 54 2984 47.06 
3412 439 Permeases of the major facilitator superfamily 17 629 41.1 38 2026 38.11 
3414 194 dTDP-4-dehydrorhamnose 3,5-epimerase (EC 
5.1.3.13) 
57 1600 35.87 54 2983 36.31 
3418 180 Superoxide dismutase [Mn] (EC 1.15.1.1) 108 3412 44.63 62 3637 38.15 
3419 860 Valyl-tRNA synthetase (EC 6.1.1.9) 108 3442 42.15 8 172 44.84 
P a g e  | 349 
Gene Length Function Contig Gene percent 
identity 
(%) 
Contig Gene percent 
identity (%) 
R. equi 
ATCC13557  
 
P. putida SJTE-1 Sphingomonas sp. KC8 
3420 477 Dihydrofolate synthase (EC 6.3.2.12)  
@ Folylpolyglutamate synthase (EC 6.3.2.17) 
33 1080 29.87 42 2383 33.96 
3422 140 Nucleoside diphosphate kinase (EC 2.7.4.6) 106 3314 48.09 51 2836 43.18 
3425 104 LSU ribosomal protein L21p 99 3147 45.1 26 1066 47 
3426 66 LSU ribosomal protein L27p 99 3148 50.85 26 1065 59.57 
3427 487 GTP-binding protein Obg 99 3149 44.19 26 1061 42.12 
3428 367 Glutamate 5-kinase (EC 2.7.2.11) 99 3150 43.9 26 1060 41.33 
3430 155 Glyoxalase family protein 142 4728 42.67 38 2077 46.31 
3438 462 D-serine/D-alanine/glycine transporter 109 3526 46.68 30 1538 38.32 
3439 428 Gamma-glutamyl phosphate reductase (EC 
1.2.1.41) 
62 2148 49.14 8 177 49.51 
3442 247 Nicotinate-nucleotide adenylyltransferase (EC 
2.7.7.18) 
62 2147 34.29 8 178 27.46 
3443 139 Ribosomal silencing factor RsfA (former Iojap) 62 2146 33.66 8 179 31.11 
3451 257 Aquaporin Z 116 4000 43.4 42 2440 43.28 
3454 621 Translation elongation factor LepA 59 1750 53.31 57 3320 53.05 
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3455 311 FIG00994303: hypothetical protein 132 4349 35.23 54 3152 37.8 
3462 295 Sulfate transport system permease protein CysT 76 2538 45.31 34 1807 44.4 
3463 269 Sulfate transport system permease protein 
CysW 
76 2537 45.68 34 1808 45.54 
3464 316 Sulfate and thiosulfate import ATP-binding 
protein CysA (EC 3.6.3.25) 
76 2536 54.09 34 1809 60.7 
3472 248 Phosphoadenylyl-sulfate reductase [thioredoxin] 
(EC 1.8.4.8) 
 / Adenylyl-sulfate reductase [thioredoxin] (EC 
1.8.4.10) 
28 756 35.78 39 2216 35.9 
3473 570 Ferredoxin--sulfite reductase, actinobacterial 
type (EC 1.8.7.1) 
17 671 27.96 39 2218 26.87 
3474 396 Hypothetical radical SAM family enzyme in  
heat shock gene cluster, similarity with CPO of 
BS HemN-type 
73 2466 34.87 26 1177 34.38 
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3478 254 Ribosomal RNA small subunit methyltransferase 
E (EC 2.1.1.-) 
68 2319 32.37 27 1189 29.78 
3482 334 Phosphate starvation-inducible protein PhoH, 
predicted ATPase 
62 2125 56.11 59 3415 47.1 
3483 181 Metal-dependent hydrolase YbeY,  
involved in rRNA and/or ribosome maturation 
and assembly 
62 2126 38.94 59 3414 29.73 
3485 306 GTP-binding protein Era 81 2782 46.43 66 3858 49.12 
3490 268 Undecaprenyl diphosphate synthase (EC 
2.5.1.31) 
59 1644 40.25 8 199 46.09 
3497 149 Zinc uptake regulation protein ZUR 45 1293 32.22 59 3420 30.89 
3502 430 Deoxyguanosinetriphosphate 
triphosphohydrolase (EC 3.1.5.1) 
30 953 36.29 21 854 47.26 
3503 644 DNA primase (EC 2.7.7.-) 90 2852 35.6 62 3598 36.34 
3513 389 3-oxoacyl-[acyl-carrier-protein] synthase, KASII 
(EC 2.3.1.179) 
34 1116 41.28 42 2405 44.44 
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3514 104 Acyl carrier protein 34 1117 40.28 42 2404 40.3 
3515 291 Malonyl CoA-acyl carrier protein transacylase 
(EC 2.3.1.39) 
34 1119 31.84 42 2402 30.94 
3527 329 Adenosylcobinamide-phosphate synthase (EC 
6.3.1.10) 
50 1461 42.11 38 1975 39.51 
3529 323 Cytochrome oxidase biogenesis protein Surf1, 
facilitates heme A insertion 
45 1281 22.89 38 2005 26.61 
3530 136 Low molecular weight protein tyrosine 
phosphatase (EC 3.1.3.48) 
34 1130 39.85 26 1163 36.89 
3545 435 Adenosylmethionine-8-amino-7- 
oxononanoate aminotransferase (EC 2.6.1.62) 
68 2318 36.41 56 3238 38 
3546 389 8-amino-7-oxononanoate synthase (EC 
2.3.1.47) 
86 2826 37.82 56 3235 38.95 
3547 232 Dethiobiotin synthetase (EC 6.3.3.3) 86 2829 36.36 56 3237 34.88 
3549 530 Alkyl hydroperoxide reductase protein F (EC 
1.6.4.-) 
16 597 77.3 62 3620 36.13 
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3550 188 Alkyl hydroperoxide reductase protein C (EC 
1.6.4.-) 
16 599 54.35 42 2449 36.14 
3564 367 Biotin synthase (EC 2.8.1.6) 86 2825 33.33 54 2998 36.92 
3572 344 Quinolinate synthetase (EC 2.5.1.72) 110 3691 34.45 39 2137 39.88 
3573 526 L-aspartate oxidase (EC 1.4.3.16) 59 1756 39.93 54 3167 42.17 
3574 287 Quinolinate phosphoribosyltransferase 
[decarboxylating] (EC 2.4.2.19) 
103 3238 41.22 39 2138 44.4 
3580 372 glycosyl transferase, group 1 family protein 60 1814 33.59 11 374 35.14 
3592 414 Histidinol dehydrogenase (EC 1.1.1.23) 108 3433 38.59 38 2058 42.79 
3594 205 Imidazoleglycerol-phosphate dehydratase (EC 
4.2.1.19) 
72 2424 42.03 54 3031 51.98 
3597 212 Imidazole glycerol phosphate synthase 
amidotransferase subunit (EC 2.4.2.-) 
72 2425 39.72 54 3032 39.63 
3599 245 Phosphoribosylformimino-5-aminoimidazole  
carboxamide ribotide isomerase (EC 5.3.1.16)  
72 2427 34.44 54 3033 39.26 
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/ Acting phosphoribosylanthranilate isomerase 
(EC 5.3.1.24) 
3601 258 Imidazole glycerol phosphate synthase cyclase 
subunit (EC 4.1.3.-) 
72 2428 61.39 54 3034 62.14 
3602 116 Phosphoribosyl-AMP cyclohydrolase (EC 
3.5.4.19) 
68 2349 53.12 26 1077 51.06 
3604 188 Transcriptional regulator, TetR family 30 883 48.17 14 515 51.11 
3608 399 Beta-lactamase class C and other penicillin 
binding proteins 
110 3591 43.08 26 1067 26.01 
3616 346 Aliphatic amidase AmiE (EC 3.5.1.4) 137 4543 80.47 34 1810 27.44 
3621 486 Methylated-DNA--protein-cysteine 
methyltransferase (EC 2.1.1.63) 
99 3166 36.87 39 2294 39.24 
3638 299 Dehydrogenases with different specificities  
(related to short-chain alcohol dehydrogenases) 
11 378 53.15 44 2539 40.94 
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3709 324 Transcriptional regulator containing an 
 amidase domain and an AraC-type DNA-
binding HTH domain 
29 820 39.37 54 3077 34.88 
 
 
 
 
 
 
 
 
 
 
 
  
